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Zusammenfassung  
Diese Doktorarbeit beschreibt unsere Studien zu den Totalsynthesen des marinen Diterpenoids 
Waixenicin A (Teil I) und des Alkaloids Jerantinin E (Teil II). 
 
Teil I: Waixenicin A ist ein Xenia Diterpenoid, das aus der hawaiianischen Oktokoralle Anthelia 
edmondsoni isoliert wurde. Dieser Sekundärmetabolit ist ein selektiver und wirkungsvoller TRPM7 
Ionenkanalblocker und somit ein potentielles Krebsmedikament. Waixenicin A hat darüber hinaus 
ein sehr interessantes Molekülgerüst mit einer 6,9-bizyklischen Grundstruktur, die sich wiederum 
aus einem Dihydropyran mit drei aufeinander folgenden stereogenen Zentren und einem 
(E)-konfigurierten Cyclononen-Fragment zusammensetzt. Waixenicin A gehört zur Xenicin 
Unterfamilie der Xenia Diterpenoide und konnte trotz seiner bemerkenswerten biologischen 
Wirkung und faszinierenden Molekülstruktur bisher noch nicht totalsynthetisch hergestellt werden. 
 
Der erste Teil dieser Doktorarbeit beschreibt die erfolgreiche Entwicklung einer praktischen und 
enantioselektiven Syntheseroute für die bizyklische Kernstruktur von Waixenicin A. Die 
erarbeitete Route begann mit der Verknüpfung der zwei Bausteine I und II mittels einer 
dreistufigen Synthesesequenz (Michael-Addition, Mukaiyama-Aldoladdition, Formaldehyd-
abspaltung). Die Einführung der Stereozentren in Position C2 und C3 wurde dabei durch das 
Stereozentrum in Position C18 gesteuert. Als Nächstes wurde eine intramolekulare α-Alkylierung 
eines Phenylsulfon-Anions mit einem allylischen Bromid dazu verwendet um das 6,9-Grundgerüst 
aufzubauen, das nicht nur in Waixenicin A, sondern auch in vielen anderen Xenicinen zu finden ist. 
 
 
 
Abbildung A. Kurze und konvergente Syntheseroute für die Kernstruktur von Waixenicin A. 
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Teil II: Der zweite Teil dieser Doktorarbeit beschäftigt sich mit dem Monoterpen-Indolalkaloid 
Jerantinin E, das aus der malaysischen Pflanze Tabernaemontana corymbose isoliert wurde. Dieser 
Sekundärmetabolit gehört zur Familie der Aspidosperma Alkaloide und besitzt ein komplexes 
pentazyklisches Kohlenstoffgerüst mit einer Indolstruktur. Jerantinin E ist ein vielversprechendes 
Zytostatikum, dessen Wirkung auf Hemmung der Tubulin-Polymerisation beruht. Seit vielen 
Jahrzehnten sind Monoterpen-Indolalkaloide beliebte Zielmoleküle für Synthesechemiker. 
Aufgrund ihrer strukturellen Komplexität und ihren vielfältigen biologischen Wirkungen wurden 
bereits viele dieser Naturstoffe in der Vergangenheit synthetisch hergestellt. 
 
Unsere Synthesestrategie für Jerantinin E basierte auf der Verwendung unserer kürzlich 
entwickelten Eintopf-Methode für die selektive β-Bromierung von zyklischen Enonen. Damit sollte 
die Syntheseroute für das trizyklische Tetrahydrocarbazolon-Fragment im Vergleich zu bisherigen 
Routen verkürzt werden. In unseren Studien wurde eine skalierbare und robuste Route für die 
Synthese des funktionalisierten Tetrahydrocarbazolons IX ausgehend von Enon VI entwickelt. Die 
Indolstruktur wurde mittels Palladium-katalysierter Aminierung und anschließender Palladium-
katalysierter oxidativer Indolsynthese aufgebaut. Die weitere Funktionalisierung des 
Zwischenprodukts VIII führte dann zur Synthese von Tetrahydrocarbazolon IX, das bereits alle 
Kohlenstoffatome von Jerantinin E besitzt. 
 
 
Abbildung B. Kurze Synthese eines funktionalisierten Tetrahydrocarbazolons für die Totalsynthese von 
Jerantinin E. 
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Abstract 
This Ph.D. thesis describes progress toward the total syntheses of the marine diterpenoid waixenicin 
A (part I) and the alkaloid jerantinine E (part II). 
 
Part I: Waixenicin A is a Xenia diterpenoid isolated from the octocoral Anthelia edmondsoni, 
collected on Hawaiian shores. This secondary metabolite was found to act as a selective and potent 
TRPM7 ion channel inhibitor, which makes it a potential chemotherapeutic agent. Waixenicin A 
furthermore possesses an interesting molecular scaffold, comprising a 6,9-bicyclic framework with 
a dihydropyran ring with three contiguous stereogenic centers trans-fused to an (E)-configured 
cyclononene. Waixenicin A belongs to the xenicin subclass of the Xenia diterpenoids and despite 
its remarkable bioactivity and fascinating structure, no total synthesis has been reported to date. 
 
The first part of this thesis describes our successful efforts in developing a practical and 
enantioselective synthetic route to the bicyclic core structure of waixenicin A. The elaborated route 
commenced with the assembly of the two building blocks I and II by a three-step sequence 
(conjugate addition, Mukaiyama aldol reaction, formaldehyde extrusion). The stereocenter at C18 
thereby directed introduction of the two contiguous stereocenter at C2 and C3. Next, an 
intramolecular α-alkylation of a phenylsulfonyl anion onto an allylic bromide was devised to 
produce the 6,9-framework V of waixenicin A, which is also commonly found in several other 
xenicin members. 
 
 
Scheme A. Convergent and short synthesis of the core structure of waixenicin A. 
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Part II: The second part of this thesis focuses on with the monoterpene indole alkaloid 
jerantinine E, isolated from the Malayan plant Tabernaemontana corymbose. This secondary 
metabolite belongs to the Aspidosperma alkaloid family and comprises a complex pentacyclic 
carbon skeleton with an indole substructure. Jerantinine E was found to be a potent 
chemotherapeutic agent that acts by inhibiting tubulin polymerization. Monoterpene indole 
alkaloids have been attractive targets for synthetic chemists for several decades due to their 
structural complexity and diverse biological activities and many of these unique natural products 
have been synthesized in the past. 
 
Our synthetic efforts toward jerantinine E were based on the utilization of our recently developed 
one-pot procedure for the selective β-bromination of cyclic enones. Thereby, the synthetic route for 
the tricyclic tetrahydrocarbazolone fragment could be achieved in a more concise manner compared 
to previously reported approaches. A scalable and robust synthetic approach to functionalized 
tetrahydrocarbazolone IX was developed starting from readily prepared enone VI. The indole 
substructure of the natural product was then installed by palladium-catalyzed amination and 
subsequent palladium-catalyzed oxidative indole formation. Functionalization of intermediate VIII 
afforded tetrahydrocarbazolone IX, which already contained all carbon atoms of jerantinine E.  
 
 
Scheme B. Short synthesis of a functionalized tetrahydrocarbazolone en route to jerantinine E. 
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1 Introduction 
1.1 General Introduction 
Natural products have long been a traditional source of medicines. Isolated from terrestrial plants 
and microorganisms, natural products are usually secondary metabolites. While secondary 
metabolites are not essential for organisms, they generally serve survival functions to the organism 
including defense against other competing organisms and/or agents of symbiosis. The isolation of 
the pain reliever morphine from poppy straw1 and the discovery of the first antibiotic penicillin 
from mold2 are early examples for highly bioactive natural products that have been marketed as 
drugs. Over the last decades, pharmacologically active compounds from plants and microbes have 
played an important role for drug discovery. From the 1940s to 2006, 47% of all approved anti-
cancer agents worldwide have been “either natural products or directly derived therefrom”.3 
1.2 Marine Natural Products as a Source of New Drugs 
The isolation of the first marine natural product was reported in 1940.4 While only few compounds 
from the sea were isolated and reported in the next 30 years, Werner Bergman reported the isolation 
of unusual arabino- and ribo-pentosyl nucleosides in the 1950s from marine sponges collected in 
Florida, USA.5–7 The discovery of these compounds ultimately led to the development of two sugar 
modified nucleoside analogs, vidarabine (1) and cytarabine (2) (Figure 1).8 Vidarabine (1) (brand 
name: Vira-A®) is a diastereomer of adenosine with the D-ribose replaced with D-arabinose. It was 
later the first agent to be approved for the treatment of systematic herpes virus infection in humans. 
Cytarabine (2) (brand name: Cytosar-U®) is a diastereomer of cytidine and an anti-metabolic agent 
that is used for treatment of different forms of leukemia.  
 
Figure 1. The sugar modified nucleosides vidarabine (1) and cytarabine (2). 
The systematic exploration of the oceans only began in the mid-1970s when modern snorkeling 
and scuba diving techniques emerged. The number of reported marine natural products rapidly 
increased and by 2013, a total amount of 23,750 natural products isolated from marine organisms 
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has been reported.9 The remarkable biological activities of marine natural products led to an 
increased interest of several pharmaceutical companies. However, the sustainable harvesting of 
significant amounts of the source organism remained the major challenge. The relatively low 
natural abundance of most of the bioactive compounds and the fact that many marine organisms, 
such as corals and sponges, are largely unculturable, make the development of drugs from marine 
natural products difficult. Additionally, extensive harvesting of wild marine invertebrates would 
have a huge impact on the marine environments. In order to solve this supply problem, several 
possible solutions ranging from total synthesis or semi-synthesis to aquacultures of marine 
organisms have to be taken into consideration. Given all these difficulties, it took several decades 
before the first marine-derived natural product was approved in the United States. In 2004, 
ziconotide (brand name: Prialt®) was approved for the treatment of severe and chronic pain.10 The 
peptide is the synthetic version of an ω-conotoxin peptide, which was found in the toxic venom of 
the tropical cone snail Conus magnus. The approval of the first marine-derived anti-cancer agent, 
ecteinascidin 743 (4) (brand name: Yondelis®), was a significant milestone in 2007. The anti-tumor 
properties of this tetrahydroisoquinoline alkaloid, isolated from the Caribbean sea-squirt 
Ecteinascidia turbinata, were first reported in 1969. Unfortunately, ecteinascidin 743 (4) was one 
of the least abundant compounds (~10 ppm) of the organism and it took more than 20 years before 
the structures of the active compounds, the ecteinascidins, were finally elucidated.11,12 The first 
enantioselective total synthesis of ecteinascidin 743 (4) was achieved by E. J. Corey in 199613 and 
several other synthetic approaches have been published since then.14–16 However, owning to the 
complex structure of ecteinascidin 743 (4), total synthesis was not the key to success in preparing 
sufficient amounts for clinical trials. Nevertheless, the development of a synthetic route for the total 
synthesis of ecteinascidin 743 (4) led to the discovery of the synthetic derivative phthalascidin with 
comparable antitumor properties.17 A major breakthrough was then achieved by the company 
PharmaMar who could finally access ecteinascidin 743 (4) via large scale semi-synthesis from 
cyanosafracin B (3), an antibiotic of bacterial origin which can be prepared by fermentation of the 
bacteria Pseudomonas fluorescens (Scheme 1).18  
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Scheme 1. The gram-scale production of ecteinascidin 743 (4) from cyanosafracin B (3) by PharmaMar. 
Today, eight marine natural product derived compounds are on the market with only three of them 
being the original natural product.19 Besides ziconotide (Prialt®) and ecteinascidin 743 (Yondelis®), 
Iota-carrageenan (Carragelose®), a linear sulphated polysaccharide isolated from Rhodophyceae 
seaweeds, is marketed as an anti-viral nasal spray. The other five compounds became drugs after 
modification of the original natural products. Besides the nucleoside analog cytarabine (2, 
Cytosar-U®) and the natural product ecteinascidin 743 (4, Yondelis®), two additional marine natural 
products derivatives are on the market as anti-cancer agents. The halichondrin B analog eribulin 
mesylate (Halaven®) is an anti-cancer drug that is mainly used for the treatment of metastatic breast 
cancer. Brentuximab vedotin 63 (Adcetris®) was approved for the treatment of Hodgkin and 
systemic anaplastic large cell lymphoma and is a synthetic analog of dolastatin 10 linked to an anti-
CD30 antibody. The last example for FDA-approved marine natural product derived drugs is 
Lovaza®, a group of ethyl esters of several omega-3 fatty acids from fish oils that is used as an anti-
hypertriglyceridemia drug. Several other compounds of marine origin are currently in different 
phases of the clinical trial and an overview on these compounds is given in Table 1.20  
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Table 1. Marine natural products and derivatives in clinical development (Phase II and III).20 
Entry Compound name 
Chemical 
Class 
Source 
Disease 
area 
Status 
1 Halichondrin B (5) 
Polyether 
macrolide 
Sponge Cancer Phase III 
2 Soblidotin (6) Peptide -a Cancer Phase III 
3 Tetrodotoxin (7) Alkaloid Fish 
Cancer-associated 
pain 
Phase II/III 
4 DMXBA (8) Alkaloid -b 
Central nervous 
system 
Phase II 
5 Plitidepsin Peptide Tunicate Cancer Phase II 
6 Elisidepsin Peptide -c Cancer Phase II 
7 PM00104 Alkaloid -d Cancer Phase II 
8 Plinabulin (9) Diketopiperazine 
Marine 
fungi 
Cancer Phase II 
9 ILX-651 Peptide -e Cancer Phase II 
10 
Pseudopterosin A 
(10) 
Diterpene 
glycoside 
Coral 
Wound healing 
Inflammation 
Phase II 
 
aSynthetic derivative of dolastatin 10. bSynthetic imitative of anabaseine. cSynthetic analog of the kahalalide family. dSemi-
synthetic analog of jorumycin. eSynthetic analog of dolastatin-15. 
 
The structures of selected compounds are shown in Figure 2.  
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Figure 2. Structures of selected natural products and natural product derived compounds that are currently 
in phase II or III clinical trials. 
These examples demonstrate that the field of marine natural products remains highly interesting for 
the pharmaceutical industry. Furthermore, it was recently found that many natural products isolated 
from marine macroorganisms, such as sponges and tunicates, are synthesized by symbiotic bacteria 
that live with the larger host organisms.21 Most of these symbionts are as-yet unculturable, but these 
microorganisms can definitely be seen as a valuable source for the discovery of unknown natural 
products. 
 
1.3 Soft Corals of the Genus Xenia 
Soft corals are a rich source of highly bioactive secondary metabolites. They are filter feeding 
invertebrates that harvest plankton from the water. Most coral colonies live in symbiosis with the 
single-celled planktonic organism zooxanthellae.22 Zooxanthellae are photosynthetic organisms 
and their photosynthetic pigments are responsible for the bright colors of the soft corals. They are 
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essential for the survival of their host colonies and provide the corals with carbohydrates which are 
needed for the corals’ growth, metabolism and reproduction. As compared to hard corals, soft corals 
lack a protective calcium carbonate skeleton. Furthermore, they possess a very simple immune 
system. Their defense strategy against predators relies on the production of chemical compounds 
that renders the corals unpalatable. Additionally, chemicals are produced to inhibit the growing of 
other organisms that compete for food and light.23 Due to the high dilution of these compounds in 
the water, it is not surprising that numerous bioactive compounds have been isolated from soft 
corals. Current studies on these compounds revealed that at least some secondary metabolites 
isolated from soft corals are produced by their symbiotic partners and not by the corals 
themselves.24  
One example for soft corals that have been a rich source of bioactive natural products are the 
members of the genus Xenia (order Alcyonacea, family Xeniidae) (Figure 3).  
 
Figure 3. Images of soft corals of the genus Xenia: Xenia umbellata* (left) and Xenia sp.† 
The Xenia genus includes 28 species that live in the shallow water of tropical reefs in the Indo-
Pacific. These corals are producers of diterpenoids, the so-called Xenia diterpenoids, that exhibit a 
variety of anti-cancer and anti-microbial activities.25 
  
                                                     
* photograph by Fernando Herranz Martin, distributed under a CC-BY 2.0 license. 
† photograph by Dawson, distributed under a CC-BY 2.0 license 
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1.4 Synthesis of Xenia Diterpenoids and Related Metabolites Isolated from Marine 
Organisms 
 
 
 
Reprinted with permission from T. Huber,† L. Weisheit,† T. Magauer, Beilstein J. Org. Chem. 2015, 
11, 2521–2539. Copyright © 2015 Beilstein-Institut. († = Equal contributors.) 
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2 Project Outline 
2.1 Waixenicin A – Isolation and Bioactivity 
Waixenicin A (11) is a xenicane diterpenoid that was isolated in 1984 from the octocoral Anthelia 
edmondsoni (family Xeniidae), collected on Hawaiian shores.26 Isolation of the natural product was 
carried out by hexane extraction of the freeze-dried organism, followed by extraction with methanol 
and purification with reversed phase HPLC to give waixenicin A (11) in 0.17% yield. 
Waixenicin B (12), which differs from waixenicin A (11) by oxygenation at C9,‡ was also isolated 
from Anthelia edmondsoni and its structure has been further proven by single crystal X-ray 
analysis§ (Figure 4).26 The natural product belongs to the xenicine subfamily and contains the 
characteristic (E)-cyclononene framework found in most members of the xenicane family of natural 
products. The nine-membered ring is trans-fused to a dihydropyran ring. 
Figure 4. The two xenicins waixenicin A (11) and waixenicin B (12), and the molecular structure of 
waixenicin B (12). Hydrogen atoms are omitted for clarity and no absolute configuration is implied. 
Waixenicin A (11) was found to have an inhibitory effect on the growth and proliferation of cells. 
Its cytotoxicity originates from the strong and specific inhibition of transient receptor potential 
melastatin 7 (TRPM7) channels.27–29 TRPM7 is a protein that contains both an ion channel and an 
intrinsic kinase domain. These channels mediate the influx of divalent metal cations 
(especially Mg2+) into the cytosol and are thus involved in cellular and systemic Mg2+ 
homeostasis.30 In recent years, waixenicin A (11) has become a useful pharmacological tool to 
study the function of TRPM7 channels. The inhibitory effect of the natural product on TRPM7 was 
found to be highly dependent on the intracellular Mg2+ concentration. Furthermore, it was found 
that inhibition of TRPM7 receptors caused a cell cycle arrest in the G0/G1 phase in cancer cells.27 
                                                     
‡ The common numbering of the xenicane skeleton, introduced by Schmitz and van der Helm in: J. Am. Chem. Soc. 1977, 
99, 5780–5784, is used throughout this thesis (except for the Experimental Part).  
§ CCDC deposition number 1132300 contains the supplementary crystallographic data for waixenicin B (12). The data 
can be obtained from The Cambridge Crystallographic Data Centre via https://www.ccdc.cam.ac.uk/structures/  
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These properties identified TRPM7 channels as promising targets for the suppression of cancer 
(especially breast and gastric cancer), but also for the treatment of neurological, immunological 
and cardiovascular diseases.  
The investigations of the inhibitory effect of waixenicin A (11) on TRPM7 channels were carried 
out with small amounts of the secondary metabolite isolated from natural sources. For further 
investigations, especially regarding the use of this natural product as a potential anti-cancer agent, 
the development of a reliable synthetic route is required. It was therefore the goal of this Ph.D. 
thesis to develop a convergent and modular synthesis of waixenicin A (11). 
2.2 Aims of the Project 
Waixenicin A (11) represents a unique and challenging target for total synthesis and no completed 
synthesis for this natural product has been reported to date. The primary challenge lies in the 
successful incorporation of the (E)-cyclononene fragment. Additionally, the trans-fused 
dihydropyran motif was expected to cause difficulties in its preparation. The low degree of 
functionalization of the nine-membered carbocycle also limits the possible retrosynthetic 
disconnections. From a synthetic point of view, the main task of a synthesis of waixenicin A (11) 
is therefore the construction of the 6,9-bicyclic core structure. We planned to access waixenicin A 
(11) by two different strategies (Figure 5). At first, we aimed to synthesize the core structure with 
a Grob fragmentation approach by disconnection of bond C1−C6 (disconnection “a”), relying on 
established methodology for the synthesis of (E)-cyclononenes (Figure 5, left). In addition, we set 
out to investigate the direct cyclization of the nine-membered carbocycle from acyclic precursors 
by disconnection of bond C4−C5 (disconnection “b”) (Figure 5, right).  
 
 
Figure 5. Retrosynthetic bond disconnections for the 6,9-bicyclic core structure of waixenicin A (11) (PG = 
protecting group). 
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3 Results and Discussion 
3.1 First-generation Approach: SmI2-mediated Grob Fragmentation 
Medium-sized carbocycles consist of eight to eleven carbon atoms and have the largest ring strain 
compared to the most prevalent five- or six-membered rings, and large rings, containing more than 
eleven carbon atoms. The main sources of this ring strain are transannular interactions between 
hydrogen atoms pointing into the ring. Ring expansion or fragmentation reactions31–36 have often 
been utilized in the past to access substituted medium-sized rings and are the best way to overcome 
the entropic and enthalpic factors37 associated with their formation. The initial approach for the 
synthesis of waixenicin A (11) was based on a fragmentation reaction to construct the 
(E)-cyclononene fragment. Our retrosynthetic analysis is depicted in Scheme 2.  
 
Scheme 2. Initial retrosynthetic analysis of waixenicin A (11). 
Literature-known aldehyde 1438 and triflate 13 should be reductively coupled to introduce the side 
chain of the natural product 11. The exocyclic double bond of the cyclononene should be introduced 
via olefination. The characteristic (E)-cyclononene fragment was intended to be constructed by a 
unique samarium dihalide-mediated radical cyclization-fragmentation cascade of enone 16. Our 
plans for the preparation of this cyclization precursor were based on a B-alkyl Suzuki cross coupling 
between alkene 19 and vinyl iodide 18. These two building blocks were in turn envisioned to be 
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derived from literature-known chiral enone 2039 and commercially available 2-methyl-2-
cyclopenten-1-one. 
The sequential radical cyclization-fragmentation reaction for the construction of the 
(E)-cyclononene motif is further illustrated in Scheme 3. The cascade should be initiated by a 
samarium dihalide-mediated single-electron transfer (SET) to afford ketyl radical 21, which should 
attack the enone moiety in a 6-endo-trig cyclization mode to give intermediate 22. Addition of an 
additional equivalent of samarium dihalide should then generate samarium(III) alkoxide 23, which 
should undergo a stereospecific Grob fragmentation40–42 to afford the nine-membered ring. The 
synperiplanar orientation between the methyl group and the mesylate should establish the 
(E)-configuration of the trisubstituted C–C double bond.  
 
Scheme 3.  The cyclization-fragmentation cascade for the construction of the (E)-cyclononene fragment. 
Our retrosynthetic analysis was inspired by Molander’s work where eight-, nine- and ten-membered 
rings were accessed by a SmI2-mediated cyclization-fragmentation cascade of simple 
iodocycloalkanones.43 In this domino reaction, a bicyclic system was first formed, which then 
fragmented to afford the carbocycles (24→26) (Scheme 4). 
 
Scheme 4. Molander’s SmI2-mediated cyclization-fragmentation cascade for the synthesis of medium-sized 
rings. 
Our synthetic route commenced with the  preparation of vinyl iodide 18 in six steps from 
commercially available furfuryl alcohol.44 The introduction of the stereocenter was achieved via 
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enzymatic resolution by treatment of racemic acetal 27 with immobilized lipase PS.45 The synthesis 
of enantiopure para-methoxybenzyl (PMB) protected enone 20 was accomplished using Feringa’s 
procedure for stereospecific palladium-catalyzed acetal formation.39 Treatment of enone 20 with 
iodine and pyridine afforded α-iodo enone 29. The following reduction was achieved using the 
nitrogen analog of the Meerwein–Ponndorf–Verley reduction.46 Thus, reaction of α-iodo enone 29 
with lithium diisopropylamide (LDA) and subsequent trapping of the generated alkoxide with tert-
butyldimethylsilyl trifluoromethanesulfonate (TBSOTf) afforded vinyl iodide 18 (Scheme 5). 
 
Scheme 5. Synthesis of vinyl iodide 18 from furfuryl alcohol. 
For the synthesis of building block 19, the first step was the preparation of enantiomerically pure 
allylic alcohol 30 (Scheme 6). This task was realized by the enantioselective reduction of 
commercially available 2-methyl-2-cyclopenten-1-one with stoichiometric amounts of borane-
dimethyl sulfide complex and (S)-methyl-CBS-oxazaborolidine at 0 °C. The enantiomeric excess 
of alcohol 30 (95% ee) was determined by 19F NMR analysis of the two diastereomeric Mosher’s 
ester derivatives.47 Hydroxy-directed epoxidation of 30 with meta-chloroperbenzoic acid 
(m-CPBA) provided epoxy alcohol 31 in good yield. Oxidation of the alcohol with Dess‒Martin 
periodinane (DMP)48 afforded epoxyketone 32 and subsequent addition of vinyl magnesium 
bromide resulted in the formation of allylic alcohol 33 as a single diastereomer. The following 
semi-pinacol rearrangement49 proceeded in high yields using borane trifluoride-etherate as Lewis 
acid to furnish ketone 34. In summary, the synthesis of chiral building block 34 has been 
accomplished in five steps starting from 2-methyl-2-cyclopenten-1-one with an overall yield of 
41%. Treatment of intermediate 34 with TBSOTf in the presence of 2,6-lutidine afforded the TBS 
enol ether 19.  
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Scheme 6. Enantioselective synthesis of building block 19. 
With the requisite coupling partners in hand, efforts toward the fragment coupling were undertaken 
(Scheme 7). As a guide, we considered previous studies on the transmetalation of alkyllithium 
species with B-methoxy-9-BBN, followed by a Suzuki‒Miyaura cross coupling using Buchwald’s 
SPhos ligand and SPhos second generation precatalyst.50 In initial studies, the corresponding 
lithium boronate 35 was used as a model boronate to examine the feasibility of the coupling with 
α-iodo enone 29 or vinyl iodide 18. It was found that the reaction of α-iodo enone 29 with in situ 
generated boronate 35 resulted in complete decomposition of 29. However, the coupling of vinyl 
iodide 18 with intermediate boronate 35 occurred smoothly at 50 °C within two hours using 5 mol% 
of the catalyst to give the coupled product 37 in good yield. 
 
Scheme 7. (a) In situ preparation of boronate 35 from n-butyl lithium and B-OMe-9-BBN. (b) Suzuki‒Miyaura 
cross coupling coupling of iodides 29 and 18 with boronate 35. 
Motivated by this result, alkene 19 was first converted to the corresponding organoborane species 
40 by treatment with two equivalents of 9-BBN (THF, 60 °C), which was then submitted to vinyl 
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iodide 18 and exposed to the previously established coupling conditions. In an initial attempt, a 
mixture of the desired coupling product 39 (28% yield) and alkene 38 (69% yield) was obtained 
(Table 2, entry 1). The alkene functionality of 38 was assumed to be formed by hydroboration of 
the TBS enol ether (Scheme 8). Presumably, hydroboration of both the exocyclic vinyl group and 
the TBS enol ether resulted in the formation of intermediate 41. Elimination of the β-tert-
butyldimethylsiloxy organoborane then led to the formation of the endocyclic alkene 4251 and the 
following Suzuki−Miyaura cross coupling with vinyl iodide 18 finally afforded the coupling 
product 38. By lowering the amount of 9-BBN, this side reaction should be completely suppressed. 
 
Scheme 8. Hydroboration of building block 19 with two equivalents of 9-BBN and subsequent 
Suzuki−Miyaura cross coupling with vinyl iodide 18. 
To examine the hydroboration step, alkene 19 was treated with different quantities of 9-BBN 
(Table 2). Monitoring of the hydroboration reaction revealed that 1.3 equivalents of 9-BBN were 
required for complete consumption of alkene 19. Since 9-BBN was obtained as a commercially 
available solution in tetrahydrofuran (THF), we assumed that the concentration of the solution was 
lower than reported. Treatment of alkene 19 with more than 1.30 equivalents of 9-BBN resulted in 
the formation of side product 38. With this optimized hydroboration procedure in hand, coupling 
product 39 could be obtained in excellent yield (92%) and with high chemoselectivity. 
Table 2. Optimization of the B-alkyl Suzuki-Miyaura coupling by variations of 9-BBN amounts. 
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Entry 9-BBN (equiv) Yield 
1a 2.00 39 (28%), 38 (69%) 
2a 1.05 39 (44%), 38 (0%) 
3a 1.30 39 (81%), 38 (traces) 
4b 1.30 39 (92%), 38 (traces) 
aThe reactions were performed on a 0.08 to 0.1 mmol scale using 5 mol% SPhos Pd G2 and 5 mol% SPhos in a mixture of 
degassed DMF and H2O (v/v = 9:1). 
bThe reaction was performed on a 0.42 mmol scale using 5 mol% SPhos Pd G2 and 5 
mol% SPhos in a mixture of degassed DMF and H2O (v/v = 9:1). 
Next, a global deprotection of all three TBS groups of 39 using tetrabutylammonium fluoride 
(TBAF) was examined (Scheme 9). After 30 min, all starting material was consumed. NMR 
analysis later revealed that only the allylic silyl ether and the TBS enol ether had been cleaved. We 
reasoned that steric hindrance of the secondary silyl ether led to prolonged reaction times and thus 
alcohol 44 could be obtained in good yields by treatment of 39 with excess TBAF over 18 h. 
 
Scheme 9. Deprotection of 39 with TBAF. 
The chemoselective oxidation of allylic alcohol 44 was investigated next (Table 3). First, oxidation 
with DMP resulted in a mixture of products 45 and 46, with triketone 46 as the major product 
(entry 1). Fortunately, the oxidation with manganese dioxide (MnO2) was found to regioselectively 
afford enone 45 (entry 2). 
Table 3. Chemoselective oxidation of allylic alcohol 44. 
 
Entry Oxidant Yield 
1 DMP (1.2 equiv) 45 (15%), 46 (56%) 
2 MnO2 (25 equiv) 45 (54%), 46 (0%) 
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With enone 45 in hand, TBS protection and mesylation of the alcohol then afforded the two key 
step precursors 47 and 48 (Scheme 10). 
 
Scheme 10. Preparation of the key step precursors. 
Studies for the investigation of the challenging key cyclization-fragmentation cascade were then 
based on the use of a series of different Sm(II) halides and additives to modulate the reactivity and 
chemoselectivity of the reductant. In general, the reactivity of Sm(II) reductants has been found to 
correlate with their thermodynamic redox potentials.52 SmCl2 (‒1.78 eV) and SmBr2 (−1.55 eV) 
were readily prepared from a solution of SmI2 (‒0.89 eV) in THF by treatment with an excess of 
anhydrous lithium chloride or bromide, respectively. Initially, enone 47 was subjected to different 
Sm(II) halides to examine the first step of the cascade reaction (Table 4). Unfortunately, treatment 
of enone 47 with both SmI2 and SmBr2 resulted in the formation of complex product mixtures and 
no cyclization product(s) could be isolated (entries 1, 2). When SmCl2 in tert-butanol (t-BuOH) 
was used, no conversion was observed either (entry 3). In a final attempt, enone 47 was subjected 
to the powerful reductant SmI2‒HMPA (‒1.75 eV) in the presence of hexafluoroisopropanol 
(HFIP), but only a mixture of several unidentified products was isolated (entry 4). 
Table 4. Reductive cyclization of ketone 47 with samarium(II) reductants. 
 
Entry Additive T (°C) t (min) Observation 
1a - ‒78 5 complex mixture 
2a LiBr (6 equiv/SmI2) ‒78 5 complex mixture 
3b LiCl (6 equiv/SmI2), t-BuOH ‒78 15 no conversion 
4a HMPA (10 equiv), HFIP (2 equiv) ‒78 0.5 complex mixture 
 
aAddition of SmX2 to a solution of 47 or addition of 47 to a solution of SmX2. 
b Addition of 47 to a solution of SmCl2 and 
t-BuOH. 
Results and Discussion 
37 
 
Further attempts to accomplish the cascade reaction with mesylate 48 only afforded a complex 
mixture of several unidentified products in <5 min at 0 °C or –78 °C, respectively (Table 5). Careful 
separation by flash column chromatography and HPLC afforded trace amounts of cyclized 
product 15. 
Table 5. Reductive cyclization of ketone 48 with samarium(II) iodide. 
 
Entry T (°C) t (min) Observation 
1 0 5 complex mixture 
2b ‒78 5 complex mixture 
3c ‒78 5 complex mixture 
4d ‒78 60 complex mixture 
bAddition of SmI2 to a solution of 48. 
cAddition of 48 to a solution of SmI2. 
dSlow addition of 48 over 60 min via syringe pump. 
In conclusion, the efficient synthesis of a key intermediate for the synthesis of waixenicin A (11) 
has been accomplished by using a B-alkyl Suzuki cross coupling strategy. Nonetheless, the 
samarium(II) halide-mediated cyclization-fragmentation cascade as key step for the construction 
of the (E)-cyclononene fragment could not be realized. During our cyclization studies, we observed 
the formation of significant amounts of PMB alcohol and reasoned that the dihydropyran building 
block could be labile under reductive conditions. Thus, it was envisioned to install the six-
membered ring after the fragmentation step. 
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3.2 Second-generation Approach: Furan Oxidation and Grob Fragmentation 
For the second-generation strategy, we envisioned to trace waixenicin A (11) back to key 
intermediate 53, which contains the (E)-cyclononene ring fused to a furan ring (Scheme 11). In this 
strategy, installation of the dihydropyran ring should be realized by a late-stage Achmatowicz 
oxidation of the furfuryl alcohol to give dihydropyranone 52. Reduction of the enone should afford 
the 6,9-bicyclic core structure 51 of the natural product. The construction of the (E)-cyclononene 
ring should again be achieved by a stereospecific Grob fragmentation of precursor 54. Further 
dissection of this tricycle by an intramolecular olefin cross metathesis and a 1,2-addition of a 3-
lithiated 3,4-dihalofuran would lead back to two building blocks: 3,4-dibromofuran (56) and 
already prepared functionalized cyclopentanone 34. 
 
Scheme 11. Second-generation retrosynthetic analysis of a common intermediate of waixenicin A (11). 
Our synthetic route commenced with the preparation of 3,4-dibromofuran (56) from commercially 
available trans-2,3-dibromo-2-butene-1,4-diol (57) by oxidation and aromatization with chromic 
acid (Scheme 12).53 The product was extracted from the reaction mixture by steam distillation. 
Although the reaction afforded 3,4-dibromofuran (56) in low yield (28%), this transformation was 
found to be a reliable way to prepare >10 g of the furan building block in one day. 
 
Scheme 12. Synthesis of 3,4-dibromofuran (56). 
On a 2 g scale, 3,4-dibromofuran (56) was coupled to ketone 58 via bromine-lithium exchange and 
subsequent attack of the generated lithium species on the ketone. The resultant alcohol 59 was 
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obtained as a single diastereomer and converted to its trimethylsilyl (TMS) ether 60 under standard 
silylation conditions (TMSCl, imH) (Scheme 13). The relative configuration of the newly installed 
stereogenic center at C5 position was verified by NOESY experiments. 
 
Scheme 13. Synthesis of 3-bromofuran 60. 
The following formylation with dimethylformamide (DMF) proceeded in moderate yield (53%) to 
furnish aldehyde 61 (Scheme 14). A competing retro-Brook rearrangement lowered the yield of 
this transformation and resulted in the formation of side product 62. All attempts to suppress this 
side reaction by performing the reaction in less polar solvents (e.g. hexanes/diethyl ether = 1:1) had 
no effect. 
 
Scheme 14. Synthesis of tricycle 54. 
Next, a high-yielding Wittig olefination and an ensuing olefin metathesis using Grubbs second 
generation catalyst under optimized reaction conditions afforded 5,6,5-tricycle 64 in high yield. 
Hydrogenation of the double bond and regioselective formylation of the furan ring using sec-butyl 
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lithium and DMF afforded aldehyde 66. The global deprotection of the silyl ethers was best 
achieved using TBAF and gave diol 67. Regioselective conversion of the tertiary alcohol to 
mesylate 54 proceeded in good yield under optimized reaction conditions. 
With fragmentation precursor 54 in hand, the envisioned key step for the construction of the nine-
membered carbocyclic ring was investigated (Table 6). However, treatment of aldehyde 54 with 
different bases (NaH, KOt-Bu or KHMDS) either resulted in no conversion (entries 1, 2) or in 
decomposition (entries 3, 4). 
Table 6. Fragmentation of alcohol 54. 
 
Entry Base (equiv) Solvent Observation 
1 KHMDS (1.1) THF no reaction 
2 NaH (1.1) DMF no reaction 
3 NaH (2.0) DMF decomposition 
4 KOt-Bu (1.0) t-BuOH decomposition 
 
Aldehyde 54 was therefore reduced to primary alcohol 69 with sodium borohydride in good yield. 
In a first attempt, fragmentation product 53 could be obtained in 50% yield by using 
two equivalents of sodium hydride (Scheme 15). All attempts to further optimize this 
transformation by employing different bases (e.g. KOt-Bu in t-BuOH, KHMDS in THF) did not 
provide better yields. 
 
Scheme 15. Successful construction of the (E)-cyclononene ring.  
With bicycle 53 in hand, the ensuing key Achmatowicz rearrangement54,55 could be investigated 
(Table 7). Unfortunately, oxidative ring expansion of the furfuryl alcohol in the presence of either 
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N-bromosuccinimide (NBS)56 or VO(acac)2/tert-butylhydroperoxide (TBHP)57 resulted in 
decomposition (entries 1, 2). In order to perform the reaction chemoselectively at the furan moiety, 
a singlet oxygen-induced Achmatowicz rearrangement protocol58,59 was employed. However, a 
complex product mixture was obtained when the photooxygenation of furfuryl alcohol 53 was 
performed at ‒78 °C (entry 3). 2D NMR analysis revealed the formation of different products 
resulting from an ene reaction of the trisubstituted C–C double bond with singlet oxygen. 
Table 7. Conditions for the oxidative rearrangement of furan 53. 
 
Entry Conditions T (°C) Observation 
1 NBS, NaOAc, NaHCO3 23 decomposition 
2 VO(acac)2, TBHP 0 to 23 decomposition 
3 1O2,a then Me2S ‒78 to 0 unidentified products 
aSinglet oxygen (1O2) was generated using rose bengal as photosensitizer and by irradiation with a Replux Belgium RL 
160 W lamp. 
To determine the influence of the benzylic ketone on the oxidative ring expansion, ketone 53 was 
reduced to the corresponding alcohol 71 by treatment with sodium borohydride. However, no 
product formation was observed when the Achmatowicz rearrangement was performed with NBS 
or VO(acac)2/TBHP (Scheme 16). 
 
Scheme 16. Reduction of the benzylic ketone to alcohol 71 and subsequent Achmatowicz rearrangement. 
We next employed a two-step procedure to afford TBS ether 73. Unfortunately, no product 
formation was observed when furfuryl alcohol 73 was subjected to different oxidative ring 
expansion conditions (Scheme 17).  
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Scheme 17.  Synthesis of TBS ether 73 and attempted oxidative ring expansion of the furan moiety. 
Cirumventing difficulties with the oxidation of the furan ring in the presence of the cyclononene, 
the Grob fragmentation should be performed after conversion of the furan to the dihydropyran. 
Thus, aldehyde 66 was reduced to primary alcohol 75 by treatment with sodium borohydride 
(Scheme 18). The following oxidative rearrangement of furfuryl alcohol 75 to dihydropyranone 76 
was successfully realized using stoichiometric quantities of recrystallized NBS, supplemented by 
addition of sodium acetate and sodium bicarbonate to buffer the hydrobromic acid formed.56 Using 
these conditions, the corresponding dihydropyranone 76 could be obtained in excellent yield (89%) 
and with good diastereoselectivity (d.r. = 7:1, major diastereomer is shown in Scheme 18). Single 
crystal X-ray analysis of the major diastereomer of dihydropyranone 76 also confirmed the 
configuration of the hydroxyl group of the lactol moiety.  
 
Scheme 18. Synthesis and molecular structure of dihydropyranon 76. 
Protection of the lactol functionality was next investigated (Table 8). First, a methyl and PMB 
group were chosen as protecting groups due to their stability toward a variety of conditions. 
However, methylation using methyl iodide or PMB protection using Dudley's reagent II60 were 
low-yielding (Table 8, entries 1, 2). We next converted lactol 76 to acetal 77c by treatment with 
acetic anhydride under basic conditions in very good yield (entry 3). A palladium-catalyzed 
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transacetalization with PMB alcohol39 should then install the PMB group, but this reaction proved 
to the difficult and no conversion was observed (entry 4). We then decided to install a benzoate 
protecting group (entry 5). The introduction of silyl ethers was also investigated, but TBS protection 
of the lactol was unsuccessful (entries 6, 7). However, TMS-protection of lactol 76 could be 
performed with high yield (entry 8). 
Table 8. Introduction of a variety of protecting groups on the lactol moiety of 76. 
  
Entry R Electrophile Reagent(s)  Product Yield 
1 Me MeI Ag2O  77a 25% 
2 PMB Dudley II MgO, MeOTf  77b 15% 
3 Ac Ac2O py, DMAP  77c 85% 
4 PMB PMBOH Pd(OAc)2, P(OPh)3  77b 0% 
5 Bz BzCl py, DMAP  77d 97% 
6 TBS TBSCl AgNO3, py  77e 0% 
7 TBS TBSOTf 2,6-lutidine  77e 0% 
8 TMS TMSCl AgNO3, py  77f 95% 
 
With a range of substrates in hand, we investigated the hydrogenation of the tetrasubstituted double 
bond in enones 76, 77a, 77d and 77f (Table 9). First, hydrogenation reactions under heterogeneous 
conditions using 10% palladium on charcoal (Pd/C) or platinum oxide (PtO2) as catalysts were 
investigated. For the hydrogenation reactions with Pd/C, an excess of sodium bicarbonate (up to 
four equivalents) was added to prevent hydrolysis of the acetal. Hydrogenation of enone 77a at 
1 bar in either ethyl acetate or methanol resulted in no conversion (entries 1, 2). The rate of 
hydrogenation reactions is generally increased at elevated hydrogen pressure. However, no 
reduction of the double bond of tricycle 77a was observed at 8 bar, 18 bar or 80 bar, respectively 
(entries 3−5). The use of PtO2 as catalyst in a mixture of methanol and THF at 10 bar hydrogen 
pressure also resulted in no conversion (entry 6). Decomposition of the substrate was observed 
when lactol 76 was used (entry 7). Hydrogenation of benzoate 77d resulted in no reaction at 1 bar 
hydrogen pressure, but hydrogenation in an autoclave under higher pressure (5 bar) surprisingly 
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led to a mixture of products, containing dihydropyran 79 as the major product (entries 8, 9). We 
next investigated homogeneous hydrogenation with Crabtree's catalyst61 ([Ir(PCy3)(py)(cod)]PF6) 
and the BArF-variant thereof, using either benzoate 77d, TMS acetal 77f or lactol 76. However, no 
hydrogenation of the different enones was observed (entries 10–13). The use of (S,S)-[Rh(Et-
DuPhos)(cod)]BF4 as catalyst was also unsuccessful (entry 14).  
Table 9. Hydrogenation of different enones. 
 
Entry R Catalyst Additive 
H2 
Pressure 
Solvent Observation 
1 Me Pd/C NaHCO3 1 bar EtOAc no conversion 
2 Me Pd/C NaHCO3 1 bar MeOH no conversion 
3 Me Pd/C NaHCO3 8 bar THF no conversion 
4 Me Pd/C NaHCO3 18 bar THF no conversion 
5 Me Pd/C NaHCO3 80 bar THF no conversion, 
slow decomp. 
6 Me PtO2 - 10 bar MeOH, THF no conversion 
7 H Pd/C NaHCO3 1 bar MeOH decomposition 
8 Bz Pd/C NaHCO3 1 bar THF no conversion 
9 Bz Pd/C NaHCO3 5 bar THF 79 (traces) 
10 Bz [Ir(PCy3)(py)(cod)]PF6 - 1 bar CH2Cl2 no conversion 
11 H [Ir(PCy3)(py)(cod)]PF6 - 1 bar CH2Cl2 no conversion 
12 H [Ir(PCy3)(py)(cod)]PF6 - 15 bar CH2Cl2 no conversion 
13 TMS [Ir(PCy3)(py)(cod)]BArF - 60 bar Cl(CH2)2Cl deprotection of 
tert. TMS ether 
14 TMS (S,S)-[Rh(Et-
DuPhos)(cod)]BF4 
- 60 bar Cl(CH2)2Cl deprotection of 
TMS acetal 
15 TMS Pd/C NaHCO3 1 bar EtOAc no conversion 
16 TMS Pd/C NaHCO3 35 bar EtOAc no conversion 
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Additionally, we examined the hydrogenation of TMS lactol 77f under hetereogenous conditions. 
To our surprise, 77f was found to be stable under buffered hydrogenation conditions. However, 
even hydrogenation at 35 bar (22 h in ethyl acetate) was unsuccessful and only starting material 
was recovered (entries 15, 16). 
By looking at the molecular structure of lactol 76 (Scheme 18), we concluded that hydrogenation 
of the double bond might occur from the more accessible β-face, which is also sterically shielded 
by the TMS ether of the acetal moiety. Thus, a global deprotection of the silyl ethers should provide 
a substrate with less steric encumbrance. Furthermore, the free tertiary hydroxyl group could direct 
hydrogenation from the α-face. The synthesis of diol 80 was realized by treatment of benzoate 77d 
with triethylamine trihydrofluoride (Scheme 19). 
 
 
Scheme 19. Global deprotection of the silyl ethers.  
However, hydrogenation of diol 80 using Pd/C only resulted in partial elimination of benzoic acid 
(Table 10, entry 1). When Crabtree's catalyst was used, either no conversion (entry 2) or 
decomposition of the substrate was observed (entry 3).  
Table 10. Hydrogenation of diol 80. 
 
Entry Catalyst H2 Pressure Solvent Observation 
1 Pd/C 1 bar THF 82 (traces) 
2 Crabtree 1 bar CH2Cl2 no conversion 
3 Crabtree 6 bar CH2Cl2 decomposition 
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Given the difficulties encountered with heterogeneous and homogeneous hydrogenation reactions, 
we next examined various 1,4-reduction protocols (Table 11). First, transition metal-mediated 
reductions with sodium borohydride were investigated. Treatment of enone 77d with copper(II) 
chloride and sodium borohydride resulted in a mixture of several products, with allylic alcohol 83 
as the major product (entry 1). The use of cobalt(II) chloride and sodium borohydride resulted in 
no conversion when the reaction was performed in water and in decomposition with methanol as 
solvent (entries 2, 3). Additionally, the use of in situ generated copper(I) hydride from copper(II) 
acetate, 1,1'-bis(diphenylphosphino)ferrocene (dppf) and tetramethyldisiloxane (TMDS) proved to 
be ineffective (entry 4). Although few examples for the reduction of tetrasubstituted enones with 
copper(I) hydrides are known, we reasoned that sterical hindrance of the enone might prohibit their 
reaction. Next, Shenvi's mild protocol for the radical hydrogenation of alkenes using 
manganese(III) or cobalt(II) catalysts was employed.62 However, no conversion was observed for 
benzoate 77d and lactol 76, even when a large excess of the reagents was used (entries 5, 6).  
Table 11. Conditions for the 1,4-reduction of enones 76 and 77a,d. 
 
Entry R Metal salt Reducing agent Solvent Observation 
1 Me CuCl2 NaBH4 EtOH 1,2-reduction 
2 Bz CoCl2·6H2O NaBH4 H2O no conversion 
3 Bz CoCl2·6H2O NaBH4 MeOH decomposition 
4 Bz Cu(OAc)2, dppf TMDS THF no conversion 
5 Bz Mn(dpm)3 PhSiH3 i-PrOH no conversion 
6 H Mn(dpm)3 PhSiH3 i-PrOH no conversion 
 
In conclusion, a Grob fragmentation of a tricyclic monomesylated 1,3-diol afforded the desired 
(E)-configured cyclononene present in waixenicin A (11), which was fused to a furan ring. 
Nonetheless, a regioselective oxidation of the furan moiety for the construction of the dihydropyran 
could not be achieved. On the other hand, oxidation of the furan ring of the tricyclic fragmentation 
precursor afforded the corresponding tricyclic enone. However, the steric hindrance of the 
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tetrasubstituted double bond and the lability of the dihydropyran unit toward both acids and bases 
made reduction of the enone very challenging.  
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3.3 Third-generation Approach: Radical and Grob Fragmentations 
3.3.1 Radical Fragmentations 
While the use of radical cyclizations for the synthesis of medium-sized rings has been extensively 
studied over the past few decades, radical fragmentations have not found widespread application.63 
Some selected examples are shown in Scheme 20. For example, Lange and Crimmins both reported 
the fragmentation of tricyclic compounds containing a cyclobutane unit under free radical 
conditions to construct eight-membered carbocycles in the 1990s (Scheme 20a, b).64–66 As radical 
precursors, they employed either thiocarbamates, xanthates or alkyl iodides. The utilization of this 
strategy was further demonstrated by Crimmins in 2000, where a ten-membered ring was prepared 
by radical fragmentation of xanthate 89 (Scheme 20c).67   
 
Scheme 20. Exemplary radical fragmentation reactions. 
In general, radicals can easily break C−C bonds when they are generated adjacent to a strained ring, 
such as a cyclobutane ring. However, the C−C bond of larger rings can also be cleaved if the 
resulting radical is appropriately stabilized, as exemplified by Reddy et al. (Scheme 21).68 Thereby, 
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the fragmentation only occurs when the single occupied molecular orbital (SOMO) of the radical 
efficiently overlaps with the σ-orbital of the C−C bond that should be cleaved.69  
 
Scheme 21. Radical fragmentation of 5,5,5-tricyle 91. 
During extensive studies directed toward the total synthesis of the xeniolide xenibellol A (93) 
together with Simon Schnell, a master student in the group of Prof. Thomas Magauer, the epi-
methyl core structure (94) of this natural product (highlighted in blue color) could be successfully 
prepared from two building blocks: known enone 20 and TMS ketene acetal 97 (Scheme 22).70  
 
Scheme 22. Studies toward the synthesis of xenibellol A (93). 
We now envisioned using tricyclic alcohol 95, an intermediate in the synthesis of tetracycle 94, as 
a versatile precursor for radical fragmentation reactions to construct the nine-membered carbocycle 
of waixenicin A (11). In our approach, an ester functionality should be used as radical stabilizing 
substituent. For this synthetic strategy, we envisioned to convert alcohol 95 to thiocarbamate 98, 
which should then fragment under free radical conditions to afford the 6,9-bicyclic core structure 
101 of waixenicin A (Scheme 23). 
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Scheme 23. Planned radical fragmentation for the construction of the bicyclic core structure of waixenicin A 
(11). 
For the synthesis of radical fragmentation precursor 98, two building blocks had to be prepared. 
First, the preparation of TMS ketene acetal 97 is illustrated in Scheme 24. Previously prepared 
hydroxyketone rac-34** was TIPS-protected and the exocyclic vinyl group was further 
functionalized by a hydroboration/oxidation sequence (rac-34→104). Protection of the generated 
primary alcohol 104 as TIPS ether, followed by chemoselective deprotection of the TIPS enol ether 
afforded ketone 105 in good yield. The required C1-elongation of the ketone was then achieved by 
conversion to epoxide 106, which was further transformed to aldehyde 107 by a Lewis acid-
mediated stereocontrolled epoxide rearrangement. The use of several different Lewis acids for this 
transformation was examined,†† but the best results were achieved with the exceptionally bulky 
Lewis acid MABR (= methylaluminum bis(4-bromo-2,6-di-tert-butylphenoxide)).71 The reaction 
afforded aldehyde 107 as a mixture of diastereomers (d.r. = 1:1.4), which could be epimerized with 
DBU to the major diastereomer shown in Scheme 24. The aldehyde was then oxidized to the 
corresponding carboxylic acid 108, followed by conversion to methyl ester 109. The formation of 
TMS ketene acetal 97 was best achieved by treatment of methyl ester 109 with a freshly prepared 
solution of LDA as base in a highly concentrated solution and by subsequent trapping of the 
generated ester enolate with freshly distilled TMSCl. 
                                                     
** Cyclopentanone 34 was prepared in racemic fashion for the studies presented in this chapter. All other compounds are 
also racemic and only one enantiomer is shown. 
†† The screening of different Lewis acids for this transformation was carried out by Fabian Hernichel. 
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Scheme 24. Synthesis of TMS ketene acetal 97. 
An extensive screening for the realization of the following key step, a Mukaiyama−Michael 
reaction between previously prepared racemic enone rac-20 and racemic TMS ketene acetal 97, 
resulted in the diastereoselective preparation of ketone 96 by using stoichiometric amounts of boron 
trifluoride etherate. Chemoselective deprotection of the primary TIPS ether, followed by oxidation 
gave aldehyde 111.‡‡ The structure of aldehyde 111 was further verified by single crystal X-ray 
analysis (Scheme 25). 
                                                     
‡‡ Optimization of the synthetic steps shown in Scheme 25 and 26 was carried out by Simon Schnell. 
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Scheme 25. Synthesis of aldehyde 111 and its molecular structure. 
With aldehyde 111 in hand, a proline-catalyzed aldol condensation resulted in the construction of 
tricycle 112, as proven by X-ray diffraction of a single crystal of 112 (Scheme 26). The enone 
moiety was then reduced to ketone 113 by palladium-catalyzed hydrogenation. Deprotection of the 
secondary alcohol and conversion to thiocarbamate 98 afforded the first precursor for the 
envisioned radical fragmentation. 
 
Scheme 26. Synthesis of thiocarbamate 98. 
With thiocarbamate 98 in hand, fragmentation to bicycle 101 under radical conditions was first 
examined by premixing the substrate with excess tributyltin hydride (n-Bu3SnH)/AIBN and by 
heating to 80 °C. However, mixed O,S-acetal 114 was isolated as the only product (Scheme 27a). 
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Trying to avoid this side reaction, a mixture of n-Bu3SnH and AIBN in benzene was added dropwise 
via syringe pump to a refluxing solution of thiocarbamate 98 in benzene. The reaction cleanly 
afforded a single product, which was assigned to be tricycle 115 (Scheme 27b). Although the 
secondary radical was generated, no fragmentation occurred. By performing the reaction in 
chlorobenzene at 122 °C, the fragmentation should be more facile and might precede hydrogen 
abstraction. Instead, γ-lactone 116 was obtained in 94% yield and its structure was verified by 
single crystal X-ray analysis (Schemes 27c and 28). This reaction presumably proceeded via an 
SN2-type attack of the ester carbonyl at the thiocarbamate and displayed another competing side 
reaction for the fragmentation. 
 
Scheme 27. Screening of radical fragmentation reactions. 
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Scheme 28. Molecular structure of tetracycle 94. 
Next, the reaction was performed with TTMSS (= tris(trimethylsilyl)silane)62 instead of tributyltin 
hydride as hydrogen donor. The dissociation energy of the Si−H bond in TTMSS is slightly higher 
(79 kcal/mol)72 than the dissociation energy of the Sn−H bond strength in n-Bu3SnH (74 kcal/mol) 
and therefore, TTMSS is a slower hydrogen donor than n-Bu3SnH. Unfortunately, only the product 
resulting from hydrogen abstraction (98→115) was isolated in good yields when the reaction was 
performed in refluxing benzene (Scheme 29). 
 
Scheme 29. Attempted radical fragmentation reactions with TTMSS (= tris(trimethylsilyl)silane). 
In conclusion, the utilization of a radical fragmentation for the synthesis of the nine-membered ring 
of waixenicin A (11) was found to be very challenging. This could be a consequence of the low 
thermodynamic driving force for the radical fragmentation of cyclopentanes as compared to 
cyclobutanes.  
3.3.2 Grob Fragmentation 
In previous chapters, the Grob fragmentation of monomesylated 1,3-diols has been studied. This 
strategy has been successfully employed for the synthesis of the (E)-cyclononene fragment of 
waixenicin A (see chapter 3.2). In addition to the use of 1,3-diols as fragmentation precursors, other 
1,3-diheterosubstituted substrates can also undergo Grob fragmentations.42 For example, in 1955, 
Grob and Baumann demonstrated that cis-1,4-dibromocyclohexane (116a) and cis-1,4-
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diiodocyclohexane (116b) could be fragmented to hexa-1,5-diene upon treatment with zinc 
(Scheme 30).73  
 
Scheme 30. Grob fragmentation of cis-1,4-dihalocyclohexanes 116a and 116b with zinc. 
Based on this discovery, we decided to investigate a similar fragmentation by generating the 
carbanion in a different way. We envisioned to investigate the use of samarium diiodide (SmI2) as 
reductant for the utilization of a Grob fragmentation. The SmI2-HMPA complex has been described 
to efficiently reduce xanthates to carbanions via two SETs.74 For the preparation of a suitable 
substrate for the SmI2-mediated fragmentation, the ketone had to be converted to the corresponding 
enol ether. Otherwise a reaction of the ketone with SmI2 would lead to the formation of a ketyl 
radical which would interfere with the fragmentation reaction. Thus, tricycle 113 was converted to 
vinyl triflate 117 which was smoothly reduced to enol ether 118 (Scheme 31). Deprotection of the 
TIPS ether and introduction of the thiocarbamate then delivered fragmentation precursor 119.  
 
Scheme 31. Samarium(II) iodide-mediated Grob-type fragmentation. 
However, dropwise addition of the substrate to a premixed solution of excess SmI2 and HMPA only 
resulted in hydrolysis of the thiocarbamate. The use of freshly dried HMPA produced the same 
result. Given the difficulties encountered with the Grob fragmentation of xanthates, we next 
investigated the conversion of the ester group to the corresponding primary halide. Zinc insertion 
or reduction with SmI2 should then generate a primary carbanion, which should readily fragment 
to give an exo-methylene group and thus generate the nine-membered carbocycle.  
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First, reduction of ester 118 with an excess of lithium aluminum hydride afforded primary alcohol 
121, which should be further converted to iodide 122. However, only decomposition of the 
substrate was observed under Appel’s conditions. The enol ether moiety of the six-membered ring 
was presumably not tolerated under these conditions. We therefore prepared mesylate 123 by 
treatment of alcohol 121 with mesyl chloride and triethylamine (Scheme 32). 
 
Scheme 32. Formation of primary alcohol 121, attempted iodination and successful mesylation. 
Next, conversion of the mesylate to the corresponding bromide or iodide was examined. While the 
reaction of mesylate 123 with sodium iodide in DMF resulted in decomposition, the use of additives 
(e.g. NaHCO3 or 2,6-lutidine) to trap in situ generated hydroiodic acid resulted in the formation of 
rearranged alkene 124, a side product that is sometimes observed for neopentylic sulfonates or 
halides (Scheme 33). 
 
Scheme 33. Formation of alkene 124 under Finkelstein conditions. 
As an alternative to the use of halides for the generation of carbanions by metal insertion or 
reduction, mesylates can be reduced to carbanions by using a mixture of activated zinc, HMPA and 
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sodium iodide in refluxing DMF.75 We therefore prepared dimesylate 126 from diol 125 by 
deprotection of the TIPS ether, followed by mesylation of the two hydroxyl groups (Scheme 34). 
When dimesylate 126 was subjected to these rather harsh conditions, at least two new products 
were formed with alkene 128 as the major product. Unfortunately, it was not possible to avoid the 
formation of the undesired rearrangement product. Furthermore, when dimesylate 126 was added 
to a refluxing solution of SmI2 in THF, only slow and sluggish conversion of 126 was observed and 
this strategy was not further pursued. Treatment of dimesylate 126 with Zn/HMPA/NaI at 110 °C 
resulted in the isolation of low amounts of rearrangement product 128. 
 
Scheme 34. Attempted fragmentation of dimesylate 126. 
In a final attempt, diol 125 was converted to bisthiocarbamate 129 and was subjected to radical 
fragmentation reactions by using n-Bu3SnH/AIBN at 80 °C or 110 °C, but only decomposition was 
observed (Scheme 35). 
 
Scheme 35. Attempted radical fragmentation of bisthiocarbamate 129. 
In conclusion, several tricyclic precursors for the investigation of a radical or Grob fragmentation 
to construct the (E)-cyclononene fragment of waixenicin A (11) have been prepared. Extensive 
fragmentation studies under free radical conditions revealed that although the generation of the 
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secondary alkyl radical was successful, no fragmentation occurred. All further attempts to realize 
a Grob fragmentation using SmI2 or zinc as reductants were also found to be challenging.  
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3.4 Fourth-generation Approach: Cyclization of Acyclic Precursors 
In previous synthetic studies directed toward the construction of the 6,9-bicyclic scaffold of 
waixenicin A (11), the application of a Grob fragmentation for the assembly of the (E)-cyclononene 
fragment was found to be challenging (see chapters 3.1, 3.2, 3.3). In this approach, the direct 
synthesis of (E)-cyclononenes from acyclic precursors will be examined. Circumventing steric 
constraints and entropic barriers37 remains the major challenge in the direct ring closure of nine-
membered rings and general methods have not been described so far. Previous studies aimed at the 
synthesis of xeniolides and structurally related natural products made use of an intramolecular 
Tsuji–Trost allylation,76 an intramolecular B-alkyl Suzuki coupling77 and a Nozaki–Hiyama–Kishi 
coupling78 for the construction of the nine-membered carbocycle from acyclic precursors.  
Our plans for the synthesis of waixenicin A (11) were designed to investigate the utilization of 
different ring closing reactions for the direct construction of (E)-cyclononenes from acyclic 
substrates by B-alkyl Suzuki coupling,79 Heck reaction,80 Barbier reaction,81 
Nozaki−Hiyama−Kishi (NHK) reaction, radical cyclization reactions and α-alkylation reactions in 
parallel. The (E)-configured trisubstituted alkene should be installed in the acyclic precursor by 
olefination and should remain intact during the ring closing reactions. A general retrosynthetic 
analysis is shown in Scheme 36.  
 
Scheme 36. Retrosynthetic analysis of waixenicin A (11). 
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The side chain of waixenicin A (11) should be introduced by formylation of enol ether 130, 
followed by asymmetric allylation. The bicyclic core structure of the natural product should be 
accessed by different ring closing reactions as described above. The different cyclization precursors 
could be traced back to the three general building blocks: literature-known enone 20, formaldehyde 
as C1-building block and vinyl bromides 135 or 136, respectively. Functionalization of enone 20 
by conjugate addition of vinyl bromide 135 or 136 and subsequent trapping of the generated enolate 
with formaldehyde should give access to the three precursors 132, 133 and 134 for the key steps. 
3.4.1 B-Alkyl Suzuki Cross Coupling 
Following our retrosynthetic plan, the employment of the B-alkyl Suzuki cross coupling and the 
intramolecular Heck reaction for the formation of the nine-membered ring was investigated. Thus, 
a two-step procedure for the synthesis of vinyl bromide 135 was established (Scheme 37). 
Reduction of literature-known ester 137 using LiAlH4,82 followed by TIPS-protection of generated 
alcohol 138 afforded building block 135. 
 
Scheme 37. Two-step procedure to access vinylbromide 135. 
Conjugate addition of vinyl bromide 135 to enantiopure enone 20 and subsequent trapping of the 
generated enolate with TMSCl afforded TMS enol ether 139 (Scheme 38). Treatment with an 
aqueous formaldehyde solution in the presence of catalytic amounts of ytterbium(III) triflate then 
resulted in the formation of a product mixture containing β-hydroxy ketone 141 and products 
resulting from formaldehyde over-addition, such as lactol 140. However, excess formaldehyde 
could be removed by heating the reaction to 90 °C in the presence of 4 Å molecular sieves to give 
β-hydroxy ketone 141 in good yield over three steps and in gram quantities.83 TES-protection of 
the alcohol and triflation of the ketone using LDA and PhNTf2 afforded triflate 143. Remarkably, 
the two contiguous stereocenters at the C2 and C3 position of the natural product could be installed 
via this diastereoselective sequence. The synthesis of the dihydropyran fragment was then finalized 
by reduction of the triflate to the corresponding enol ether 144. For the synthesis of the 
Suzuki−Miyaura and Heck coupling precursors, the primary alcohol of 144 was oxidized to 
aldehyde 145, which was further transformed to an exocyclic vinyl group. The olefination of 
aldehyde 145 proved to be challenging and initial Wittig or Horner reactions led to inseparable 
mixtures of unidentified products. The use of LiCH2TMS afforded a mixture of recovered 
aldehyde 145 and its conjugated isomer. Finally, a cerium(III)-modified Peterson olefination 
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procedure84 could be successfully employed. Premixing cerium(III) chloride and LiCH2TMS, 
followed by addition of aldehyde 145 afforded a diastereomeric β-hydroxy silane, which generated 
alkene 146 upon treatment with NaHMDS. No epimerization at the C3 position was observed. 
Deprotection of the TBS ether with TBAF and oxidation of the generated alcohol afforded 
aldehyde 148, which was converted to dibromoalkene 132. The addition of triethylamine was found 
to be crucial for the success of this transformation. 
 
Scheme 38. Synthesis of dibromolefin 132. 
With substrate 132 in hand, the reactivity of the vinyl group was explored by applying different 
hydroboration conditions (Table 12). To our surprise, the vinyl group proved to be sterically more 
hindered than expected. Hydroboration under standard conditions (9-BBN, 25 °C) resulted in no 
conversion (entry 1). Prolonged reaction times or heating to 60 °C resulted in slow conversion to 
multiple products (entries 2, 3). To exclude the undesired reactivity from the dibromoalkene, we 
Results and Discussion 
62 
 
also investigated the use of substrate 146. Again, 9-BBN displayed poor reactivity toward the 
sterically congested alkene 146 at 25 °C or 60 °C, respectively (entries 4, 5). When 
dicyclohexylborane (Cy2BH) was used, formation of a new product was observed (entry 6). 2D 
NMR studies indicated that hydroboration occurred not only at the vinyl group, but also at the enol 
ether moiety. The use of milder reaction conditions by treating alkene 132 with catecholborane in 
the presence of Wilkinson’s catalyst85 resulted in no conversion (entry 7). In conclusion, 
chemoselective hydroboration of the vinyl group was not possible under standard conditions and 
we therefore turned our attention to a different approach. 
Table 12. Hydroboration studies. 
 
 
Entry Substrate Reagentsa T (°C) t (h) Observation 
1 132 9-BBN 25 3 no reaction 
2 132 9-BBN 25 24 decomposition 
3 132 9-BBN 60 5 decomposition 
4 146 9-BBN 25 24 no reactionb 
5 146 9-BBN 60 3 no reaction 
6 146 Cy2BH 25 24 40% unidentified product 
7 132 
catecholborane, 
(Ph3P)3RhCl 
25 24 no reaction 
aAll reactions were performed in THF. Oxidation of the borane species with 3 M aqueous sodium hydroxide solution (9 equiv) 
and hydrogen peroxide (30 wt% in water, 9 equiv) at 25 °C for 1 to 2 h. b61% starting material was recovered by flash 
column chromatography. 
3.4.2 Nozaki−Hiyama−Kishi (NHK) Coupling 
Another approach was examined by the conversion of alkene 132 to aldehyde 151 as precursor for 
an intramolecular NHK reaction. First, alkene 132 was subjected to aldehyde-selective Wacker 
oxidation conditions (Scheme 39a),86 but no conversion was observed. A two-step procedure 
consisting of a regioselective olefin cross metathesis reaction of alkene 132 with vinylboronic acid 
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pinacol ester, followed by oxidative hydrolysis of the resulting boronic ester successfully furnished 
aldehyde 151 (Scheme 39b). With this substrate in hand, we next investigated the intramolecular 
NHK coupling. 
 
Scheme 39. Oxidation of terminal alkene 132 to aldehyde 151. 
Treatment of aldehyde 151 with chromium(II) chloride and catalytic amounts of nickel(II) chloride 
should induce the ring closure and form the nine-membered ring. However, no conversion was 
observed (Scheme 40).  
 
Scheme 40. Attempted NHK coupling of 151. 
The preparation of the corresponding diiodoalkene to facilitate the oxidative addition of Ni(0) into 
the carbon-halide bond was also unsuccessful (Scheme 41). 
 
Scheme 41. Attempted preparation of diiodoalkene 154. 
In parallel, we also investigated the application of a Heck reaction. 
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3.4.3 Intramolecular Heck Reaction 
In general, the 8-exo-trig cyclization is favored over the 9-endo-trig cyclization in intramolecular 
Heck reactions. This can be mainly attributed to a lesser steric hindrance associated with the 
intermediate palladacycle in the 8-exo-trig cyclization mode.87 Nevertheless, the use of phosphine-
free88–90 palladium(0)-catalyzed Heck coupling conditions was found to result in the formation of 
nine-membered rings via the 9-endo-trig cyclization mode.91 This reaction, however, is highly 
substrate-dependent and no generally applicable method for the synthesis of nine-membered 
carbocycles via intramolecular Heck reaction has been described to date. Unfortunately, alkene 132 
decomposed under the harsh reaction conditions and no cyclization was observed (Scheme 42). 
 
Scheme 42. Attempted 9-endo Heck cyclization. 
3.4.4 Radical Cyclization 
In another approach, we envisioned closing the nine-membered ring by means of a radical 
cyclization of chloro enone 156. Generation of an allylic radical from an allylic chloride using free 
radical conditions and subsequent cyclization onto the exo-enone moiety, should afford the desired 
cyclononene motif (Scheme 43). 
 
Scheme 43. Proposed radical cyclization for the synthesis of the (E)-cyclononene. 
The radical cyclization precursor should be readily accessible by employing a similar synthetic 
strategy as before. The vinyl bromide building block was slightly modified, as illustrated in 
Scheme 44. First, reduction of tert-butyl ester 137 with DIBAL-H afforded aldehyde 159, which 
was converted to conjugated methyl ester 160 by Wittig olefination. Next, reduction with 
DIBAL-H, followed by conversion of the generated alcohol 161 to its silyl ether gave vinyl bromide 
136 in high yield (Scheme 44). 
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Scheme 44. Three-step procedure for the synthesis of vinyl bromide 136. 
With gram quantities of vinyl bromide 136 in hand, β-hydroxy ketone 163 could be prepared by 
using the previously optimized three-step procedure (Scheme 45). The following elimination of the 
primary alcohol was best achieved by treatment of 163 with dicyclohexylcarbodiimide (DCC) in 
the presence of copper(I) chloride.92 The direct introduction of the conjugated exo-methylene group 
was also investigated by reaction of TMS enol ether 162 with Eschenmoser’s salt 
(dimethylmethylideneammonium iodide)93 (not shown). However, the reaction afforded a mixture 
of different unidentified products. Thus, the sequence shown in Scheme 45 was used for the 
preparation of enone 164. Deprotection of the silyl ether with triethylamine trihydrofluoride and 
chlorination of the allylic alcohol finally afforded allylic chloride 156. 
 
Scheme 45. Preparation of enone 156. 
With substrate 156 in hand, the free radical cyclization was investigated (Table 13). The initial 
attempt to convert enone 156 to bicycle 158 in the presence of n-Bu3SnH and AIBN at 80 °C was 
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discouraging and resulted in decomposition (entry 1). Next, a solution of n-Bu3SnH/AIBN was 
added dropwise via syringe pump which led to the isolation of reduction product 166 in low yield 
(entry 2). This result implied that palladium impurities in the reaction mixture catalyzed a 
hydrostannylation reaction of enone 156 at the expense of the radical cyclization. This undesired 
side reaction could be suppressed when the reaction was performed in new glass ware with new stir 
bars, but only decomposition was observed. 
Table 13. Radical cyclization conditions. 
 
Entry Conditionsa Observation 
1b n-Bu3SnH, AIBN decomposition 
2c n-Bu3SnH, AIBN 166 (27%) + decomposition 
3c,d n-Bu3SnH, AIBN decomposition 
aAll reactions were performed in degassed benzene at 80 °C. bThe substrate was premixed with the reagents. cSlow addition 
(1 h 20 min) of n-Bu3SnH and AIBN via syringe pump. 
dNew glass ware and a new magnetic stir bar were used. 
As attempts for the free radical cyclization of enone 156 gave only unsatisfactory results, we 
decided to base our investigations on more stable key step precursors. 
3.4.5 Barbier Reaction 
Another popular ring closing method is the Barbier reaction, a nucleophilic addition reaction of 
halocarbonyl compounds in the presence of reductants (Scheme 46). 
 
Scheme 46. Attempted Barbier cyclization. 
The precursor for this key reaction could be easily accessed from previously prepared β-hydroxy 
ketone 163. A suitable protecting group needed to be installed to further transform the dihydropyran 
core. For this purpose, we intended to directly introduce an acetate protecting group, but treatment 
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of 163 with acetic anhydride in the presence of pyridine resulted in elimination affording an 
exocyclic methylene group (not shown). Thus, a TES ether was chosen as protecting group and 
alcohol 168 was subjected to standard silylation conditions (Scheme 47). Treatment of ketone 168 
with LHMDS and PhNTf2 afforded vinyl triflate 169. A palladium-catalyzed reduction of the vinyl 
triflate to enol ether 170 resulted in partial cleavage of the TES ether and provided a mixture of 
alcohol 171 and TES ether 170. The selective deprotection of the TES ether in the presence of the 
TBS ether with catalytic amounts of pyridinium para-toluenesulfonate (PPTS) afforded primary 
alcohol 171 in high yield, which was converted to acetate 172. The next steps were based on 
previously employed conditions to convert the allylic TBS ether to the corresponding allylic 
chloride, followed by deprotection of the acetate group to afford alcohol 175 in good yields. 
 
Scheme 47. Preparation of allylic chloride 133.  
Unfortunately, attempted oxidation of the alcohol under Swern conditions94 resulted in 
decomposition of the substrate (not shown). Treatment of alcohol 175 with NaHCO3-buffered DMP 
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afforded the aldehyde in moderate yields, which was found to be highly unstable. Consequently, 
aldehyde 133 was prepared and then immediately subjected to different Barbier cyclization 
conditions. 
SmI2-mediated Barbier reactions of halocarbonyl compounds are popular methods for the synthesis 
of five- to eight-membered rings.95 Based on these results, our studies on the Barbier cyclization 
commenced with the use of SmI2 as the reagent of choice (Table 14). The direct Barbier coupling 
of aldehyde 133 in the presence of SmI2 or the SmI2-HMPA complex resulted in decomposition at 
25 °C and in no conversion at −78 °C (entries 1−4). We therefore turned our attention to indium(0)-
mediated allylation reactions which have been described to be α-selective when the reaction was 
performed in water.96 Thus, aldehyde 133 was treated with indium in a mixture of water and 
dichloromethane, but no conversion was observed (entry 5). The addition of tetrabutylammonium 
iodide (TBAI) to the reaction mixture to generate the allylic iodide was also unsuccessful (entry 6). 
Next, the in situ formation of the allylic iodide by treatment of 133 with sodium iodide and 
subsequent addition of SnCl297 cleanly gave alcohol 176 as a diastereomeric mixture, resulting from 
a 7-endo-trig cyclization mode (entry 7). This result was not surprising because γ-allylation 
reactions are usually favored over α-allylation due to higher stabilization of the generated allyl 
anion in γ-position.  
Table 14. Barbier reaction conditions. 
 
Entry Conditions Solvent T (°C) Observation 
1 SmI2, HMPA THF 0 decomposition 
2 SmI2, HMPA THF −78 no conversion 
3 SmI2 THF −78 no conversion 
4 SmI2 THF 25 decomposition 
5 In0 H2O, CH2Cl2 25 no conversion 
6 In0, TBAI H2O, CH2Cl2 25 no conversion 
7 SnCl2, NaI DMF 25 to 60 176 (86% yield) 
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3.4.6 α-Alkylation 
As the Barbier reaction was not applicable to the synthesis of the (E)-cyclononene fragment, the 
next synthetic strategy was based on circumventing the undesired γ-allylation. An intramolecular 
α-alkylation of a sulfone-stabilized carbanion onto an allylic halide was envisaged as key step to 
construct the cyclononene. Although this strategy has been employed in the past for medium-sized 
rings, such as eight-,98 ten-99 and eleven-membered rings,100 the use of this reaction for the 
formation of nine-membered rings is unprecedented.  
Starting from triflate 169 as a common intermediate, the phenylsulfonyl group was introduced by 
conversion of alcohol 177 to iodide 178 and by subsequent nucleophilic displacement of the iodide 
with sodium benzene sulfinate (Scheme 48). To our surprise, the yield of this transformation was 
unexpectedly low and it was found that a competing elimination reaction generated a diene. All 
attempts to improve the yield of the nucleophilic displacement product 179 were unsuccessful (e.g. 
different reaction solvents, temperature and bases) (not shown). While the yield of this 
transformation was only moderate, the reaction provided ample material to proceed with the 
synthesis. Deprotection of the silyl ether and mesylation of the generated allylic alcohol gave an 
allylic mesylate, which was directly subjected to a THF-solution of lithium bromide to afford allylic 
bromide 180. 
 
Scheme 48. Preparation of sulfone 180 and attempted α-alkylation. 
Next, the intramolecular α-alkylation of sulfone 180 was examined to construct the nine-membered 
carbocycle. To our disappointment, we were unable to realize this transformation. Treatment of 
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180 with different bases only resulted in the formation of a complex product mixture. We reasoned 
that the triflate might interfere with the α-alkylation reaction and decided to proceed with an enol 
ether moiety instead. Thus, alcohol 171 was used as starting material (Scheme 49). By employing 
the same transformations as described before (see Scheme 48), the sulfone group and the allylic 
bromide were introduced to afford cyclization precursor 134. Interestingly, lower C–H acidity at 
C3 position of enol ether 182 as compared to vinyl triflate 178 resulted in an increased yield for the 
sulfonylation reaction. We additionally prepared the corresponding allylic chloride 184. 
 
Scheme 49. Synthesis of sulfones 184 and 134. 
With sulfones 184 and 134 in hand, we proceeded to the investigation of the intramolecular 
α-alkylation (Table 15). 
Table 15. Cyclization of sulfones 184 and 134. 
 
Entry Substrate Base, Additive T (°C) t (h) Yielda 
1b 184 LHMDS 60 6 10% 
2b 184 KHMDS, 18-crown-6 60 2 0% (decomposition) 
3b 134 KHMDS 0 to 25  1.25 0% (decomposition) 
4c 134 NaHMDS 0 1.25 67% 
aIsolated yield. b Dropwise addition of base to 184 or 134. cDropwise addition of 134 to base. 
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First, LHMDS or KHMDS/18-crown-6 were slowly added to a solution of sulfone 184 at 60 °C 
(entries 1, 2). While 10% yield of bicycle 185 were obtained with LHMDS as base, a complex 
product mixture was isolated when KHMDS/18-crown-6 was used. When substrate 134 was treated 
with KHMDS at 0 °C, decomposition was observed (entry 3). Fortunately, slow addition of 
NaHMDS (4.1 equiv) to 184 at 0 °C afforded bicycle 185 in good yield and as a single diastereomer 
(entry 4). This example highlights the utility of sulfonyl group for α-regioselective cyclization 
reactions. 
With this successful method for the direct formation of the (E)-cyclononene in hand, the next goal 
in the synthesis of waixenicin A (11) was the removal of the phenylsulfonyl group. Several standard 
conditions for the reductive desulfonylation were employed as shown in Table 16.  
Table 16. Screening of desulfonylation conditions. 
 
Entry Conditions T (°C) Observation 
1 Mg (exess), MeOH 23 to 50 complex mixture 
2 Mg (exess), NiBr2, MeOH 23 to 50 no conversion 
3 Mg (exess), HgCl2 (cat.), MeOH 23 complex mixture 
4 Mg (3.0 equiv), NaH2PO4, HgCl2 (cat.), 
THF, EtOH 
23 to 50 no conversion 
5 SmI2, HMPA, t-BuOH –78 to 23 no conversion 
6 Al(Hg), THF, H2O 25 to 50 no conversion 
7 Al, HgCl2, MeOH 60 no conversion 
8 Na(Hg), NaH2PO4, THF, MeOH 23 no conversion 
9 Na(Hg) (20 equiv), Na2HPO4, MeOH, 
THF 
23 complex mixture 
10 Raney-Ni (2800), EtOH 70 complex mixture 
11 Raney-Ni (2800), THF 25 complex mixture 
12 NiCl2 • 6 H2O, NaBH4 25 no conversion 
13 Lithium naphthalenide, THF –78 complex mixture 
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Unfortunately, an extensive screening of reaction conditions for the reductive desulfonylation was 
unsuccessful and either no conversion or complete decomposition of the starting material was 
observed. At this point, it remained unclear if the enol ether moiety or a subsequent intramolecular 
reaction with one of the double bonds of the cyclononene were responsible for the formation of 
complex product mixtures. 
Further attempts to reduce sulfone 185 to the corresponding sulfide also proved to be unsuccessful 
(Scheme 50).  
 
Scheme 50. Attempted reduction of sulfone 185. 
Given the difficulties encountered with the reductive desulfonylation of 185, we next investigated 
the oxidation of the alkyl sulfone to the corresponding ketone 187 or alcohol 189 (Scheme 51).101 
 
Scheme 51. Attempted oxidation of sulfone 185 (MoOPH = oxodiperoxymolybdenum(pyridine)-
(hexamethylphosphoric triamide)). 
Since none of the reactions resulted in consumption of the starting material 185, it was examined 
if the deprotonation at C4 position was feasible. Thus, sulfone 185 was treated with LHMDS 
(6 equiv) at 0 °C for 45 min before an excess of deuterium oxide was added. NMR studies revealed 
that no deuterium incorporation at C4 position took place (Scheme 52). 
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Scheme 52. Deuterium incorporation experiment. 
We reasoned that the general sterical hindrance in the nine-membered ring prevented deprotonation 
of the methine proton at C4 position. This explanation was substantialized by the optimized 
structure of sulfone 185 at the ωB97X-D/6-31G* computational level of theory, which further 
demonstrated the sterically challenging environment of the proton (Scheme 53). 
 
Scheme 53. DFT-optimized molecular structure of bicycle 185. 
Another strategy to remove the sulfonyl group was based on the change of the electronic properties 
of the aryl group. We reasoned that the introduction of more electron-deficient aryl substituents 
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would facilitate reductive cleavage of the sulfonyl group and would allow for the use of milder 
conditions. Thus, the preparation of a series of electron-deficient sulfinate salts was examined. In 
general, sodium aryl sulfinates can be either prepared by reduction of the corresponding aryl 
sulfonyl chlorides102 or by oxidation of the corresponding aryl thiols under basic conditions.103 The 
first strategy was applied for the syntheses of sodium 4-(trifluoromethyl)benzene sulfinate (192) 
and sodium 3,5-bis(trifluoromethyl)benzene sulfinate (194). The corresponding pyridine and 
pyrimidine sulfinate salts 196 and 198 were prepared by oxidation with hydrogen peroxide 
(Scheme 54).  
 
Scheme 54. Preparation of different sodium arylsulfinates. 
While none of the reactions resulted in selective formation of the sulfinate salts, tedious purification 
by recrystallization from ethanol was necessary to obtain pure material. To our surprise, when 
iodide 182 was reacted with the different sulfinate salts 192, 194, 196 and 198 using the previously 
optimized reaction conditions, the corresponding elimination product was always obtained as the 
major, if not the only, product (Table 17). The installation of electron-withdrawing substituents on 
the aryl moiety apparently had a dramatic effect on the nucleophilicity of the sulfinate salts. 
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Table 17. Introduction of different sulfones. 
 
Entry R Product Yielda  
1 Ph 183 45–50% 
2 3,5-(CF3)2-C6H3 199 0% 
3 4-CF3-C6H4 200 23% 
4 pyrimidine 201 0%b 
5 pyridine 202 16% 
aIsolated yield. bThe reaction was also performed in MeCN at 25 °C and 50 °C, but no yield improvement was observed. 
Given these results, we decided to abandon this strategy and examined the oxidation of the 
corresponding sulfides instead. By contrast to the nucleophilic substitution with sulfinate salts, the 
synthesis of the sulfides from primary iodide 182 gave the products in high yields and no competing 
elimination reaction was observed. Pyrimidine sulfide 203 was chosen as substrate for a screening 
of different oxidation conditions (Table 18). While the use of m-CPBA, magnesium 
monoperoxyphthalate (MMPP) and ammonium molybdate/hydrogen peroxide104 resulted in the 
formation of complex product mixtures (entries 1−4), no reaction was observed when manganese 
sulfate/hydrogen peroxide105 or TPAP/NMO106 were used (entries 5, 6). 
Table 18. Screening of oxidation conditions for sulfide 203. 
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Entry Oxidant(s) Solvent T (°C) Yield 
1 m-CPBA CH2Cl2 0 0% 
2 m-CPBA CH2Cl2 −30 0% 
3 silica supported MMPP CH2Cl2 40 0% 
4 H2O2, (NH4)6Mo7O24 EtOH 25 0% 
5 H2O2, MnSO4·H2O MeCN 25 0% 
6 TPAP, NMO, 4 Å MS MeCN 25 0% 
aIsolated yield. (MMPP = magnesium monoperoxyphthalate, TPAP = tetrapropylammonium perruthenate). 
We reasoned that the electron-rich C−C double bond of the enol ether is very susceptible to attack 
by electrophiles and thus decided to use vinyl triflate 178 instead (Table 19). While the use of 
m-CPBA as oxidant resulted both in oxidation of the sulfide to the sulfoxide and in epoxidation of 
the trisubstituted double bond (entry 1), the use of sodium tungstate/hydrogen peroxide107 (entry 2) 
resulted in no conversion. In constrast, an ammonium molybdate catalyzed hydrogen peroxide 
oxidation procedure gave low amounts of the product, when 10 mol% of the catalyst was employed 
(entry 3). When 50 mol% of the catalyst were used, the reaction afforded sulfone 206 in 21% yield 
on a 28 mg scale (entry 4). To our surprise, the yield was increased to 94%, when the reaction was 
performed with 15 mol% catalyst on a 13 mg scale (entry 5). However, all attempts to repeat this 
result by employing between 10 and 20 mol% of the catalyst only gave inconsistent results and this 
route was therefore not further pursued.  
Table 19. Screening of oxidation conditions for sulfide 205. 
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Entry Oxidant(s) Solvent T (°C) Yielda 
1 m-CPBA CH2Cl2 0 0% 
2 H2O2, Na2WO4·2 H2O EtOAc, H2O 25 0% 
3 H2O2, (NH4)6Mo7O24 EtOH 25 ~10%b 
4 H2O2, (NH4)6Mo7O24 EtOH 25 21%c 
5 H2O2, (NH4)6Mo7O24 EtOH 25 94%d 
aIsolated yield. b10 mol% of the catalyst were used. c50 mol% of the catalyst were used. d15 mol% of the catalyst were used.  
3.4.7 Side Chain Introduction 
Due to these unsuccessful results, we abandoned these investigations at this stage to further explore 
the introduction of the side chain of the natural product by functionalization of the enol ether. We 
reasoned that a higher substitution of the enol ether would lead to an enhanced stability of this base 
and acid labile group for desulfonylation reactions. Therefore, model substrate 209 was efficiently 
prepared in four steps from racemic enone 20 (Scheme 55).  
 
Scheme 55. Preparation of model substrate 209. 
In general, we envisioned two different strategies for the introduction of the side chain 
(Scheme 56). First, a coupling of the corresponding vinylic organometallic species 211 with known 
aldehyde 14 and second, allylation of α,β-unsaturated aldehyde 213. 
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Scheme 56. Two different strategies for the introduction of the side chain. 
With model substrate 209 in hand, the halogenation of the enol ether was examined first. Treatment 
of 209 with NIS or NBS and silver nitrate108 in the presence or absence of NaHCO3 as buffer 
resulted in full decomposition of the starting material (Scheme 57a).  
 
Scheme 57. Attempted (a) halogenation, (b) formylation and (c) acylation of enol ether 209. 
Next, enol ether 209 was subjected to the Vilsmeier reagent, prepared from either POCl3/DMF or 
(COCl)2/DMF. While trace amounts of the desired aldehyde were observed by 1H NMR 
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spectroscopy, the product could not be isolated (Scheme 57b). Vilsmeier acylation with acetyl 
chloride as a model substrate for the side chain was also unsuccessful (Scheme 57c). 
Given these difficulties encountered with the functionalization of the enol ether, we set out to 
functionalize the vinyl triflate at an early stage of the total synthesis. Our first idea for the 
introduction of the side chain was the reductive coupling between triflate 169 and literature-known 
aldehyde 1438 (Scheme 58). However, treatment of aldehyde 14 and vinyl triflate 169 with an 
excess of chromium(II) chloride and catalytic amounts of nickel(II) chloride resulted in no 
conversion. It was assumed that the low reactivity of the triflate hampered a successful reaction. 
The use of 4-tert-butyl pyridine as additive has been described to generally enhance the reaction 
rate by dissolving solid chromium(II) salts and by suppressing homo coupling reactions. With the 
addition of 4-tert-butyl pyridine, vinyl triflates have been found to show good reactivity under NHK 
conditions.109 However, no conversion was observed when 4-tert-butyl pyridine was added to the 
NHK reaction mixture of aldehyde 14 and vinyl triflate 169. 
 
Scheme 58. Attempted NHK coupling. 
Our next synthetic strategy was based on the conversion of the triflate to the corresponding α,β-
unsaturated aldehyde. The aldehyde should then later be functionalized by Mukaiyama aldol 
reaction or by asymmetric allylation to install the side chain of the natural product. Initial studies 
for the introduction of the aldehyde were directed to palladium-catalyzed carbonylation reactions 
(Scheme 59). In a first attempt, the TES protecting group of triflate 169 was found to be unstable 
under these conditions and only trace amounts of lactone 216 could be isolated. Thus, the reaction 
was repeated by using sulfone 179 instead, but the yield could only be slightly improved. 
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Scheme 59. Palladium-catalyzed carbonylation reactions.  
Next, palladium-catalyzed hydroxymethenylation of triflate 169 with Bu3SnCH2OH under Stille 
conditions was examined (Table 20). In a first attempt, reduction product 170 was obtained as major 
product (43% yield) together with the desired alcohol 218 (23% yield, entry 1). By changing the 
solvent from THF to 1,4-dioxane the yield increased to 47% after 2 h at 60 °C (entry 2). The use of 
Pd(dba)2, P(o-fur)3 and ZnCl2 in THF at 60 °C resulted in decomposition (entry 3). 
Table 20. Stille conditions. 
 
Entry Conditions Solvent Yielda 
1 Pd(PPh3)4, LiCl THF 218 (23%), 170 (43%) 
2 Pd(PPh3)4, LiCl 1,4-dioxane 218 (47%), 170 (17%) 
3 Pd(dba)2, P(o-fur)3, ZnCl2 1,4-dioxane decomposition 
aIsolated yield. 
With alcohol 218 in hand, oxidation to the aldehyde was investigated (Table 21). Initially, treatment 
of alcohol 218 with DMP or activated manganese dioxide resulted in no product formation (entries 
1, 2). The use of Ley−Griffith oxidation conditions110 (TPAP, NMO) finally gave aldehyde 219 in 
good yields (entry 3). 
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Table 21. Oxidation conditions. 
 
Entry Conditions Observation 
1 DMP, NaHCO3 complex mixture 
2 MnO2 no conversion 
3 NMO, TPAP, 4 Å MS 219: 58% yield 
 
Starting from aldehyde 219, different ways for the introduction of the side chain were examined. 
First, a boron trifluoride-mediated Mukaiyama aldol reaction of literature-known TBS ketene 
acetal 220111 with aldehyde 219 should afford alcohol 221, but the TES ether was deprotected under 
these conditions (Scheme 60). Next, treatment of 219 with the lithium enolate of tiglic acid methyl 
ester (222) in the presence of HMPA should give the product under milder conditions, but no 
conversion was observed.  
 
Scheme 60. Unsuccessful introduction of the side chain by Mukaiyama aldol reaction or by addition of a 
lithium enolate. 
Given these difficulties with the functionalization of aldehyde 219, an allylation/olefin cross 
metathesis sequence was pursued. Introduction of the ally group by reaction of aldehyde 219 with 
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ally magnesium bromide afforded alcohol 223 as a mixture of diastereomers (d.r. = 1:1) 
(Scheme 61).  
 
Scheme 61. Reaction of aldehyde 219 with allyl magnesium bromide. 
Olefin cross metathesis of the terminal alkene with a large excess of methyl methacrylate 
(30 equivalents) should then introduce the upper part of the side chain, but the formation of a 
complex product mixture was observed instead (Scheme 62). To verify if the free allylic hydroxyl 
group of 223 could be responsible for this observation, alcohol 223 was oxidized to ketone 224. 
The allylic ketone was then directly subjected to the previously employed olefin cross metathesis 
conditions. Again, a complex product mixture was obtained. 
 
Scheme 62. Unsuccessful allylation/olefin metathesis strategy. 
The control of regioselectivity appeared to be a major problem in this reaction. In general, α,β-
unsaturated esters are excellent cross metathesis partners with terminal alkenes.112 The choice of 
catalyst could be crucial for a regio- and stereoselective olefin cross metathesis of  the terminal 
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alkene with methyl methacrylate. Future studies should therefore be focused on the screening of 
different cross metathesis catalysts. 
Following a different idea, the introduction of a higher substituted allyl group was examined by 
using 3,3-dimethylallyl bromide as model substrate. Certain titanium(III)113- or indium(0)-
mediated96 allylation reaction are known to proceed with high α-regioselectivity and were therefore 
the methods of choice for the allylation of aldehyde 219. To our surprise, no conversion was 
observed under both conditions (Scheme 63). 
 
Scheme 63. Attempted α-allylation reactions. 
Further studies on the introduction of the side chain are currently under investigation in our 
laboratory.  
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4 Summary and Outlook 
Progress toward the total synthesis of the Xenia diterpenoid waixenicin A (11) has been detailed in 
this thesis. At first, the characteristic (E)-cyclononene fragment has been constructed by employing 
a Grob fragmentation strategy. However, the installation of the dihydropyran ring trans-fused to 
the (E)-cyclononene was found to be challenging with this synthetic strategy. Thus, the direct 
synthesis of the nine-membered ring from acyclic precursors has been studied in detail. These 
studies resulted in the development of an enantioselective and versatile route for the synthesis of 
the core structure of the natural product.  
Starting from enantiomerically pure enone 20 and readily available vinyl bromide 136, we prepared 
β-hydroxy ketone 163 in three steps by diastereoselective cuprate addition, trapping of the 
generated enolate as its TMS enol ether and subsequent Mukaiyama aldol reaction with 
formaldehyde (Scheme 64). 
 
Scheme 64. Convergent asymmetric synthesis of the core structure of waixenicin A (11) and DFT-optimized 
structure of sulfone 185. 
In this transformation, the stereocenter of the acetal group directed the formation of the two 
contiguous stereocenters at C2 and C3. Subsequent introduction of the enol ether motif was 
achieved by triflation of the ketone and reduction of the resultant vinyl triflate to alkene 171. In 
four additional steps, the phenylsulfonyl group and the allylic bromide were introduced. The 
challenging cyclization to form the (E)-cyclononene fragment was successfully achieved by a 
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sulfonyl-anion mediated α-alkylation. It is noteworthy that the cyclization resulted in the formation 
of sulfone 185 as a single diastereomer. 
With an established route toward the core structure of the natural product in hand, we extensively 
investigated conditions for the reductive desulfonylation of the phenylsulfonyl group of 185. As 
sulfone 185 proved to be challenging to reduce under several conditions, we resorted to introduce 
the side chain of waixenicin A (11) prior to the key cyclization to enhance the stability of the enol 
ether motif. In initial experiments, we succeeded in transforming the vinyl triflate 169 to aldehyde 
219 (Scheme 65). The introduction of an allyl group has also been established and future studies 
should be directed to the introduction of the allylic fragment of the side chain of the natural product. 
 
 
Scheme 65. Functionalization of triflate 169. 
Afterwards, the substrate should be further transformed to allylic bromide 228. The intramolecular 
base-mediated α-alkylation using previously established conditions should then afford sulfonyl-
waixenicin A analog 229, which should be subjected to late-stage desulfonylation conditions 
(Scheme 66). 
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Scheme 66. Synthesis of sulfonyl-waixenicin A analog 229 en route to waixenicin A (11). 
In an alternative approach, allylic sulfone 231 should be prepared and the realization of an 
intramolecular α-alkylation reaction should be investigated. The resulting sulfone 232 could then 
be reduced using significantly milder desulfonylation conditions, e.g. lithium 
triethylborohydride/Pd(dppp)Cl2 (Scheme 67). 
 
 
Scheme 67. Envisioned synthesis of allylic sulfone 232 and palladium-catalyzed reduction of the sulfonyl 
group. 
Overall, the pursued strategies presented in this thesis constitute significant progress toward the 
first total synthesis of waixenicin A (11) or any member of the xenicin subfamily of natural 
products. The developed convergent and asymmetric route to the bicyclic core structure of 
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waixenicin A (11) provides a basis for further efforts toward these structurally unique natural 
products. Further studies on the completion of the total synthesis of waixenicin A (11) are currently 
under investigation in the Magauer laboratories. 
 
 
  
 
 
 
 
 
 
 
 
PART II 
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5 Introduction 
5.1 Monoterpene Indole Alkaloids 
Monoterpene indole alkaloids are one the largest classes of alkaloids, comprising over 2000 
members.114 The individual compounds are mainly derived from plants of three families: 
Rubiaceae, Loganiaceae and Apocynaceae. Some representative members of this class of natural 
products and their biological functions are shown in Figure 6. Many members of the monoterpene 
indole alkaloids exhibit promising biological effects including anti-cancer (e.g. vinblastine (233), 
brucine (235)), anti-malarial, anti-hypertensive (e.g. ajmalicine (234)) or insecticidal (e.g. 
aspidophytine (236)) activities. For decades, these remarkable biological features and their 
interesting structural complexity rendered these alkaloids attractive targets for synthetic and 
medicinal chemists.  
 
Figure 6. Representative members of the monoterpene indole alkaloid family and their biological features. 
The indole subunits are highlight in blue 
5.2 Biosynthesis of Monoterpene Indole Alkaloids 
Monoterpene indole alkaloids are biosynthetically derived from two building blocks: secologanin 
(239) and tryptamine (241).114,115 Secologanin (239) itself is a natural product derived from the 
monoterpene geraniol (237).116–118 Tryptamine (241) is obtained by an enzymatic decarboxylation 
of tryptophan (240).119 In the first step of the biosynthesis, an enzymatic Pictet−Spengler reaction120 
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between secologanin (239) and tryptamine (241) leads to strictosidine (242) (Scheme 68). The 
Cinchona alkaloids are directly derived from this intermediate. Next, strictosidine (242) is 
deglycosylated to give a reactive hemi-acetal,121 which opens to form dialdehyde 243. This 
intermediate reacts with the secondary amine to form iminium ion 244, which can either directly 
lead to the Yohimbinoid alkaloid family or to geissoschizine (245) after reduction. The Ajmalicine 
alkaloids are in turn derived from geissoschizine (245).  
 
Scheme 68. Biosynthetic pathway to geissoschizine (245). 
The entrance into the Vinca, Aspidosperma and Strychnos alkaloids starting from 
geissoschizine (245) is less understood (Scheme 69). The exact mechanism of the formation of 
preakuammicine (246) from geissoschizine (245) has not been fully elucidated to date. An 
isomerization of the exocyclic double bond to form an enamine affords intermediate 248, which 
forms dehydrosecodine (249) after a ring-opening reaction through enzymatic dehydroxylation. 
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The Iboga alkaloids are biosynthetically derived from dehydrosecodine (249). A Diels−Alder 
reaction is then believed to result in the formation of tabersonine (250) and a final reduction step 
should lead to vincadifformine (251), an archetypical member and precursor for various members 
of the Vinca, Aspidosperma and Strychnos alkaloids. 
 
Scheme 69. Biosynthetic pathway from geissoschizine (245) to tabersonine (250) and vincadifformine (251). 
5.3 Jerantinines A−G 
The monoterpene indole alkaloids jerantinine A−G (252−258) were isolated from leaf extracts of 
the Malayan plant Tabernaemontana corymbose of the Apocynaceae family in 2008 (Figure 7a).122 
These secondary metabolites belong to the Aspidosperma alkaloid subclass, which all have a 
characteristic pentacyclic [6.5.6.6.5]-ring system with an indole substructure in common. All 
compounds were isolated by extraction of the ground leaf material with ethanol and dilute acid, 
followed by separation of the individual compounds by column chromatography on silica gel using 
dichloromethane and varying amounts of methanol. Jerantinine A (252) constitutes the major 
compound isolated from the leaf extract.  
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Figure 7. a) Tabernaemontana corymbose§§ and b) jerantinines A−G (252−258). 
Preliminary studies on the cytotoxicity of these alkaloids revealed in vitro cytotoxicity against 
human KB cells (IC50 = 0.28−5.1 μM) with jerantinine D (255) being the most potent compound 
(IC50 = 0.28 μM).122 It was furthermore discovered that acetylation of jerantinine A (252) and 
B (253) resulted in an enhancement of the cytotoxic effect. Given these promising cytotoxic 
activities of the jerantinines, further biological studies have been directed toward a better 
understanding of these effects. Jerantinine A (252), B (253) and E (256) were later described as 
microtubule disrupting agents (MDA) which act by inhibition of tubulin polymerization and by 
inducing G2/M cell cycle arrest.123–126 Natural product MDAs find use in chemotherapy because 
cancer cells grow more quickly than normal cells through continuous mitotic division. Thus, these 
                                                     
§§ photograph by BernhardM, distributed under a CC-BY-SA 2.5 license. 
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cells are sensitive to inhibition of mitosis. MDAs prevent cells from undergoing mitosis by 
disrupting microtubule polymerization by interfering with either the assembly or the disassembly 
of microtubule polymers.127 One commonly used and effective MDA for the treatment of several 
types of cancer (e.g. breast cancer) is paclitaxel (259) (brand name: taxol). Paclitaxel acts by 
stabilizing the microtubule polymer and thus protects it from disassembly.  
 
Figure 8. The MDA paclitaxel (259) (brand name: taxol). 
5.4 Selected Examples of Synthetic Strategies Toward Aspidosperma Alkaloids 
Due to their structural complexity and their remarkable biological activities, monoterpene indole 
alkaloids have been attractive targets for synthetic chemists for several decades. Many of these 
unique secondary metabolites have been synthesized in the past and several different synthetic 
approaches have been described in the literature.115 Given the numerous synthetic strategies, this 
paragraph only highlights some recent syntheses of Aspidosperma alkaloids with a focus on the 
construction of the tricyclic tetrahydrocarbazolone core (highlighted with bold bonds). 
In the first two examples, the construction of the tetrahydrocarbazolone core was realized by 
employing a condensation/C−H bond activation sequence. In 2013, Qiu et al. reported an 
asymmetric total synthesis of (−)-aspidophytine (236) from chiral 1,3-diketone 261 and 
2,3-dimethoxyaniline (262).128 Enantiopure 1,3-diketone 261 was in turn prepared from known 
phenylthioether 260 in four steps. The tricyclic tetrahydrocarbazolone core was constructed by a 
condensation reaction of 1,3-diketone 261 and 2,3-dimethoxyaniline (262), followed by a 
palladium-catalyzed oxidative indole formation. Further 16 steps then completed the total synthesis 
of (−)-aspidophytine (236) (Scheme 70).  
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Scheme 70. Qiu’s total synthesis of (−)-aspidophytine (236). 
A similar synthetic strategy was employed by Shao et al. in 2014 for the asymmetric total syntheses 
of four different Aspidosperma alkaloids, including aspidospermine (269).129 In his work, the 
tetrahydrocarbazolone core fragment 267 was prepared from 1,3-cyclohexadione (266) and 
2-methoxyaniline (265) by TsOH-mediated condensation and subsequent oxidative indole 
formation (Scheme 71). In contrast to Qiu’s work, this tricyclic intermediate was functionalized 
after its formation in further four steps to give tricycle 268. The synthesis of the natural product 
was then finalized in five steps.  
 
Scheme 71. Shao’s total synthesis of (+)-aspidospermine (269). 
In another approach for the formal synthesis of racemic aspidospermidine (269), an efficient 
palladium(II)-catalyzed tandem reaction was employed for the synthesis of the tricyclic 
tetrahydrocarbazolone core of the Aspidosperma alkaloids (Scheme 72).130 First, the indole core 
was generated by an intramolecular aminopalladation of the alkyne moiety. Second, the Pd(II)-
indole intermediate 271 attacked the nitrile group to form the C ring. Furthermore, the addition of 
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para-toluenesulfonic acid (TsOH) resulted in a deprotection of the acetal moiety to afford 
aldehyde 272. Further three steps then completed the formal synthesis of aspidospermidine (269). 
 
Scheme 72. Palladium(II)-catalyzed tandem cyclization reaction for the synthesis of the ABC core of 
aspidospermidine (269). 
The first synthesis of a member of the jerantinines was reported by Waser in 2013 (Scheme 73).126  
For the synthesis of jerantinine E, Waser commenced with commercially available δ-valerolactone 
(273). A selective copper(II)-triflate catalyzed cyclization of aminopropane 274 (formal homo-
Nazarov reaction) was employed as key reaction for the synthesis of the tetracyclic core structure 
of jerantinine E (256). The synthesis of jerantinine E (256) was then finalized in further eight steps. 
 
Scheme 73. The Waser synthesis of jerantinine E (256). 
Inspired by the proposed biosynthesis of the Aspidosperma alkaloids (see chapter 5.2), several 
approaches on the utilization of indole-linked δ-lactam intermediates for the construction of the 
pentacyclic core structure of these natural products have been described recently. In 2012, 
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Movassaghi et al. reported a unique synthetic strategy for a group of structurally related 
Aspidosperma alkaloids via a double-cyclization cascade of lactam 278.131 The lactam 278 was 
prepared from C2-chlorinated tryptamine 276 and amide 277 in two steps. The remarkable key step 
to generate diiminium ion 279 was realized by treatment of amide 278 with trifluorosulfonic 
anhydride (Tf2O) and a pyridine base. Diimimium ion 279 could then be either transformed to 
(+)-N-methylquebrachamine (281) or to (−)-N-methylaspidospermidine (280) in further two steps, 
respectively (Scheme 74). 
 
Scheme 74. Movassaghi’s synthesis of different Aspidosperma alkaloids. 
Movassaghi and Hoveyda later employed a similar synthetic strategy for the total synthesis of the 
Aspidosperma alkaloid (−)-deoxoapodine (286).132 For the preparation of the key step precursor, 
an enantioselective ring-closing metathesis reaction was employed to afford amide 283 
(Scheme 75). Amide activation with tributyltin hydride (n-Bu3SnH) and Tf2O then afforded 
iminium ion 284, which could be in situ reduced with sodium borohydride to give the characteristic 
pentacyclic core structure of the Aspidosperma alkaloids. Further five steps, including a 
transannular spirocyclization, finalized the total synthesis of (−)-deoxoapodine (286). 
Introduction 
97 
 
 
Scheme 75. Movassaghi’s and Hoveyda’s asymmetric total synthesis of (−)-deoxoapodine (286) (R = 
para-nitrobenzoyl). 
In 2016, Dixon et al. reported the development of a unique cascade reaction for the synthesis of a 
group of Aspidosperma alkaloids.133 Their key step precursor was an indole-linked δ-lactam (287), 
which was reduced to reactive enamine 288 in the presence of tetramethyldisiloxane (TMDS) under 
iridium(I)-catalysis (Scheme 76). This enamine then underwent an enamine Michael addition to 
afford betaine 289. In two competing pathways, betaine 289 was either converted to 
(±)-vincaminorine (290) by reduction of the iminium ion (path a) or to (±)-minovine (291) via a 
transannular Mannich reaction (path b). Later, three other Aspidosperma-type alkaloids have also 
been synthesized by using this method.133 
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Scheme 76. Dixon’s unique cascade reaction for the total synthesis of (±)-vincaminorine (291) and 
(±)-minovine (290). 
In another biomimetic approach, Oguri et al. prepared artificial intermediates 294a−c for the 
syntheses of five skeletally different indole alkaloid scaffolds (Scheme 77).134 Their synthetic 
strategy was based on the imitation of the common biosynthetic intermediate 
dehydrosecodine (249), which was further converted to different types of monoterpene indole 
alkaloids via distinct [4+2] cycloadditions (see chapter 5.2). Starting from tryptamine 
hydrochloride (292), three different ene-ynes 293a−c were prepared in five to six steps. Copper(I)-
catalyzed cyclization of 293a, followed by a one-pot Diels−Alder reaction afforded the skeletal 
scaffold of the Iboga-type alkaloids 296. The Andranginine-type alkaloids could also be accessed 
from 294b by formation of silyl enol ether 297 and by subsequent [4+2] cyclization. Furthermore, 
regioselective hydrogenation of 294c, followed by another Diels−Alder reaction gave the 
Aspidosperma-type scaffold.  
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Scheme 77. Oguri’s biosynthetically inspired syntheses of three different indole alkaloid scaffolds. 
In summary, a large variety of methods have been developed to prepare the Aspidosperma skeleton 
over the past decades. In general, recent efforts toward the synthesis of Aspidosperma alkaloids 
have proceeded to the development of more general synthetic routes for the preparation of a group 
of structurally related indole alkaloids.  
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5.5 β-Halogenated Enones as Versatile Building Blocks*** 
β-Functionalized enones have found widespread application as important building blocks in organic 
synthesis and the corresponding β-acylvinyl anions and cations are important synthons for 
retrosynthetic planning. These compounds have been synthetically accessed by either 
functionalization of enones (Scheme 78a), by conjugate addition of alkynones (b) or by 
transformation of 1,3-diketones (c). 
 
Scheme 78. Strategies for the synthesis of β-functionalized enones. 
In recent years, the direct β-functionalization of enones has only been achieved with heteroatoms 
such as silicon,135 sulfur136–138 and nitrogen,139 but not with halogens. The preparation of 
β-functionalized enones by 1,4-addition to alkynones was limited to acyclic systems and resulted 
in the generation of double bond isomers. For example, β-trimethylsilyl enones have been prepared 
by conjugate addition of  trimethylsilyl halides to alkynones.140–146 Additionally, (Z)-configured 
β-chloroenones have been accessed by Lewis acid catalyzed acylation of alkynes with gallium(III) 
chloride,147 iron(III) chloride,148 or aluminum(III) chloride.149 The formation of β-functionalized 
enones from six-membered 1,3-diketones is a commonly employed standard transformation, 
                                                     
*** This chapter has been adapted from the article “Experimental Studies on the Selective β-C–H Halogenation of Enones” 
− T. Huber, D. Kaiser, J. Rickmeier, T. Magauer, J. Org. Chem. 2015, 80, 2281−2294. 
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especially for the synthesis of β-halogenated enones.150–153 The reaction usually proceeds with high 
regioselectivity if the six-membered 1,3-diketone is substituted symmetrically. The halogenation 
of unsymmetrical substituted 1,3-diketones was found to be unselective and resulted in the 
formation of product mixtures.150  
The commercial availability and the ease of preparation of many α,β-unsaturated carbonyl 
compounds made the development of a direct procedure for the β-C−H halogenation an attractive 
research field. Thus, a novel method for the β-selective bromination and chlorination of five- to 
seven-membered cyclic enones has been developed in the Magauer research laboratories during my 
Master thesis.154 Our developed one-pot three step protocol was based on fundamental work by 
Severin.155,156 In his work, the general strategy was the Umpolung of the electrophilic β-position of 
the carbonyl group through hydrazone formation. The α,β-unsaturated hydrazones could be 
regioselectively halogenated using bromine, chlorine or iodine. Unfortunately, the procedure 
suffered from harsh reaction conditions for the introduction and the cleavage of the hydrazones, as 
well as from incompatibility of the individual steps. We therefore set out to develop a conceptual 
similar methodology that should convert enones to β-halo enones in one flask. Hydrazone formation 
was best achieved by heating a mixture of the enone and tert-butyl carbazate (BocNHNH2) in 
1,2-dichloroethane in the presence of sodium sulfate as drying agent (Scheme 79). The following 
halogenation was then efficiently mediated by N-bromosuccinimide (NBS), or by Palau’chlor (301, 
CBMG = 2-chloro-1,3-bis(methoxycarbonyl)guanidine) in dichloromethane.157 Hydrolysis of the 
hydrazone moiety was achieved by heating the reaction mixture to 50 °C in the presence of 
Amberlyst 15, an acidic ion exchange resin. 
 
Scheme 79. The one-pot procedure for the β-C−H halogenation of enones by the Magauer group. 
These relatively mild conditions allowed us to perform the three individual steps in one flask. With 
the optimized one-pot procedure in hand, cyclic enones with different substitution patterns could 
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be successfully brominated or chlorinated in their β-position. Various functional groups, including 
alkynes, nitriles, esters, alcohols and ethers, were tolerated under these conditions.  
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6 Project Outline 
6.1 Previous Work 
In earlier studies during my Master thesis, a short and modular synthesis of the tricyclic core 
structure of the Aspidosperma alkaloid jerantinine E (256) has been developed to further 
demonstrate the utilization of our newly established one-pot procedure for the selective 
β-halogenation of enones (Scheme 80).154 Racemic enone 302 was readily prepared by alkylation 
of β-ethoxy cyclohex-2-en-1-one with benzyl chloromethyl ether (BOMCl) and subsequent 
Stork−Danheiser enone transposition.158 The following one-pot β-C−H bromination was performed 
in good yield over three steps (44%) on a 5 mmol scale to give β-bromo enone 303. The aromatic 
amine fragment was then installed via palladium-catalyzed amination of β-bromo enone 303 with 
3,4-dimethoxyaniline (304). Palladium-catalyzed oxidative indole formation of enaminone 305 
finally afforded the tricyclic ABC core structure 306 of jerantinine E (256). In conclusion, this 
three-step sequence allowed for the efficient and modular preparation of tetrahydrocarbazolone 
structures. 
 
Scheme 80. Synthesis of the tricyclic jerantinine E core 306. 
6.2 Aims and Significance of the Project 
It was the second goal of this Ph.D. thesis to continue our studies directed toward the total synthesis 
of jerantinine E (256). All retrosynthetic considerations should be based on the use of a substituted 
β-bromo enone as building block, which should be prepared by our one-pot β-C−H bromination 
protocol. While the reported three-step sequence for the construction of the tricyclic core structure 
of jerantinine E (256) has only been carried out in a racemic fashion, future studies should also be 
directed to the realization of an asymmetric synthesis. Compared to other reported synthetic routes 
for the construction of the tetrahydrocarbazolone core structure of Aspidosperma alkaloids, our 
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synthetic approach allows structural modiﬁcations prior to assembly of the tetrahydrocarbazolone 
fragment. This is especially useful for the synthesis of indole alkaloids with a highly oxygenated 
indole core (A/B rings) and/or a highly substituted C ring. Furthermore, the installation of the D 
and E ring of the natural product should be examined. 
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7 Results and Discussion 
7.1 Development of a β-C–H Bromination Approach Toward the Synthesis of 
Jerantinine E 
 
 
 
Reprinted with permission from T. Huber,†
 
T. Preuhs,† C. K. G. Gerlinger, T. Magauer, J. Org. 
Chem. 2017, 82, 7410−7419. Copyright © 2017 American Chemical Society. († = Equal 
contributors.) 
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8 Summary 
The Aspidosperma alkaloids are a large family of secondary metabolites isolated from plants with 
fascinating structures and remarkable biological activities. The jerantinines are members of this 
family that have been isolated in 2008. They were found to be microtubule disrupting agents 
(MDA) and could find use as anti-cancer agents in the future. Jerantinine E (256) has been already 
synthetically accessed in 2013 and our goal was to shorten the synthesis of its core structure by 
employing our previously developed one-pot procedure for the selective β-C−H bromination of 
cyclic enones.  
 
Figure 9. The Aspidosperma alkaloid jerantinine E (256). 
Thus, the successful development of a short and convergent synthesis of the core structure of 
jerantinine E (256) has been detailed in the second part of this thesis. The use of an enone building 
block with a CH2OBn substituent in γ-position, as described earlier, had to be revised due to base 
induced elimination of the benzyl ether under various alkylation conditions. Instead, an enantiopure 
γ-hydroxylated enone could be utilized. Starting with the β-bromination of PMB protected 
enone 307 by using our own methodology, β-bromo enone 308 was obtained (Scheme 81). The 
indole substructure was then constructed via Buchwald−Hartwig amination with 3,4-
dimethoxyaniline (304) and by subsequent palladium-catalyzed oxidative indole formation to 
afford the tricyclic tetrahydrocarbazolone core structure 309 of the natural product. Benzylation of 
the indole fragment gave tricycle 310, whose structure was further proven by single crystal X-ray 
analysis. 
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Scheme 81. Synthesis of the tricyclic tetrahydrocarbazolone core 310) of jerantinine E (256) and its 
molecular structure. 
With an established route for the tetrahydrocarbazolone core in hand, functionalization of the C ring 
for the installation of the D and E ring was investigated. Therefore, various alkylation procedures 
were extensively examined. Unfortunately, direct alkylation of tetrahydrocarbazolone 310 was 
found to be challenging. Thus, ketone ent-310 was converted to its allyl β-keto ester, which was 
then alkylated with readily prepared alkyl iodide 311. The stereocenter at C16 thereby directed the 
alkylation reaction. A diastereoselective palladium-catalyzed decarboxylative allylation reaction 
should later set the quaternary stereocenter at C18. This two-step procedure gave functionalized 
tetrahydrocarbazolone 312, which contained all carbon atoms of the D and E ring of 
jerantinine E (256) (Scheme 82).  
 
Scheme 82. Functionalization of the tetrahydrocarbazolone core ent-310 by acylation and subsequent 
alkylation. 
In future studies, a thorough screening of reaction conditions such as catalysts, ligands, solvents 
and temperatures will be required for the realization of the palladium-catalyzed decarboxylative 
allylation. 
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9 Experimental Section for Part I 
9.1 General Experimental Details 
9.1.1 General Working Methods 
All reactions were performed in glassware fitted with rubber septa under a positive pressure of 
argon, unless otherwise noted. All glassware was dried in an oven at 130 °C prior to use. Air‐ and 
moisture‐sensitive liquids were transferred via syringe or stainless-steel cannula through rubber 
septa. Solids were added under inert gas or were dissolved in appropriate solvents. High pressure 
reactions were conducted in a miniclave steel apparatus from BÜCHI AG. Low temperature‐
reactions were carried out in a Dewar vessel filled with a cooling agent: acetone/dry ice (−78 °C), 
H2O/ice (0 °C). Reaction temperatures above 23 °C were conducted in a heated oil bath. The 
reactions were magnetically stirred and monitored by NMR spectroscopy or analytical thin‐layer 
chromatography (TLC), using glass plates precoated with silica gel (0.25 mm, 60 Å pore size, 
Merck) impregnated with a fluorescent indicator (254 nm). TLC plates were visualized by exposure 
to ultraviolet light (UV), were stained by submersion in aqueous basic potassium permanganate 
solution (KMnO4), aqueous acidic ceric ammonium molybdate solution (CAM), or an aqueous 
acidic p-anisaldehyde solution and were developed by heating with a heat gun. Flash‐column 
chromatography on silica gel was performed as described by Still et al.,159 employing silica gel (60 
Å, 40–63 μm, Merck KGaA). Flash column chromatography on silica gel using triethylamine 
pretreated silica gel was performed by preparing the silica gel slurry with triethylamine (7.5% v/v 
in corresponding eluent mixture) and flushing the column with the eluent prior to loading the 
compound on the column. The yields refer to chromatographically and spectroscopically (1H and 
13C NMR) pure material. 
9.1.2 Solvents and Reagents 
Tetrahydrofuran (THF) and diethyl ether (Et2O) were distilled from sodium/benzophenone prior to 
use. Dichloromethane (CH2Cl2), triethylamine (Et3N), diisopropylamine (DIPA) and N,N-
diisopropylethylamine (DIPEA) were distilled under nitrogen atmosphere from calcium hydride 
prior to use. Benzene (PhH), Chlorobenzene (PhCl), toluene (PhMe), 1,4-dioxane, 
dimethylformamide (DMF), dimethyl sulfoxide (DMSO), acetonitrile (MeCN), ethanol (EtOH) 
and methanol (MeOH) were purchased from Acros Organics as 'extra dry' reagents and used as 
received. All other reagents and solvents were purchased from chemical suppliers (Sigma‐Aldrich, 
Acros Organics, Alfa Aesar, Strem Chemicals, TCI Europe, carbolution, ABCR) and were used as 
received. Solvents for extraction, crystallization and flash column chromatography on silica gel 
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were purchased in technical grade and distilled under reduced pressure prior to use. Lithium 
chloride and lithium bromide were dried at 100 °C under vacuum (0.1 mmHg) for 12 h and stored 
in a drying oven at 130 °C (760 mmHg); the hot, dried solid was flame dried under vacuum (0.1 
mmHg) for 4–5 min immediately prior to use. 4 Å molecular sieves were washed (methanol, 
acetone, dichloromethane) and then dried at 100 °C under vacuum (0.1 mmHg) for 12 h and stored 
in a drying oven at 130 °C (760 mmHg); the molecular sieves were flame dried under vacuum (0.1 
mmHg) for 4–5 min immediately prior to use. The molarity of n‐butyllithium solutions was 
determined by titration against diphenylacetic acid as an indicator (average of three 
determinations).160 
9.1.3 NMR Spectroscopy 
NMR spectra were measured on a Bruker Avance III HD 800 MHz spectrometer equipped with a 
CryoProbeTM, Bruker Avance III HD 400 MHz spectrometer equipped with a CryoProbeTM, 
Bruker AXR300, Varian VXR400 S and Bruker AMX600 spectrometers operating at 800 MHz, 
400 MHz, 300 MHz, 400 MHz and 600 MHz for proton nuclei (200 MHz, 100 MHz, 75 MHz, 100 
MHz, 150 MHz for carbon nuclei), respectively. Proton chemical shifts are expressed in parts per 
million (ppm, δ scale) and are referenced to residual protium in the NMR solvent (CHCl3: δ 7.26, 
CDHCl2: δ 5.32, C6HD5: 7.16). Carbon chemical shifts are expressed in parts per million (δ scale, 
assigned carbon atom) and are referenced to the carbon resonance of the NMR solvent (CDCl3: δ 
77.16, CD2Cl2: δ 54.00, C6D6: 128.06, acetone‐d6: 29.84). 1H NMR spectroscopic data are reported 
as follows: Chemical shift in ppm (multiplicity, coupling constants J (Hz), integration intensity, 
assigned proton) (e.g. “5.21 (t, 3J9/8 = 7.3 Hz, 1H, H-9)”). The multiplicities are abbreviated with s 
(singlet), br s (broad singlet), d (doublet), t (triplet), q (quartet), p (pentet), se (sextet), h (heptet) 
and m (multiplet). In case of combined multiplicities, the multiplicity with the larger coupling 
constant is stated first. Except for multiplets, the chemical shift of all signals, as well for 
centrosymmetric multiplets, is reported as the center of the resonance range. Protons of 
diastereotopic methylene groups are reported as H-Xa and H-Xb, where H-Xa is the more 
downfield shifted proton. The nomenclature is arbitrarily and does not correspond to the spin 
system. Furthermore, the numbering of the proton and carbon atoms does not correspond to the 
IUPAC nomenclature. 13C NMR spectroscopic data are reported as follows: Chemical shift in ppm 
(assigned carbon) (e.g. “159.22 (C‐21)”). In cases were resonances overlap or cannot be 
unambiguously assigned to a single proton or carbon atom, multiple assignments are listed (e.g. the 
13C NMR assignment “18.29 (C‐16, C‐17), 17.84 (C‐16, C‐17)” indicates that the resonance at 
18.29 is either C‐16 or C‐17). In addition to 1H and 13C NMR measurements, 2D NMR techniques 
such as homonuclear correlation spectroscopy (COSY), heteronuclear single quantum coherence 
(HSQC) and heteronuclear multiple bond coherence (HMBC) were used to assist signal 
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assignment. For further elucidation of 3D structures of the products, nuclear Overhauser 
enhancement spectroscopy (NOESY) was conducted. All raw FID files were processed and the 
spectra analyzed using the program MestReNova 9.0.1 from Mestrelab Research S. L. 
9.1.4 Mass Spectrometry 
All mass spectra were measured by the analytic section of the Department of Chemistry, Ludwig‐
Maximilians‐Universität München. Mass spectra were recorded on the following spectrometers 
(ionisation mode in brackets): MAT 95 (EI) and MAT 90 (ESI) from Thermo Finnigan gmbH. 
Mass spectra were recorded in high‐resolution. The method used is reported at the relevant section 
of the experimental section. 
9.1.5 IR Spectroscopy 
IR spectra were recorded on a PerkinElmer Spectrum BX II FT‐IR system. Data are represented in 
frequency of absorption (cm−1). 
9.1.6 Optical Rotation 
Optical rotation values were recorded on a PerkinElmer 241 or Anton Paar MCP 200 polarimeter. 
The specific rotation is calculated as follows: 
 
[𝛼]λ
𝜑
=  
𝛼
𝛽 ∙ 𝑑
 
 
α: recorded optical rotation 
β: concentration of the analyte in 10 mg/mL 
d: length of the cuvette in dm 
φ: measuring temperature in °C 
λ: wave length in nm  
 
The respective concentration and the solvent are denoted in the analytical part of the experimental 
description. 
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9.1.7 Melting Point Ranges 
Melting point ranges were measured on a B-540 melting point apparatus from BÜCHI Labortechnik 
AG and are uncorrected. 
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9.2 Experimental Procedures 
9.2.1 Experimental Procedures for Chapter 3.1 
 
 
α-Iodo enone 29. Pyridine (25 mL) was added to a solution of iodine (5.08 g, 20.0 mmol, 
2.00 equiv) in diethyl ether (25 mL) at 23 °C. The solution was cooled to 0 °C and stirred in the 
dark. After 20 min, (S)-6-(4-methoxybenzyl)oxy-2H-pyran-3(6H)-one39 (20) (2.35 g, 10.0 mmol, 
1 equiv) was added. After 75 min, the reaction mixture was allowed to warm to 23 °C. After 1.5 h, 
the reaction mixture was diluted with aqueous sodium thiosulfate solution (0.1 M, 180 mL). The 
layers were separated and the aqueous phase was extracted with ethyl acetate (4×100 mL). The 
combined organic layers were washed with aqueous copper(II) sulfate solution (1 M, 100 mL), 
water (50 mL) and saturated aqueous sodium chloride solution (50 mL). The washed solution was 
dried over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The 
residue was purified by flash column chromatography on silica gel (10% to 15% ethyl acetate in 
hexanes) to yield 29 (2.79 g, 78%) as light yellow crystals.  
 
TLC (10% ethyl acetate in hexanes), Rf = 0.19 (KMnO4, UV).  
 
1H NMR (CDCl3, 400 MHz) δ 7.58 (d, J = 3.7 Hz, 1H), 7.30–7.27 (m, 2H), 6.94–6.87 (m, 2H), 
5.16 (d, J = 3.7 Hz, 1H), 4.75 (d, J = 11.3 Hz, 1H), 4.66 (d, J = 16.7 Hz, 1H), 4.58 (d, J = 11.3 Hz, 
1H), 4.34 (d, J = 16.6 Hz, 1H), 3.82 (s, 3H). 13C NMR (CDCl3, 100 MHz) δ 188.2, 159.9, 153.3, 
130.2, 128.6, 114.3, 103.0, 94.0, 78.7, 65.9, 55.5.  
 
HRMS (EI): calcd for (C13H13IO4)+: 359.9853; found: 359.9845.  
 
IR (Diamond-ATR, neat) ṽmax: 3048, 2927, 2833, 1705, 1606, 1516, 1328, 1305, 1251, 1177, 1131, 
1019 cm-1. 
 
[𝜶]589
20  = –9.1 (c = 1.2 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
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Vinyl iodide 18. n-Butyllithium (2.3 M in hexanes, 0.180 mL, 0.420 mmol, 1.20 equiv) was added 
to a solution of diisopropylamine (59.4 μL, 0.420 mmol, 1.20 equiv) in tetrahydrofuran (1 mL) at 
‒78 °C and the reaction mixture was stirred for 10 min at ‒78 °C and then 20 min at 0 °C. The 
reaction mixture was cooled to ‒78 °C and a solution of α-iodo enone 29 (126 mg, 0.35 mmol, 
1 equiv) in tetrahydrofuran (0.7 mL) was added dropwise. After 45 min, t-butyldimethylsilyl 
trifluoromethanesulfonate (121 μL, 0.53 mmol, 1.50 equiv) was added. After 1 h, the solution was 
allowed to warm to 23 °C. After 1 h at 23 °C, saturated ammonium chloride solution (5 mL) and 
ethyl acetate (10 mL) were added. The layers were separated and the aqueous layer was extracted 
with ethyl acetate (3×5 mL). The combined organic layers were washed with saturated aqueous 
sodium chloride solution (5 mL) and the washed solution was dried over sodium sulfate. The dried 
solution was filtered and the filtrate was concentrated. The residue was purified by flash column 
chromatography on silica gel (5% diethyl ether in hexanes) to provide 18 (73 mg, 44%) as a light 
yellow solid.  
 
TLC (5% diethyl ether in hexanes): Rf = 0.26 (CAM, UV). 
 
1H NMR (400 MHz, CDCl3) δ 7.27 (d, J = 8.7 Hz, 2H), 6.94–6.84 (m, 2H), 6.43 (dt, J = 3.0, 1.4 
Hz, 1H), 4.84 (d, J = 3.1 Hz, 1H), 4.69 (d, J = 11.3 Hz, 1H), 4.45 (d, J = 11.4 Hz, 1H), 4.19 (ddd, 
J = 9.4, 5.9, 1.6 Hz, 1H), 3.89–3.76 (m, 5H), 0.93 (d, J = 1.1 Hz, 9H), 0.21 (d, J = 1.1 Hz, 3H), 
0.11 (d, J = 1.0 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 159.5, 136.5, 129.8, 129.6, 114.0, 110.6, 
94.6, 69.6, 68.1, 63.7, 55.4, 26.0, 18.3, –4.1, –4.3. 
 
HRMS (ESI): calcd for (C11H20IO2Si)+ (M‒C8H9O2)+: 339.0277; found: 339.0274. 
 
IR (Diamond-ATR, neat) ṽmax: 2928, 2856, 1613, 1514, 1463, 1352, 1251, 1174, 1119, 1061, 1053 
cm-1. 
 
[𝜶]589
20  = +7.5 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
Experimental Section for Part I 
125 
 
 
 
(R)-2-Methyl-2-cyclopenten-1-ol (30). (S)-(‒)-Methyl-CBS-oxazaborolidine (4.45 g, 15.8 mmol, 
1.05 equiv, neat, 98% purity) was dissolved in dichloromethane (60 mL) and borane-methylsulfide 
complex (1.20 g, 15.8 mmol, 1.05 equiv) was added. The solution was cooled to 0 °C and a solution 
of 2-methyl-2-cyclopenten-1-one (1.47 g, 15.0 mmol, 1 equiv) in dichloromethane (30 mL) was 
added dropwise over 1.5 h via syringe pump. Upon completion of the addition, stirring was 
continued for 30 min. The mixture was then carefully diluted with methanol (8 mL) and the solution 
was allowed to warm to 23 °C. Water (20 mL) was added, the layers were separated and the 
aqueous layer was extracted with dichloromethane (3×50 mL). The combined organic layers were 
washed with saturated aqueous sodium chloride solution (30 mL) and the washed solution was 
dried over sodium sulfate. The dried solution was filtered and the filtrate was concentrated 
(Caution, the compound is volatile! Vacuum > 600 mbar, water bath: 35 °C). The crude product 
was purified by flash column chromatography on silica gel (33% diethyl ether in pentane) to afford 
30 (1.23 g, 84%, >95% ee as determined by Mosher analysis using 19F spectroscopy) as a colorless 
oil. 
 
1H NMR (400 MHz, CDCl3) δ 5.55–5.50 (m, 1H), 4.63–4.54 (m, 1H), 2.45–2.25 (m, 2H), 2.24–
2.13 (m, 1H), 1.78 (s, 3H), 1.69 (ddt, J = 13.2, 8.8, 4.4 Hz, 1H), 1.47–1.38 (m, 1H). 13C NMR (100 
MHz, CDCl3) δ 141.9, 128.3, 80.1, 34.2, 29.9, 13.7. 
 
HR-MS (EI): calcd for (C6H10O)+: 98.0732, found: 98.0726. 
 
IR (Diamond-ATR, neat) ṽmax: 3320, 3040, 2963, 2938, 2915, 2854, 2239, 1448, 1437, 1377, 1333, 
1313, 1164, 1052, 1029 cm-1. 
 
[𝜶]589
21  = +40.8 (c = 1.00 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
(1R,2R,5S)-1-Methyl-6-oxabicyclo[3.1.0]hexan-2-ol (31). (R)-2-Methyl-2-cyclopenten-1-ol (30) 
(1.68 g, 17.1 mmol, 1 equiv) was dissolved in dichloromethane (100 mL) and the solution was 
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cooled to 0 °C. 3-Chloroperbenzoic acid (25.7 mmol, 5.76 g, 1.50 equiv, 75% purity) was added in 
two portions and upon completion of the addition, the suspension was allowed to warm to 23 °C. 
After 2 h, the solution was diluted with saturated aqueous sodium thiosulfate solution (100 mL), 
the layers were separated and the aqueous layer was extracted with dichloromethane (3×90 mL). 
The combined organic layers were washed with saturated aqueous sodium bicarbonate solution 
(40 mL) and saturated aqueous sodium chloride solution (40 mL). The washed solution was dried 
over sodium sulfate, the dried solution was filtered and the filtrate was concentrated (vacuum > 
580 mbar, water bath: 35 °C). The residue was purified by flash column chromatography on silica 
gel (50% to 66% diethyl ether in pentane) to afford 31 (1.79 g, 92%) as a colorless oil. 
 
TLC (50% ethyl acetate in hexanes): Rf = 0.33 (Anis). 
 
1H NMR (400 MHz, CD2Cl2) δ 4.00 (t, J = 7.9 Hz, 1H), 3.27–3.23 (m, 1H), 1.98–1.87 (m, 3H), 
1.59 (dddd, J = 14.2, 10.5, 8.4, 1.3 Hz, 1H), 1.44 (s, 3H), 1.30–1.18 (m, 1H). 13C NMR (100 MHz, 
CD2Cl2) δ 75.9, 65.5, 63.2, 29.3, 25.5, 14.8. 
 
HR-MS (EI): calcd for (C6H10O2)+: 114.0681, found: 114.0672. 
 
IR (Diamond-ATR, neat) ṽmax: 3405, 2952, 1438, 1335, 1067, 993, 949 cm-1. 
 
[𝜶]589
21  = –10.8 (c = 0.95 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
(1S,5S)-1-Methyl-6-oxabicyclo[3.1.0]hexan-2-one (32). To a solution of (1R,2R,5S)-1-methyl-6-
oxabicyclo[3.1.0]hexan-2-ol (31) (1.79 g, 15.7 mmol, 1 equiv) in dichloromethane (79 mL) was 
added Dess‒Martin periodinan (9.31 g, 22.0 mmol, 1.40 equiv) at 0 °C. The solution was allowed 
to warm to 0 °C. After 3 h, the solution was diluted with saturated aqueous sodium thiosulfate 
solution (100 mL) and dichloromethane (50 mL). The layers were separated and the aqueous layer 
was extracted with dichloromethane (3×90 mL). The combined organic layers were washed with 
saturated aqueous sodium bicarbonate solution (100 mL) and saturated aqueous sodium chloride 
solution (100 mL). The washed solution was dried over sodium sulfate and the dried solution was 
filtered. The filtrate was concentrated and the residue was purified by flash column chromatography 
on silica gel (50% diethyl ether in pentane) to afford 32 (1.12 g, 64%) as a colorless oil. 
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TLC (50% diethyl ether in pentanes): Rf = 0.42 (CAM). 
 
1H NMR (400 MHz, CDCl3) δ 3.77 (d, J = 1.6 Hz, 1H), 2.43–2.21 (m, 2H), 2.18–2.05 (m, 1H), 
2.03–1.93 (m, 1H), 1.44 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 211.0, 64.3, 61.1, 31.3, 22.4, 10.1. 
 
HR-MS (EI): calcd for (C6H8O2)+: 112.0524, found: 112.0522. 
 
IR (Diamond-ATR, neat) ṽmax: 2935, 1737, 1445, 1407, 1374, 1092, 1069, 967, 542 cm-1. 
 
[𝜶]589
21  = –34.9 (c = 0.18 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
Ketone 34. To a solution of (1S,5S)-1-methyl-6-oxabicyclo[3.1.0]hexan-2-one (32) (1.12 g, 
9.99 mmol, 1 equiv) in tetrahydrofuran (50 mL) was added a solution of vinylmagnesium bromide 
(1.0 M in tetrahydrofuran) dropwise via syringe pump at ‒78 °C. After 1 h, the solution was diluted 
with saturated aqueous ammonium chloride solution (50 mL) and the suspension was allowed to 
warm to 25 °C. The layers were separated and the aqueous layer was extracted with diethyl ether 
(3×50 mL). The combined organic layers were washed with saturated aqueous ammonium chloride 
solution (50 mL) and saturated aqueous sodium chloride solution (50 mL). The washed solution 
was dried over sodium sulfate, the dried solution was filtered and the filtrate was concentrated. The 
residue was used without further purification for the next step.  
Crude 33 (assumed: 1.40 g, 9.99 mmol, 1 equiv) was dissolved in dichloromethane 
(59 mL) and the solution was cooled to 0 °C. Borontrifluoride etherate (5.25 mL, 20.0 mmol, 
2.00 equiv, 47% in diethyl ether) was added dropwise. After 1 h, saturated aqueous sodium 
bicarbonate solution (25 mL) was added dropwise at 0 °C. Upon completion of the addition, one 
spatula of solid sodium bicarbonate was added and the suspension was allowed to warm to 25 °C. 
When gas evolution deceased, the layers were separated and the aqueous layer was extracted with 
dichloromethane (3×80 mL). The combined organic layers were washed with saturated aqueous 
sodium chloride solution (80 mL) and the washed solution was dried over sodium sulfate. The dried 
solution was filtered and the filtrate was concentrated (vacuum >550 mbar, water bath: 35 °C). The 
crude product was purified by flash column chromatography on silica gel (33% to 50% diethyl 
ether in pentanes) to afford 34 (1.16 g, 83%) as a colorless oil. 
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TLC (50% ethyl acetate in hexanes): Rf = 0.50 (CAM). 
 
1H NMR (400 MHz, CDCl3) δ 5.73 (dd, J = 17.5, 10.7 Hz, 1H), 5.17 (dd, J = 10.7, 0.7 Hz, 1H), 
5.11 (dd, J = 17.5, 0.7 Hz, 1H), 4.30–4.25 (m, 1H), 2.53–2.41 (m, 1H), 2.33–2.20 (m, 2H), 2.00–
1.89 (m, 1H), 1.79 (d, J = 3.5 Hz, 1H), 1.14 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 218.1, 138.6, 
116.3, 76.8, 57.6, 34.4, 27.8, 15.5. 
 
HR-MS (EI): calcd for (C8H12O2)+: 140.0837, found: 140.0832. 
 
IR (Diamond-ATR, neat) ṽmax:  3440, 2975, 1731, 1631, 1450, 1407, 1368, 1261, 1217, 1182, 1066 
cm-1. 
 
[𝜶]589
21  = +11.7 (c = 0.75 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
TBS enol ether 19. 2,6-Lutidine (0.48 mL, 4.10 mmol, 4.10 equiv) was added to a solution of 
ketone 34 (80% solution in diethyl ether, 159 mg, 1.00 mmol, 1 equiv) in dichloromethane (5 mL) 
at 0 °C. Tert-butyldimethylsilyl trifluoromethanesulfonate (0.47 mL; 2.05 mmol, 2.05 equiv) was 
then added dropwise. Upon completion of the addition, the solution was allowed to warm to 23 °C. 
After 30 min, the reaction mixture was diluted with saturated aqueous ammonium chloride solution 
(10 mL) and dichloromethane (10 mL). The layers were separated and the aqueous layer was 
extracted with dichloromethane (3×10 mL). The combined organic layers were washed with 
saturated aqueous sodium chloride solution (10 mL), the washed solution was dried over sodium 
sulfate and the dried solution was filtered. The filtrate was concentrated and the crude product was 
purified by flash column chromatography on silica gel (hexanes) to afford 19 (352 mg, 96%) as a 
colorless oil. 
TLC (hexanes): Rf = 0.70 (CAM). 
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1H NMR (400 MHz, CDCl3) δ 5.75 (dd, J = 17.5, 10.6 Hz, 1H), 5.04 (d, J = 4.3 Hz, 1H), 5.01 (s, 
1H), 4.43–4.36 (m, 1H), 4.09 (t, J = 6.8 Hz, 1H), 2.40 (ddd, J = 14.5, 7.2, 2.8 Hz, 1H), 2.08 (ddt, J 
= 14.4, 6.6, 1.4 Hz, 1H), 1.04 (s, 3H), 0.89 (s, 9 H), 0.87 (s, 9H), 0.13 (s, 6H), 0.01 (s, 6H). 13C 
NMR (100 MHz, CDCl3) δ 157.6, 144.1, 113.3, 96.5, 78.0, 53.3, 35.9, 26.0, 25.8, 18.3, 18.2, 15.5, 
−4.4, −4.5, −4.6, −4.8. 
 
HR-MS (EI): calcd. for (C20H40O2Si2)+: 368.2567, found: 368.2561. 
 
 IR (Diamond-ATR, neat) ṽmax: 2956, 2930, 1640, 1472, 1463, 1251, 1239, 1099 cm-1. 
 
[𝜶]589
21  = +21.3 (c = 0.83 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
Alkene 39. To a solution of 9-borabicyclo[3.3.1]nonane in tetrahydrofuran (0.5 M, 1.64 mL, 
0.820 mmol, 1.95 equiv) was added dropwise a solution of alkene 19 (232 mg, 0.420 mmol, 
1.50 equiv) in tetrahydrofuran (2.5 mL) at 25 °C. The solution was heated to 60 °C. After 3 h 
45 min, heating was ceased and the solution was allowed to cool to 25 °C. In a separate flask, 
cesium carbonate (287 mg, 0.880 mmol, 2.10 equiv), SPhos Pd g2 (15 mg, 21 µmol, 0.05 equiv), 
SPhos (8.6 mg, 21 µmol, 0.05 equiv) and vinyl iodide 18 (200 mg, 0.420 mmol, 1 equiv) were 
dissolved in a mixture of degassed dimethylformamide and water (v/v = 9:1, 4.7 mL). The solution 
of the generated borane was added dropwise and complete transfer was ensured by using an 
additional 0.5 mL of degassed tetrahydrofuran. The orange solution was heated to 50 °C. After 2 h, 
heating was ceased and the solution was allowed to cool to 25 °C. The solution was diluted with 
water (10 mL) and ethyl acetate (10 mL). The layers were separated and the aqueous layer was 
extracted with ethyl acetate (3×10 mL). The combined organic layers were washed with saturated 
aqueous sodium chloride solution (10 mL), the washed solution was dried over sodium sulfate and 
the dried solution was filtered. The filtrate was concentrated and the crude product was purified by 
flash column chromatography on silica gel (2% ethyl acetate in hexanes) to afford 39 (278 mg, 
92%) as a colorless oil. 
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TLC (3% ethyl acetate in hexanes): Rf = 0.21 (UV, CAM). 
 
1H NMR (600 MHz, CDCl3) δ 7.33–7.27 (m, 2H), 6.96–6.81 (m, 2H), 5.44–5.34 (m, 1H), 5.01–
4.92 (m, 1H), 4.70 (d, J = 11.5 Hz, 1H), 4.48 (d, J = 11.5 Hz, 1H), 4.36–4.29 (m, 1H), 4.20–4.14 
(m, 1H), 4.07 (dd, J = 7.4, 5.9 Hz, 1H), 3.80 (s, 3H), 3.76–3.63 (m, 2H), 2.37 (dddd, J = 14.4, 7.4, 
4.2, 2.5 Hz, 1H), 2.30–2.21 (m, 1H), 2.03 (dddd, J = 16.5, 8.6, 4.5, 2.2 Hz, 1H), 1.86–1.73 (m, 1H), 
1.48–1.37 (m, 2H), 0.92 (s, 3H), 0.90–0.86 (m, 27H), 0.14–0.12 (m, 6H), 0.09–0.06 (m, 6H), 0.03–
0.00 (m, 6H). 13C NMR (150 MHz, CDCl3) δ 159.4, 157.9, 146.3, 130.4, 129.9, 129.8, 118.6, 
114.0, 95.8, 94.0, 75.1, 69.3, 66.5, 63.1, 55.4, 50.0, 36.4, 33.1, 26.0, 25.9, 25.8, 18.2, −4.1, −4.1, 
−4.5, −4.6, −4.8, −4.9. 
 
HR-MS (ESI): calcd for (C31H61O4Si3)+ (M–C8H9O2)+: 581.3878, found: 581.3884. 
 
IR (Diamond-ATR, neat) ṽmax: 2956, 2929, 1640, 1614, 1514, 1472, 1463, 1362, 1337, 1250, 1095, 
1077, 1029, 1007 cm-1. 
 
[𝜶]589
21  = +14.1 (c = 0.51 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
Sideproduct 38.  
 
TLC (3% ethyl acetate in hexanes): Rf = 0.15 (UV, CAM). 
 
1H NMR (599 MHz, CDCl3) δ 7.31–7.27 (m, 2H), 6.91–6.85 (m, 2H), 5.57–
5.49 (m, 2H), 5.39 (dq, J = 3.2, 1.6 Hz, 1H), 4.99–4.94 (m, 1H), 4.70 (d, J = 
11.4 Hz, 1H), 4.47 (d, J = 11.5 Hz, 1H), 4.26–4.19 (m, 1H), 4.00 (dd, J = 7.1, 6.0 Hz, 1H), 3.80 (s, 
3H), 3.75–3.66 (m, 2H), 2.49 (dddd, J = 16.1, 7.1, 2.5, 1.6 Hz, 1H), 2.20 (ddt, J = 16.2, 6.0, 2.0 Hz, 
1H), 2.16–2.08 (m, 1H), 2.07–1.99 (m, 1H), 1.50 (td, J = 12.9, 4.6 Hz, 1H), 1.39–1.30 (m, 1H), 
0.93 (s, 3H), 0.89 (d, J = 3.5 Hz, 18H), 0.10 (s, 3H), 0.08 (s, 3H), 0.03 (s, 6H). 13C NMR (151 MHz, 
CDCl3) δ 159.4, 146.3, 138.5, 130.3, 129.8, 126.33, 119.4, 114.0, 93.9, 78.7, 69.4, 66.0, 63.0, 55.4, 
50.7, 40.7, 37.0, 26.6, 26.0, 25.9, 19.2, 18.3, 18.2, −3.9, −4.2, −4.7. 
 
HR-MS (ESI): calcd. for (C33H60O5NSi2)+ (M+NH4)+: 606.4010, found: 606.4023. 
 
IR (Diamond-ATR, neat) ṽmax: 2956, 2929, 2857, 1613, 1514, 1463, 1361, 1251, 1111, 1076, 1034 
cm-1.  
 
[𝜶]589
21  = +35.0 (c = 1.0∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
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Diol 44. A solution of tetrabutylammonium fluoride in tetrahydrofuran (1 M, 2.0 mL, 2.0 mmol, 
5.0 equiv) was added dropwise to a solution of alkene 38 (289 mg, 0.400 mmol, 1 equiv) in 
tetrahydrofuran (4.1 mL) at 0 °C. Upon completion of the addition, the solution was allowed to 
warm to 25 °C. After 14 h, the solution was diluted with ethyl acetate (10 mL) and saturated 
aqueous sodium bicarbonate solution (10 mL). The layers were separated and the aqueous layer 
was extracted with ethyl acetate (3×15 mL). The combined organic layers were washed with 
saturated aqueous sodium chloride solution (15 mL), the washed solution was dried over sodium 
sulfate and the dried solution was filtered. The filtrate was concentrated and the crude product was 
purified by flash column chromatography on silica gel (ethyl acetate) to afford 44 (98 mg, 65%) as 
a colorless oil. 
 
TLC (ethyl acetate): Rf = 0.41 (UV, CAM). 
 
1H NMR (600 MHz, CDCl3) δ 7.30–7.26 (m, 2H), 6.90–6.84 (m, 2H), 5.48–5.45 (m, 1H), 4.99–
4.96 (m, 1H), 4.73 (d, J = 11.4 Hz, 1H), 4.49 (d, J = 11.4 Hz, 1H), 4.23–4.16 (m, 1H), 4.11–4.05 
(m, 1H), 3.80 (s, 3H), 3.77 (d, J = 6.2 Hz, 2H), 2.48–2.41 (m, 1H), 2.33 (s, 1H), 2.27–2.15 (m, 3H), 
2.12–2.05 (m, 1H), 1.87–1.80 (m, 2H), 1.66 (ddd, J = 13.9, 11.2, 5.0 Hz, 1H), 1.57 (ddd, J = 14.0, 
11.4, 5.4 Hz, 1H), 0.99 (s, 3H). 13C NMR (150 MHz, CDCl3) δ 221.0, 159.5, 143.7, 129.9, 129.9, 
122.4, 114.0, 94.5, 75.2, 69.7, 65.3, 64.3, 55.4, 53.1, 35.2, 32.4, 27.8, 26.7, 15.4. 
 
HR-MS (ESI): calcd for (C21H28O6Na)+ (M+Na)+: 399.1784, found: 399.1785. 
 
IR (Diamond-ATR, neat) ṽmax: 3423, 2963, 1732, 1612, 1214, 1463, 1248, 1174, 1067, 1029 cm-1. 
 
[𝜶]589
21  = +1.5 (c = 0.54 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
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Enone 45. Activated manganese(IV) oxide (754 mg, 7.81 mmol, 30.0 equiv) was added to a 
solution of diol 44 (98 mg, 0.26 mmol, 1 equiv) in dichloromethane (2.7 mL) at 25 °C. After 1 h 
30 min, the suspension was filtered through a short plug of celite and the filter cake was rinsed with 
dichloromethane. The filtrate was concentrated and the crude product was purified by flash column 
chromatography on silica gel (50% ethyl acetate in hexanes) to afford 45 (52.5 mg, 54%) as a 
colorless oil. 
 
TLC (50% ethyl acetate in hexanes): Rf = 0.50 (UV, CAM). 
 
1H NMR (400 MHz, CDCl3) δ 7.31–7.27 (m, 2H), 6.93–6.87 (m, 2H), 6.60–6.57 (m, 1H), 5.26 (dq, 
J = 3.5, 0.7 Hz, 1H), 4.75 (d, J = 11.4 Hz, 1H), 4.57 (d, J = 11.4 Hz, 1H), 4.45 (dd, J = 16.9, 0.6 
Hz, 1H), 4.27–4.20 (m, 1H), 4.08 (dd, J = 16.9, 0.7 Hz, 1H), 3.81 (d, J = 0.7 Hz, 3H), 2.52–2.39 
(m, 1H), 2.31–2.14 (m, 4H), 1.93–1.82 (m, 1H), 1.78 (d, J = 4.4 Hz, 1H), 1.58–1.45 (m, 2H), 1.02 
(d, J = 0.7 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 219.6, 194.9, 159.6, 139.1, 138.6, 129.9, 129.0, 
114.0, 92.7, 75.4, 75.4, 70.3, 66.2, 55.3, 52.8, 34.8, 33.0, 27.7, 22.5, 14.7. 
 
HR-MS (ESI): calcd. for (C21H26O6Na)+ (M+Na)+: 397.1627, found: 397.1626. 
 
IR (Diamond-ATR, neat) ṽmax: 3470, 2934, 1734, 1689, 1612, 1514, 1464, 1339, 1303, 1249, 1174, 
1032 cm-1. 
 
 
 
Mesylate 48. Triethylamine (17 µL, 0.12 mmol, 2.1 equiv) and mesyl chloride (7.0 µL, 88 µmol, 
1.5 equiv) was added to a solution of enone 45 (22 mg, 59 µmol, 1 equiv) in dichloromethane 
(1 mL) at ‒78 °C. After 3.5 h, the solution was diluted with saturated aqueous sodium chloride 
(10 mL) and dichloromethane (10 mL). The layers were separated and the aqueous layer was 
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extracted with dichloromethane (3×15 mL). The combined organic layers were dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated. The crude product was 
purified by flash column chromatography on silica gel (50% ethyl acetate in hexanes) to afford 48 
(19.5 mg, 73%) as a colorless oil  
 
1H NMR (400 MHz, CD2Cl2) δ 7.32–7.24 (m, 2H), 6.93–6.84 (m, 2H), 6.61 (dt, J = 3.6, 1.3 Hz, 
1H), 5.27 (dd, J = 3.6, 0.8 Hz, 1H), 5.10 (t, J = 5.5 Hz, 1H), 4.74 (d, J = 11.2 Hz, 1H), 4.55 (d, J = 
11.3 Hz, 1H), 4.43 (dd, J = 16.8, 0.3 Hz, 1H), 4.05 (d, J = 16.8 Hz, 1H), 3.79 (s, 3H), 3.06 (s, 3H), 
2.55–2.38 (m, 2H), 2.34–2.10 (m, 4H), 1.63–1.48 (m, 2H), 1.07 (s, 3H). 13C NMR (100 MHz, 
CD2Cl2) δ 216.6, 195.2, 160.2, 140.1, 138.5, 130.4, 129.9, 114.4, 93.7, 84.8, 70.9, 66.8, 55.8, 52.9, 
39.1, 35.0, 33.5, 26.8, 23.2, 16.3. 
 
HR-MS (ESI): calcd for (C14H19O6S)+ (M–C8H9O2)+: 315.0902, found: 315.0903. 
 
IR (Diamond-ATR, neat) ṽmax: 2933, 2892, 1742, 1689, 1612, 1515, 1464, 1354, 1303, 1249, 1176, 
1032 cm-1. 
 
[𝜶]589
21  = –21.7 (c = 0.29 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
TBS ether 47. Tert-butyldimethylchlorosilane (9.5 mg, 63 µmol, 2.0 equiv) was added to a solution 
of enone 45 (11.8 mg, 31.5 µmol, 1 equiv) and imidazole (2.4 mg, 35 µmol, 1.1 equiv) in 
dichloromethane (0.3 mL) at 25 °C. After 24 h, imidazole (2.4 mg, 35 µmol, 1.1 equiv) and tert-
butyldimethylchlorosilane (9.5 mg, 63 µmol, 2.0 equiv) were added. After a total of 60 h, the 
solution was diluted with saturated aqueous ammonium chloride solution (10 mL) and ethyl acetate 
(10 mL). The layers were separated and the aqueous layer was extracted with ethyl acetate 
(3×10 mL). The combined organic layers were washed with saturated aqueous sodium chloride 
solution (10 mL), the washed solution was dried over sodium sulfate and the dried solution was 
filtered. The filtrate was concentrated and the crude product was purified by flash column 
chromatography on silica gel (12.5% ethyl acetate in hexanes) to afford 47 (9.7 mg, 63%) as a 
colorless oil. 
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TLC (17% ethyl acetate in hexanes): Rf = 0.65 (UV, CAM). 
 
1H NMR (800 MHz, CDCl3) δ 7.31–7.27 (m, 2H, PMB), 6.92–6.88 (m, 2H, PMB), 6.57–6.55 (m, 
1H, H-12), 5.25 (d, 3J13/12 = 3.5 Hz, 1H, H-13), 4.75 (d, 2J = 11.4 Hz, 1H, PMB), 4.57 (d, 2J = 11.4 
Hz, 1H, PMB), 4.44 (d, 2J1a/1b = 16.9 Hz, 1H, H-1a), 4.16 (dd, 3J8/9 = 6.2, 5.1 Hz, 1H, H-8), 4.08 (d, 
2J1b/1a = 16.9 Hz, 1H, H-1b), 3.81 (s, 3H, PMB), 2.45–2.38 (m, 1H, H-9a), 2.22–2.11 (m, 4H, H-9b, 
H-4, H-10a), 1.86–1.78 (m, 1H, H-10b), 1.52–1.42 (m, 2H, H-5), 0.98 (s, 3H, H-7), 0.88 (s, 9H, 
TBS), 0.09 (s, 3H, TBS), 0.08 (s, 3H, TBS). 13C NMR (200 MHz, CDCl3) δ 220.7 (C-11), 194.9 
(C-2), 159.7 (PMB), 139.0 (C-12), 138.9 (C-3), 130.1 (PMB), 129.2 (PMB), 114.1 (PMB), 93.0 
(C-13), 76.0 (C-8), 70.4 (PMB), 66.4 (C-1), 55.5 (PMB), 53.6 (C-6), 34.9 (C-9), 33.2 (C-5), 28.6 
(C-10), 25.9 (TBS), 22.8 (C-4), 18.1 (TBS), 15.6 (C-7), −4.1 (TBS), −4.8 (TBS). 
 
HR-MS (ESI): calcd for (C19H31O4Si)+ (M–C8H9O2)+: 351.1992, found: 351.1993. 
 
IR (Diamond-ATR, neat) ṽmax: 2930, 1738, 1692, 1612, 1515, 1464, 1250, 1161, 1115, 1033 cm-1. 
 
[𝜶]589
21  = –26.9 (c = 0.09 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
9.2.2 Experimental Procedures for Chapter 3.2 
 
 
3,4-Dibromofuran (56).53 2,3-Dibromo-2-butene-1,4-diol (57) (19.7 g, 80.0 mmol, 1 equiv) was 
suspended in 7.5 wt% aqueous sulfuric acid (50 mL) and the solution was heated to 85 °C. The 
suspension turned clear at temperatures above 80 °C. The solution was then heated to reflux (oil 
bath: 120‒125 °C) while a solution of potassium dichromate (24.7 g, 84.0 mmol, 1.05 equiv) in 
concentrated sulfuric acid (17 mL) and water (80 mL) was added dropwise via a dropping funnel 
while hot water steam was bubbled through the dark green solution. Within the first 1.5 h, the 
majority of the product has been collected. After a total of 2.5 h, the solution was cooled to 23 °C. 
The distillate was extracted with hexanes (3×250 mL), the combined organic layers were washed 
with saturated aqueous sodium bicarbonate solution (100 mL) and saturated aqueous sodium 
chloride solution (100 mL). The washed solution was dried over sodium sulfate, the dried solution 
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was filtered and the filtrate was concentrated (Caution! The product is volatile. Vacuum >200 mbar) 
to afford 56 (5.0 g, 28%) as a yellowish oil. The analytical data matched those previously described 
in the literature.161 
  
steam 
generator 
chromic 
acid 
Figure 10. Setup for the synthesis of 3,4-dibromofuran (56). 
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TBS ether 58. To a solution of ketone 34 (209 mg, 1.49 mmol, 1 equiv) in dimethylformamide 
(3.8 mL) were added imidazole (152 mg, 2.24 mmol, 1.50 equiv) and tert-
butyldimethylchlorosilane (449 mg, 2.98 mmol, 2.00 equiv) at 0 °C. Upon completion of the 
addition, the solution was allowed to warm to 23 °C. After 20 h, the reaction mixture was diluted 
with saturated aqueous ammonium chloride solution (10 mL) and ethyl acetate (10 mL). The layers 
were separated and the aqueous layer was extracted with ethyl acetate (3×10 mL). The combined 
organic layers were washed with saturated aqueous sodium chloride solution (80 mL) and the 
washed solution was dried over sodium sulfate. The dried solution was filtered and the filtrate was 
concentrated to afford a yellowish oil. The residue was purified by flash column chromatography 
on silica gel (5% ethyl acetate in hexanes) to afford 58 (375 mg, 99%) as a colorless oil. 
 
TLC (20% ethyl acetate in hexanes): Rf = 0.70 (CAM). 
 
1H NMR (400 MHz, CDCl3) δ 5.69 (dd, J = 17.5, 10.7 Hz, 1H), 5.16–5.01 (m, 2H), 4.17 (dd, J = 
4.5, 3.6 Hz, 1H), 2.49–2.34 (m, 1H), 2.28–2.07 (m, 2H), 1.93–1.80 (m, 1H), 1.10 (s, 3H), 0.88 (s, 
9H), 0.07 (d, J = 8.5 Hz, 6H). 13C NMR (101 MHz, CDCl3) δ 218.7, 138.9, 116.0, 77.6, 58.3, 34.4, 
28.7, 25.9, 18.2, 16.3, −4.7, −4.7. 
 
HR-MS (EI): calcd for (C14H26O2Si)+: 254.1702, found: 254.1690. 
 
IR (Diamond-ATR, neat) ṽmax: 2955, 2930, 1743, 1631, 1472, 1463, 1253, 1121, 1077 cm-1. 
 
[𝜶]589
21  = +38.3 (c = 0.91 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
3-Bromofuran 60. n-Butyllithium (2.1 M solution in hexanes, 2.06 mL, 4.33 mmol, 1.15 equiv) 
was added dropwise to a solution of 3,4-dibromofuran (56) (1.09 g, 4.33 mmol, 1.15 equiv, 90% 
purity) in diethyl ether (18 mL) at ‒78 °C. After 20 min, a solution of TBS ether 58 (958 mg, 
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3.77 mmol, 1 equiv) in diethyl ether (5 mL) was added dropwise. After 3 h, the solution was diluted 
with water (25 mL) and diethyl ether (15 mL) and the biphasic mixture was allowed to warm to 
23 °C. The layers were separated and the aqueous layer was extracted with diethyl ether (3×75 mL). 
The combined organic layers were washed with brine (25 mL), the washed solution was dried over 
sodium sulfate and the dried solution was filtered. The filtrate was concentrated to afford a yellow 
oil which was used without further purification for the next step.  
The crude product (assumed 1.51 g, 3.77 mmol) was dissolved in dimethylformamide 
(4.2 mL) and imidazole (770 mg, 11.3 mmol, 3.00 equiv) and 4-dimethylaminopyridine (46 mg, 
0.38 mmol, 0.10 equiv) were added. The solution was cooled to 0 °C. Chlorotrimethylsilane 
(0.96 mL, 7.54 mmol, 2.00 equiv) was added dropwise and upon completion of the addition, the 
solution was allowed to warm to 23 °C. After 30 min, the solution was diluted with saturated 
aqueous sodium bicarbonate solution (25 mL) and ethyl acetate (25 mL). The layers were separated 
and the aqueous layer was extracted with ethyl acetate (3×30 mL). The combined organic layers 
were washed with brine (30 mL), the washed solution was dried over sodium sulfate and the dried 
solution was filtered. The filtrate was concentrated to afford yellow oil. Purification by flash 
column chromatography on silica gel (hexanes) afforded 60 (1.31 g, 73%) as a colorless oil. 
 
 
The relative stereochemistry at C-5 was established by 
key NOE correlations as depicted aside. 
 
 
TLC (hexanes): Rf = 0.49 (UV, CAM). 
 
1H NMR (800 MHz, CDCl3) δ 7.33 (d, 3J1/4 = 1.9 Hz, 1H, H-1), 7.15 (d, 3J4/1 = 1.9 Hz, 1H, H-4), 
5.57 (dd, 3J8/9 = 17.3, 11.1 Hz, 1H, H-8), 4.94–4.89 (m, 2H, H-9), 3.96 (dd, 3J10/11a = 8.1 Hz, 3J10/11b 
= 6.9 Hz, 1H, H-10), 2.25–2.17 (m, 2H, H-12), 2.12 (m, 1H, H-11a), 1.82 (m, 1H, H-11b), 1.13 (s, 
3H, H-7), 0.87 (s, 9H, TBS), 0.04 (s, 9H, TMS), -0.00 (s, 3H, TBS), -0.03 (s, 3H, TBS). 13C NMR 
(200 MHz, CDCl3) δ 143.5 (C-8), 142.3 (C-1), 140.8 (C-4), 129.9 (C-3), 113.5 (C-9), 101.0 (C-2), 
83.3 (C-5), 77.0 (C-10), 56.7 (C-6), 36.0 (C-12), 31.7 (C-11), 26.0 (TBS), 18.2 (TBS), 14.2 (C-7), 
2.0 (TMS), −4.2 (TBS), −4.6 (TBS). 
 
HR-MS (EI): calcd for (C21H37BrO3Si2)+: 472.1465, found: 472.1459. 
 
IR (Diamond-ATR, neat) ṽmax:  2955, 2857, 1472, 1250, 1080, 1060, 909 cm-1. 
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[𝜶]589
20  = +17.9 (c = 1.1 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
Aldehyde 61. n-Butyllithium (2.1 M solution in hexanes, 0.50 mL, 1.1 mmol, 1 equiv) was added 
dropwise to a solution of 3-bromofuran 60 (500 mg, 1.06 mmol, 1 equiv) in diethyl ether (5.3 mL) 
at ‒78 °C. After 5 min, dimethylformamide (0.33 mL, 4.2 mmol, 4.0 equiv) was added. After 3 h, 
the solution was diluted with water (20 mL) and diethyl ether (25 mL) and the biphasic mixture 
was allowed to warm to 23 °C. The layers were separated and the aqueous layer was extracted with 
diethyl ether (3×50 mL). The combined organic layers were washed with brine (40 mL), the washed 
solution was dried over sodium sulfate and the dried solution was filtered. The filtrate was 
concentrated and the crude product was purified by flash column chromatography on silica gel (2% 
ethyl acetate in hexanes) to afford 61 (238 mg, 53%) as a colorless oil. 
 
TLC (5% ethyl acetate in hexanes): Rf = 0.58 (UV, CAM). 
 
1H NMR (400 MHz, CDCl3) δ 9.98 (s, 1H), 7.98 (d, J = 1.6 Hz, 1H), 7.20 (d, J = 1.7 Hz, 1H), 5.41 
(dd, J = 17.5, 10.7 Hz, 1H), 5.11–5.02 (m, 2H), 3.88 (t, J = 7.8 Hz, 1H), 2.43–2.32 (m, 1H), 2.19–
2.06 (m, 2H), 1.92–1.78 (m, 1H), 1.13 (s, 3H), 0.83 (s, 9H), 0.01 (s, 9H), -0.04 (s, 3H), -0.09 (s, 
3H). 13C NMR (100 MHz, CDCl3) δ 190.2, 147.7, 143.4, 139.5, 131.4, 127.9, 116.6, 83.4, 76.7, 
55.5, 36.9, 30.9, 25.9, 18.1, 12.9, 2.0, −4.3, −4.6. 
 
HR-MS (ESI): calcd for (C22H38O4Si2Na)+ (M+Na)+: 445.2206, found: 445.2204. 
 
IR (Diamond-ATR, neat) ṽmax:  2956, 1683, 1569, 1528, 1472, 1252, 1089, 1058 cm-1. 
 
[𝜶]589
20  = +7.1 (c = 0.6 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
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Diene 63. A solution of methyltriphenylphosphonium bromide (993 mg, 2.78 mmol, 1.25 equiv) 
in tetrahydrofuran was cooled to 0 °C and a solution of n-butyl lithium (2.1 M in hexanes, 1.16 mL, 
2.45 mmol, 1.10 equiv) was added dropwise. After 30 min, a solution of aldehyde 61 (940 mg, 
2.22 mmol, 1 equiv) in tetrahydrofuran (4.4 mL) was added dropwise. After 2 h, the suspension 
was diluted with water (30 mL) and diethyl ether (30 mL). The layers were separated and the 
aqueous layer was extracted with diethyl ether (3×30 mL). The combined organic layers were dried 
over sodium sulfate and the dried solution was filtered. The filtrate was concentrated and the crude 
product was purified by flash column chromatography on silica gel (hexanes) to afford 63 (449 mg, 
90%) as a colorless oil. 
 
TLC (hexanes): Rf = 0.70 (UV, CAM). 
 
1H NMR (400 MHz, C6D6) δ 7.33–7.31 (m, 1H), 7.00–6.90 (m, 2H), 5.69 (dd, J = 17.4, 10.8 Hz, 
1H), 5.27 (dd, J = 17.9, 1.8 Hz, 1H), 5.12 (dd, J = 17.4, 1.6 Hz, 1H), 5.07–4.95 (m, 2H), 3.97 (t, J 
= 7.6 Hz, 1H), 2.21–2.11 (m, 1H), 1.94–1.68 (m, 3H), 1.32 (s, 3H), 0.97 (s, 9H), 0.09 (s, 9H), -0.00 
(s, 3H), -0.04 (s, 3H). 13C NMR (100 MHz, C6D6) δ 144.1, 140.0, 139.6, 130.7, 130.4, 126.2, 114.9, 
112.5, 84.0, 77.2, 56.0, 37.4, 31.5, 26.1, 18.3, 13.5, 2.0, −4.3, −4.5. 
 
HR-MS (EI): calcd for (C23H40O3Si2)+: 420.2516, found: 420.2512. 
 
IR (Diamond-ATR, neat) ṽmax: 2955, 2857, 1629, 1472, 1250, 1091, 1066 cm-1. 
 
[𝜶]589
20  = +15.4 (c = 0.14 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
Tricycle 64. In a pressure flask, diene 63 (441 mg, 1.05 mmol, 1 equiv) was dissolved in freshly 
degassed (freeze-pump-thaw, 3 cycles) toluene (53 mL) and grubbs second generation catalyst 
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(89 mg, 0.11 mmol, 0.10 equiv) was added. The flask was sealed and the solution was heated to 
80 °C. After 22 h, heating was ceased and the solution was allowed to cool to 23 °C. The solution 
was concentrated and the residue was purified by flash column chromatography on silica gel 
(hexanes) to afford 64 (321 mg, 78%) as a colorless oil. Some diene 63 could also be recovered 
(68 mg, 15%). 
 
TLC (hexanes): Rf = 0.53 (UV, CAM). 
 
1H NMR (400 MHz, CD2Cl2) δ 7.39 (dd, J = 1.4, 0.8 Hz, 1H), 7.31 (d, J = 1.4 Hz, 1H), 6.37 (dd, 
J = 9.7, 0.8 Hz, 1H), 5.62 (d, J = 9.7 Hz, 1H), 3.77–3.68 (m, 1H), 2.26–2.17 (m, 2H), 1.88–1.75 
(m, 1H), 1.62 (dddd, J = 13.3, 10.8, 8.0, 6.8 Hz, 1H), 1.10 (s, 3H), 0.85 (s, 9H), -0.07 (s, 3H), -0.09 
(s, 3H), -0.12 (s, 9H). 13C NMR (100 MHz, CD2Cl2) δ 140.1, 138.1, 137.5, 126.8, 121.9, 115.5, 
79.5, 76.4, 52.7, 36.8, 30.5, 26.1, 18.5, 14.3, 1.8, −4.4, −4.6. 
 
HR-MS (EI): calcd for (C21H36O3Si2)+: 392.2203, found: 392.2196. 
 
IR (Diamond-ATR, neat) ṽmax: 2956, 2858, 2360, 1549, 1472, 1250, 1104, 1082 cm-1. 
 
[𝜶]589
20  = +22.9 (c = 0.35 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
Tricycle 65. To a solution of tricycle 64 (321 mg, 0.82 mmol, 1 equiv) was added sodium 
bicarbonate (442 mg, 5.26 mmol, 6.40 equiv), followed by palladium on charcoal (87 mg, 82 μmol, 
0.10 equiv). An atmosphere of hydrogen was maintained by sparging the mixture with a stream of 
hydrogen gas using a stainless steel needle for 1 min and vigorous stirring of the suspension was 
then continued under hydrogen atmosphere at 23 °C. After 18 h, hydrogen gas was released from 
the flask and the suspension was filtered through a short pad of celite. The filter cake was rinsed 
with ethyl acetate and the filtrate was concentrated to afford 65 (311 mg, 96%) as a colorless oil. 
 
TLC (hexanes): Rf = 0.62 (UV, CAM). 
 
1H NMR (400 MHz, CD2Cl2) δ 7.39 (d, J = 1.5 Hz, 1H), 7.12 (q, J = 1.5 Hz, 1H), 3.82 (dd, J = 8.8, 
7.3 Hz, 1H), 2.65–2.56 (m, 1H), 2.45 (dddd, J = 16.8, 11.9, 6.9, 1.8 Hz, 1H), 2.26–2.13 (m, 1H), 
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2.07–1.98 (m, 1H), 1.79 (app dtd, J = 13.2, 9.2, 6.5 Hz, 1H), 1.68–1.48 (m, 3H), 0.91 (s, 3H), 0.88 
(s, 9H), -0.01 (s, 3H), -0.03 (s, 3H), -0.06 (s, 9H).  13C NMR (100 MHz, CD2Cl2) δ 140.5, 137.7, 
129.5, 121.0, 76.3, 72.5, 48.8, 37.3, 30.3, 27.2, 26.1, 18.4, 16.3, 16.0, 2.1, −4.0, −4.7. 
 
HR-MS (EI): calcd for (C21H38O3Si2)+: 394.2359, found: 394.2353. 
 
IR (Diamond-ATR, neat) ṽmax: 2955, 2929, 2895, 2857, 1535, 1471, 1463, 1362, 1299, 1249, 1135, 
1102, 1083, 1057, 1047 cm-1. 
 
[𝜶]589
20  = +4.2 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
Aldehyde 66. sec-Butyllithium (1.1 M in cyclohexane, 0.79 mL, 0.86 mmol, 1.1 equiv) was added 
to a solution of tricycle 65 (311 mg, 0.790 mmol, 1 equiv) in tetrahydrofuran (3.9 mL) at ‒78 °C. 
After 45 min, dimethylformamide (0.24 mL, 3.1 mmol, 4.0 equiv) was added. After 30 min, the 
solution was allowed to warm to ‒30 °C. After further 30 min, the solution was allowed to warm 
to 0 °C. After 1 h, the solution was diluted with water (10 mL) and ethyl acetate (10 mL). The 
layers were separated and the aqueous layer was extracted with ethyl acetate (3×30 mL). The 
combined organic layers were washed with brine (30 mL), the washed solution was dried over 
sodium sulfate and the dried solution was filtered. The filtrate was concentrated to afford 66 
(333 mg, quant., 10:1 mixture of regioisomers) as a colorless oil. 
 
TLC (10% ethyl acetate in hexanes): Rf = 0.37 (UV, CAM). 
 
1H NMR (400 MHz, CDCl3) δ 9.73 (s, 1H), 7.60 (s, 1H), 3.72 (dd, J = 8.8, 7.3 Hz, 1H), 3.01 (ddd, 
J = 18.8, 6.1, 2.7 Hz, 1H), 2.67 (ddd, J = 18.8, 11.2, 7.7 Hz, 1H), 2.31–2.20 (m, 1H), 2.08–1.96 (m, 
1H), 1.83–1.71 (m, 1H), 1.71–1.58 (m, 3H), 0.93 (s, 3H), 0.88 (s, 9H), −0.01 (s, 3H), −0.02 (s, 9H), 
−0.04 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 177.8, 147.3, 145.2, 142.6, 132.4, 75.5, 71.8, 48.4, 
36.5, 29.9, 26.0, 25.9, 18.1, 17.1, 15.9, 2.2, −4.0, −4.7. 
 
HR-MS (ESI): calcd for (C22H39O4Si2)+ (M+H)+: 423.2387, found: 423.2387. 
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IR (Diamond-ATR, neat) ṽmax: 2955, 2857, 1682, 1595, 1519, 1472, 1370, 1251, 1107, 1087 cm-1.  
 
[𝜶]589
20  = +6.8 (c = 0.73 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
Diol 67. Tetrabutylammonium fluoride (1.0 M solution in tetrahydrofuran, 1.43 mL, 1.10 equiv) 
was added dropwise to a solution of aldehyde 66 (550 mg, 1.30 mmol, 1 equiv) in tetrahydrofuran 
(6.5 mL) at 25 °C. After 1.5 h, the solution was diluted with ethyl acetate (10 mL) and saturated 
aqueous sodium bicarbonate solution (10 mL). The layers were separated and the aqueous layer 
was extracted with ethyl acetate (3×10 mL). The combined organic layers were washed with 
saturated aqueous sodium chloride solution (10 mL) and the washed solution was dried over sodium 
sulfate. The dried solution was filtered and the filtrate was concentrated. The residue was purified 
by flash column chromatography on silica gel (66% ethyl acetate in hexanes) to afford 67 (204 mg, 
66%) as a white solid. 
 
TLC (66% ethyl acetate in hexanes): Rf = 0.21 (UV, CAM). 
 
1H NMR (400 MHz, CD2Cl2) δ 9.68 (s, 1H), 7.66 (s, 1H), 3.92 (td, J = 6.1, 1.4 Hz, 1H), 3.06–2.74 
(m, 3H), 2.36–2.17 (m, 3H), 2.06 (ddd, J = 15.2, 11.5, 6.0 Hz, 1H), 1.94–1.80 (m, 1H), 1.69–1.46 
(m, 2H), 1.06 (s, 3H). 13C NMR (101 MHz, CD2Cl2) δ 178.5, 147.8, 144.7, 132.1, 81.5, 80.2, 49.6, 
40.6, 32.2, 31.7, 17.7, 12.6. (one aryl carbon is missing). 
 
HR-MS (EI): calcd for (C13H16O4)+: 236.1049, found: 236.1034. 
 
IR (Diamond-ATR, neat) ṽmax:  3406, 2938, 2852, 2022, 1666, 1598, 1416, 1371 cm-1. 
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Mesylate 54. To a solution of diol 67 (54 mg, 0.23 mmol, 1 equiv) in dichloromethane (4 mL) was 
added triethylamine (73 μL, 0.53 mmol, 2.3 equiv) and the solution was cooled to ‒78 °C. After 
3.5 h, the solution was diluted with saturated aqueous sodium chloride solution (10 mL) and 
dichloromethane (10 mL). The layers were separated and the aqueous layer was extracted with 
dichloromethane (3×25 mL). The combined organic layers were dried over sodium sulfate, the 
dried solution was filtered and the filtrate was concentrated to afford 54 as a yellow solid. The crude 
product was used without further purification for the next step. 
 
TLC (66% ethyl acetate in hexanes): Rf = 0.21 (UV, CAM). 
 
1H NMR (400 MHz, CDCl3) δ 9.69 (s, 1H), 7.73 (s, 1H), 4.78 (dd, J = 7.5, 3.9 Hz, 1H), 3.02 (s, 
3H), 2.99–2.83 (m, 2H), 2.41–2.25 (m, 2H), 2.23–2.04 (m, 2H), 2.03 (s, 1H), 1.82–1.63 (m, 2H), 
1.10 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 178.6, 147.8, 145.4, 131.7, 88.0, 77.8, 49.3, 39.2, 
38.9, 31.4, 29.8, 17.5, 14.0. 
 
HR-MS (EI): calcd for (C14H18O6S)+: 314.0824, found: 314.0838. 
 
IR (Diamond-ATR, neat) ṽmax: 3432, 1669, 1597, 1347, 1172, 936 cm-1. 
 
Crude 54 (assumed 72 mg, 0.23 mmol, 1 equiv) was dissolved in a mixture of methanol and 
dichloromethane (v/v = 1:1, 2.5 mL) and the solution was cooled to 0 °C. Sodium borohydride 
(9.5 mg, 0.25 mmol, 1.1 equiv) was added. After 10 min, the solution was diluted with pH 7 
phosphate buffer solution (10 mL) and dichloromethane (10 mL). The layers were separated and 
the aqueous layer was extracted with dichloromethane (3×10 mL). The combined organic layers 
were dried over sodium sulfate, the dried solution was filtered and the filtrate was concentrated to 
afford a yellow oil. The crude product was purified by flash column chromatography on silica gel 
(66% ethyl acetate in hexanes) to afford 69 (45 mg, 62% over 2 steps) as a colorless oil. 
 
TLC (100% ethyl acetate in hexanes): Rf = 0.47 (CAM). 
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1H NMR (800 MHz, CD2Cl2) δ 7.46 (s, 1H), 4.77 (dd, J = 7.9, 4.7 Hz, 1H), 4.51 (d, J = 4.5 Hz, 
2H), 3.00 (s, 3H), 2.63–2.58 (m, 2H), 2.31–2.22 (m, 2H), 2.13–2.02 (m, 2H), 1.86 (s, 1H), 1.74–
1.61 (m, 3H), 1.08 (s, 3H). 13C NMR (200 MHz, CD2Cl2) δ 148.5, 139.4, 129.9, 117.3, 87.4, 77.7, 
56.2, 49.0, 38.9, 38.9, 31.6, 29.5, 16.2, 14.3. 
 
HR-MS (EI): calcd for (C14H20O6S)+: 316.0981, found: 316.0977.  
 
IR (Diamond-ATR, neat) ṽmax: 3396, 2938, 1557, 1344, 1171 cm-1. 
 
 
 
Cyclononene 53. Sodium hydride (11.4 mg, 0.280 mmol, 2.00 equiv, 60% dispersion in mineral 
oil) was added in two portions within 15 min to a solution of mesylate 69 (45 mg, 0.14 mmol, 
1 equiv) in dimethylformamide (1.2 mL) at 0 °C. After 15 min, the solution was allowed to warm 
to 25 °C. After 2 h, the solution was carefully diluted with pH 7 buffer solution (10 mL) and ethyl 
acetate (10 mL). The layers were separated and the aqueous layer was extracted with ethyl acetate 
(3×15 mL). The combined organic layers were dried over sodium sulfate and the dried solution was 
filtered. The filtrate was concentrated to afford a yellow oil. The crude product was purified by 
flash column chromatography on silica gel (40% ethyl acetate in hexanes) to afford 53 (16 mg, 
50%) as a colorless oil. 
 
TLC (50% ethyl acetate in hexanes): Rf = 0.54 (UV, CAM). 
 
1H NMR (400 MHz, CDCl3) δ 7.41 (s, 1H, H-13), 5.08 (ddd, 3J8/9 = 12.2 Hz, 3J = 4.5, 1.7 Hz, 1H, 
H-8), 4.58 (s, 2H, H-1), 3.01 (td, 3J10/9 = 10.4, 8.4 Hz, 1H, H-10a), 2.77 (tdd, 3J9a/8 = 12.2 Hz, 3J9a/10 
= 10.6, 8.1 Hz, 1H, H-9a), 2.68–2.57 (m, 2H, H-10b, H-4a), 2.46 (ddd, 3J4/5 = 14.1, 12.8 Hz, 2J4a/4b 
= 2.4 Hz, 1H, H-4b), 2.35–2.20 (m, 2H, H-9b, H-5a), 1.78 (m, 2H, H-5b, OH), 1.62 (s, 3H, H-7). 
13C NMR (100 MHz, CDCl3) δ 202.9 (C-11), 150.2 (C-2), 139.7 (C-13), 135.8 (C-6), 133.4 (C-
12), 125.0 (C-8), 120.9 (C-3), 55.3 (C-2), 44.4 (C-10), 41.4 (C-5), 24.3 (C-9), 21.5 (C-4), 16.8 (C-
7). 
 
HR-MS (EI): calcd for (C13H16O3)+: 220.1099, found: 220.1093. 
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IR (Diamond-ATR, neat) ṽmax: 3413, 2926, 2854, 1688, 1537, 1453 cm-1. 
 
 
 
Furfuryl alcohol 75. Sodium borohydride (16 mg, 0.43 mmol, 1.1 equiv) was added to a solution 
of aldehyde 66 (166 mg, 0.390 mmol, 1 equiv) in methanol (3.9 mL) at 0 °C. After 30 min, 
saturated aqueous ammonium chloride solution (10 mL) and ethyl acetate (10 mL) were added and 
the layers were separated. The aqueous layer was extracted with ethyl acetate (3×10 mL) and the 
combined organic layers were dried over sodium sulfate. The dried solution was filtered and the 
filtrate was concentrated to afford a yellowish oil. The crude product was purified by flash column 
chromatography on silica gel (15% ethyl acetate in hexanes) to afford 75 (100 mg, 60%) as 
colorless oil. 
 
TLC (15% ethyl acetate in hexanes): Rf = 0.27 (UV, CAM). 
 
1H NMR (400 MHz, CDCl3) δ 7.34 (s, 1H), 4.54 (d, J = 2.2 Hz, 2H), 3.77 (dd, J = 8.7, 7.3 Hz, 1H), 
2.58 (ddd, J = 16.7, 6.5, 2.5 Hz, 1H), 2.40 (ddd, J = 16.8, 11.7, 7.0 Hz, 1H), 2.19 (td, J = 12.5, 6.4 
Hz, 1H), 1.99 (ddd, J = 12.6, 9.4, 4.3 Hz, 1H), 1.84–1.69 (m, 2H), 1.68–1.50 (m, 3H), 0.90 (s, 3H), 
0.87 (s, 9H), -0.02 (s, 3H), -0.04 (s, 3H), -0.06 (s, 9H). 13C NMR (100 MHz, CDCl3) δ 147.3, 139.4, 
123.0, 118.3, 75.9, 72.1, 56.0, 48.4, 36.9, 30.0, 26.8, 25.9, 18.1, 16.1, 15.7, 2.1, −4.0, −4.7. 
 
HR-MS (EI): calcd for (C22H40O4Si2)+: 424.2465, found: 424.2464. 
 
IR (Diamond-ATR, neat) ṽmax: 3319, 2954, 2857, 1471, 1462, 1249 cm-1. 
  
Experimental Section for Part I 
146 
 
 
 
Lactol 76. To a solution of furfuryl alcohol 75 (38 mg, 89 μmol, 1 equiv) in a mixture of 
tetrahydrofuran/ water (v/v = 4:1, 0.9 mL) were added sodium bicarbonate (15 mg, 0.18 mmol, 
2.0 equiv) and sodium acetate (7.3 mg, 89 μmol, 1 equiv), successively. The solution was cooled 
to 0 °C and N-bromosuccinimide (16 mg, 89 μmol, 1 equiv) was added. After 30 min, the solution 
was diluted with saturated aqueous sodium bicarbonate solution (10 mL) and ethyl acetate (10 mL). 
The layers were separated and the aqueous layer was extracted with ethyl acetate (3×15 mL). The 
combined organic layers were washed with saturated aqueous sodium chloride solution (10 mL) 
and the washed solution was dried over sodium sulfate, the dried solution was filtered and the 
filtrate was concentrated to afford 76 (38 mg, 89%, d.r. = 7:1) as a crystalline off-white solid. 
Recrystallization of the product from diethyl ether gave crystals suitable for single crystal X-ray 
diffraction analysis. 
 
TLC (20% ethyl acetate in hexanes): Rf = 0.33 (UV, CAM). 
 
Peaks of the minor diastereomer are also visible in the NMR spectra, but only chemical shifts of 
the major diastereomer are reported: 
 1H NMR (800 MHz, C6D6) δ 5.52 (d, 3J13/OH = 3.7 Hz, 1H, H-13), 4.49 (d, 2J1a/1b = 17.4 Hz, 1H, 
H-1a), 4.02 (d, 2J1b/1a = 17.4 Hz, 1H, H-1b), 3.78 (dd, J = 8.7, 6.7 Hz, 1H, H-8), 2.45–2.31 (m, 2H, 
H-4), 2.14 (ddd, J = 13.8, 9.3, 4.9 Hz, 1H, H-10a), 2.02 (ddd, J = 13.3, 11.7, 6.5 Hz, 1H, H-10b), 
1.92 (d, 3JOH/13 = 4.3 Hz, 1H, OH), 1.90–1.83 (m, 1H, H-9a), 1.62–1.54 (m, 1H, H-9b), 1.49 (ddd, 
J = 14.0, 6.5, 3.2 Hz, 1H, H-5a), 1.41 (ddd, J = 14.0, 10.4, 6.7 Hz, 1H, H-5b), 1.05 (s, 3H, H-7), 
0.94 (s, 9H, TBS), 0.19 (s, 9H, TMS), -0.07 (s, 3H, TBS), -0.08 (s, 3H, TBS). 13C NMR (200 MHz, 
C6D6) δ 195.0 (C-2), 152.5 (C-12), 130.8 (C-3), 88.9 (C-13), 81.1 (C-11), 73.3 (C-8), 65.2 (C-1), 
47.8 (6), 33.1 (C-10), 30.2 (C-9), 26.5 (C-5), 26.1 (TBS), 18.3 (C-4), 18.2 (TBS), 17.5 (C-7), 2.8 
(TMS), −4.3 (TBS), −4.9 (TBS). 
 
HR-MS (EI): calcd for (C22H40O5Si2)+: 440.2414, found: 440.2404. 
 
IR (Diamond-ATR, neat) ṽmax: 3406, 2955, 2929, 1687, 1672, 1251, 1087 cm-1. 
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Benzoat 77d. To a solution of lactol 76 (47 mg, 0.11 mmol, 1 equiv) in dichloromethane (10 mL) 
were added pyridine (17 μL, 0.21 mmol, 2.0 equiv) and 4-dimethylaminopyridine (1.3 mg, 
11 μmol, 0.10 equiv) and the solution was cooled to 0 °C. Benzoyl chloride (15 μL, 0.13 mmol, 
1.2 equiv) was added dropwise and upon completion of the addition the solution was allowed to 
warm to 25 °C. After 14 h, the solution was diluted with saturated aqueous sodium chloride solution 
(10 mL) and dichloromethane (10 mL). The layers were separated and the aqueous layer was 
extracted with dichloromethane (3×10 mL). The combined organic layers were dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated to afford a yellow oil. The 
crude product was purified by flash column chromatography on silica gel (5% ethyl acetate in 
hexanes) to afford 77d (56 mg, 97%) as a colorless oil. 
 
TLC (5% ethyl acetate in hexanes): Rf = 0.34 (UV, KMnO4). 
 
1H NMR (400 MHz, CDCl3) δ 7.85–7.81 (m, 2H), 7.44–7.38 (m, 1H), 7.30–7.23 (m, 2H), 6.71 (s, 
1H), 4.31 (d, J = 17.8 Hz, 1H), 4.03 (d, J = 17.8 Hz, 1H), 3.59 (dd, J = 8.1, 6.5 Hz, 1H), 2.13 (tt, J 
= 5.9, 2.4 Hz, 2H), 1.86–1.75 (m, 1H), 1.61–1.48 (m, 2H), 1.43–1.25 (m, 3H), 0.72 (s, 3H), 0.67 
(s, 9H), 0.00 (s, 9H), -0.17 (s, 3H), -0.21 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 195.4, 165.2, 
150.4, 134.0, 132.6, 130.0, 129.2, 128.9, 88.0, 81.0, 73.4, 66.4, 47.9, 32.7, 30.5, 26.8, 25.9, 18.2, 
18.1, 17.3, 2.9, −4.2, −4.7. 
 
HR-MS (EI): calcd for (C29H44O6Si2)+: 544.2676, found: 544.2669. 
 
IR (Diamond-ATR, neat) ṽmax: 2954, 2928, 1791, 1731, 1689, 1471, 1252, 1080 cm-1. 
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TMS acetal 77f. To a solution of lactol 76 (9.7 mg, 22 μmol, 1 equiv) in tetrahydrofuran (0.25 mL) 
were added pyridine (8.0 μL, 99 μmol, 4.5 equiv) and silver(I) nitrate (4.5 mg, 26 μmol, 1.2 equiv). 
The suspension was stirred at 25 °C. After 10 min, chlorotrimethylsilane (3.7 μL, 29 μmol, 
1.3 equiv) was added and a thick white precipitate was formed. After 5 min, the suspension was 
filtered through a short pad of silica gel and the filter cake was rinsed with ethyl acetate (10 mL). 
The filtrate was concentrated and the crude product was purified by flash column chromatography 
on silica gel (2% ethyl acetate in hexanes) to afford 77f (10.7 mg, 95%) as a colorless oil. 
 
TLC (10% ethyl acetate in hexanes): Rf = 0.77 (UV, CAM). 
 
1H NMR (400 MHz, CD2Cl2) δ 5.61 (d, J = 1.1 Hz, 1H), 4.44 (d, J = 17.5 Hz, 1H), 4.02 (d, J = 
17.5 Hz, 1H), 3.74 (dd, J = 8.9, 6.6 Hz, 1H), 2.27–2.08 (m, 2H), 2.10–1.94 (m, 2H), 1.79 (dtd, J = 
13.2, 9.0, 7.1 Hz, 1H), 1.59–1.49 (m, 2H), 1.49–1.37 (s, 1H), 0.90 (s, 3H), 0.88 (s, 9H), 0.22 (s, 
9H), 0.15 (s, 9H), 0.02 (s, 3H), 0.00 (s, 3H). 13C NMR (100 MHz, CD2Cl2) δ 196.6, 154.0, 130.0, 
89.4, 81.1, 72.8, 65.5, 47.8, 32.6, 30.1, 26.2, 26.1, 18.4, 18.2, 17.8, 3.0, 0.1, −4.1, −4.6. 
 
HR-MS (EI): calcd for (C25H48O5Si3)+: 512.2810, found: 512.2813. 
 
IR (Diamond-ATR, neat) ṽmax: 2956, 2929, 1689, 1472, 1251, 1089 cm-1. 
 
 
 
Diol 80. Benzoate 77d (21 mg, 39 μmol, 1 equiv) was dissolved in tetrahydrofuran (0.5 mL) and 
triethylamine trihydrofluoride (63 μL, 0.39 mmol, 10 equiv) was added. After 14 h, the solution 
was diluted with half-saturated sodium bicarbonate solution (10 mL) and ethyl acetate (10 mL). 
The layers were separated and the aqueous layer was extracted with ethyl acetate (3×15 mL). The 
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combined organic layers were washed with saturated aqueous sodium chloride solution (15 mL), 
the washed solution was dried over sodium sulfate and the dried solution was filtered. The filtrate 
was concentrated and the residue was purified by flash column chromatography on silica gel (33% 
ethyl acetate in hexanes) to afford 80 (12 mg, 87%) as a colorless oil. 
 
TLC (33% ethyl acetate in hexanes): Rf = 0.16 (UV, CAM). 
 
1H NMR (400 MHz, C6D6) δ 8.13–8.07 (m, 2H), 7.68 (d, J = 1.9 Hz, 1H), 7.15–7.09 (m, 1H), 7.08–
7.01 (m, 2H), 4.36 (d, J = 16.9 Hz, 1H), 4.06 (d, J = 16.9 Hz, 1H), 3.23 (dd, J = 5.7, 2.5 Hz, 1H), 
3.18 (s, 1H), 2.53 (ddd, J = 19.0, 6.4, 1.8 Hz, 1H), 2.02 (dddd, J = 18.7, 12.0, 6.5, 2.1 Hz, 1H), 1.91 
(ddd, J = 14.2, 10.1, 4.5 Hz, 1H), 1.74 (ddd, J = 14.0, 11.7, 5.2 Hz, 1H), 1.63 (dddd, J = 14.6, 11.7, 
5.6, 4.4 Hz, 1H), 1.38–1.26 (m, 2H), 0.90 (ddd, J = 13.8, 6.5, 1.8 Hz, 1H), 0.85–0.73 (m, 4H). 13C 
NMR (100 MHz, C6D6) δ 193.4, 164.9, 151.5, 133.5, 130.4, 130.2, 130.0, 128.8, 87.4, 81.6, 81.3, 
66.3, 49.0, 40.4, 31.5, 29.1, 18.3, 12.7. 
 
HR-MS (EI): calcd for (C20H22O6)+: 358.1416, found: 358.1413. 
 
IR (Diamond-ATR, neat) ṽmax: 3468, 2939, 2279, 1729, 1685, 1451, 1266, 1082, 1064 cm-1. 
9.2.3 Experimental Procedures for Chapter 3.3 
 
 
TIPS enol ether 103. Alcohol rac-34 (4.99 g, 35.6 mmol, 1 equiv) was dissolved in 
dichloromethane (178 mL) and the solution was cooled to 0 °C. Triethylamine (20.8 mL, 
150 mmol, 4.20 equiv) was added, followed by triisopropylsilyl trifluoromethanesulfonate (19.6 g, 
73.0 mmol, 2.05 equiv). The solution was allowed to warm to 25 °C and after 30 min, saturated 
aqueous ammonium chloride solution (60 mL) was added. The layers were separated and the 
aqueous layer was extracted with ethyl acetate (3×40 mL). The combined organic layers were 
washed with saturated aqueous sodium chloride solution (50 mL) and the washed solution was 
dried over sodium sulfate. The dried solution was filtered, and the filtrate was concentrated. The 
crude product was purified by flash column chromatography (hexanes) to afford 103 (13.5 g, 84%) 
as a colorless oil. 
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TLC (hexanes): Rf = 0.76 (CAM). 
1H NMR (400 MHz, CDCl3) δ 5.79 (dd, J = 17.5, 10.7 Hz, 1H), 5.12–4.98 (m, 2H), 4.35 (dd, J = 
2.8, 2.0 Hz, 1H), 4.24 (t, J = 6.9 Hz, 1H), 2.46 (ddd, J = 14.1, 7.1, 2.8 Hz, 1H), 2.19–2.08 (m, 1H), 
1.22–1.13 (m, 3H), 1.12 (s, 3H), 1.08–1.02 (m, 39H). 13C NMR (100 MHz, CDCl3) δ 157.4, 144.4, 
113.5, 95.3, 78.5, 54.0, 36.4, 18.3, 18.2, 18.2, 18.2, 15.3, 12.7, 12.6. 
 
HR-MS (EI): calcd for (C26H51O2Si2)+ (M–H)+: 451.3428, found: 451.3411. 
 
IR (Diamond-ATR, neat) ṽmax: 2944, 2867, 1642, 1464, 1246, 1105 cm-1. 
 
 
 
Alcohol 104. 9-Borabicyclo[3.3.1]nonane (0.5 M in tetrahydrofuran, 2.36 mL, 1.18 mmol, 
1.15 equiv) was added dropwise to a solution of TIPS enol ether 103 (464 mg, 1.02 mmol, 1 equiv) 
in tetrahydrofuran (2 mL) at 25 °C. The mixture was heated to 60 °C. After 4 h, the mixture was 
cooled to 0 °C and aqueous sodium hydroxide solution (10 wt%, 3.07 mL, 9.22 mmol, 9.00 equiv) 
followed by aqueous hydrogen peroxide (30 wt%, 0.942 mL, 9.22 mmol, 9.00 equiv) were added. 
The solution was allowed to warm to 25 °C. After 2 h, the solution was diluted with water (20 mL) 
and ethyl acetate (20 mL) and the layers were separated. The aqueous layer was extracted with 
ethyl acetate (3×40 mL). The combined organic layers were washed with saturated aqueous sodium 
chloride solution (40 mL) and the washed solution was dried over sodium sulfate. The dried 
solution was filtered, and the filtrate was concentrated. The colorless crude product was purified 
by flash column chromatography on silica gel (5% ethyl acetate in hexanes) to afford 104 (428 mg, 
89%) as a colorless oil. 
 
TLC (30% ethyl acetate in hexanes): Rf = 0.78 (CAM). 
 
1H NMR (200 MHz, CDCl3) δ 4.36 (t, J = 2.4Hz, 1H), 4.22 (t, J = 7.2Hz, 1H), 3.72 (q, J = 6.1Hz, 
2H), 2.53–2.28 (m, 2H), 2.24–2.08 (m, 1H), 1.85–1.61 (m, 2H), 1.09 (d, J = 6.1Hz, 45H). 
 
HR-MS (EI): calcd for (C26H54O3Si2)+: 470.3611, found: 470.3586. 
 
IR (Diamond-ATR, neat) ṽmax: 2941, 2889,2864, 1462, 1096, 1064 cm-1. 
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TIPS enol ether S1. Alcohol 104 (1.24 g, 2.63 mmol, 1 equiv) was dissolved in dichloromethane 
(13.5 mL) and the solution was cooled to 0 °C. Triethylamine (0.81 mL, 5.8 mmol, 2.2 equiv) was 
added followed by triisopropylsilyl trifluoromethanesulfonate (0.740 mL, 2.77 mmol, 1.05 equiv). 
The solution was allowed to warm to 25 °C and after 40 min, saturated aqueous ammonium chloride 
solution (20 mL) was added. The layers were separated and the aqueous layer was extracted with 
ethyl acetate (3×20 mL). The combined organic layers were washed with saturated aqueous sodium 
chloride solution (20 mL) and the washed solution was dried over sodium sulfate. The dried 
solution was filtered, and the filtrate was concentrated. The crude product was purified by flash 
column chromatography on silica gel (hexanes) to afford S1 (1.46 g, 89%) as a colorless oil. 
TLC (hexanes): Rf = 0.47 (CAM). 
 
1H NMR (400 MHz, CDCl3) δ 4.28 (t, J = 2.4 Hz, 1H), 4.21 (t, J = 6.8 Hz, 1H), 3.79–3.69 (m, 2H), 
2.42 (ddd, J = 14.2, 7.2, 2.8 Hz, 1H), 2.09 (ddd, J = 14.1, 6.4, 2.0 Hz, 1H), 1.82–1.63 (m, 2H), 
1.11–1.01 (m, 63H), 1.00 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 158.1, 94.9, 76.5, 60.7, 49.3, 
40.3, 36.2, 18.3, 18.3, 18.2, 18.2, 18.0, 12.7, 12.7, 12.2. 
 
HR-MS (EI): calcd for (C35H74O3Si3)+: 626.4946, found: 626.4937. 
 
IR (Diamond-ATR, neat) ṽmax: 2943, 2892, 1640, 1463, 1106, 1069 cm-1. 
 
 
 
Ketone 105. Tetrabutylammonium fluoride (1 M in tetrahydrofuran, 20.2 mL, 20.2 mmol, 
1.02 equiv) was added dropwise to a solution of TIPS enol ether S1 (12.4 g, 19.8 mmol, 1 equiv) 
in tetrahydrofuran (198 mL) at −78 °C. After 10 min, saturated aqueous sodium bicarbonate 
solution (160 mL) was added and the mixture was allowed to warm to 25 °C. Ethyl acetate (25 mL) 
was added and the layers were separated. The aqueous layer was extracted with ethyl acetate 
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(3×50 mL), the combined layers were washed with saturated aqueous sodium chloride solution 
(50 mL) and the washed solution was dried over sodium sulfate. The dried solution was filtered, 
and the filtrate was concentrated to afford a colorless oil. The crude product was purified by flash 
column chromatography on silica gel (5% ethyl acetate in hexanes) to afford 105 (9.20 g, 99%) as 
a colorless oil.  
 
TLC (5% ethyl acetate in hexanes): Rf = 0.44 (CAM). 
 
1H NMR (400 MHz, CDCl3) δ 4.45 (t, J = 5.6 Hz, 1H), 3.78–3.70 (m, 2H), 2.47–2.30 (m, 1H), 
2.29–2.16 (m, 2H), 1.93–1.82 (m, 1H), 1.77 (dt, J = 14.0, 7.5 Hz, 1H), 1.63 (dt, J = 14.0, 6.3 Hz, 
1H), 1.12–0.98 (m, 45H). 13C NMR (100 MHz, CDCl3) δ 76.4, 59.6, 52.9, 38.1, 34.9, 28.9, 18.3, 
18.3, 18.1, 16.5, 12.7, 12.1. 
 
HR-MS (EI): calcd for (C25H51O3Si2)+ (M–CH3)+: 455.3371, found: 455.3370. 
 
IR (Diamond-ATR, neat) ṽmax: 2941, 2865, 1743, 1462, 1101, 1067, 1012 cm-1. 
 
 
 
Epoxide 106. Sodium hydride (60% dispersion in mineral oil, 81.5 mg, 2.04 mmol, 1.20 equiv) 
was added to dimethyl sulfoxide (6.8 mL) and trimethylsulfonium iodide (416 mg, 2.04 mmol, 
1.20 equiv) was added in one portion. The solution was stirred for 30 min before a solution of 
ketone 105 (800 mg, 1.70 mmol, 1 equiv) in tetrahydrofuran (5 mL) was added to the yellow 
solution. After 18 h, the dark red solution was diluted with water (5 mL) and diethyl ether (5 mL). 
The layers were separated and the aqueous layer was extracted with diethyl ether (6×10 mL). The 
combined organic layers were washed with saturated aqueous sodium chloride solution (2×20 mL) 
and the washed solution was dried over sodium sulfate. The dried solution was filtered, and the 
filtrate was concentrated to afford an orange oil. The crude product was purified by flash column 
chromatography on silica gel (5% diethyl ether in pentanes) to afford 106 (654 mg, 79%) as a 
colorless oil. 
 
TLC (5% diethyl ether in pentanes): Rf = 0.38 (CAM). 
 
Experimental Section for Part I 
153 
 
1H NMR (400 MHz, CDCl3) δ 4.18–4.14 (m, 1H), 3.78–3.66 (m, 2H), 2.75 (d, J = 4.7 Hz, 1H), 
2.64 (d, J = 4.7 Hz, 1H), 2.05–1.72 (m, 4H), 1.66–1.42 (m, 2H), 1.13–0.99 (m, 42H), 0.87 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ 79.0, 68.0, 59.9, 49.5, 45.7, 40.7, 30.9, 29.0, 18.4, 18.3, 18.2, 14.5, 
12.8, 12.1. 
 
HR-MS (EI): calcd for (C26H54O3Si2)- (M–CH2)-: 470.3611, found: 470.3413. 
 
IR (Diamond-ATR, neat) ṽmax: 2941, 2865, 1462, 1101, 1065, 1012 cm-1. 
 
 
 
Carbaldehyde 107. 4-Bromo-2,6-di-tert-butylphenol (9.46 g, 33.2 mmol, 4.00 equiv) was 
dissolved in dichloromethane (44 mL) and trimethylaluminium (2 M in toluene, 8.29 mL, 
16.6 mmol, 2.00 equiv) was added at 25 °C. The yellow mixture was stirred for 1 h, before it was 
cooled to −78 °C. A solution of epoxide 106 (4.02 g, 8.29 mmol, 1 equiv) in dichloromethane 
(10 mL) was added dropwise. After 1 h, the solution was allowed to warm to −40 °C. After 30 min, 
the mixture was allowed to warm to 0 °C. Stirring was continued for 30 min and then aqueous 
hydrochloric acid (1 M, 8 mL), dichloromethane (10 mL) and water (10 mL) were added. The 
layers were separated and the aqueous layer was extracted with dichloromethane (3×15 mL). The 
combined organic layers were washed with saturated aqueous sodium bicarbonate solution 
(30 mL), followed by saturated aqueous sodium chloride solution (30 mL). The washed solution 
was dried over sodium sulfate and the dried solution was filtered. The filtrate was concentrated to 
afford a yellow oil and the crude product was purified by flash column chromatography on silica 
gel (10% to 30% dichloromethane in hexanes), to afford 107 (1.57 g, 39%) and S2 (1.91 g, 48%) 
as colorless oils. 
 
Minor diastereomer (107):  
 
TLC (30% dichloromethane in hexanes): Rf = 0.14 (CAM). 
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1H NMR (400 MHz, C6D6) δ 9.77 (d, J = 2.5 Hz, 1H, H-6), 3.92–3.80 (m, 3H, H-3, H-8), 2.41 
(ddd, J = 9.3, 7.2, 2.5 Hz, 1H, H-1), 2.09–2.00 (m, 1H, H-5a), 1.85–1.78 (m, 1H, H-7a), 1.74–1.66 
(m, 2H, H-7b, H-4a), 1.55–1.44 (m, 1H, H-4b), 1.44–1.34 (m, 2H, H-5b), 1.15–1.03 (m, 42H, 
TIPS), 0.98 (s, 3H, H-9). 13C NMR (101 MHz, C6D6) δ 203.0 (C-6), 80.6 (C-3), 60.5 (C-8), 56.6 
(C-1), 48.5 (C-2), 43.3 (C-7), 31.5 (C-4), 19.9 (C-5), 18.4 (TIPS), 18.4 (TIPS), 18.3 (TIPS), 15.1 
(C-9), 12.9 (TIPS), 12.3 (TIPS). 
 
HR-MS (ESI): calcd for (C27H57O3Si2)+: 485.3841, found: 485.3847. 
 
IR (Diamond-ATR, neat) ṽmax: 2944, 2892, 2867, 1720, 1606, 1463, 1384, 1365, 1248, 1129, 1100, 
1070, 1014 cm ̶ 1. 
 
Major diastereomer (S2): 
 
The relative stereochemistry at C-1 was established by the key NOE 
correlation as depicted aside. 
 
TLC (30% dichloromethane in hexanes): Rf = 0.17 (CAM). 
 
1H NMR (400 MHz, C6D6) δ 9.76 (d, J = 2.0 Hz, 1H), 4.18–4.15 (m, 1H, H-3), 3.76 (td, J = 6.5, 
2.1 Hz, 2H, H-8), 2.67–2.63 (m, 1H, H-1), 2.00–1.87 (m, 2H, H-4a, H-5a), 1.68–1.60 (m, 3H, H-
5b, H-7), 1.56–1.50 (m, 1H, H-4b), 1.18 (s, 3H, H-9), 1.11–1.02 (m, 42H). 13C NMR (101 MHz, 
C6D6) δ 203.6 (C-6), 80.4 (C-3), 60.5 (C-8), 58.9 (C-1), 49.6 (C-2), 38.2 (C-7), 31.7 (C-4), 20.6 (C-
5), 19.8 (C-9), 18.5 (TIPS), 18.4 (TIPS), 18.3 (TIPS), 12.9 (TIPS), 12.3 (TIPS). 
 
HR-MS (EI): calcd for (C27H56O3Si2)+: 484.3786, found: 484.3750. 
 
IR (Diamond-ATR, neat) ṽmax: 2944, 2892, 2867, 2714, 1721, 1464, 1383, 1366, 1246, 1149, 1099, 
1068 cm  ̶1. 
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Isomerization of carbaldehyde S2. Carbaldehyde S2 (1.91 g, 3.94 mmol, 1 equiv) was dissolved 
in tetrahydrofuran (15 mL) and 1,8-diazabicyclo[5.4.0]undec-7-ene (1.17 mL, 7.84 mmol, 
2.00 equiv) was added at 25 °C. After 7 h, the solvent was removed and the colorless crude product 
was purified by flash column chromatography on silica gel (10% to 30% dichloromethane in 
hexanes) to afford a mixture of carbaldehyde 107 (1.23 g, 2.54 mmol, 65%) and carbaldehyde S2 
(646 mg, 1.33 mmol, 34%). Through repetition of this isomerization a total yield of 
carbaldehyde 107 (3.16 g, 6.55 mmol, 78%) could be obtained over two steps from epoxide 106. 
 
 
 
Carboxylic acid 108. 2-Methyl-2-butene (23.9 mL, 225 mmol, 40.0 equiv) was added to a solution 
of carbaldehyde 107 (2.73 g, 5.63 mmol, 1 equiv) in tert-butanol (165 mL) at 25 °C. A solution of 
monosodium dihydrogenphosphate dihydrate (2.63 g, 16.9 mmol, 3.00 equiv) and sodium chlorite 
(1.53 g, 16.9 mmol, 3.00 equiv) in water (188 mL) was added via a drop addition funnel. After 1 h, 
water (20 mL), diethyl ether (20 mL) and aqueous hydrochloric acid (1 M, 15 mL) were added 
sequentially. The mixture was stirred for 10 min before the layers were separated. The aqueous 
layer was extracted with diethyl ether (3×20 mL). The combined organic layers were washed with 
aqueous saturated sodium chloride solution (20 mL) and the aqueous layer was extracted with 
diethyl ether (310 mL). The washed solution was dried over sodium sulfate and the dried solution 
was filtered. The filtrate was concentrated to yield a colorless oil, which was purified by flash 
column chromatography on silica gel (30% ethyl acetate in hexanes) to afford 109 (2.72 g, 96%) 
as a colorless oil. 
 
TLC (30% ethyl acetate in hexanes): Rf = 0.68 (CAM). 
 
1H NMR (400 MHz, CDCl3) δ 11.00 (br s, 1H, H-6), 4.02 (t, J = 8.2 Hz, 1H, H-3), 3.94 ̶ 3.83 (m, 
2H, H-8), 2.79 (t, 3J1/5 = 8.6 Hz, 1H, H-1), 2.33  ̶2.22 (m, 1H, H-5a), 2.02 ̶ 1.89 (m, 2H, H-4a, H-
7a), 1.80 ̶ 1.64 (m, 3H, H-4b, H-5b, H-7b) 1.22 ̶ 1.05 (m, 42H, TIPS), 0.88 (s, 3H, H-9). 13C NMR 
(101 MHz, CDCl3) δ 174.0 (C-6), 77.8 (C-3), 60.3 (C-8), 48.5 (C-1), 46.9 (C-2), 38.8 (C-7), 30.1 
(C-4), 21.5 (C-5), 18.3 (TIPS), 18.2 (TIPS), 18.0 (TIPS), 18.0 (TIPS), 16.2 (C-9), 12.7 (TIPS), 11.9 
(TIPS). 
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HR-MS (ESI): calcd for (C27H57O4Si2)+ (M+H)+: 501.3790, found: 501.3794. 
 
IR (Diamond-ATR, neat) ṽmax: 2943, 2890, 2866, 1704, 1463, 1419, 1384, 1365, 1293, 1240, 1127, 
1102, 1068, 1013 cm  ̶1. 
 
 
 
Methyl ester 109. Carboxylic acid 108 (1.46 g, 2.91 mmol, 1 equiv) was dissolved in acetonitrile 
(26 mL) and 1,8-diazabicyclo[5.4.0]undec-7-ene (1.33 mL, 8.72 mmol, 3.00 equiv) and 
iodomethane (0.907 mL, 14.6 mmol, 5.00 equiv) were added subsequently. After 2 h, water 
(20 mL) and ethyl acetate (20 mL). were added to the resulting yellow solution. The layers were 
separated and the aqueous phase was extracted with ethyl acetate (3×30 mL). The combined 
organic layers were washed with saturated aqueous sodium chloride solution (20 mL) and the 
washed solution was dried over sodium sulfate. The dried solution was filtered and the filtrate was 
concentrated to afford a yellow oil. The crude product was purified by flash column 
chromatography (5% ethyl acetate in hexanes) to afford 109 (1.41 g, 94%) as a colorless oil.  
 
TLC (5% ethyl acetate in hexanes): Rf = 0.46 (Anis). 
 
1H NMR (400 MHz, CDCl3) δ 4.01 (t, 3J3/4 = 8.1 Hz, 1H, H-3), 3.90–3.73 (m, 2H, H-10), 3.66 (s, 
3H, H-7), 2.61 (t, 3J1/5 = 9.1 Hz, 1H, H-1), 2.17–2.05 (m, 1H, H-5a), 1.91–1.85 (m, 1H, H-4a), 
1.82–1.78 (m, 2H, H-9),  1.71–1.62 (m, 2H, H-4b, H-5b), 1.07–1.05 (m, 42H, TIPS), 0.83 (s, 3H, 
H-8). 13C NMR (101 MHz, CDCl3) δ 175.0 (C-6), 79.4 (C-3), 60.2 (C-10), 51.4 (C-7), 48.9 (C-1), 
47.3 (C-2), 42.0 (C-9), 30.8 (C-4), 22.5 (C-5), 18.4 (TIPS), 18.3 (TIPS), 18.2 (TIPS), 15.4 (C-8), 
12.9 (TIPS), 12.1 (TIPS). 
 
HR-MS (EI): calcd for (C28H58O4Si2)+: 514.3874, found: 514.3848. 
 
IR (Diamond-ATR, neat) ṽmax: 2944, 2891, 2866, 1739. 1463, 1435, 1384, 1365, 1257, 1194, 1166, 
1127, 1100, 1068, 1013 cm-1. 
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TMS ketene acetal 97. Diisopropylamine (0.499 mL, 3.53 mmol, 1.15 equiv) was dissolved in 
tetrahydrofuran (3 mL). The solution was cooled to −78 °C and n-butyllithium (2.31 M in hexane, 
1.39 mL, 3.22 mmol, 1.05 equiv) was added dropwise. The solution was stirred for 10 min before 
it was allowed to warm to 0 °C. After 20 min, the solution was cooled to −78 °C and ester 109 (1.58 
g, 3.07 mmol, 1 equiv) in tetrahydrofuran (1.5 mL) was added over 5 min. Stirring was continued 
at −78 °C for 1 h. Freshly distilled chlorotrimethylsilane (0.412 mL, 3.22 mmol, 1.05 equiv) was 
added and after 1 h, the solution was allowed to warm to 25 °C. After 16 h, the solution was diluted 
with diethyl ether (15 mL) and the suspension was filtered through a short pad of celite covered 
with silica gel. The filter cake was rinsed with diethyl ether (70 mL) and the filtrate was 
concentrated to afford 97 (1.78 g, 99%) as a clear yellow oil. The crude product was used in the 
next step without further purification. 
 
1H NMR (800 MHz, C6D6) δ 4.23 (dd, J = 8.8, 5.5 Hz, 1H), 4.00 (td, J = 9.4, 6.5 Hz, 1H), 3.96 (td, 
J = 9.5, 6.1 Hz, 1H), 3.33 (s, 3H), 2.43 (ddd, J = 15.7, 8.2, 3.1 Hz, 1H), 2.28–2.10 (m, 2H), 2.06 
(ddd, J = 15.5, 10.2, 7.7 Hz, 1H), 1.87–1.83 (m, 1H), 1.67 (ddt, J = 11.8, 10.1, 8.6 Hz, 1H), 1.35 
(s, 3H), 1.20– 1.17 (m, 42H), 0.18 (s, 9H). 13C NMR (201 MHz, C6D6) δ 148.5, 104.7, 79.5, 61.7, 
55.4, 46.2, 41.3, 32.2, 25.4, 21.6, 18.6, 18.5, 18.4, 13.1, 12.5, 0.2. 
 
HR-MS (EI): calcd for (C31H66O4Si3)+: 586.4269, found: 586.4266. 
 
IR (Diamond-ATR, neat) ṽmax: 2943, 2866, 2279, 1698, 1618, 1453, 1330, 1252, 1162, 1070 cm-1. 
 
 
 
Mukaiyama−Michael adduct 96. Boron trifluoride diethyl ether complex (47 wt% in diethyl 
ether, 50.0 μL, 0.190 mmol, 1.05 equiv) was added dropwise to a solution of TMS ketene acetal 97 
(145 mg, 0.254 mmol, 1.40 equiv) in a mixture of dichloromethane and diethyl ether (v/v = 9:1, 
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0.77 mL) at −78 °C. Enone 20 (42.5 mg, 0.181 mmol, 1 equiv) in a mixture of dichloromethane 
and diethyl ether (v/v = 9:1, 0.22 mL) was then added over two minutes. After 45 min, excess boron 
trifluoride diethyl ether complex was quenched by dropwise addition of saturated aqueous sodium 
bicarbonate solution (7 mL) at −78 °C. The mixture was allowed to warm to 25 °C and solid sodium 
bicarbonate was added until no further gas evolution was observed. The mixture was diluted with 
dichloromethane (3 mL) and the layers were separated. The aqueous layer was extracted with 
dichloromethane (3×20 mL). The combined organic layers were washed with saturated aqueous 
sodium chloride solution (20 mL) and the washed solution was dried over sodium sulfate. The dried 
solution was filtered, and the filtrate was concentrated to yield a slightly yellow oil. The crude 
product was purified by flash column chromatography on silica gel (5% to 15% ethyl acetate in 
hexanes) to afford 96 (82.3 mg, 61%) as a colorless oil. 
 
TLC (20% ethyl acetate in hexanes): Rf = 0.41 (CAM). 
 
1H NMR (400 MHz, CDCl3) δ 7.28 (d, J = 8.6 Hz, 2H, PMB), 6.87 (d, J = 8.6 Hz, 2H, PMB), 5.64 
(d, J = 3.9 Hz, 1H, H-5), 4.65 (d, J = 10.8 Hz, 1H, PMB), 4.44 (d, J = 10.9 Hz, 1H, PMB), 4.39 
(dd, J = 8.2, 6.5 Hz, 1H, H-8), 4.10 (d, J = 17.9 Hz, 1H, H-1a), 3.87 (d, J = 17.9 Hz, 1H, H-1b), 
3.85–3.75 (m, 2H, H-13), 3.81 (s, 3H, PMB), 3.68 (s, 3H, H-15), 2.56–2.34 (m, 3H, H-3, H-4), 
2.22–2.13 (m, 1H, H-9a), 2.07 (ddd, J = 13.2, 10.2, 4.9 Hz, 1H, H-10a), 1.82 (ddd, J = 13.2, 10.3, 
4.9 Hz, 1H, H-12a), 1.66–1.58 (m, 2H, H -10b, H-12b), 1.54–1.47 (m, 1H, H-9b), 1.10 (s, 3H, H-
11), 1.06–1.02 (m, 42H, TIPS). 13C NMR (101 MHz, CDCl3) δ 211.9 (C-2), 175.5 (C-14), 159.4 
(PMB), 129.9 (PMB), 129.7 (PMB), 113.9 (PMB), 99.0 (C-5), 79.5 (C-8), 69.7 (PMB), 65.6 (C-1), 
60.9 (C-6), 60.3 (C-13), 55.4 (PMB), 51.7 (C-7), 51.4 (C-15), 45.3 (C-4), 41.7 (C-12), 38.5 (C-3), 
31.4 (C-10), 31.0 (C-9), 18.4 (TIPS), 18.3 (TIPS), 18.2 (TIPS), 14.7 (C-11), 13.1 (TIPS), 12.2 
(TIPS). 
 
HR-MS (ESI): calcd for (C41H76O8Si2)+ (M+NH4)+: 766.5104, found: 766.5129. 
 
IR (Diamond-ATR, neat) ṽmax: 2944, 2892, 2866, 2362, 1726, 1614, 1587, 1516, 1464, 1388, 1358, 
1303, 1250, 1205, 1180, 1096, 1069, 1035, 1013 cm-1. 
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Alcohol 110. Triethylamine trihydrofluoride (1.50 mL, 9.20 mmol, 7.50 equiv) was added to a 
solution of Mukaiyama−Michael adduct 96 (919 mg, 1.23 mmol, 1 equiv) in tetrahydrofuran 
(6.1 mL) at 25 °C. After 18 h, saturated aqueous sodium bicarbonate (15 mL) was added dropwise. 
Solid sodium bicarbonate was then added until no further gas evolution was observed. The 
suspension was diluted with ethyl acetate (15 mL) and the layers were separated. The aqueous layer 
was extracted with ethyl acetate (3×20 mL) and the combined organic layers were washed with 
saturated aqueous sodium chloride solution (10 mL). The washed solution was dried over sodium 
sulfate and the dried solution was filtered. The filtrate was concentrated to afford a colorless oil 
and the crude was purified by flash column chromatography on silica gel (30% to 60% ethyl acetate 
in hexanes) to afford 110 (662 mg, 91%) as a colorless oil.  
 
TLC (40% ethyl acetate in hexanes): Rf = 0.35 (CAM). 
 
1H NMR (400 MHz, C6D6) δ 7.21 (d, J = 8.6 Hz, 2H, PMB), 6.78 (d, J = 8.7 Hz, 2H, PMB), 5.87 
(d, J = 4.4 Hz, 1H, H-5), 4.53 (d, J = 11.2 Hz, 1H, PMB), 4.48 (t, J = 8.2 Hz, 1H, H-8), 4.28 (d, J 
= 11.1 Hz, 1H, PMB), 4.11 (d, J = 17.7 Hz, 1H, H-1a), 3.86–3.77 (m, 1H, H-13a), 3.80 (d, J = 
17.6 Hz, 1H, H-1b), 3.63 (ddd, J = 10.8, 7.9, 5.2 Hz, 1H, H-13b), 3.28 (s, 3H, PMB), 3.25 (s, 3H, 
H-15), 2.47 (dd, J = 14.2, 13.1 Hz, 1H, H-3a), 2.26 (dd, J = 14.2, 4.3 Hz, 1H, H-3b), 2.16 (dt, J = 
13.1, 4.4 Hz, 1H, H-4), 2.07–1.98 (m, 1H, H-9a), 1.86–1.76 (m, 2H, H-10a, H-12a), 1.57 (dt, J = 
13.6, 7.5 Hz, 1H, H-12b), 1.40–1.31 (m, 1H, H-9b), 1.12–0.99 (m, 25H, H-10b, H-11, TIPS), 0.47 
(br s, 1H, OH). 13C NMR (101 MHz, C6D6) δ 210.0 (C-2), 175.1 (C-14), 160.0 (PMB), 130.5 
(PMB), 129.7 (PMB), 114.2 (PMB), 98.1 (C-5), 80.8 (C-8), 69.0 (PMB), 65.5 (C-1), 60.6 (C-6), 
59.4 (C-13), 54.8 (PMB), 51.5 (C-7), 51.1 (C-15), 46.1 (C-4), 41.4 (C-12), 38.6 (C-3), 31.9 (C-10), 
30.5 (C-9), 18.4 (TIPS), 18.4 (TIPS), 13.8 (C-11), 13.4 (TIPS). 
 
HR-MS (ESI): calcd for (C24H43O6Si)- (M ̶ OPMB)-: 455.2623, found: 455.2834. 
 
IR (Diamond-ATR, neat) ṽmax: 3444, 2946, 2867, 1724, 1614, 1587, 1516, 1464, 1390, 1359, 1303, 
1250, 1205, 1176, 1100, 1067, 1034 cm-1. 
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Aldehyde 111. Sodium bicarbonate (17.7 mg, 0.211 mmol, 5.00 equiv) was added to a solution of 
alcohol 110 (25.0 mg, 42.2 μmol, 1 equiv) in dichloromethane (0.5 mL). The suspension was 
cooled to 0 °C and Dess−Martin periodinane (26.8 mg, 63.3 μmol, 1.50 equiv) was added in one 
portion. The ice bath was removed and the mixture was stirred for 4.5 h at 25 °C. The suspension 
was then diluted with diethyl ether (10 mL) and was filtered through a short pad of celite. The filter 
cake was rinsed with diethyl ether (50 mL) and the filtrate was concentrated. The crude product 
was purified by flash column chromatography on silica gel (20% ethyl acetate in hexanes) to afford 
111 (22.9 mg, 92%) as a colorless solid. Recrystallization of the product from diethyl ether gave 
crystals suitable for single crystal X-ray diffraction analysis. 
 
TLC (20% ethyl acetate in hexanes): Rf = 0.26 (CAM). 
 
1H NMR (400 MHz, C6D6) δ 9.84 (dd, J = 3.6, 2.4 Hz, 1H, H-13), 7.22 (d, J = 8.6 Hz, 2H, PMB), 
6.78 (d, J = 8.6 Hz, 2H, PMB), 5.76 (d, J = 4.3 Hz, 1H, H-5), 4.49–4.43 (m, 2H, H-8, PMB), 4.30 
(d, J = 11.2 Hz 1H, PMB), 4.08 (d, J = 17.7 Hz, 1H, H-1a), 3.76 (d, J = 17.7 Hz, 1H, H-1b), 3.30 
(s, 3H, PMB ), 3.21 (s, 3H, H-15), 2.31 (t, J = 13.7 Hz, 1H, H-3a), 2.19 ̶ 2.14 (m, 3H, H-3b, H-12), 
2.07 (dt, J = 13.3, 4.4 Hz, 1H, H-4), 1.98–1.90 (m, 1H, H-9a), 1.88–1.81 (m, 1H, H-10a), 1.34–
1.24 (m, 1H, H-9b), 1.22 (s, 3H, H-11) 1.08–0.97 (m, 22H, H-10b, TIPS). 13C NMR (101 MHz, 
C6D6) δ 209.6 (C-2), 200.2 (C-13), 174.6 (C-14), 160.2 (PMB), 131.0 (PMB), 129.2 (PMB), 114.3 
(PMB), 97.2 (C-5), 79.1 (C-8), 68.8 (PMB), 65.4 (C-1), 59.5 (C-6), 54.8 (PMB), 51.8 (C-12), 51.6 
(C-7), 51.3 (C-15), 46.3 (C-4), 38.3 (C-3), 31.7 (C-10), 29.4 (C-9), 18.4 (TIPS), 18.3 
(TIPS), 14.8 (C-11), 13.1 (TIPS). 
 
HR-MS (ESI): calcd for (C32H54NO8Si)+ (M+NH4)+: 608.3613, found: 608.3635. 
 
IR (Diamond-ATR, neat) ṽmax: 2942, 2865, 1727, 1709, 1613, 1584, 1515, 1460, 1410, 1385, 1331, 
1307, 1254, 1242, 1226, 1206, 1178, 1129, 1098, 1067, 1010 cm-1. 
 
Melting Point: 107  ̶108 °C. 
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Enone 112. A 1:1 mixture of D-proline (108 mg, 0.941 mmol, 0.800 equiv) and L-proline (108 mg, 
0.941 mmol, 0.800 equiv) was added to a solution of aldehyde 111 (492 mg, 1.18 mmol, 1 equiv) 
in degassed dimethyl sulfoxide (23.6 mL). After 24 h, before water (10 mL) and ethyl acetate 
(20 mL) were added. The layers were separated and the aqueous phase was extracted with ethyl 
acetate (3×30 mL). The combined organic layers were washed with saturated aqueous sodium 
chloride solution (20 mL) and the washed solution was dried over sodium sulfate. The dried 
solution was filtered, and the filtrate was concentrated. The colorless crude product was purified 
by flash column chromatography on silica gel (20% ethyl acetate in hexanes) to afford 112 (405 mg, 
60%) as a colorless liquid. Recrystallization of the product from diethyl ether gave crystals suitable 
for single crystal X-ray diffraction analysis. 
 
TLC (20% ethyl acetate in hexanes): Rf = 0.29 (UV, CAM). 
 
1H NMR (400 MHz, C6D6) δ 7.22 (d, J = 8.6 Hz, 2H, PMB), 6.93 (dt, J = 6.3, 2.2 Hz, 1H, H-4), 
6.79 (d, J = 8.6 Hz, 2H, PMB), 5.29 (d, J = 7.2 Hz, 1H, H-12), 4.67 (d, J = 11.3 Hz, 1H, PMB), 
4.57 (dd, J = 8.9, 6.7 Hz, 1H, H-7), 4.37 (d, J = 11.3 Hz, 1H, PMB), 4.27 (d, J = 15.8 Hz, 1H, H-
1a), 3.92 (d, J = 15.8 Hz, 1H, H-1b), 3.37–3.33 (m, 1H, H-11), 3.28 (s, 3H, PMB), 3.10 (s, 3H, H-
15), 2.43–2.38 (m, 1H, H-5a), 2.36–2.29 (m, 1H, H-8a), 2.15–2.08 (m, 2H, H-5b, H-9a), 1.77 (ddd, 
J = 13.4, 11.9, 6.4 Hz, 1H, H-9b), 1.65–1.56 (m, 1H, H-8b), 1.11–1.01 (m, 21H, TIPS), 0.99 (s, 
3H, H-13). 13C NMR (101 MHz, C6D6) δ 197.2 (C-2), 176.1 (C-14), 160.0 (PMB), 136.0 (C-4), 
134.3 (C-3), 130.2 (PMB), 130.0 (PMB), 114.1 (PMB), 97.6 (C-12), 77.5 (C-7), 69.3 (PMB), 66.3 
(C-1), 55.3 (C-10), 54.8 (PMB), 51.7 (C-15), 47.3 (C-6), 45.0 (C-11), 35.2 (C-5), 32.4 (C-8), 27.3 
(C-9), 18.4 (TIPS), 18.3 (TIPS), 16.7 (C-13), 12.7 (TIPS). 
 
HR-MS (ESI): calcd for (C32H52NO7Si)+ (M+NH4)+: 590.3508, found: 590.3512. 
 
IR (Diamond-ATR, neat) ṽmax: 2943, 2866, 2356, 1727, 1613, 1514, 1463, 1367, 1249, 1196, 1148, 
1109, 1096, 1062, 1034 cm-1. 
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Tricycle 113. Palladium on charcoal (10 wt%, 105 mg, 98.5 μmol, 0.15 equiv) was added to a 
solution of enone 112 (376 mg, 0.66 mmol, 1 equiv) in a mixture of methanol and dichloromethane 
(v/v = 10:1, 3.6 mL). The suspension was purged with hydrogen gas (1 atm) through a stainless 
steel needle for 1 min. Stirring of the suspension was then continued under a hydrogen atmosphere 
(1 atm) at 25 °C. After 3 h, hydrogen gas was released from the flask, the suspension was purged 
with argon and the mixture was filtered through a short pad of celite. The filter cake was rinsed 
with ethyl acetate (30 mL) and the filtrate was concentrated. The colorless crude product was 
purified by flash column chromatography on silica gel (10% ethyl acetate in hexanes) to afford 113 
(319 mg, 85%) as a colorless solid. 
 
TLC (20% ethyl acetate in hexanes): Rf = 0.58 (CAM). 
 
1H NMR (400 MHz, C6D6) δ 7.20 (d, J = 8.3 Hz, 2H, PMB), 6.77 (d, J = 8.3 Hz, 2H, PMB), 5.35 
(d, J = 4.4 Hz, 1H, H  ̶12), 4.89 (dd, J = 9.0, 6.4 Hz, 1H, H-7), 4.52 (d, J = 11.7 Hz, 1H, PMB), 
4.35 (d, J = 11.7 Hz, 1H, PMB), 4.16 (d, J = 17.6 Hz, 1H, H-1a), 3.90 (d, J = 17.6 Hz, 1H, H-1b), 
3.27 (s, 3H, PMB), 3.06 (s, 3H, H-15), 3.02 (dd, J = 6.4, 4.5 Hz, 1H, H-11), 2.62–2.56 (m, 2H, H-
3, H-5a), 2.04–1.89 (m, 4H, H-4a, H-5b, H-8a, H-9a), 1.80–1.73 (m, 1H, H-9b), 1.71–1.68 (m, 1H, 
H-4b), 1.54–1.47 (m, 1H, H-8b), 1.18 (s, 3H, H-13), 1.13–1.01 (m, 21H, TIPS). 13C NMR 
(151 MHz, C6D6) δ 210.7 (C-2), 176.0 (C-14), 160.1 (PMB), 130.2 (PMB), 129.9 (PMB), 114.2 
(PMB), 96.10 (C-12), 76.4 (C-7), 69.0 (PMB), 65.1 (C-1), 56.8 (C-10), 54.8 (PMB), 51.7(C-15), 
47.8 (C-6), 45.9 (C-3), 44.0 (C-11), 31.2 (C-8), 30.0 (C-4), 27.8 (C-5), 22.9 (C-9), 18.4 (TIPS), 
18.3 (TIPS), 16.0 (C-13), 12.76 (TIPS). 
 
HR-MS (ESI): calcd for (C32H54NO7Si)+ (M+NH4)+: 592.3664, found: 592.3665. 
 
IR (Diamond-ATR, neat) ṽmax: 2944, 2866, 2280, 1728, 1613, 1586, 1558, 1514, 1463, 1367, 1330, 
1301, 1249, 1196, 1173, 1148, 1110, 1096, 1063, 1034 cm-1. 
 
Melting point: 116−121 °C. 
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Alcohol 95. Tetrabutylammonium fluoride (1 M solution in tetrahydrofuran, 0.118 mL, 
0.118 mmol, 1.02 equiv) was added to a solution of tricycle 113 (66.6 mg, 0.116 mmol, 1 equiv) in 
tetrahydrofuran (1 mL) at 0 °C. Upon completion of the addition, the solution was allowed to warm 
to 25 °C. After 6.5 h, saturated aqueous sodium bicarbonate solution (10 mL) was added and the 
layers were separated. The aqueous layer was extracted with ethyl acetate (3×10 mL) and the 
combined organic layers were washed with saturated aqueous sodium chloride solution (10 mL). 
The washed solution was dried over sodium sulfate. The dried solution was filtered, and the filtrate 
was concentrated to afford a colorless liquid. The crude product was purified by flash column 
chromatography on silica gel (30% to 50% ethyl acetate in hexanes) to afford 95 (36.4 mg, 75%) 
as a colorless liquid. 
 
TLC (40% ethyl acetate in hexanes): Rf = 0.22 (CAM). 
 
1H NMR (400 MHz, CDCl3) δ 7.29 (d, J = 8.6 Hz, 2H), 6.89 (d, J = 8.6 Hz, 2H), 5.24 (d, J = 4.5 
Hz, 1H), 4.63 (d, J = 11.6 Hz, 1H), 4.54 (dd, J = 9.5, 6.5 Hz, 1H), 4.48 (d, J = 11.6 Hz, 1H), 4.20 
(d, J = 17.8 Hz, 1H), 4.00 (d, J = 17.8, 1H), 3.82 (s, 3H), 3.61 (s, 3H), 2.75 (dd, J = 6.4, 4.4 Hz, 
1H), 2.39–2.31 (m, 2H), 2.14–2.05 (m, 1H), 1.95–1.81 (m, 2H), 1.72–1.65 (m, 2H), 1.52–1.42 (m, 
2H), 1.03 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 212.9, 175.9, 159.7, 130.2, 129.2, 114.0, 95.6, 
75.9, 69.0, 65.0, 56.8, 55.5, 52.4, 46.6, 45.3, 43.2, 29.8, 29.0, 27.3, 22.6, 15.6. 
 
HR-MS (ESI): calcd for (C23H34NO7)+ (M+NH4)+: 436.5245, found: 436.2337. 
 
IR (Diamond-ATR, neat) ṽmax: 3434, 2951, 2838, 1725, 1612, 1586, 1514, 1461, 1368, 1302, 1247, 
1196, 1176, 1147, 1128, 1109, 1089, 1032 cm ̶ 1. 
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Thiocarbamate 98. 4-(Dimethylamino)pyridine (0.817 mg, 6.69 μmol, 0.200 equiv) and 1,1’-
thiocarbonyldiimidazole (3.72 mg, 66.9 μmol, 2.00 equiv) were added to a solution of alcohol 95 
(14.0 mg, 33.5 μmol, 1 equiv) in dichloromethane (1 mL). Triethylamine (5.11 μL, 36.8 μmol, 
1.10 equiv) was then added and the reaction was stirred for 7 h at room temperature. The solution 
was then heated to 40 °C. After 17 h, the solvent was removed and the crude product was purified 
by flash column chromatography on silica gel (60% ethyl acetate in hexanes) to afford 98 
(11.9 mg, 67%) as a yellow oil.  
 
TLC (40% ethyl acetate in hexanes): Rf = 0.22 (CAM). 
 
1H NMR (600 MHz, C6D6) δ 8.22 (s, 1H, H-17), 7.38 (t, J = 1.5 Hz, 1H, im), 7.18 (d, J = 8.6 Hz, 
2H, PMB), 6.96 (dd, J = 1.6, 0.8 Hz, 1H, im) 6.79 (d, J = 8.6 Hz, 2H, PMB), 6.28 (dd, J = 9.6, 5.7 
Hz, 1H, H-7), 5.17 (d, J = 4.1 Hz, 1H, H-12), 4.49 (d, J = 11.9 Hz, 1H, PMB), 4.33 (d, J = 11.9 Hz, 
1H, PMB), 4.13 (d, J = 17.7 Hz, 1H, H-1a), 3.89 (dd, J = 17.8, 0.7 Hz, 1H, H-1b), 3.27 (s, 3H, 
PMB), 3.08 (dd, J = 6.6, 4.1 Hz, 1H, H-11), 3.04 (s, 3H, H-19), 2.47  ̶2.41 (m, 2H, H-3, H-5a) 
2.27 ̶ 2.20 (m, 1H, H-8a), 1.79  ̶ 1.71 (m, 2H, H-4a, H-9a), 1.62  ̶ 1.53 (m, 2H, H-4b, H-9b), 
1.25 ̶ 1.19 (m, 2H, H-5b, H-8b), 0.84 (s, 3H, H-13). 13C NMR (151 MHz, C6D6) δ 210.0 (C-2), 
184.1 (C-14), 175.0 (C-18), 160.2 (PMB), 136.4 (C-17), 131.5 (im), 130.3 (PMB), 129.5 (PMB), 
118.5 (im), 114.2 (PMB), 95.2 (C-12), 87.5 (C-7), 68.6 (PMB), 65.0 (C-1), 57.2 (C-10), 54.8 
(PMB), 52.1 (C-18), 47.1 (C-6), 45.5 (C-3), 43.6 (C-11), 29.8 (C-5), 27.6 (C-9), 27.1 (C-8), 22.5 
(C-4), 17.1 (C-13). 
 
HR-MS (ESI): calcd for (C27H32N2O7S)+: 528.1930, found: 528.1908. 
 
IR (Diamond-ATR, neat) ṽmax: 3132, 2952, 1726, 1612, 1585, 1514, 1463, 1386, 1335, 1285, 1246, 
1196, 1175, 1147, 1129, 1107, 1074, 1026 cm-1. 
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Tricycle 114. In a pressure flask, tributyltin hydride (31.7 μL, 118 μmol, 4.00 equiv) and 
azobis(isobutyronitrile) (1.00 mg, 5.88 μmol, 0.20 equiv) were added to a solution of 
thiocarbamate 98 (15.5 mg, 29.4 μmol, 1 equiv) in benzene (1.5 mL). The flask was sealed and the 
mixture was heated to 80 °C and after 30 min, the solution was cooled to 25 °C and was 
concentrated. The crude product was purified by flash column chromatography on previously 
deactivated silica gel (10% ethyl acetate in hexanes) to afford tricycle 114 (14.6 mg, 66%) as a 
colorless oil.  
 
TLC (10% ethyl acetate in hexanes): Rf = 0.15 (UV, CAM). 
 
1H NMR (600 MHz, C6D6) δ 6.18 (d, 2J = 8.5 Hz, 2H, PMB), 6.76 (d, 2J = 8.5 Hz, 2H, PMB), 5.31 
(d, 3J12/11 = 4.4 Hz, 1H, H-12), 4.86 (d, 2J14a/14b = 2.1 Hz, 2H, H-14), 4.84 ̶ 4.82 (m, 1H, H-7), 4.48 
(d, 2J = 11.6 Hz, 1H, PMB), 4.29 (d, 2J = 11.7 Hz, 1H, PMB), 4.14 (d, 2J = 17.6 Hz, 1H, H-1a), 
3.89 (d, 2J = 17.6 Hz, 1H, H-1b), 3.29 (s, 3H, PMB), 3.07 (s, 3H, H-16), 2.98 (dd, J = 6.5, 4.3 Hz, 
1H, H-11), 2.74 (td, J = 13.1, 4.8 Hz, 1H, H-5a), 2.62 (dt, J = 13.6, 6.0 Hz, 1H, H-3), 2.12 ̶ 2.05 
(m, 1H, H-8a), 1.98  ̶1.92 (m, 2H, H-4a, H-9a) 1.78 ̶ 1.58 (m, 10H, H-4b, H-5b, H-9b, SnBu3), 1.40  ̶
1.33 (m, 6H, SnBu3), 1.22 ̶ 1.17 (m, 9H, H-13, SnBu3), 0.93 (app t, J = 7.3 Hz, 9H, SnBu3). 13C 
NMR (151 MHz, C6D6) δ 210.6 (C-2), 175.6 (C-15), 160.0 (PMB), 130.3 (PMB), 129.8 (PMB) 
114.1 (PMB), 95.9 (C-12), 81.9 (C-7), 69.7 (C-14), 68.9 (PMB), 65.1 (C-1), 57.1 (C-10), 54.8 
(PMB), 51.8 (C-16), 46.8 (C-6), 45.7 (C-3), 43.8 (C-11), 30.5 (C-5), 29.1 (SnBu3), 27.9 (C-8), 27.6 
(C-9), 27.5 (SnBu3), 22.7 (C-4), 16.7 (C-13), 13.9 (SnBu3), 13.8 (SnBu3). 
 
HR-MS (ESI): not found. 
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Tricycle 115. Thiocarbamate 98 (20.0 mg, 37.8 μmol, 1 equiv) was dissolved in degassed benzene 
(7.6 mL) and the solution was heated to 80 °C. A solution of tributyltin hydride 
(12.6 μL, 45.4 μmol, 1.20 equiv) and azobis(isobutyronitrile) (1.2 mg, 7.6 μmol, 0.2 equiv) in 
degassed benzene (1.9 mL) was added via syringe pump over 3 h. Upon completion of the addition, 
the solution was cooled to 25 °C and was concentrated. The crude product was purified by flash 
column chromatography on silica gel (20% ethyl acetate in hexanes) to afford 115 (8.5 mg, 56%) 
as a colorless oil. 
 
1H NMR (600 MHz, C6D6) δ 7.20–7.16 (m, 2H), 6.81–6.74 (m, 2H), 5.19 (d, J = 4.4 Hz, 1H), 4.50 
(d, J = 11.7 Hz, 1H), 4.31 (d, J = 11.7 Hz, 1H), 4.15 (d, J = 17.6 Hz, 1H), 3.89 (dd, J = 17.6, 0.8 
Hz, 1H), 3.28 (s, 3H), 3.11–3.06 (m, 4H), 2.68–2.58 (m, 2H), 2.28–2.18 (m, 1H), 2.02–1.96 (m, 
1H), 1.91 (qd, J = 13.4, 4.9 Hz, 1H), 1.71–1.63 (m, 1H), 1.62–1.50 (m, 3H), 1.38–1.27 (m, 1H), 
1.20–1.12 (m, 1H), 0.90 (s, 3H). 13C NMR (150 MHz, C6D6) δ 210.8, 175.6, 160.0, 130.2, 129.8, 
114.1, 95.9, 68.8, 65.1, 57.6, 54.8, 51.5, 45.9, 44.0, 43.3, 36.3, 31.4, 29.2, 24.3, 23.1, 19.6. 
 
HR-MS (ESI): calcd for (C23H34O6N)+ (M+NH4)+: 420.2386, found: 420.2391. 
 
IR (Diamond-ATR, neat) ṽmax: 2951, 1762, 1513, 1460, 1247, 1113, 1028 cm-1. 
 
 
 
Tetracycle 94. Thiocarbamate 98 (8.00 mg, 15.1 μmol, 1 equiv) was dissolved in chlorobenzene 
(3 mL) and the flask was evacuated and back-filled with argon three times. The solution was then 
placed in a pre-heated oil bath at 122 °C. A solution of tributyltin hydride (4.90 μL, 18.2 μmol, 
1.2 equiv) and azobis(isobutyronitrile) (0.5 mg, 3.0 μmol, 0.2 equiv) in chlorobenzene (0.8 mL) 
was added via syringe pump over 3 h. Upon completion of the addition, the solution was cooled to 
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25 °C and was concentrated. The crude product was purified by flash column chromatography on 
silica gel (40% ethyl acetate in hexanes) to afford 94 (5.5 mg, 94%) as a colorless oil.  
 
TLC (40% ethyl acetate in hexanes): Rf = 0.35 (weak by UV, CAM). 
 
1H NMR (600 MHz, C6D6) δ 7.17–7.11 (m, 2H), 6.82–6.75 (m, 2H), 4.79 (d, J = 6.3 Hz, 1H), 4.52 
(d, J = 11.7 Hz, 1H), 4.29 (d, J = 11.7 Hz, 1H), 3.99 (d, J = 16.7 Hz, 1H), 3.73 (d, J = 16.7 Hz, 1H), 
3.48 (s, 1H), 3.30 (d, J = 0.9 Hz, 3H), 2.90 (t, J = 5.9 Hz, 1H), 2.74 (dt, J = 13.0, 5.2 Hz, 1H), 1.54–
1.40 (m, 2H), 1.38–1.26 (m, 3H), 1.24–1.09 (m, 2H), 0.90 (dt, J = 13.6, 3.3 Hz, 1H), 0.30 (s, 3H). 
13C NMR (151 MHz, C6D6) δ 209.1, 177.8, 160.1, 130.3, 129.6, 114.1, 95.0, 83.0, 68.7, 65.4, 54.9, 
53.5, 48.6, 45.2, 37.8, 28.4, 27.4, 23.2, 22.6, 15.2. 
 
HR-MS (ESI): calcd for (C22H30O6N)+ (M+NH4)+: 404.2073, found: 404.2072. 
 
IR (Diamond-ATR, neat) ṽmax: 2950, 1772, 1729, 1613, 1514, 1458, 1330, 1248, 1030 cm-1. 
 
 
 
Triflate 117. To a solution of tricycle 113 (126 mg, 0.220 mmol, 1 equiv) in tetrahydrofuran 
(0.9 mL) was added a solution of potassium bis(trimethylsilyl)amide (1.0 M in tetrahydrofuran, 
0.44 mL, 0.44 mmol, 2.0 equiv) dropwise at –78 °C. After 15 min, solid 
N-phenylbis(trifluoromethanesulfonimide) (141 mg, 0.400 mmol, 1.80 equiv) was added. After 
30 min, saturated aqueous ammonium chloride solution (10 mL) and diethyl ether (10 mL) were 
added, the layers were separated and the aqueous layer was extracted with diethyl ether (3×15 mL). 
The combined organic layers were dried over sodium sulfate, the dried solution was filtered and 
the filtrate was concentrated. The crude product was purified by flash column chromatography on 
silica gel (3% ethyl acetate in hexanes) to afford 117 as a colorless oil (139 mg, 89%). 
 
TLC (10% ethyl acetate in hexanes): Rf = 0.57 (CAM). 
 
1H NMR (400 MHz, C6D6) δ 7.17 (d, J = 8.6 Hz, 2H), 6.75 (d, J = 8.6 Hz, 2H), 6.52 (s, 1H), 5.15 
(d, J = 9.0 Hz, 1H), 4.94 (dd, J = 8.5, 6.6 Hz, 1H), 4.77 (d, J = 10.9 Hz, 1H), 4.29 (d, J = 10.9 Hz, 
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1H), 3.25 (s, 3H), 3.14 (s, 3H), 3.07 (dd, J = 9.0, 5.2 Hz, 1H), 2.84  ̶2.75 (m, 1H), 2.62 ̶ 2.50 (m, 
2H), 2.05  ̶2.85 (m, 3H), 1.55 ̶ 1.43 (m, 3H), 1.15 ̶ 1.05 (m, 21H), 0.98 (s, 3H). 13C NMR (101 MHz, 
C6D6) δ 175.9, 160.3, 138.1, 137.1, 130.4, 128.8, 120.8 (q, J = 320.4 Hz), 114.3, 100.4, 76.4, 71.2, 
59.2, 54.8, 51.8, 47.6, 43.5, 36.6, 31.1, 29.3, 29.1, 25.0, 18.4, 18.4, 16.2, 12.8. 19F NMR (377 MHz, 
C6D6) δ  ̶ 74.2. 
 
HR-MS (EI): calcd for (C33H53F3NO9SSi)+ (M+NH4)+: 724.3157, found: 724.3181. 
 
IR (Diamond-ATR, neat) ṽmax: 2944, 2867, 1729, 1684, 1614, 1587, 1516, 1464, 1420, 1401, 1364, 
1330, 1303, 1248, 1212, 1142, 1098, 1060, 1038 cm-1. 
 
 
 
Enol ether 118.  To a solution of triflate 117 (48.4 mg, 68.5 µmol, 1 equiv) in dimethylformamide 
(0.7 mL) was added triethylamine (71 µL, 0.50 mmol, 7.5 equiv) and 
bis(triphenylphosphine)palladium(II) chloride (4.8 mg, 6.9 µmol, 0.10 equiv) and the solution was 
cooled to 0 °C. Formic acid (12.9 µL, 0.340 mmol, 5.00 equiv) was added and upon completion of 
the addition, the solution was allowed to warm to 25 °C. The solution then was heated to 70 °C. 
After 2 h, heating was ceased and the solution was cooled to 25 °C. Water (10 mL) and ethyl acetate 
(10 mL) were added, the layers were separated and the aqueous layer was extracted with ethyl 
acetate (3×15 mL). The combined organic layers were washed with saturated aqueous sodium 
chloride solution (10 mL), the washed solution was dried over sodium sulfate and the dried solution 
was filtered. The filtrate was concentrated and the crude product was purified by flash column 
chromatography on silica gel (5% ethyl acetate in hexanes) to afford 118 (38.2 mg, quant.) as a 
colorless oil. 
 
TLC (5% ethyl acetate in hexanes): Rf = 0.31 (UV, CAM). 
 
1H NMR (400 MHz, C6D6) δ 7.26 (d, J = 8.6 Hz, 2H), 6.74 (d, J = 8.6 Hz, 2H), 6.30 (dd, J = 5.9, 
1.4 Hz, 1H), 5.36 (d, J = 9.0 Hz, 1H), 5.01 (dd, J = 9.0, 6.3 Hz, 1H), 4.95 (d, J = 10.9 Hz, 1H), 4.64 
(dd, J = 5.9, 5.0 Hz, 1H), 4.45 (d, J = 10.9 Hz, 1H), 3.26 (s, 3H), 3.14 (s, 3H), 3.06 (dd, J = 9.0, 5.4 
Hz, 1H), 2.98 (ddd, J = 13.5, 11.8, 7.7 Hz, 1H), 2.78 (td, J = 12.9, 4.8 Hz, 1H), 2.15–2.04 (m, 2H), 
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1.96 (dtd, J = 13.5, 9.1, 7.6 Hz, 1H), 1.68–1.49 (m, 4H), 1.20–1.12 (m, 24H). 13C NMR (101 MHz, 
C6D6) δ 176.8, 160.0, 140.8, 130.4, 129.8, 114.2, 107.2, 100.0, 76.7, 70.6, 59.7, 54.8, 51.5, 47.8, 
44.7, 33.7, 31.4, 30.1, 29.7, 28.6, 18.5, 18.4, 16.6, 12.8. 
 
HR-MS (ESI): calcd for (C32H50O6NSi)+ (M+NH4)+: 576.3720, found: 576.3729. 
 
IR (Diamond-ATR, neat) ṽmax: 2943, 2866, 1726, 1515, 1463, 1250, 1148, 1123, 1061 cm-1. 
 
 
 
Thiocarbamate 119. A solution of tetrabutylammonium fluoride in tetrahydrofuran (1.0 M, 32 μL, 
32 μmol, 1.1 equiv) was added dropwise to a solution of enol ether 118 (16 mg, 29 μmol, 1 equiv) 
in tetrahydrofuran (0.4 mL) at 25 °C. After 8.5 h, the solution was diluted with saturated aqueous 
sodium bicarbonate solution (10 mL) and ethyl acetate (10 mL). The layers were separated and the 
aqueous layer was extracted with ethyl acetate (3×10 mL). The combined organic layers were 
washed with saturated aqueous sodium chloride solution (10 mL), the washed solution was dried 
over sodium sulfate and the dried solution was filtered. The filtrate was concentrated. The crude 
product was purified by flash column chromatography on silica gel (33% ethyl acetate in hexanes) 
to afford the alcohol (10.1 mg, 88%) as a white foam. 
To a solution of the obtained alcohol (10.1 mg, 25.1 μmol, 1 equiv) in dichloromethane 
(0.5 mL) were added triethylamine (5.9 μL, 43 μmol, 1.7 equiv), 4-dimethylaminopyridine 
(0.6 mg, 5 μmol, 0.2 equiv) and 1,1'-thiocarbonylimidazole (13.9 mg, 77.8 μmol, 3.10 equiv) and 
the bright yellow solution was heated to 35 °C. After 13 h, heating was ceased and the solution was 
concentrated. The crude product was purified by flash column chromatography on silica gel (40% 
ethyl acetate in hexanes) to afford 119 (11.4 mg, 89%) as a white foam. 
 
TLC (40% ethyl acetate in hexanes): Rf = 0.23 (UV, CAM). 
 
1H NMR (800 MHz, C6D6) δ 8.27 (s, 1H), 7.42 (s, 1H), 7.26–7.21 (m, 2H), 6.96 (dd, J = 1.6, 0.8 
Hz, 1H), 6.80–6.76 (m, 2H), 6.39 (dd, J = 9.6, 5.5 Hz, 1H), 6.28 (dd, J = 6.0, 1.5 Hz, 1H), 5.22 (d, 
J = 9.0 Hz, 1H), 4.93 (d, J = 11.1 Hz, 1H), 4.59 (dd, J = 5.9, 4.9 Hz, 1H), 4.43 (d, J = 11.1 Hz, 1H), 
3.27 (s, 3H), 3.10 (s, 3H), 3.07 (dd, J = 9.0, 5.6 Hz, 1H), 2.78 (ddd, J = 13.8, 11.2, 9.0 Hz, 1H), 
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2.72–2.63 (m, 1H), 2.21 (dq, J = 14.8, 9.2 Hz, 1H), 1.97 (dddd, J = 13.2, 10.4, 4.5, 1.7 Hz, 2H), 
1.47–1.43 (m, 1H), 1.34–1.24 (m, 3H), 0.82 (s, 3H). 13C NMR (200 MHz, C6D6) δ 184.2, 175.8, 
160.2, 141.0, 136.4, 131.4, 130.3, 129.4, 118.5, 114.2, 107.0, 99.5, 88.4, 70.5, 59.9, 54.8, 51.9, 
47.1, 44.4, 33.6, 30.0, 29.7, 28.0, 27.3, 18.2. 
 
HR-MS (ESI): calcd for (C27H32O6N2S)‒ (M‒HCOO)‒: 557.1958, found: 557.1960. 
 
IR (Diamond-ATR, neat) ṽmax: 2928, 1725, 1649, 1614, 1514, 1462, 1385, 1335, 1284, 1232, 1195, 
1147 cm -1. 
 
 
 
Alcohol 121.  To a solution of ester 118 (35 mg, 63 μmol, 1 equiv) in tetrahydrofuran (0.6 mL) was 
added lithium aluminum hydride (4.8 mg, 13 μmol, 2.0 equiv). After 3 h, lithium aluminum hydride 
(2.4 mg, 6.5 μmol, 1 equiv) was added. After a total of 7.5 h, water (3 drops), followed by aqueous 
sodium hydroxide solution (10 wt%, 1 drop) and water (1 drop) were added. Solid sodium sulfate 
was added and after 10 min, the suspension was filtered through a short plug of celite. The filter 
cake was rinsed with diethyl ether (40 mL) and the filtrate was concentrated. The crude product 
was purified by flash column chromatography on silica gel (25% ethyl acetate in hexanes) to afford 
121 (24 mg, 72%) as a colorless oil.  
 
TLC (25% ethyl acetate in hexanes): Rf = 0.35 (UV, CAM). 
 
1H NMR (400 MHz, C6D6) δ 7.28 (d, J = 8.4 Hz, 2H), 6.74 (d, J = 8.4 Hz, 2H), 6.40 (dd, J = 5.9, 
1.4 Hz, 1H), 5.33 (d, J = 9.2 Hz, 1H), 4.97 (d, J = 10.9 Hz, 1H), 4.70 (t, J = 5.4 Hz, 1H), 4.47 (d, J 
= 10.9 Hz, 1H), 3.90 (dd, J = 8.8, 6.6 Hz, 1H), 3.47 (d, J = 10.8 Hz, 1H), 3.25 (s, 3H), 2.97 (d, J = 
10.7 Hz, 1H), 2.86 (dd, J = 9.2, 5.9 Hz, 1H), 2.69–2.54 (m, 1H), 2.36–2.20 (m, 1H), 1.96–1.84 (m, 
1H), 1.67–1.41 (m, 5H), 1.42–1.27 (m, 1H), 1.14–0.97 (m, 24H), 0.59 (s, 1H). 13C NMR (100 
MHz, C6D6) δ 159.9, 140.7, 130.4, 130.1, 114.1, 107.4, 101.0, 78.8, 70.4, 63.8, 54.7, 50.7, 46.6, 
41.0, 31.4, 30.6, 30.2, 28.2, 27.3, 18.4, 18.4, 16.2, 12.7. 
 
HR-MS (ESI): calcd for (C31H54O5NSi)+ (M+NH4)+: 548.3771, found: 548.3776. 
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IR (Diamond-ATR, neat) ṽmax: 3404, 2928, 2866, 1613, 1515, 1464, 1303, 1249, 1151, 1123, 1097 
cm-1. 
 
 
 
Mesylate 123. Triethylamine (31 μL, 0.23 mmol, 5.0 equiv) was added to a solution of alcohol 121 
(24 mg, 45 μmol, 1 equiv) in dichloromethane (0.4 mL) and the solution was cooled to ‒78 °C. 
Methane sulfonylchloride (11 μL, 14 μmol, 3.0 equiv) then was added dropwise. After 3 h, the 
solution was diluted with saturated aqueous sodium bicarbonate solution (10 mL) and HPLC-grade 
dichloromethane (10 mL) and the suspension was allowed to warm to 25 °C. The layers were 
separated and the aqueous layer was extracted with dichloromethane (3×10 mL). The combined 
organic layers were dried over sodium sulfate and the dried solution was filtered. The filtrate was 
concentrated to afford 123 (22.4 mg, 81%) as a yellow solid, which was used without further 
purification for the next step. 
 
 
 
Alkene 124. To a solution of mesylate 123 (2.7 mg, 4.4 μmol, 1 equiv) in dioxane (0.4 mL) were 
added lithium bromide (3.9 mg, 44 μmol, 10 equiv) and sodium bicarbonate (3.7 mg, 44 μmol, 
10 equiv) and the suspension was heated to 110 °C. After 18 h, lithium bromide (7.8 mg, 88 μmol, 
20 equiv) and sodium bicarbonate (7.4 mg, 88 μmol, 20 equiv) were added and stirring at 110 °C 
was continued. After further 7 h, the solution was cooled to 25 °C and saturated aqueous sodium 
bicarbonate solution (10 mL) and ethyl acetate (10 mL) were added. The layers were separated and 
the aqueous layer was extracted with ethyl acetate (3×10 mL). The combined organic layers were 
dried over sodium sulfate and the dried solution was filtered. The filtrate was concentrated and the 
crude product was purified by flash column chromatography on silica gel (5% ethyl acetate in 
hexanes) to afford 124 (1.9 mg, 84%) as a colorless oil.  
 
TLC (10% ethyl acetate in hexanes): Rf = 0.46 (UV, CAM). 
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1H NMR (400 MHz, C6D6) δ 7.28 (d, J = 8.4 Hz, 2H), 6.79 (d, J = 8.4 Hz, 2H), 6.39 (d, J = 6.0 Hz, 
1H), 5.53–5.46 (m, 1H), 5.09 (d, J = 9.0 Hz, 1H), 4.97 (d, J = 11.4 Hz, 1H), 4.68 (t, J = 5.5 Hz, 
1H), 4.52 (d, J = 11.5 Hz, 1H), 3.69 (dd, J = 11.7, 3.3 Hz, 1H), 3.26 (s, 3H), 2.79 (dd, J = 9.0, 5.9 
Hz, 1H), 2.11 (dt, J = 13.1, 3.3 Hz, 1H), 2.00 (ddt, J = 13.3, 8.8, 5.4 Hz, 3H), 1.93–1.79 (m, 1H), 
1.69–1.53 (m, 2H), 1.51–1.24 (m, 1H), 1.12 (m, 25H). 13C NMR (100 MHz, C6D6) δ 159.8, 141.1, 
137.7, 130.5, 129.8, 126.4, 114.0, 106.5, 98.7, 79.7, 70.7, 54.7, 48.4, 40.2, 37.7, 36.0, 28.5, 28.2, 
25.6, 18.6, 18.6, 18.4, 13.4. 
 
HR-MS (ESI): calcd for (C31H52O5NSi)+ (M+NH4)+: 530.3660, found: 530.3667. 
 
IR (Diamond-ATR, neat) ṽmax: 2942, 2866, 1647, 1514, 1463, 1355, 1248, 1160, 1104, 1062, 1039 
cm-1. 
 
 
 
Diol 125. Tetrabutylammonium fluoride (1 M in tetrahydrofuran, 33 µL, 33 µmol, 1.2 equiv) was 
added dropwise to a solution of TIPS ether 121 (14.5 mg, 27.3 µmol, 1 equiv) in tetrahydrofuran 
(0.6 mL) at 25 °C. After 14 h, tetrabutylammonium fluoride (1 M in tetrahydrofuran, 33 µL, 
33 µmol, 1.2 equiv) was added. After additional 20 h, the solution was diluted with saturated 
aqueous sodium bicarbonate solution (10 mL) und ethyl acetate (10 mL). The layers were separated 
and the aqueous layer was extracted with ethyl acetate (3×10 mL). The combined organic layers 
were washed with saturated aqueous sodium chloride solution (10 mL), the washed solution was 
dried over sodium sulfate and the dried solution was filtered. The filtrate was concentrated. The 
crude product was purified by flash column chromatography on silica gel (60% to 100% ethyl 
acetate in hexanes) to afford 125 (8.5 mg, 83%) as a white foam. 
 
1H NMR (400 MHz, C6D6) δ 7.26 (d, J = 8.3 Hz, 2H), 6.76 (d, J = 8.3 Hz, 2H), 6.38 (d, J = 5.8 Hz, 
1H), 5.27 (d, J = 9.2 Hz, 1H), 4.94 (d, J = 11.0 Hz, 1H), 4.67 (t, J = 5.4 Hz, 1H), 4.46 (d, J = 11.0 
Hz, 1H), 3.49 (dd, J = 9.1, 6.8 Hz, 1H), 3.46–3.36 (m, 1H), 3.26 (s, 3H), 2.88 (d, J = 10.8 Hz, 1H), 
2.83 (dd, J = 9.2, 6.0 Hz, 1H), 2.58–2.43 (m, 1H), 2.27 (app dq, J = 11.7, 5.9 Hz, 1H), 1.87 (dtd, J 
= 13.8, 9.2, 6.8 Hz, 1H), 1.67–1.51 (m, 1H), 1.50–1.24 (m, 4H), 1.24–1.13 (m, 1H), 0.92 (s, 3H), 
0.71 (br s, 2H). 13C NMR (100 MHz, C6D6) δ 159.9, 140.7, 130.4, 130.0, 114.1, 107.5, 100.9, 77.9, 
70.3, 63.5, 54.7, 51.1, 45.6, 41.0, 30.5, 30.5, 29.4, 28.0, 27.1, 15.9. 
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HR-MS (ESI): calcd for (C22H34O5N)+ (M+NH4)+: 392.2437, found: 392.2434. 
 
IR (Diamond-ATR, neat) ṽmax: 3385, 2929, 2868, 1656, 1612, 1514, 1464, 1303, 1248, 1235, 1150, 
1039, 1012 cm-1. 
 
 
 
Dimesylate 126. Triethylamine (17 µL, 0.12 mmol, 8.0 equiv) was added to a solution of diol 125 
(7.0 mg, 15 µmol, 1 equiv) in dichloromethane (0.4 mL) and the solution was cooled to –78 °C. 
Methanesulfonyl chloride (6.0 µL, 77 µmol, 5.0 equiv) was added dropwise. After 3 h, saturated 
aqueous sodium bicarbonate solution (10 mL) and HPLC-grade dichloromethane (10 mL) were 
added. The suspension was allowed to warm to 25 °C. The layers were separated and the aqueous 
layer was extracted with dichloromethane (3×10 mL), the combined organic layers were washed 
with saturated aqueous sodium chloride solution (10 mL) and the washed solution was dried over 
sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The crude product 
was purified by flash column chromatography on silica gel (50% ethyl acetate in hexanes) to afford 
126 (8.1 mg, 99%) as a colorless oil. 
 
TLC (50% ethyl acetate in hexanes): Rf = 0.21 (UV, CAM). 
 
1H NMR (400 MHz, C6D6) δ 7.20–7.17 (m, 2H), 6.78–6.70 (m, 2H), 6.28 (dd, J = 6.0, 1.5 Hz, 1H), 
5.08 (d, J = 9.0 Hz, 1H), 4.84 (d, J = 11.0 Hz, 1H), 4.63 (dd, J = 9.5, 6.4 Hz, 1H), 4.56 (t, J = 5.3 
Hz, 1H), 4.36 (d, J = 11.1 Hz, 1H), 4.28–4.22 (m, 1H), 3.88 (d, J = 10.0 Hz, 1H), 3.25 (s, 3H), 
2.67–2.52 (m, 2H), 2.23 (dq, J = 11.9, 6.0 Hz, 1H), 2.12 (s, 3H), 2.10–2.04 (m, 1H), 2.02 (s, 3H), 
1.79 (ddd, J = 13.7, 9.2, 2.3 Hz, 1H), 1.62–1.51 (m, 1H), 1.43 (dd, J = 12.7, 3.9 Hz, 1H), 1.34–1.27 
(m, 1H), 1.25–1.09 (m, 2H), 0.91 (s, 3H). 13C NMR (100 MHz, C6D6) δ 160.1, 140.6, 130.6, 129.3, 
114.2, 107.1, 99.7, 86.6, 70.4, 68.8, 54.8, 50.0, 46.1, 41.9, 37.6, 36.8, 30.3, 29.1, 27.3, 27.1, 27.1, 
16.7. 
 
HR-MS (ESI): calcd for (C24H38O9NS2)+ (M+NH4)+: 548.1988, found: 548.1996. 
 
IR (Diamond-ATR, neat) ṽmax: 2936, 1515, 1352, 1250, 1174, 1041, 947 cm-1. 
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Bisthiocarbamate 129. 1,1’-Thiocarbonyldiimidazole (17.3 mg, 87.6 µmol, 4.00 equiv) and 
4-dimethylaminopyridine (0.54 mg, 4.4 µmol, 0.2 equiv) were combined in a pressure tube and a 
solution of diol 125 (8.2 mg, 22 µmol, 1 equiv) in dichloromethane (0.5 mL), followed by 
triethylamine (6.7 µL, 48 µmol, 2.2 equiv) were added. The tube was sealed and the solution was 
heated to 40 °C. After 7 h, heating was ceased and the solution was cooled to 25 °C. The mixture 
was concentrated and the crude product was purified by flash column chromatography on silica gel 
(60% dichloromethane in ethyl acetate) to afford 129 (13.3 mg, quant.) as a slightly yellow oil.  
 
TLC (50% dichloromethane in ethyl acetate): Rf = 0.33 (UV, CAM). 
 
1H NMR (800 MHz, C6D6) δ 8.33 (s, 1H), 8.24 (s, 1H), 7.38 (s, 1H), 7.30 (s, 1H), 7.21–7.19 (m, 
2H), 6.96 (app q, J = 0.9 Hz, 1H), 6.82 (app q, J = 0.8 Hz, 1H), 6.80–6.79 (m, 2H), 6.27 (dd, J = 
6.0, 1.6 Hz, 1H), 5.42 (dd, J = 9.4, 6.2 Hz, 1H), 5.08 (d, J = 8.9 Hz, 1H), 4.88 (d, J = 11.2 Hz, 1H), 
4.65 (dd, J = 11.1, 2.5 Hz, 1H), 4.56 (dd, J = 6.0, 4.9 Hz, 1H), 4.41 (d, J = 11.2 Hz, 1H), 4.26 (d, J 
= 10.9 Hz, 1H), 3.26 (s, 3H), 2.45–2.38 (m, 2H), 2.22–2.16 (m, 2H), 1.57–1.52 (m, 1H), 1.38–1.35 
(m, 1H), 1.31–1.23 (m, 1H), 1.21–1.10 (m, 2H), 1.07–1.03 (m, 1H), 0.71 (s, 3H). 13C NMR (201 
MHz, C6D6) δ 184.6, 184.2, 160.3, 140.8, 137.2, 136.4, 131.8, 131.7, 130.4, 129.3, 118.4, 117.7, 
114.3, 106.7, 99.1, 89.0, 74.5, 70.3, 54.9, 50.2, 46.6, 43.1, 30.3, 30.2, 29.9, 27.7, 27.4, 26.6, 17.8. 
 
HR-MS (ESI): calcd for (C30H35O5N4S2)+ (M+H)+: 595.2094, found: 595.2058. 
 
IR (Diamond-ATR, neat) ṽmax: 2928, 1760, 1655, 1612, 1514, 1464, 1388, 1334, 1284, 1232, 1108, 
1041, 988 cm-1. 
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9.2.4 Experimental Procedures for Chapter 3.4 
 
 
 
TIPS ether 135. Triethylamine (2.34 mL, 16.8 mmol, 2.10 equiv) was added to a solution of 
4-bromo-4-penten-1-ol (138)82 (1.32 g, 8.00 mmol, 1 equiv) in dichloromethane (40 mL) at 0 °C. 
Triisopropylsilyl trifluoromethanesulfonate (2.26 mL, 8.40 mmol, 1.05 equiv) was added 
dropwise. The solution was then allowed to warm to 25 °C. After 25 min, the solution was diluted 
with saturated aqueous sodium bicarbonate solution (50 mL) and the layers were separated. The 
aqueous layer was extracted with dichloromethane (3×100 mL), the combined organic layers were 
washed with saturated aqueous sodium chloride solution (50 mL) and the washed solution was 
dried over sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The 
crude product was purified by flash column chromatography on silica gel (2% ethyl acetate in 
hexanes) to afford 135 (2.26 g, 88%) as a colorless oil. 
 
1H NMR (400 MHz, Chloroform-d) δ 5.59 (q, J = 1.3 Hz, 1H), 5.40 (d, J = 1.6 Hz, 1H), 3.71 (t, J 
= 6.1 Hz, 2H), 2.54 (td, J = 7.3, 1.1 Hz, 2H), 1.79 (ddt, J = 8.4, 7.3, 6.2 Hz, 2H), 1.07–1.04 (m, 
21H). 13C NMR (100 MHz, CDCl3) δ 134.6, 116.8, 61.9, 38.1, 31.4, 18.2, 12.1. 
 
HR-MS (EI): calcd for (C14H3079BrO28Si)+ (M+H)+: 321.1244, found: 321.1289. 
 
IR (Diamond-ATR, neat) ṽmax: 2942, 2866, 1630, 1463, 1383, 1105, 1059, 882 cm-1. 
 
 
 
TMS enol ether 139. To a solution of vinyl bromide 135 (1.67 g, 5.20 mmol, 1.30 equiv) in 
tetrahydrofuran (40 mL) was added a solution of tert-butyl lithium (1.70 M in pentanes, 5.65 mL, 
9.60 mmol, 2.40 equiv) dropwise at ‒78 °C. After 45 min, solid magnesium bromide etherate 
(1.45 g, 5.60 mmol, 1.40 equiv) was added. After 45 min, copper(I) bromide dimethyl sulfide 
adduct (247 mg, 1.20 mmol, 0.300 equiv) was added. After 1 h, hexamethylphosphoramide 
(2.09 mL, 12.0 mmol, 3.00 equiv) was added. After 10 min, a solution of enone 20 (937 mg, 
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4.00 mmol, 1 equiv) and freshly distilled chlorotrimethylsilane (1.53 mL, 12.0 mmol, 3.00 equiv) 
in tetrahydrofuran (4 mL) was added dropwise. After 1 h, the solution was warmed to ‒40 °C and 
after 45 min, the solution was diluted with a mixture of saturated aqueous ammonium chloride 
solution and 25 wt% aqueous ammonia solution (v/v = 3:1, 60 mL) and diethyl ether (50 mL). The 
biphasic mixture was allowed to warm to 25 °C and after 1 h, the layers were separated and the 
aqueous layer was extracted with diethyl ether (3×150 mL). The combined organic layers were 
washed with saturated aqueous sodium chloride solution (2×100 mL), the washed solution was 
dried over sodium sulfate and the dried solution was filtered. The filtrate was concentrated to afford 
139 as a slightly yellow oil, which was used without further purification immediately for the next 
step. 
 
1H NMR (400 MHz, C6D6) δ 7.29–7.23 (m, 2H), 6.81–6.75 (m, 2H), 5.19–5.15 (m, 1H), 5.05–5.01 
(m, 1H), 4.93 (d, J = 4.6 Hz, 1H), 4.89 (d, J = 2.1 Hz, 1H), 4.76 (d, J = 11.6 Hz, 1H), 4.47 (d, J = 
11.7 Hz, 1H), 4.23 (d, J = 15.1 Hz, 1H), 4.05 (d, J = 14.8 Hz, 1H), 3.62 (t, J = 6.4 Hz, 2H), 3.29 (s, 
3H), 3.24–3.20 (m, 1H), 2.38–2.23 (m, 2H), 1.75 (ddt, J = 16.4, 9.7, 6.6 Hz, 2H), 1.12 (d, J = 5.2 
Hz, 21H), 0.14 (s, 9H). 13C NMR (100 MHz, C6D6) δ 159.8, 150.1, 148.5, 130.6, 129.7, 129.7, 
114.1, 114.1, 112.1, 101.8, 99.2, 69.3, 63.4, 61.7, 54.7, 47.1, 31.8, 31.6, 18.4, 12.4, 0.2. 
 
HR-MS (ESI): calcd for (C30H56O5NSi2)+ (M+NH4)+: 566.3697, found: 566.3704. 
 
IR (Diamond-ATR, neat) ṽmax: 2942, 2865, 1682, 1514, 1250, 1211, 1100, 1036 cm -1. 
 
[𝜶]589
20  = +66.4 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
β-Hydroxy ketone 141. To a solution of crude TMS enol ether 139 (assumed: 2.20 g, 4.00 mmol, 
1 equiv) in tetrahydrofuran (31 mL) was added aqueous formaldehyde solution (37 wt% in water, 
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7.8 mL) and ytterbium triflate (192 mg, 0.40 mmol, 0.10 equiv) was added at 25 °C. After 14 h, the 
solution was diluted with saturated aqueous sodium bicarbonate solution (50 mL) and ethyl acetate 
(50 mL). The layers were separated and the aqueous layer was extracted with ethyl acetate 
(3×50 mL). The combined organic layers were washed with brine (30 mL), the washed solution 
was dried over sodium sulfate and the dried solution was filtered. The filtrate was concentrated and 
the crude product was used without further purification for the next step.  
 The crude product was dissolved in toluene (20 mL) and the solution was added to Schlenk 
flask containing dry and activated 4 Å molecular sieves (2.46 g). The Schlenk flask was attached 
to a gas washing bottle containing water (15 mL) and the solution was heated to 90 °C under a 
constant stream of argon. After 5 h, heating was ceased and the solution was cooled to 25 °C. 
Saturated aqueous sodium bicarbonate solution (50 mL) and ethyl acetate (50 mL) were added and 
the biphasic mixture was filtered through a fritted glass funnel. The layers were separated and the 
aqueous layer was extracted with ethyl acetate (3×50 mL), the combined organic layers were 
washed with saturated aqueous sodium chloride solution (50 mL) and the washed solution was 
dried over sodium sulfate. The dried solution was filtered and the filtrate was concentrated. The 
crude product was purified by flash column chromatography on previously deactivated silica gel 
(7.5% triethylamine) (15% to 25% ethyl acetate in hexanes) to afford 141 (1.17 g, 58% over 3 
steps) as a yellow oil. 
 
 
Figure 11. Setup for the formaldehyde gas outlet for the synthesis of β-hydroxy ketone 141. 
 
 
Argon 
water 
Argon/ CH2O mixture 
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TLC (25% ethyl acetate in hexanes): Rf = 0.31 (UV, CAM). 
 
1H NMR (600 MHz, C6D6) δ 7.12–7.08 (m, 2H, PMB), 6.74 (d, 3J = 8.6 Hz, 2H, PMB), 4.87–4.83 
(m, 2H, H-11, H-7), 4.77–4.75 (m, 1H, H-7), 4.50 (d, 2J = 11.7 Hz, 1H, PMB), 4.26 (d, 2J = 11.7 
Hz, 1H, PMB), 4.00 (d, 2J1a/1b = 17.5 Hz, 1H, H-1a), 3.83–3.75 (m, 1H, H-4a), 3.66 (d, 2J1b/1a = 17.5 
Hz, 1H, H-1b), 3.52 (m, 3H, H-10, H-4b), 3.26 (s, 3H, PMB), 2.57 (dd, 3J5/3 = 12.5 Hz, 3J5/11 = 5.1 
Hz, 1H, H-5), 2.47 (ddd, 3J3/5 = 12.5 Hz, 3J3/4 = 5.6, 2.8 Hz, 1H, H-3), 2.29 (t, 3JOH/4 = 6.4 Hz, 1H, 
OH), 2.12–2.07 (m, 2H, H-8), 1.64–1.56 (m, 2H, H-9), 1.09–1.03 (m, 21H, TIPS). 13C NMR (150 
MHz, C6D6) δ 212.7 (C-2), 159.9 (PMB), 147.6 (C-6), 129.9 (PMB), 129.7 (PMB), 114.1 (PMB), 
112.5 (C-7), 102.0 (C-11), 69.5 (PMB), 66.5 (C-1), 63.0 (C-10), 59.1 (C-4), 54.8 (PMB), 49.7 (C-
3), 48.2 (C-5), 31.5 (C-8), 31.2 (C-9), 18.3 (TIPS), 12.4 (TIPS). 
 
HR-MS (ESI): calcd for (C28H50O6NSi)+ (M+NH4)+: 524.3407, found: 524.3407. 
 
IR (Diamond-ATR, neat) ṽmax: 3494, 2941, 2865, 1725, 1613, 1514, 1463, 1248, 1105, 1033 cm-1. 
 
[𝜶]589
20  = +71.4 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
TES ether 142. Imidazole (210 mg, 3.08 mmol, 2.60 equiv) was added to a solution of β-hydroxy 
ketone 141 (600 mg, 1.18 mmol, 1 equiv) in dimethylformamide (2.4 mL) at 25 °C. 
Chlorotriethylsilane (232 mg, 1.54 mmol, 1.30 equiv) was added. After 4 h, the solution was 
diluted with saturated aqueous sodium bicarbonate solution (20 mL) and ethyl acetate (20 mL). The 
layers were separated and the aqueous layer was extracted with ethyl acetate (3×30 mL), the 
combined organic layers were washed with saturated aqueous sodium chloride solution (20 mL) 
and the washed solution was dried over sodium sulfate. The dried solution was filtered and the 
filtrate was concentrated. The crude product was purified by flash column chromatography on silica 
gel (10% ethyl acetate in hexanes) to afford 142 (624 mg, 85%) as a colorless oil. 
 
TLC (10% ethyl acetate in hexanes): Rf = 0.23 (UV, CAM). 
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1H NMR (600 MHz, C6D6) δ 7.18 (d, J = 8.6 Hz, 2H), 6.79 (d, J = 8.6 Hz, 2H), 5.01 (s, 1H), 4.96 
(d, J = 5.8 Hz, 1H), 4.89 (s, 1H), 4.61 (d, J = 11.8 Hz, 1H), 4.37 (d, J = 11.7 Hz, 1H), 4.18–4.14 
(m, 2H), 3.79 (d, J = 16.9 Hz, 1H), 3.68–3.64 (m, 3H), 3.31 (s, 3H), 3.04 (dd, J = 12.1, 5.8 Hz, 1H), 
2.42 (ddd, J = 12.1, 3.8, 2.7 Hz, 1H), 2.29 (dq, J = 19.2, 8.2 Hz, 2H), 1.78 (tt, J = 7.7, 6.2 Hz, 2H), 
1.15–1.10 (m, 21H), 1.03 (t, J = 7.9 Hz, 9H), 0.70–0.61 (m, 6H). 13C NMR (150 MHz, C6D6) δ 
208.0, 159.9, 148.4, 130.1, 129.8, 114.1, 112.0, 102.4, 69.4, 66.9, 63.3, 57.9, 54.8, 50.1, 47.1, 32.2, 
31.4, 18.3, 12.4, 7.2, 4.8. 
 
HR-MS (ESI): calcd for (C34H64O6NSi)+ (M+NH4)+: 638.4272, found: 638.4275. 
 
IR (Diamond-ATR, neat) ṽmax: 2942, 2866, 1736, 1613, 1514, 1462, 1381, 1302, 1248, 1172, 1105, 
1038 cm-1. 
 
[𝜶]589
20  = +95.4 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
Vinyl triflate 143. A solution of n-butyl lithium (2.3 M in hexanes, 0.540 mL, 1.25 mmol, 
1.25 equiv) was added dropwise to a solution of diisopropyl amine (0.18 mL, 1.3 mmol, 1.3 equiv) 
in tetrahydrofuran (1.7 mL) at ‒78 °C. After 10 min, the solution was allowed to warm to 0 °C. 
After 20 min at 0 °C, the solution was cooled to ‒78 °C and a solution of TES ether 142 (623 mg, 
1.00 mmol, 1 equiv) was added dropwise. After 45 min, a solution of 
N-phenylbis(trifluoromethanesulfonimide) (502 mg, 1.40 mmol, 1.40 equiv) in tetrahydrofuran 
(1 mL) was added dropwise. The solution was slowly allowed to warm to 25 °C over 2 h. After 2 h 
at 25 °C, the solution was diluted with saturated aqueous sodium bicarbonate solution (10 mL) and 
diethyl ether (10 mL). The layers were separated and the aqueous layer was extracted with diethyl 
ether (3×30 mL). The combined organic layers were washed with saturated aqueous sodium 
chloride solution (30 mL), the washed solution was dried over sodium sulfate and the dried solution 
was filtered. The filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (3% to 5% ethyl acetate in hexanes) to afford 143 (607 mg, 80%) as 
a colorless oil.  
 
1H NMR (800 MHz, C6D6) δ 7.13 (d, J = 8.5 Hz, 2H), 6.78 (d, J = 8.6 Hz, 2H), 6.62 (d, J = 1.5 Hz, 
1H), 5.01–4.96 (m, 2H), 4.87 (d, J = 5.6 Hz, 1H), 4.66 (d, J = 11.3 Hz, 1H), 4.29–4.25 (m, 1H), 
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3.96 (dd, J = 10.0, 5.8 Hz, 1H), 3.78 (dd, J = 9.9, 3.7 Hz, 1H), 3.62 (t, J = 6.2 Hz, 2H), 3.30 (s, 3H), 
3.09 (t, J = 6.0 Hz, 1H), 2.91–2.86 (m, 1H), 2.22 (dddd, J = 42.0, 15.5, 9.9, 5.6 Hz, 2H), 1.83–1.67 
(m, 2H), 1.14–1.09 (m, 21H), 0.99 (t, J = 8.0 Hz, 9H), 0.64–0.56 (m, 6H). 13C NMR (200 MHz, 
C6D6) δ 160.1, 147.2, 138.5, 135.4, 129.8, 128.4, 114.1, 112.1, 100.7, 70.9, 63.2, 60.0, 54.8, 44.1, 
42.9, 32.8, 31.4, 18.3, 12.4, 7.0, 4.7. 
 
HR-MS (ESI): calcd for (C35H63O8NF3SSi2)+ (M+NH4)+: 770.3765, found: 770.3779. 
 
IR (Diamond-ATR, neat) ṽmax: 2942, 2867, 1514, 1421, 1398, 1247, 1208, 1141, 1099, 1067 cm-1. 
 
[𝜶]589
20  = +39.4 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
Alkene 144. To a solution of triflate 143 (607 mg, 0.810 mmol, 1 equiv) in dimethylformamide 
(5.4 mL) was added bis(triphenylphosphine)palladium(II) chloride (57 mg, 0.081 mmol, 
0.10 equiv), followed by triethylamine (0.500 mL, 3.63 mmol, 4.50 equiv). Formic acid (0.15 mL, 
2.4 mmol, 3.0 equiv) was then added dropwise. The solution was heated to 70 °C. After 20 h, 
heating was ceased and water (20 mL) and ethyl acetate (20 mL) were added. The layers were 
separated and the aqueous layer was extracted with ethyl acetate (3×20 mL). The combined organic 
layers were washed with brine (20 mL), the washed solution was dried over sodium sulfate and the 
dried solution was filtered. The filtrate was concentrated and the crude product was purified by 
flash column chromatography on previously deactivated silica gel (7.5% triethylamine) (30% ethyl 
acetate in hexanes) to afford 144 (230 mg, 58%) as a colorless oil.  
 
TLC (30% ethyl acetate in hexanes): Rf = 0.41 (UV, CAM). 
 
1H NMR (400 MHz, C6D6) δ 7.20 (d, J = 8.6 Hz, 2H), 6.77 (d, J = 8.6 Hz, 2H), 6.36 (dd, J = 6.2, 
2.1 Hz, 1H), 4.96 (d, J = 1.4 Hz, 1H), 4.90–4.86 (m, 2H), 4.82 (d, J = 11.5 Hz, 1H), 4.73 (dd, J = 
6.2, 2.8 Hz, 1H), 4.45 (d, J = 11.5 Hz, 1H), 3.61 (t, J = 6.2 Hz, 2H), 3.52 (dd, J = 10.3, 4.9 Hz, 1H), 
3.39–3.32 (m, 1H), 3.29 (s, 3H), 2.55 (dd, J = 7.7, 6.3 Hz, 1H), 2.33–2.26 (m, 1H), 2.27–2.18 (m, 
2H), 1.82–1.64 (m, 2H), 1.13–1.07 (m, 21H). 13C NMR (100 MHz, C6D6) δ 159.9, 149.4, 141.8, 
130.0, 129.8, 114.1, 110.6, 103.2, 100.4, 70.3, 65.1, 63.3, 54.8, 46.4, 39.8, 33.0, 31.5, 18.3, 12.4. 
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HR-MS (ESI): calcd for (C28H50O5NSi)+ (M+NH4)+: 508.3458, found: 508.3458. 
 
IR (Diamond-ATR, neat) ṽmax: 3409, 2941, 2865, 1651, 1514, 1463, 1248, 1106, 1034 cm-1. 
 
[𝜶]589
20  = +38.8 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
Aldehyde 145. Sodium bicarbonate (99.6 mg, 1.19 mmol, 5.00 equiv) was suspended in HPLC-
grade dichloromethane (1.4 mL) and Dess‒Martin periodinane (126 mg, 0.300 mmol, 1.50 equiv) 
was added. The solution was cooled to 0 °C and a solution of alcohol 144 (97 mg, 0.20 mmol, 
1 equiv) in HPLC-grade dichloromethane (1 mL) was added. The suspension was then allowed to 
warm to 25 °C. After 3 h, diethyl ether (5 mL) was added and the suspension was filtered through 
a short plug of celite. The filter cake was rinsed with diethyl ether (15 mL). The filtrate was 
concentrated and the crude product was purified by quick flash column chromatography on silica 
gel (20% ethyl acetate in hexanes) to afford 145 (80 mg, 83%) as a colorless oil. 
 
1H NMR (400 MHz, C6D6) δ 9.46 (d, J = 1.1 Hz, 1H), 7.16–7.13 (m, 2H), 6.79–6.74 (m, 2H), 6.20 
(dd, J = 6.2, 1.8 Hz, 1H), 5.01–4.90 (m, 3H), 4.75 (ddd, J = 6.3, 4.4, 0.8 Hz, 1H), 4.67 (d, J = 11.6 
Hz, 1H), 4.35 (d, J = 11.6 Hz, 1H), 3.56 (t, J = 6.2 Hz, 2H), 3.27 (s, 3H), 2.95 (app t, J = 4.0 Hz, 
1H), 2.64–2.57 (m, 1H), 2.18–2.11 (m, 2H), 1.70–1.61 (m, 2H), 1.13–1.09 (m, 21H). 13C NMR 
(100 MHz, C6D6) δ 199.7, 159.8, 146.9, 141.9, 129.7, 129.6, 114.1, 111.6, 98.2, 97.6, 69.7, 63.0, 
54.7, 47.1, 43.5, 32.5, 31.5, 18.3, 12.4. 
 
HR-MS (ESI): calcd for (C28H48O5NSi)+ (M+NH4)+: 506.3302, found: 506.3299. 
 
IR (Diamond-ATR, neat) ṽmax: 2942, 2865, 1727, 1654, 1613, 1514, 1463, 1248, 1104, 1036 cm-1. 
 
[𝜶]589
20  = +26.8 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
Experimental Section for Part I 
182 
 
 
 
Alkene 146. Anhydrous cerium(III) chloride (202 mg, 0.820 mmol, 5.00 equiv) was suspended in 
tetrahydrofuran (4.4 mL) and the suspension was stirred at 25 °C for 2 h. The suspension was 
sonicated for 5 min and was then cooled to ‒78 °C. A solution of (trimethylsilyl)methyllithium 
(1 M in pentanes, 0.66 mL, 0.66 mmol, 4.0 equiv) was slowly added dropwise. The yellow 
suspension was vigorously stirred for 30 min before a solution of aldehyde 145 (80 mg, 0.16 mmol, 
1 equiv) in tetrahydrofuran (0.9 mL) was added dropwise. After 30 min, the solution was allowed 
to warm to ‒30 °C. After 2 h 30 min, tetramethylethylenediamine (0.25 mL, 1.64 mmol, 
10.0 equiv) was added, followed by saturated aqueous sodium bicarbonate solution (10 mL) and 
ethyl acetate (10 mL). The biphasic mixture was allowed to warm to 25 °C. After 15 min, the layers 
were separated and the aqueous layer was extracted with ethyl acetate (3×30 mL), the combined 
organic layers were washed with saturated aqueous sodium chloride solution (25 mL) and the 
washed solution was dried over sodium sulfate. The dried solution was filtered and the filtrate was 
concentrated. The crude product was purified by flash column chromatography on silica gel (15% 
ethyl acetate in hexanes) to afford the alcohol (86 mg, 91%) as a 2:1 mixture of diastereomers. 
 The alcohol (86 mg, 0.15 mmol, 1 equiv) was dissolved in a mixture of tetrahydrofuran 
and dimethylformamide (v/v = 10:1, 12.4 mL) and a solution of sodium bis(trimethylsilyl)amide 
(1.0 M in toluene, 0.25 mL, 0.25 mmol, 1.7 equiv) was added dropwise. The solution was heated to 
50 °C. After 1.5 h, heating was ceased and the solution was allowed to cool to 25 °C. Saturated 
aqueous ammonium chloride solution (10 mL) and ethyl acetate (10 mL) were added, the layers 
were separated and the aqueous layer was extracted with ethyl acetate (3×15 mL). The combined 
organic layers were dried over sodium sulfate, the dried solution was filtered and the filtrate was 
concentrated. The crude product was purified by flash column chromatography on silica gel (5% 
ethyl acetate in hexanes) to afford 146 (65.4 mg, 90%) as a colorless oil. 
 
TLC (5% ethyl acetate in hexanes): Rf = 0.25 (UV, CAM). 
 
1H NMR (400 MHz, C6D6) δ 7.26–7.20 (m, 2H), 6.81–6.74 (m, 2H), 6.35 (dd, J = 6.1, 2.2 Hz, 1H), 
5.72 (ddd, J = 17.1, 10.1, 8.1 Hz, 1H), 5.05–4.98 (m, 2H), 4.94 (dd, J = 10.1, 1.8 Hz, 1H), 4.88 (d, 
J = 11.6 Hz, 1H), 4.84 (d, J = 7.7 Hz, 1H), 4.79 (s, 1H), 4.67 (dd, J = 6.1, 2.4 Hz, 1H), 4.50 (d, J = 
11.6 Hz, 1H), 3.60 (t, J = 6.2 Hz, 2H), 3.30 (s, 3H), 2.94–2.86 (m, 1H), 2.41 (dd, J = 9.5, 7.7 Hz, 
1H), 2.31–2.13 (m, 2H), 1.83–1.63 (m, 2H), 1.15–1.06 (m, 21H). 13C NMR (100 MHz, C6D6) δ 
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159.8, 148.5, 141.3, 140.5, 130.1, 129.8, 114.9, 114.0, 110.7, 104.4, 101.4, 70.5, 63.3, 54.7, 50.3, 
42.5, 33.5, 31.2, 18.3, 12.4. 
 
HR-MS (ESI): calcd for (C29H50O4NSi)+ (M+NH4)+: 504.3509, found: 504.3509. 
 
IR (Diamond-ATR, neat) ṽmax: 2942, 2865, 1647, 1613, 1514, 1463, 1302, 1248, 1233, 1157, 1034 
cm-1. 
 
[𝜶]589
20  = −2.4 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
Alcohol 147. Tetrabutylammonium fluoride (1.0 M solution in tetrahydrofuran, 0.170 mL, 
0.170 mmol, 1.05 equiv) was added dropwise to a solution of alkene 146 (80 mg, 0.16 mmol, 
1 equiv) in tetrahydrofuran (1.4 mL) at 0 °C. Upon completion of the addition, the solution was 
allowed to warm to 25 °C. After 3 h, the solution was diluted with saturated aqueous sodium 
bicarbonate solution (10 mL) and ethyl acetate (10 mL). The layers were separated and the aqueous 
layer was extracted with ethyl acetate (3×15 mL). The combined organic layers were washed with 
saturated aqueous sodium chloride solution (15 mL), the washed solution was dried over sodium 
sulfate and the dried solution was filtered. The filtrate was concentrated and the crude product was 
purified by flash column chromatography on silica gel (50% ethyl acetate in hexanes) to afford 147 
(53.6 mg, 99%) as a colorless oil.  
 
TLC (50% ethyl acetate in hexanes): Rf = 0.40 (UV, CAM). 
 
1H NMR (800 MHz, C6D6) δ 7.23–7.20 (m, 2H), 6.80–6.75 (m, 2H), 6.34 (dd, J = 6.1, 2.2 Hz, 1H), 
5.66 (ddd, J = 17.1, 10.1, 8.1 Hz, 1H), 4.98 (ddd, J = 17.1, 1.8, 1.0 Hz, 1H), 4.92–4.89 (m, 2H), 
4.85 (d, J = 11.5 Hz, 1H), 4.79 (d, J = 7.9 Hz, 1H), 4.75 (s, 1H), 4.65 (dd, J = 6.1, 2.3 Hz, 1H), 4.49 
(d, J = 11.5 Hz, 1H), 3.31 (t, J = 6.4 Hz, 2H), 3.28 (s, 3H), 2.86–2.81 (m, 1H), 2.35 (dd, J = 9.6, 
7.9 Hz, 1H), 2.10–1.97 (m, 2H), 1.57–1.47 (m, 2H), 0.56 (s, 1H). 13C NMR (200 MHz, C6D6) δ 
159.9, 148.2, 141.3, 140.4, 130.0, 129.9, 115.0, 114.1, 110.9, 104.5, 101.2, 70.4, 62.3, 54.8, 50.4, 
42.5, 33.2, 30.7. 
 
HR-MS (ESI): calcd for (C20H30O4N)+ (M+NH4)+: 348.2175, found: 348.2167. 
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IR (Diamond-ATR, neat) ṽmax: 3364, 2937, 2874, 1648, 1613, 1514, 1248, 1233, 1108, 1031 cm-1. 
 
[𝜶]589
20  = −0.2 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
Aldehyde 148. Dess‒Martin periodinane (96.3 mg, 0.230 mmol, 1.50 equiv) was added to a 
suspension of sodium bicarbonate (63.6 mg, 0.760 mmol, 5.00 equiv) in dichloromethane (1 mL) 
at 0 °C. A solution of alcohol 147 (50 mg, 0.15 mmol, 1 equiv) in dichloromethane (0.5 mL) was 
added dropwise and upon completion of the addition, the suspension was allowed to warm to 25 °C. 
After 3 h, diethyl ether (10 mL) was added and the suspension was filtered through a short plug of 
celite. The filter cake was rinsed with diethyl ether (50 mL). The filtrate was concentrated and the 
crude product was purified by flash column chromatography on silica gel (30% ethyl acetate in 
hexanes) to afford 148 (43.5 mg, 88%) as a colorless oil. 
 
1H NMR (400 MHz, C6D6) δ 9.25 (t, J = 1.5 Hz, 1H), 7.18 (d, J = 9.1 Hz, 2H), 6.82–6.75 (m, 2H), 
6.32 (dd, J = 6.1, 2.2 Hz, 1H), 5.56 (ddd, J = 17.1, 10.1, 8.0 Hz, 1H), 4.93 (ddd, J = 17.1, 1.8, 1.0 
Hz, 1H), 4.88 (ddd, J = 10.1, 1.8, 0.6 Hz, 1H), 4.81 (d, J = 11.5 Hz, 1H), 4.74 (s, 1H), 4.70 (d, J = 
8.0 Hz, 1H), 4.64 (s, 1H), 4.61 (dd, J = 6.1, 2.2 Hz, 1H), 4.44 (d, J = 11.5 Hz, 1H), 3.28 (s, 3H), 
2.79–2.70 (m, 1H), 2.25–2.09 (m, 3H), 2.05–1.95 (m, 2H). 13C NMR (100 MHz, C6D6) δ 200.4, 
160.0, 147.0, 141.4, 140.0, 130.0, 129.8, 115.2, 114.1, 111.4, 104.3, 101.1, 70.5, 54.8, 50.2, 42.6, 
41.3, 29.4. 
 
HR-MS (ESI): calcd for (C20H28O4N)+ (M+NH4)+: 346.2018, found: 346.2011. 
 
IR (Diamond-ATR, neat) ṽmax: 2909, 1723, 1648, 1612, 1514, 1248, 1233, 1109, 1031 cm-1. 
 
[𝜶]589
20  = -1.0 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
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Dibromoalkene 132. A solution of triphenylphosphine (128 mg, 0.490 mmol, 4.00 equiv) in 
dichloromethane (0.4 mL) was added dropwise to a solution of carbon tetrabromide (80.8 mg, 
0.240 mmol, 2.00 equiv) in dichloromethane (0.7 mL) at 0 °C. After 15 min, triethylamine 
(0.14 mL, 0.97 mmol, 8.0 equiv) was added and the solution turned pink. After 10 min, a solution 
of aldehyde 148 (40 mg, 0.12 mmol, 1 equiv) in dichloromethane (0.5 mL) was added dropwise. 
Upon completion of the addition, the brown solution was allowed to warm to 25 °C. After 3 h, 
saturated aqueous sodium bicarbonate solution (10 mL) and dichloromethane (10 mL) were added. 
The layers were separated and the aqueous layer was extracted with dichloromethane (3×10 mL). 
The combined organic layers were washed with saturated aqueous sodium chloride solution 
(10 mL), the washed solution was dried over sodium sulfate and the dried solution was filtered. 
The filtrate was concentrated and the crude product was purified by flash column chromatography 
on silica gel (15% ethyl acetate in hexanes) to afford 132 (48.5 mg, 82%) as a yellow oil. 
 
TLC (25% ethyl acetate in hexanes): Rf = 0.56 (UV, CAM). 
 
1H NMR (400 MHz, C6D6) δ 7.22–7.18 (m, 2H, PMB), 6.83–6.77 (m, 2H, PMB), 6.33 (dd, 3J1/2 = 
6.1 Hz, 4J1/3 = 2.2 Hz, 1H, H-1), 6.07 (t, 3J11/10 = 6.8 Hz, 1H, H-11), 5.58 (ddd, 3J4/5 = 17.1 Hz, 3J4/5 
= 10.1, 3J4/3 = 8.1 Hz, 1H, H-4), 4.99–4.88 (m, 2H, H-5), 4.83 (d, 2J = 11.4 Hz, 1H, PMB), 4.76 (s, 
1H, H-8a), 4.70 (d, 3J13/6 = 8.0 Hz, 1H, H-13), 4.66 (s, 1H, H-8b), 4.62 (dd, 3J2/1 = 6.1 Hz, 3J2/3 = 
2.2 Hz, 1H, H-2), 4.46 (d, 2J = 11.5 Hz, 1H, PMB), 3.29 (s, 3H, PMB), 2.79–2.69 (m, 1H, H-3), 
2.22 (dd, 3J6/3 = 9.8 Hz, 3J6/13 =  8.0 Hz, 1H, H-6), 2.03–1.94 (m, 2H, H-10), 1.90–1.80 (m, 2H, H-
9). 13C NMR (100 MHz, C6D6) δ 160.0 (PMB), 147.0 (C-8), 141.4 (C-1), 140.1 (C-4), 138.8 (C-
11), 130.0 (PMB), 129.8 (PMB), 115.3 (PMB), 114.1 (C-5), 111.4 (PMB), 104.3 (C-2), 101.1 (C-
13), 89.1 (C-12), 70.5 (PMB), 54.8 (PMB), 50.1 (C-6), 42.6 (C-3), 34.7 (C-9), 30.9 (C-10). 
 
HR-MS (EI): calcd for (C21H24O379Br2)+: 482.0092, found: 482.0109. 
 
IR (Diamond-ATR, neat) ṽmax: 2909, 1647, 1612, 1513, 1301, 1247, 1231, 1107, 1032 cm-1. 
 
[𝜶]589
20  = −4.6 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
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Boronic acid ester 152. To a solution of alkene 132 (8.00 mg, 16.5 µmol, 1 equiv) in benzene 
(0.4 mL) was added grubb’s second generation catalyst (1.4 mg, 1.7 µmol, 0.10 equiv) at the 
solution was heated to 80 °C. After 2 h 15 min, the solution was cooled to 25 °C and was 
concentrated. The residue was purified by flash column chromatography on silica gel (5% to 30% 
ethyl acetate in hexanes) to afford 152 (7 mg, 69%) as slightly brown oil.  
 
1H NMR (400 MHz, C6D6) δ 7.22–7.17 (m , 2H), 6.83–6.73 (m, 3H), 6.28 (dd, J = 6.1, 2.2 Hz, 
1H), 6.04 (t, J = 6.8 Hz, 1H), 5.76 (dd, J = 17.9, 1.1 Hz, 1H), 4.79 (d, J = 11.6 Hz, 1H), 4.72 (s, 
1H), 4.68–4.60 (m, 3H), 4.43 (d, J = 11.6 Hz, 1H), 3.30 (s, 3H), 2.92–2.82 (m, 1H), 2.27 (dd, J = 
9.8, 7.9 Hz, 1H), 1.99–1.89 (m, 2H), 1.89–1.75 (m, 2H), 1.07 (s, 12H). 13C NMR (100 MHz, C6D6) 
δ 159.9, 154.7, 146.8, 141.5, 138.9, 130.0, 129.9, 114.1, 111.6, 103.6, 101.0, 88.9, 83.1, 70.4, 54.8, 
49.6, 44.0, 34.9, 30.9, 25.0, 25.0. (signal for C5 is missing, verified by HSQC). 
 
HR-MS (EI): calcd for (C27H35O511B79Br2)+: 608.0939, found: 608.0971. 
 
IR (Diamond-ATR, neat) ṽmax: 2977, 2927, 1634, 1514, 1358, 1323, 1249, 1144 cm-1. 
 
 
 
Aldehyde 151. Sodium perborate tetrahydrate (1.94 mg, 12.6 µmol, 1.10 equiv) was added to a 
solution of boronic acid ester 152 (7.00 mg, 11.5 µmol, 1 equiv) at 25 °C. After 4 h 45 min, water 
(10 mL) and diethyl ether (10 mL) were added. The layers were separated and the aqueous layer 
was extracted with diethyl ether (3×15 mL). The combined organic layers were dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated. The crude product was 
purified by flash column chromatography on silica gel (20% ethyl acetate in hexanes) to afford 151 
(4.2 mg, 73%) as a slightly yellow oil. 
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TLC (20% ethyl acetate in hexanes): Rf = 0.43 (UV, CAM). 
 
1H NMR (400 MHz, C6D6) δ 9.24 (t, J = 1.4 Hz, 1H), 6.82–6.77 (m, 2H), 6.23 (dd, J = 6.2, 2.1 Hz, 
2H), 6.03 (t, J = 6.9 Hz, 1H), 4.77 (d, J = 11.5 Hz, 1H), 4.71–4.66 (m, 3H), 4.57 (dd, J = 6.2, 2.6 
Hz, 1H), 4.40 (d, J = 11.4 Hz, 1H), 3.30 (s, 3H), 2.56 (app tdd, J = 8.6, 5.0, 2.5 Hz, 1H), 2.16 (ddd, 
J = 17.4, 5.0, 1.2 Hz, 1H), 2.06 (dd, J = 8.8, 7.0 Hz, 1H), 1.96 (q, J = 7.6 Hz, 2H), 1.89–1.67 (m, 
4H). 13C NMR (100 MHz, C6D6) δ 199.8, 160.0, 146.7, 140.9, 138.6, 130.1, 129.7, 114.2, 112.0, 
104.5, 100.2, 89.4, 70.3, 54.8, 49.4, 48.1, 33.5, 31.0, 31.0. 
 
HR-MS (EI or ESI): not found. 
 
IR (Diamond-ATR, neat) ṽmax: 2928, 1722, 1649, 1613, 1514, 1248, 1112 cm-1. 
 
 
 
4-Bromopent-4-enal (159). To a solution of 4-bromo-4-penten-1-ol (138)82 (385 mg, 2.33 mmol, 
1 equiv) in HPLC-grade dichloromethane (12 mL) was added solid sodium bicarbonate (980 mg, 
11.7 mmol, 5.00 equiv) and the suspension was cooled to 0 °C. Dess‒Martin periodinane (1.39 g, 
3.27 mmol, 1.40 equiv) was added in one portion. After 5 min, the suspension was allowed to warm 
to 25 °C. After 3 h, the solution was diluted with diethyl ether (20 mL), the suspension was filtered 
through a short plug of celite and the filter cake was rinsed with diethyl ether (20 mL). The filtrate 
was concentrated und the crude product was purified by flash column chromatography on silica gel 
(30% diethyl ether in pentanes) to afford 159 (349 mg, 92%) as a volatile brownish oil. The product 
was isolated as a 69 wt% solution in diethyl ether and was immediately used as received for the 
next step.  
 
 
 
Alternative preparation of 4-bromopent-4-enal (159). Di-iso-butylaluminum hydride (1.0 M in 
dichloromethane, 24.0 mL, 24.0 mmol, 1 equiv) was added dropwise via syringe pump (addition 
rate: 50 mL/h) to a solution of ester 137 (5.65 g, 24.0 mmol, 1 equiv) in dichloromethane (121 mL) 
at ‒78 °C. After 50 min, saturated aqueous Rochelle salt solution (50 mL) was added dropwise and 
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the suspension was allowed to slowly warm to 0 °C. Ethyl acetate (200 mL) and water (50 mL) 
were added, the layers were separated and the aqueous layer was extracted with ethyl acetate 
(3×250 mL). The combined organic layers were washed with saturated aqueous sodium chloride 
solution (150 mL), the washed solution was dried over sodium sulfate and the dried solution was 
filtered. The filtrate was concentrated and the crude product was purified by flash column 
chromatography (30% diethyl ether in pentanes) to afford 159 (2.84 g, 73%) as a slightly yellow 
oil. 
 
 
Methyl (E)-6-bromo-3-methylhepta-2,6-dienoate (160). To a solution of 
1-methoxycarbonylethyltriphenylphosphonium bromide162 (1.56 g, 3.64 mmol, 1.70 equiv) in 
dichloromethane (7.4 mL) was added triethylamine (0.89 mL, 6.4 mmol, 3.0 equiv) dropwise at 
25 °C. After 20 min, a solution of 4-bromopent-4-enal (159) (349 mg, 2.14 mmol, 1 equiv) in 
dichloromethane (1.8 mL) was added dropwise. After 1 h, saturated aqueous ammonium chloride 
solution (30 mL) and ethyl acetate (50 mL) were added. The layers were separated and the aqueous 
layer was extracted with ethyl acetate (3×25 mL). The combined organic layers were washed with 
saturated aqueous sodium chloride solution (25 mL), the washed solution was dried over sodium 
sulfate and the washed solution was dried over sodium sulfate. The dried solution was filtered and 
the filtrate was concentrated. The crude product was purified by flash column chromatography on 
silica gel (3% ethyl acetate in hexanes) to afford 160 (358 mg, 72%) as a colorless oil. 
 
TLC (3% ethyl acetate in hexanes): Rf = 0.17 (UV, KMnO4). 
 
1H NMR (400 MHz, CDCl3) δ 6.80–6.63 (m, 1H), 5.68–5.56 (m, 1H), 5.49–5.32 (m, 1H), 3.73 (s, 
3H), 2.55 (t, J = 7.5 Hz, 2H), 2.46 (t, J = 7.4 Hz, 2H), 1.89–1.83 (m, 3H). 13C NMR (100 MHz, 
CDCl3) δ 168.6, 139.8, 133.2, 129.0, 117.6, 51.9, 40.3, 27.3, 12.7. 
 
HR-MS (EI): calcd for (C9H13O279Br)+: 232.0093, found: 232.0095. 
 
IR (Diamond-ATR, neat) ṽmax: 2950, 1714, 1629, 1435, 1268, 1197, 1144, 1112 cm-1. 
 
Experimental Section for Part I 
189 
 
 
 
(E)-6-Bromo-3-methylhepta-2,6-dien-1-ol (161). To a solution of methyl (E)-6-bromo-3-
methylhepta-2,6-dienoate (160) (345 mg, 1.48 mmol, 1 equiv) in dichloromethane (7.4 mL) was 
added dropwise a solution of di-iso-butylaluminum hydride (1.0 M in dichloromethane, 3.7 mL, 
3.7 mmol, 2.5 equiv) at ‒78 °C. After 40 min, a solution of saturated aqueous ammonium chloride 
(6.5 mL) was added, followed by a mixture of ethyl acetate and hexanes (v/v = 1:1, 12 mL). The 
solution was allowed to slowly warm to 25 °C and saturated aqueous Rochelle salt solution (12 mL) 
was added. The solution was stirred at 25 °C for 20 min. The layers then were separated and the 
aqueous layer was extracted with ethyl acetate (3×25 mL). The combined organic layers were 
washed with saturated aqueous sodium chloride solution (10 mL), the washed solution was dried 
over sodium sulfate and the dried solution was filtered. The filtrate was concentrated and the crude 
product was purified by flash column chromatography on silica gel (20% ethyl acetate in hexanes) 
to afford 161 (305 mg, quant.) as a colorless oil. 
 
TLC (20% ethyl acetate in hexanes): Rf = 0.22 (CAM). 
 
1H NMR (400 MHz, CDCl3) δ 5.57 (q, J = 1.3 Hz, 1H), 5.43–5.36 (m, 2H), 4.06–3.97 (m, 2H), 
2.48 (ddd, J = 7.3, 6.5, 1.0 Hz, 2H), 2.36–2.27 (m, 2H), 1.69 (d, J = 1.3 Hz, 3H). 13C NMR (100 
MHz, CDCl3) δ 136.4, 134.1, 123.7, 116.9, 68.8, 41.3, 26.3, 13.9. 
 
HR-MS (EI): calcd for (C8H1179Br)+: 186.0039, found: 186.0047. 
 
IR (Diamond-ATR, neat) ṽmax: 3312, 2914, 2860, 1629, 1430, 1180, 1118, 1064, 1005 cm-1. 
 
 
 
TBS ether 136. Imidazole (142 mg, 2.09 mmol, 1.40 equiv) was added to a solution of 
(E)-6-bromo-3-methylhepta-2,6-dien-1-ol (161) (305 mg, 1.49 mmol, 1 equiv) in dichloromethane 
(3 mL) and the solution was cooled to 0 °C. Tert-butyldimethylchlorosilane (292 mg, 1.94 mmol, 
1.30 equiv) was added in one portion and the solution was allowed to warm to 25 °C. After 16 h, 
saturated aqueous sodium bicarbonate solution (15 mL) and dichloromethane (15 mL) were added, 
the layers were separated and the aqueous layer was extracted with dichloromethane (3×15 mL). 
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The combined organic layers were washed with brine (15 mL), the washed solution was dried over 
sodium sulfate and the dried solution was filtered. The filtrate was concentrated. The crude product 
was purified by flash column chromatography on silica gel (3% ethyl acetate in hexanes) to afford 
136 (446 mg, 94%) as a colorless oil.  
 
TLC (3% ethyl acetate in hexanes): Rf = 0.48 (CAM). 
 
1H NMR (400 MHz, CDCl3) δ 5.56 (d, J = 1.4 Hz, 1H), 5.43–5.33 (m, 2H), 4.01 (s, 2H), 2.50–2.43 
(m, 2H), 2.35–2.25 (m, 2H), 1.62 (s, 3H), 0.91 (s, 9H), 0.06 (s, 6H). 13C NMR (100 MHz, CDCl3) 
δ 136.0, 134.4, 122.1, 116.8, 68.5, 41.5, 26.3, 26.1, 18.6, 13.7, −5.1. 
 
HR-MS (EI): calcd for (C13H24O79Br28Si)+: 303.0774, found: 303.0768. 
 
IR (Diamond-ATR, neat) ṽmax: 2954, 2856, 1629, 1462, 1471, 1251, 1110, 1066 cm-1. 
 
 
 
TMS enol ether 162. To a solution of vinyl bromide 136 (415 mg, 1.30 mmol, 1.30 equiv) in 
tetrahydrofuran (10 mL) was added a solution of tert-butyl lithium (1.49 M in pentanes, 1.61 mL, 
2.40 equiv) dropwise at ‒78 °C. After 45 min, solid magnesium bromide etherate (362 mg, 
1.40 mmol, 1.40 equiv) was added. After 45 min, copper(I) bromide dimethyl sulfide adduct 
(62 mg, 0.30 mmol, 0.30 equiv) was added. After 1 h, hexamethylphosphoramide (538 mg, 
3.00 mmol, 3.00 equiv) was added. After 10 min, a solution of enone 20 (234 mg, 1.00 mmol, 
1 equiv) and freshly distilled chlorotrimethylsilane (0.38 mL, 3.0 mmol, 3.0 equiv) in 
tetrahydrofuran (6 mL) was added dropwise. After 1 h, the solution was warmed to ‒40 °C and 
after 45 min, the solution was diluted with a mixture of saturated aqueous ammonium chloride 
solution and 25 wt% aqueous ammonia solution (v/v = 3:1, 20 mL) and diethyl ether (10 mL). The 
biphasic mixture was allowed to warm to 25 °C and after 1 h, the layers were separated and the 
aqueous layer was extracted with diethyl ether (3×50 mL). The combined organic layers were 
washed with saturated aqueous sodium chloride solution (50 mL), the washed solution was dried 
over sodium sulfate and the dried solution was filtered. The filtrate was concentrated to afford 162 
as a slightly yellow oil, which was used without further purification immediately for the next step. 
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β-Hydroxy ketone 163. To a solution of crude TMS enol ether 162 (assumed: 547 mg, 1.00 mmol, 
1 equiv) in tetrahydrofuran (7.8 mL) was added aqueous formaldehyde solution (37 wt% in water, 
1.95 mL) and ytterbium triflate (45 mg, 0.10 mmol, 0.10 equiv) was added at 25 °C. After 14 h, the 
solution was diluted with saturated aqueous sodium bicarbonate solution (50 mL) and ethyl acetate 
(50 mL). The layers were separated and the aqueous layer was extracted with ethyl acetate 
(3×100 mL). The combined organic layers were washed with brine (2×100 mL), the washed 
solution was dried over sodium sulfate and the dried solution was filtered. The filtrate was 
concentrated and the crude product was used without further purification for the next step.  
 The crude product was dissolved in toluene (5 mL) and the solution was added to Schlenk 
flask containing dry and activated 4 Å molecular sieves (617 mg). The Schlenk flask was attached 
to a gas washing bottle containing water (25 mL) and the solution was heated to 90 °C. After 5 h, 
heating was ceased and the solution was cooled to 25 °C. Saturated aqueous sodium bicarbonate 
solution (50 mL) and ethyl acetate (50 mL) were added and the biphasic mixture was filtered 
through a fritted glass funnel. The layers were separated and the aqueous layer was extracted with 
ethyl acetate (3×100 mL), the combined organic layers were washed with saturated aqueous sodium 
chloride solution (50 mL) and the washed solution was dried over sodium sulfate. The dried 
solution was filtered and the filtrate was concentrated. The crude product was purified by flash 
column chromatography on previously deactivated silica gel (7.5% triethylamine) (25% ethyl 
acetate in hexanes) to afford 163 (235 mg, 47% over 3 steps) as a yellow oil. 
 
TLC (25% ethyl acetate in hexanes): Rf = 0.28 (UV, CAM). 
 
1H NMR (599 MHz, CDCl3) δ 7.14 (d, 3J = 8.7 Hz, 2H, PMB), 6.78 (d, 3J = 8.7 Hz, 2H, PMB), 
5.44 (ddt, J = 7.0, 5.5, 1.4 Hz, 1H, H-10), 4.89–4.86 (m, 1H, H-7a), 4.85 (d, 3J14/5 = 5.1 Hz, 1H, H-
14), 4.82–4.79 (m, 1H, H-7b), 4.54 (d, 2J = 11.7 Hz, 1H, PMB), 4.30 (d, 2J = 11.7 Hz, 1H, PMB), 
4.05 (d, 2J1a/1b = 17.5 Hz, 1H, H-1a), 4.00–3.98 (m, 2H, H-13), 3.82 (ddd, J = 14.6, 6.6, 3J4a/3 = 2.9 
Hz, 1H, H-4a), 3.70 (d, 2J1b/1a = 17.5 Hz, 1H, H-1b), 3.54 (dt, J = 11.7, 6.0 Hz, 1H, H-4b), 3.30 (s, 
3H, PMB), 2.59 (dd, 3J5/3 = 12.5 Hz, 3J5/14 = 5.1 Hz, 1H, H-5), 2.45 (ddd, 3J3/5 = 12.5 Hz, 3J3/4b = 
5.8 Hz, 3J3/4a = 2.9 Hz, 1H, H-3), 2.29 (t, 3JOH/4 = 6.9 Hz, 1H, OH), 2.16–2.10 (m, 2H, H-9), 2.02 
(td, 3J8/9 = 6.9 Hz, 4J8/10 = 2.0 Hz, 2H, H-8), 1.58 (s, 3H, H-12), 1.00 (s, 9H, TBS), 0.09 (s, 6H, 
TBS). 13C NMR (151 MHz, CDCl3) δ 212.6 (C-2), 159.9 (PMB), 147.3 (C-6), 135.4 (C-11), 129.9 
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(PMB), 129.7 (PMB), 124.1 (C-10), 114.2 (PMB), 112.7 (C-7), 101.8 (C-14), 69.4 (PMB), 68.8 
(C-13), 66.5 (C-2), 59.1 (C-4), 54.8 (PMB), 49.5 (C-3), 48.1 (C-5), 35.0 (C-8), 26.2 (TBS), 25.8 
(C-9), 18.6 (TBS), 13.6 (C-12), −5.1 (TBS). 
 
HR-MS (ESI): calcd for (C28H48O6NSi)+ (M+NH4)+: 522.3251, found: 522.3257. 
 
IR (Diamond-ATR, neat) ṽmax: 3496, 2954, 2929, 2856, 2280, 1724, 1613, 1514, 1462, 1302, 1248, 
1173, 1067, 1032 cm-1. 
 
[𝜶]589
20  = +80.0 (c = 1.0 ∙ 10 g ∙  mL-1, CH2Cl2). 
 
 
 
Enone 164. N,N‘-Dicyclohexylcarbodiimide (45.8 mg, 0.220 mmol, 2.00 equiv), anhydrous 
copper(I) chloride (5.5 mg, 56 µmol, 0.50 equiv) and β-hydroxy ketone 163 (56 mg, 0.11 mmol, 
1 equiv) were suspended in dichloromethane (1.11 mL) in a pressure tube. The tube was sealed and 
the suspension was heated to 60 °C. After 4 h, heating was ceased and the suspension was filtered 
through a short plug of celite. The filter cake was rinsed with ethyl acetate (10 mL). The filtrate 
was concentrated and the crude product was purified by flash column chromatography on silica gel 
(10% ethyl acetate in hexanes) to afford 164 (46 mg, 85%) as a colorless oil. 
 
TLC (10% ethyl acetate in hexanes): Rf = 0.39 (UV, CAM). 
 
1H NMR (400 MHz, C6D6) δ 7.17–7.12 (m, 2H), 6.75 (d, J = 8.3 Hz, 2H), 6.40 (t, J = 1.3 Hz, 1H), 
5.43 (t, J = 6.4 Hz, 1H), 5.05 (d, J = 1.4 Hz, 1H), 4.96 (d, J = 2.7 Hz, 1H), 4.90 (s, 2H), 4.53 (d, J 
= 11.8 Hz, 1H), 4.31 (d, J = 11.8 Hz, 1H), 4.23 (d, J = 17.7 Hz, 1H), 4.09 (d, J = 17.7 Hz, 1H), 3.97 
(s, 2H), 3.42–3.39 (m, 1H), 3.28 (s, 3H), 2.12 (dt, J = 11.8, 5.7 Hz, 2H), 2.05 (dt, J = 11.6, 5.4 Hz, 
2H), 1.55 (s, 3H), 1.00 (s, 9H), 0.07 (s, 6H). 13C NMR (101 MHz, C6D6) δ 195.2, 160.0, 147.9, 
140.9, 135.3, 129.8, 129.6, 125.5, 123.9, 114.2, 113.8, 98.3, 69.3, 68.8, 67.6, 54.8, 52.7, 34.3, 26.2, 
26.0, 18.6, 13.6, −5.1. 
 
HR-MS (ESI): calcd for (C28H46O5NSi)+ (M+NH4)+: 504.3145, found: 504.3141. 
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IR (Diamond-ATR, neat) ṽmax: 2954, 2856, 1706, 1613, 1514, 1463, 1250, 1169, 1112, 1068, 1035 
cm-1. 
 
[𝜶]589
20  = +46.0 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
Allyl alcohol 165. Triethylamine trihydrofluoride (0.12 mL, 0.71 mmol, 7.5 equiv) was added 
dropwise to a solution of enone 164 (46 mg, 95 µmol, 1 equiv) in tetrahydrofuran (1 mL). After 
15 h, saturated aqueous sodium bicarbonate solution (10 mL) was carefully added, followed by 
ethyl acetate (10 mL). Solid sodium bicarbonate was added until no further gas evolution was 
observed. The layers were separated and the aqueous layer was extracted with ethyl acetate 
(3×15 mL). The combined organic layers were washed with saturated aqueous sodium chloride 
solution (15 mL), the washed solution was dried over sodium sulfate and the dried solution was 
filtered. The filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (10% ethyl acetate in hexanes) to afford 165 (27 mg, 77%) as a 
colorless oil. 
 
TLC (50% ethyl acetate in hexanes): Rf = 0.29 (UV, CAM). 
 
1H NMR (400 MHz, C6D6) δ 7.16–7.12 (m, 2H), 6.78–6.73 (m, 2H), 6.39 (s, 1H), 5.29–5.19 (m, 
1H), 5.06–5.02 (m, 1H), 4.96 (d, J = 2.8 Hz, 1H), 4.89 (s, 2H), 4.53 (d, J = 11.8 Hz, 1H), 4.31 (d, 
J = 11.8 Hz, 1H), 4.23 (d, J = 17.7 Hz, 1H), 4.09 (d, J = 17.7 Hz, 1H), 3.75 (s, 2H), 3.40 (br s, 1H), 
3.27 (s, 3H), 2.10–1.96 (m, 4H), 1.49 (s, 3H), 0.88 (br s, 1H). 13C NMR (101 MHz, C6D6) δ 195.3, 
160.0, 147.9, 140.8, 135.9, 129.9, 129.5, 125.6, 124.4, 114.2, 113.8, 98.1, 69.2, 68.5, 67.6, 54.8, 
52.8, 34.1, 26.1, 13.7. 
 
HR-MS (ESI): calcd for (C22H32O5N) (M+NH4)+: 390.2280, found: 390.2277. 
 
IR (Diamond-ATR, neat) ṽmax: 3426, 2916, 1703, 1612, 1514, 1457, 1424, 1389, 1303, 1249, 1171, 
1120, 1069, 1034 cm-1. 
 
[𝜶]589
20  = +63.8 (c = 0.7 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
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Allyl chloride 156. Mesyl chloride (5.7 µL, 73 mmol, 2.6 equiv) was added dropwise to a solution 
of allyl alcohol 165 (10.5 mg, 28.2 µmol, 1 equiv) and triethylamine (12.5 µL, 90.2 µmol, 
3.20 equiv) at ‒40 °C. After 1 h 10 min, the solution was transferred to a separate flask containing 
lithium chloride (9.6 mg, 0.22 mmol, 8.0 equiv) in tetrahydrofuran (0.3 mL) at 25 °C. After 2 h, 
the solution was diluted with pentane (5 mL) and water (5 mL). The layers were separated and the 
organic layer was washed with water (3×5 mL). The washed solution was dried over sodium 
sulfate, the dried solution was filtered and the filtrate was concentrated. The crude product was 
purified by quick flash column chromatography on silica gel (10% ethyl acetate in hexanes) to 
afford 156 as a colorless oil. The product was immediately used for the next step. 
 
1H NMR (200 MHz, C6D6) δ 7.16–7.10 (m, 2H), 6.75 (d, J = 8.4 Hz, 2H), 6.39 (s, 1H), 5.19–5.07 
(m, 1H), 5.01 (s, 1H), 4.96–4.75 (m, 3H), 4.53 (d, J = 11.7 Hz, 1H), 4.38–3.98 (m, 3H), 3.64 (s, 
2H), 3.39–3.32 (m, 1H), 3.27 (s, 3H), 2.17–1.81 (m, 4H), 1.50 (s, 3 H). 
 
 
 
TES ether 168. Chlorotriethylsilane (0.12 mL, 0.71 mmol, 1.2 equiv) was added to a solution of 
β-hydroxy ketone 163 (300 mg, 0.590 mmol, 1 equiv) and imidazole (81 mg, 1.2 mmol, 2.0 equiv) 
in dichloromethane (1.2 mL) at 25 °C. After 2 h, the solution was diluted with saturated aqueous 
sodium bicarbonate solution (20 mL) and ethyl acetate (20 mL). The combined organic layers were 
washed with saturated aqueous sodium chloride solution (20 mL), the washed solution was dried 
over sodium sulfate and the dried solution was filtered. The filtrate was concentrated and the crude 
product was purified by flash column chromatography on silica gel (10% ethyl acetate in hexanes) 
to afford 168 (299 mg, 81%) as a colorless oil. 
 
TLC (10% ethyl acetate in hexanes): Rf = 0.25 (UV, CAM). 
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1H NMR (599 MHz, C6D6) δ 7.20–7.17 (m, 2H), 6.81 – 6.75 (m, 2H), 5.55–5.51 (m, 1H), 4.98 (s, 
1H), 4.94 (d, J = 5.8 Hz, 1H), 4.90 (s, 1H), 4.61 (d, J = 11.7 Hz, 1H), 4.37 (d, J = 11.7 Hz, 1H), 
4.18 (d, J = 16.9 Hz, 1H), 4.15 (dd, J = 9.8, 2.6 Hz, 1H), 4.02 (d, J = 1.5 Hz, 2H), 3.79 (d, J = 16.9 
Hz, 1H), 3.64 (dd, J = 9.7, 3.9 Hz, 1H), 3.30 (s, 3H), 3.03 (dd, J = 12.1, 5.8 Hz, 1H), 2.36 (ddd, J 
= 12.1, 3.7, 2.7 Hz, 1H), 2.31–2.16 (m, 4H), 1.64–1.61 (m, 3H), 1.03 (t, J = 8.0 Hz, 9H), 1.00 (s, 
9H), 0.71–0.58 (m, 6H), 0.09 (s, 6H). 13C NMR (151 MHz, C6D6) δ 208.0, 159.9, 148.3, 135.2, 
130.1, 129.8, 124.3, 114.1, 112.0, 102.4, 69.4, 68.9, 66.9, 57.8, 54.8, 50.1, 47.0, 35.8, 26.2, 26.0, 
13.6, 7.1, 4.8, −5.1. 
 
HR-MS (ESI): calcd for (C34H62O6NSi2) (M+NH4)+: 636.4116, found: 636.4101. 
 
IR (Diamond-ATR, neat) ṽmax: 2954, 2878, 1736, 1614, 1515, 1463, 1250, 1113, 1038 cm-1. 
 
[𝜶]589
20  = +86.4 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
Vinyl triflate 169. Lithium bis(trimethylsilyl)amide (1.0 M in tetrahydrofuran, 1.78 mL; 
1.78 mmol, 1.20 equiv) was added dropwise to a solution of TES ether 168 (916 mg, 1.48 mmol, 
1 equiv) in tetrahydrofuran (15 mL) at ‒78 °C. After 45 min, a solution of 
N-phenylbis(trifluoromethanesulfonimide) (740 mg, 2.07 mmol, 1.40 equiv) in tetrahydrofuran 
(0.8 mL) was added dropwise. The solution was allowed to gradually warm to 25 °C over 2 h. After 
30 min at 25 °C, saturated aqueous sodium bicarbonate solution (20 mL) and ethyl acetate (50 mL) 
were added, the layers were separated and the aqueous layer was extracted with ethyl acetate 
(3×50 mL). The combined organic layers were washed with saturated aqueous sodium chloride 
solution (20 mL), the washed solution was dried over sodium sulfate and the dried solution was 
filtered. The filtrate was concentrated. The crude product was purified by flash column 
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chromatography on silica gel (3% ethyl acetate in hexanes) to afford 169 as a colorless oil, 
containing minor impurities. The product was used as received for the next step. 
 
TLC (10% ethyl acetate in hexanes): Rf = 0.38 (UV, CAM). 
 
1H NMR (599 MHz, C6D6) δ 7.15–7.11 (m, 2H), 6.81–6.74 (m, 2H), 6.62 (d, J = 1.6 Hz, 1H), 5.51–
5.45 (m, 1H), 4.98–4.95 (m, 2H), 4.84 (d, J = 5.5 Hz, 1H), 4.65 (d, J = 11.4 Hz, 1H), 4.26 (d, J = 
11.3 Hz, 1H), 3.99 (s, 2H), 3.97 (dd, J = 9.9, 5.9 Hz, 1H), 3.79 (dd, J = 9.9, 3.7 Hz, 1H), 3.29 (s, 
3H), 3.08 (app t, J = 5.9 Hz, 1H), 2.86 (app tdd, J = 5.9, 3.7, 1.6 Hz, 1H), 2.29–2.07 (m, 4H), 1.61 
(s, 3H), 1.00 (s, 9H), 0.98 (t, J = 8.0 Hz, 9H), 0.62–0.54 (m, 6H), 0.08 (s, 6H). 13C NMR (151 
MHz, C6D6) δ 160.1, 147.0, 138.5, 135.4, 129.8, 129.3, 124.0, 119.2 (q, J = 320.8 Hz), 114.1, 112.2, 
100.6, 70.8, 68.9, 60.0, 54.8, 43.9, 42.9, 36.4, 26.2, 26.0, 18.6, 13.6, 7.0, 4.7, −5.1. 19F NMR (377 
MHz, C6D6) δ −73.84. 
 
HR-MS (ESI): calcd for (C35H61O8NF3SSi2) (M+NH4)+: 768.3609, found: 768.3593. 
 
IR (Diamond-ATR, neat) ṽmax: 2955, 2934, 2858, 1314, 1515, 1422, 1249, 1211, 1142, 1099, 1069 
cm-1. 
 
[𝜶]589
20  = +40.6 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
Alkene 170 and 171. Formic acid (0.28 mL, 7.4 mmol, 5.0 equiv) was added dropwise to 
a solution of triflate 169 (1.11 g, 1.48 mmol, 1 equiv), triethylamine (1.54 mL, 11.1 mmol, 
7.50 equiv) and bis(triphenylphosphine)palladium(II) chloride (46 mg, 0.065 mmol, 0.10 equiv) in 
N,N-dimethylformamide (14.8 mL). The yellow solution was heated to 70 °C. After 15 min, heating 
was ceased and the solution was diluted with water (10 mL) and ethyl acetate (10 mL). The layers 
were separated and the aqueous layer was extracted with ethyl acetate (3×25 mL). The combined 
organic layers were washed with saturated aqueous sodium chloride solution (20 mL), the washed 
solution was dried over sodium sulfate and the dried solution was filtered. The filtrate was 
concentrated. The crude product was purified by flash column chromatography on silica gel (3% 
to 25% ethyl acetate in hexanes) to afford 170 (490 mg, 55%) and 171 (198 mg, 27%) as colorless 
oils. TES ether 170 was directly used for the next step. 
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Alcohol 171. Pyridinium p-toluenesulfonate (20.4 mg, 81.3 µmol, 0.10 equiv) was added to a 
solution of TES ether 170 (490 mg, 0.810 mmol, 1 equiv) in a mixture of methanol and 
tetrahydrofuran (v/v = 5:1, 24.5 mL) at 0 °C. After 90 min, the solution was diluted with saturated 
aqueous sodium bicarbonate solution (10 mL) and ethyl acetate (10 mL). The layers were separated 
and the aqueous layer was extracted with ethyl acetate (3×30 mL). The combined organic layers 
were dried over sodium sulfate and the dried solution was filtered. The filtrate was concentrated 
and the crude product was purified by flash column chromatography on silica gel (25% ethyl acetate 
in hexanes) to afford 171 (362 mg, 91%) as a colorless oil. 
 
TLC (50% ethyl acetate in hexanes): Rf = 0.54 (UV, CAM). 
 
1H NMR (400 MHz, C6D6) δ 7.20 (d, J = 8.4 Hz, 2H), 6.80–6.73 (m, 2H), 6.36 (dd, J = 6.3, 2.0 
Hz, 1H), 5.48 (t, J = 6.8 Hz, 1H), 4.94 (s, 1H), 4.90 (s, 1H), 4.86–4.79 (m, 2H), 4.75 (dd, J = 6.3, 
2.8 Hz, 1H), 4.44 (d, J = 11.5 Hz, 1H), 3.99 (s, 2H), 3.53 (dd, J = 10.4, 4.9 Hz, 1H), 3.34 (dd, J = 
10.4, 6.0 Hz, 1H), 3.28 (s, 3H), 2.53 (t, J = 7.0 Hz, 1H), 2.30–2.09 (m, 5H), 1.59 (s, 3H), 1.36 (s, 
1H), 1.00 (s, 9H), 0.08 (s, 6H). 13C NMR (100 MHz, C6D6) δ 159.8, 149.0, 141.7, 135.0, 130.0, 
129.8, 124.6, 114.1, 110.9, 103.3, 100.3, 70.2, 69.0, 65.0, 54.7, 46.2, 39.6, 36.3, 26.2, 26.0, 18.6, 
13.7, −5.1. 
 
HR-MS (ESI): calcd for (C28H48O5NSi)+ (M+NH4)+: 506.3302, found: 506.3293. 
 
IR (Diamond-ATR, neat) ṽmax: 3442, 2953, 2928, 2856, 1651, 1613, 1514, 1463, 1248, 1152, 1108, 
1061, 1031, 1007 cm-1. 
 
[𝜶]589
20  = +28.6 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
Acetate 172. Acetic anhydride (34 µL, 0.36 mmol, 2.6 equiv) was added dropwise to a solution of 
alcohol 171 (68.4 mg, 0.14 mmol, 1 equiv), triethylamine (58 µL, 0.42 mmol, 3.0 equiv) and 
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4-dimethylaminopyridine (1.7 mg, 14 µmol, 0.1 equiv) in dichloromethane (1.4 mL) at 0 °C. After 
30 min, saturated aqueous sodium bicarbonate solution (10 mL) and dichloromethane (10 mL) 
were added. The layers were separated and the aqueous layer was extracted with dichloromethane 
(3×10 mL). The combined organic layers were dried over sodium sulfate and the dried solution was 
filtered. The filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (20% ethyl acetate in hexanes) to afford 172 (54 mg, 73%) as a 
colorless oil. 
 
TLC (20% ethyl acetate in hexanes): Rf = 0.46 (UV, CAM). 
 
1H NMR (400 MHz, C6D6) δ 7.20 (d, J = 8.5 Hz, 2H), 6.77 (d, J = 8.3 Hz, 2H), 6.32 (dd, J = 6.2, 
1.4 Hz, 1H), 5.53–5.43 (m, 1H), 4.94 (s, 1H), 4.87 (s, 1H), 4.84–4.78 (m, 2H), 4.72 (dd, J = 6.3, 
2.1 Hz, 1H), 4.44 (d, J = 11.5 Hz, 1H), 4.31–4.24 (m, 1H), 3.99 (d, J = 7.8 Hz, 3H), 3.28 (s, 3H), 
2.50 (d, J = 5.4 Hz, 2H), 2.15 (dq, J = 19.6, 7.3 Hz, 4H), 1.67 (s, 3H), 1.60 (s, 3H), 1.00 (s, 9H), 
0.08 (s, 6H). 13C NMR (101 MHz, C6D6) δ 169.7, 159.5, 147.8, 141.4, 134.8, 129.6, 129.4, 124.0, 
113.7, 110.8, 102.0, 100.1, 69.9, 68.5, 65.7, 54.4, 45.4, 36.0, 25.8, 25.5, 20.1, 18.2, 13.3, −5.4. 
 
HR-MS (ESI): calcd for (C30H50O6NSi)+ (M+NH4)+: 548.3407, found: 548.3397. 
 
IR (Diamond-ATR, neat) ṽmax: 2930, 2856, 1742, 1653, 1613, 1514, 1463, 1362, 1248, 1232, 1110, 
1036 cm-1. 
 
[𝜶]589
20  = +9.8 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
Allylic alcohol 174. Triethylamine trihydrofluoride (0.11 mL, 0.68 mmol, 7.5 equiv) was added 
dropwise to a solution of acetate 172 (48 mg, 90 µmol, 1 equiv) in tetrahydrofuran (1 mL) at 25 °C. 
After 15 h, the solution was carefully diluted with saturated aqueous sodium bicarbonate solution 
(10 mL) and ethyl acetate (10 mL) and solid sodium bicarbonate was added until no further gas 
evolution was observed. Water (10 mL) was then added and the layers were separated. The aqueous 
layer was extracted with ethyl acetate (3×10 mL), the combined organic layers were washed with 
saturated aqueous sodium chloride (10 mL) and the washed solution was dried over sodium sulfate. 
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The dried solution was filtered and the filtrate was concentrated. The crude product (39 mg, quant.) 
was obtained as a colorless oil and was used without further purification for the next step. 
Triethylamine (42 µL, 0.30 mmol, 3.2 equiv) was added to a solution of the crude allylic 
alcohol (39 mg, 94 µmol, 1 equiv) in dichloromethane (0.6 mL), the solution was cooled to −40 °C 
and mesyl chloride (19 µL, 24 µmol, 2.6 equiv) was added dropwise. After 1 h 15 min, the solution 
was transferred to a suspension of anhydrous lithium chloride (24 mg, 0.56 mmol, 6.0 equiv) in 
tetrahydrofuran (0.6 mL) at 25 °C. Further tetrahydrofuran (0.4 mL) was added to ensure complete 
transfer of the mesylate. After 3 h, saturated aqueous sodium bicarbonate solution (10 mL) and 
diethyl ether (10 mL) were added. The layers were separated and the aqueous layer was extracted 
with diethyl ether (3×10 mL). The combined organic layers were washed with saturated aqueous 
sodium chloride solution (10 mL), the washed solution was dried over sodium sulfate and the dried 
solution was filtered. The filtrate was concentrated and the crude chloride 174 (38 mg, 93%) was 
used without further purification for the next step. 
 
1H NMR (599 MHz, C6D6) δ 7.18 (d, J = 8.5 Hz, 2H), 6.77 (d, J = 8.6 Hz, 2H), 6.32 (dd, J = 6.2, 
2.1 Hz, 1H), 5.22 (t, J = 6.5 Hz, 1H), 4.84 (s, 1H), 4.82 (s, 1H), 4.81–4.77 (m, 2H), 4.72 (dd, J = 
6.2, 2.6 Hz, 1H), 4.42 (d, J = 11.6 Hz, 1H), 4.24 (dd, J = 10.6, 5.1 Hz, 1H), 3.92 (dd, J = 10.6, 6.8 
Hz, 1H), 3.69 (s, 2H), 3.29 (d, J = 0.7 Hz, 3H), 2.46 (dtd, J = 9.3, 5.4, 4.9, 2.5 Hz, 1H), 2.42 (dd, J 
= 8.4, 6.6 Hz, 1H), 2.03–1.93 (m, 4H), 1.66 (d, J = 0.7 Hz, 3H), 1.54 (s, 3H). 13C NMR (151 MHz, 
cdcl3) δ 170.0, 159.9, 147.8, 141.8, 132.3, 130.2, 129.8, 114.1, 111.3, 102.3, 100.5, 70.4, 66.0, 54.8, 
52.2, 46.0, 36.6, 35.7, 26.2, 20.4, 14.1. 
 
HR-MS (ESI): calcd for (C24H35O5NCl)+ (M+NH4)+: 452.2204, found: 452.2197. 
 
IR (Diamond-ATR, neat) ṽmax: 2939, 1739, 1651, 1613, 1514, 1232, 1157, 1122, 1035 cm-1. 
 
[𝜶]589
20  = +10.1 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
Aldehyde 133. Sodium methoxide (0.5 M in methanol, 0.17 mL, 85 µmol, 0.50 equiv) was added 
dropwise to a solution of chloride 174 (74 mg, 0.17 mmol, 1 equiv) in methanol (1.7 mL) at 0 °C. 
The solution was allowed to slowly warm to 10 °C over the course of 3 h 15 min. Then, saturated 
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aqueous ammonium chloride solution (10 mL) and ethyl acetate (10 mL) were added. The layers 
were separated and the aqueous layer was extracted with ethyl acetate (3×15 mL). The combined 
organic layers were washed with saturated aqueous sodium chloride solution (15 mL). The washed 
solution was dried over sodium sulfate, the dried solution was filtered and the filtrate was 
concentrated. The crude alcohol (67 mg, quant.) was used without further purification for the next 
step. The product was found to be rather unstable and had to be stored at ‒30 °C in the dark. 
Complete decomposition was observed after two days in benzene at 25 °C. 
 Dess‒Martin periodinane (14.9 mg, 35.1 µmol, 1.50 equiv) was added to a suspension of 
sodium bicarbonate (12 mg, 0.14 mmol, 6.0 equiv) in HPLC-grade dichloromethane (0.4 mL) at 
0 °C. A solution of the crude alcohol (9.2 mg, 23 µmol, 1 equiv) in HPLC-grade dichloromethane 
(0.3 mL) was added dropwise and upon completion of the addition, the suspension was allowed to 
warm to 25 °C. After 1 h 15 min, diethyl ether (0.5 mL) was added and the suspension was filtered 
through a short plug of celite. The filter cake was rinsed with diethyl ether (15 mL). The filtrate 
was concentrated and the crude product was purified by quick flash column chromatography on 
silica gel (15% ethyl acetate in hexanes) to afford 133 (4.7 mg, 51%) as a colorless oil. Aldehyde 
133 was found to be highly unstable and was used for the next step immediately after its 
preparation. 
 
1H NMR (400 MHz, C6D6) δ 9.42 (s, 1H), 7.16–7.11 (m, 2H), 6.76 (d, J = 8.4 Hz, 2H), 6.20 (dd, J 
= 6.3, 1.7 Hz, 1H), 5.15 (t, J = 6.7 Hz, 1H), 4.93 (s, 1H), 4.85 (d, J = 4.0 Hz, 1H), 4.81 (s, 1H), 
4.71 (dd, J = 6.2, 4.4 Hz, 1H), 4.66 (d, J = 11.7 Hz, 1H), 4.34 (d, J = 11.6 Hz, 1H), 3.67 (s, 2H), 
3.26 (s, 3H), 2.85 (t, J = 4.3 Hz, 1H), 2.53 (t, J = 4.5 Hz, 1H), 1.99–1.83 (m, 4H), 1.53 (s, 3H). 
 
 
 
Bicycle 176. Sodium iodide (14.5 mg, 96.7 μmol, 9.00 equiv) and tin(II) chloride (9.2 mg, 48 μmol, 
4.5 equiv, 99.95% purity) were added to a dry Schlenk flask and the flask was evacuated and back-
filled with argon three times. Degassed dimethylformamide (0.27 mL) was added and the flask was 
covered with aluminum foil. The solution was stirred for 30 min at 25 °C before a solution of the 
aldehyde (4.2 mg, 11 μmol, 1 equiv) in degassed dimethylformamide (0.2 mL) was added. After 
30 min, the solution was heated to 60 °C. After 1 h 20 min, heating was ceased and the solution 
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was allowed to cool to 25 °C. Half-saturated sodium bicarbonate solution (5 mL) and ethyl acetate 
(5 mL) were added, the layers were separated and the aqueous layer was extracted with ethyl acetate 
(3×10 mL). The combined organic layers were washed with brine (2×10 mL) and the washed 
solution was dried over sodium sulfate. The dried solution was filtered and the filtrate was 
concentrated. The crude product was purified by flash column chromatography on silica gel (15% 
ethyl acetate in hexanes) to afford 176 (3.3 mg, 86%, d.r. = 3:1) as a colorless oil. 
 
Note: Bicycle 176 was isolated as a mixture of inseparable diastereomers (d.r. = 3:1). Only the 
signals for the major diastereomers are reported (assignment by 2D NMR analysis). 
 
1H NMR (400 MHz, C6D6) δ 7.27 (d, J = 8.4 Hz, 2H, PMB), 6.80–6.73 (m, 2H, PMB), 6.50 (dd, J 
= 6.2, 1.9 Hz, 1H, H-1), 5.55 (dd, J = 6.2, 1.7 Hz, 1H, H-2), 5.05 (d, J = 8.7 Hz, 1H, H-14), 4.92 
(d, J = 11.3 Hz, 1H, PMB), 4.90–4.85 (m, 1H, H-12a), 4.64–4.53 (m, 4H, H-12b, H-8, H-15), 3.27 
(s, 3H, PMB), 3.00 (app td, J = 9.5, 2.5 Hz, 1H, H-4), 2.39–2.21 (m, 3H, H-9a, H-3, H-13), 2.16–
1.93 (m, 2H, H-9b, H5), 1.81 (d, J = 2.6 Hz, 1H, OH), 1.37 (s, 3H, H-7), 1.33–1.20 (m, 2H, H-10). 
13C NMR (101 MHz, C6D6) δ 159.9 (PMB), 150.2 (C-11), 148.2 (C-6), 141.0 (C-1), 130.2 (PMB), 
130.2 (PMB), 114.0 (PMB), 112.9 (C-8), 110.4 (C-12), 105.8 (C-2), 100.5 (C-14), 76.8 (C-4), 70.7 
(PMB), 54.7 (PMB), 51.7 (C-5), 49.9 (C-3), 42.3 (C-13), 36.9 (C-9), 27.2 (C-10), 18.41 (C-7). 
 
HR-MS (ESI): calcd for (C22H32O4N)+ (M+NH4)+: 374.2331, found: 374.2326. 
 
 
 
Alcohol 177. Pyridinium p-toluenesulfonate (27 mg, 0.11 mmol, 0.15 equiv) was added to a 
solution of triflate 169 (534 mg, 0.71 mmol, 1 equiv) in a mixture of methanol and tetrahydrofuran 
(v/v = 5:1, 24 mL) at 0 °C. After 4 h, saturated aqueous sodium bicarbonate solution (25 mL) and 
ethyl acetate (50 mL) were added and the mixture was allowed to warm to 25 °C. Water (10 mL) 
was added and the layers were separated. The aqueous layer was extracted with ethyl acetate 
(3×50 mL) and the combined organic layers were washed with saturated aqueous sodium chloride 
solution (25 mL). The washed solution was dried over sodium sulfate, the dried solution was 
filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (10% to 20% ethyl acetate in hexanes) to afford 177 (276 mg, 61%) 
as a colorless oil. 
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TLC (10% ethyl acetate in hexanes): Rf = 0.14 (UV, CAM). 
 
1H NMR (599 MHz, CDCl3) δ 7.26–7.20 (m, 2H), 6.91–6.84 (m, 2H), 6.81 (d, J = 1.6 Hz, 1H), 
5.39–5.32 (m, 1H), 4.99 (d, J = 9.4 Hz, 1H), 4.90 (dd, J = 4.3, 1.0 Hz, 1H), 4.79 (d, J = 11.4 Hz, 
1H), 4.54 (d, J = 11.4 Hz, 1H), 4.00–3.97 (m, 2H), 3.88 (ddd, J = 11.6, 6.9, 4.7 Hz, 1H), 3.80 (d, J 
= 1.0 Hz, 4H), 3.70–3.64 (m, 1H), 2.74 (t, J = 4.6 Hz, 1H), 2.71–2.67 (m, 1H), 2.52 (s, 1H), 2.23–
2.03 (m, 4H), 1.58 (s, 3H), 0.90 (s, 9H), 0.06 (s, 6H). 13C NMR (151 MHz, CDCl3) δ 159.7, 146.6, 
138.3, 135.2, 134.7, 129.9, 128.3, 123.5, 118.6 (q, J = 320.7 Hz), 114.1, 112.5, 98.5, 70.7, 68.6, 
61.2, 55.4, 46.0, 41.7, 35.7, 26.1, 25.8, 18.6, 13.6, −5.1. 19F NMR (377 MHz, CDCl3) δ −73.34. 
 
HR-MS (ESI): calcd for (C29H47O8NF3SSi)+ (M+NH4)+: 654.2744, found: 654.2739. 
 
IR (Diamond-ATR, neat) ṽmax: 3444, 2955, 2931, 2887, 2857, 1614, 1515, 1419, 1248, 1208, 1140, 
1064, 1035 cm-1. 
 
[𝜶]589
20  = +53.4 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
Iodide 178. Iodine (64 mg, 0.25 mmol, 1.6 equiv) was added to a solution of triphenylphosphine 
(66 mg, 0.25 mmol, 1.6 equiv) and imidazole (34 mg, 0.50 mmol, 3.2 equiv) in tetrahydrofuran 
(1.6 mL) at 0 °C. After 15 min, a solution of alcohol 177 (100 mg, 0.160 mmol, 1 equiv) in 
tetrahydrofuran (0.5 mL) was added dropwise. After 1 h, aqueous sodium thiosulfate solution 
(0.1 M, 10 mL) and ethyl acetate (10 mL) were added and the mixture was allowed to warm to 
25 °C. The layers were separated and the aqueous layer was extracted with ethyl acetate (3×10 mL). 
The combined organic layers were dried over sodium sulfate, the dried solution was filtered and 
the filtrate was concentrated. The crude product was purified by flash column chromatography on 
silica gel (10% ethyl acetate in hexanes) to afford 178 as a colorless oil. 
 
TLC (10% ethyl acetate in hexanes): Rf = 0.36 (UV, CAM). 
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1H NMR (400 MHz, CDCl3) δ 7.24–7.18 (m, 2H), 6.90–6.86 (m, 2H), 6.81 (d, J = 1.4 Hz, 1H), 
5.39–5.32 (m, 1H), 5.00 (s, 1H), 4.97–4.91 (m, 2H), 4.78 (d, J = 11.6 Hz, 1H), 4.54 (d, J = 11.6 
Hz, 1H), 3.99 (s, 2H), 3.81 (s, 3H), 3.50 (dd, J = 10.2, 7.2 Hz, 1H), 3.36 (dd, J = 10.2, 3.0 Hz, 1H), 
2.77 (t, J = 5.6 Hz, 1H), 2.61–2.54 (m, 1H), 2.29–2.15 (m, 2H), 2.14–2.00 (m, 2H), 1.60 (s, 3H), 
0.90 (s, 9H), 0.06 (s, 6H). 13C NMR (101 MHz, CDCl3) δ 159.6, 145.4, 138.4, 135.3, 134.4, 129.6, 
128.6, 123.4, 118.6 (q, J = 320.9 Hz), 114.0, 113.0, 99.6, 70.8, 68.6, 55.4, 47.5, 40.4, 35.3, 26.1, 
25.8, 18.6, 13.7, 7.4, −5.1. 
 
HR-MS (ESI): calcd for (C29H46O7NF3ISSi)+ (M+NH4)+: 764.1761, found: 764.1751. 
 
IR (Diamond-ATR, neat) ṽmax: 2954, 2930, 2857, 1314, 1515, 1464, 1422, 1249, 1212, 1140, 1098, 
1069 cm-1. 
 
[𝜶]589
20  = +32.0 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
Sulfone 179. Sodium benzenesulfinate (33 mg, 0.20 mmol, 1.5 equiv) was added to a suspension 
of iodide 178 (100 mg, 0.130 mmol, 1 equiv) and sodium bicarbonate (12 mg, 0.15 mmol, 
1.1 equiv) in dimethylformamide (1.3 mL). The suspension was heated to 50 °C. After 15 h, heating 
was ceased, water (10 mL) and ethyl acetate (10 mL) were added. The layers were separated and 
the aqueous layer was extracted with ethyl acetate (3×10 mL). The combined organic layers were 
washed with saturated aqueous sodium chloride solution (10 mL), the washed solution was dried 
over sodium sulfate and the dried solution was filtered. The filtrate was concentrated and the crude 
product was purified by flash column chromatography on silica gel (10% ethyl acetate in hexanes) 
to afford 179 (37 mg, 36%) and S3 (43 mg, 52%) as colorless oils. 
 
179: 
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TLC (10% ethyl acetate in hexanes): Rf = 0.12 (UV, CAM). 
 
1H NMR (599 MHz, CDCl3) δ 7.86–7.81 (m, 2H), 7.68–7.63 (m, 1H), 7.58–7.51 (m, 2H), 7.25–
7.21 (m, 2H), 6.91–6.88 (m, 2H), 6.65 (d, J = 1.2 Hz, 1H), 5.41–5.36 (m, 1H), 5.03 (d, J = 1.1 Hz, 
1H), 5.01 (s, 1H), 4.95 (s, 1H), 4.69 (d, J = 11.4 Hz, 1H), 4.51 (d, J = 11.4 Hz, 1H), 4.06–3.99 (m, 
3H), 3.83 (s, 3H), 3.38 (d, J = 1.4 Hz, 1H), 3.25 (dd, J = 14.7, 1.9 Hz, 1H), 2.91 (d, J = 10.9 Hz, 
1H), 2.27–2.19 (m, 2H), 2.19–2.05 (m, 2H), 1.61 (s, 3H), 0.91 (s, 9H), 0.06 (s, 6H). 13C NMR (151 
MHz, CDCl3) δ 159.6, 145.7, 138.9, 137.4, 135.3, 134.0, 133.5, 129.6, 129.6, 129.6, 128.7, 128.1, 
123.5, 118.4 (q, J = 320.7 Hz), 114.1, 112.4, 97.7, 70.4, 68.7, 55.4, 54.7, 44.2, 35.7, 33.4, 26.1, 
26.0, 18.6, 13.7, −5.1. 19F NMR (377 MHz, CDCl3) δ −73.35. 
 
HR-MS (ESI): calcd for (C35H51O9NF3S2Si)+ (M+NH4)+: 778.2727, found: 778.2706. 
 
IR (Diamond-ATR, neat) ṽmax: 2955, 2931, 2857, 1614, 1515, 1423, 1249, 1213, 1174, 1140, 1109, 
1070 cm-1. 
 
[𝜶]589
20  = +58.0 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
S3: 
 
TLC (10% ethyl acetate in hexanes): Rf = 0.33 (UV, CAM). 
 
1H NMR (599 MHz, CDCl3) δ 7.26–7.22 (m, 2H), 6.88 (d, J = 8.8 Hz, 2H), 6.65 (d, J = 0.9 Hz, 
1H), 5.34 (tq, J = 7.0, 1.4 Hz, 1H), 5.31 (s, 1H), 5.07 (d, J = 3.3 Hz, 1H), 4.99 (t, J = 0.9 Hz, 1H), 
4.99–4.95 (m, 1H), 4.95 (t, J = 1.5 Hz, 1H), 4.76 (d, J = 11.6 Hz, 1H), 4.56 (d, J = 11.7 Hz, 1H), 
4.01–3.97 (m, 2H), 3.80 (s, 3H), 3.23 (dd, J = 3.4, 1.2 Hz, 1H), 2.19–2.12 (m, 2H), 2.12–1.96 (m, 
2H), 1.57 (s, 3H), 0.90 (s, 9H), 0.05 (s, 6H). 13C NMR (101 MHz, CDCl3) δ 159.6, 144.8, 136.6, 
135.2, 134.7, 132.2, 129.8, 128.6, 123.4, 118.7 (q, J = 320.5 Hz), 114.0, 113.3, 110.7, 99.1, 70.2, 
68.5, 55.4, 50.7, 34.1, 26.1, 25.7, 18.6, 13.6, −5.1. 19F NMR (377 MHz, CDCl3) δ −73.54. 
 
HR-MS (ESI): calcd for (C29H45O7NF3SSi)+ (M+NH4)+: 636.2838, found: 636.2626. 
 
IR (Diamond-ATR, neat) ṽmax: 2954, 2931, 2896, 2857, 1654, 1614, 1464, 1422, 1303, 1248, 1209, 
1141, 1081, 1061, 1110 cm-1. 
 
[𝜶]589
20  = +68.7 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
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Bromide 180. Triethylamine trihydrofluoride (41 µL, 0.25 mmol, 7.0 equiv) was added to a 
solution of sulfone 179 (27 mg, 36 µmol, 1 equiv) in tetrahydrofuran (0.6 mL) a 25 °C. After 24 h, 
the solution was carefully diluted with saturated aqueous sodium bicarbonate solution (5 mL) and 
ethyl acetate (5 mL). Solid sodium bicarbonate was then added until no further gas evolution was 
observed. The layers were separated and the aqueous layer was extracted with ethyl acetate 
(3×10 mL). The combined organic layers were washed with saturated aqueous sodium chloride 
solution (10 mL). The washed solution as dried over sodium sulfate, the dried solution was filtered 
and the filtrate was concentrated. The crude product S4 was used without further purification for 
the next step. 
 Triethylamine (19 µL, 0.14 mmol, 3.8 equiv) was added to a solution of the crude allylic 
alcohol S4 (assumed: 23 mg, 36 µmol, 1 equiv) in dichloromethane (0.3 mL) and the solution was 
cooled to ‒40 °C. Methanesulfonyl chloride (6.4 µL, 83 µmol, 2.3 equiv) was added dropwise.  
After 2 h, the solution was transferred to a flask containing anhydrous lithium bromide (47 mg, 
0.54 mmol, 15 equiv) in tetrahydrofuran (0.3 mL) at 23 °C. Tetrahydrofuran (2×0.2 mL) was used 
to assure complete transfer. After 45 min, aqueous pH 7 buffer solution (10 mL) and diethyl ether 
(10 mL) were added. The layers were separated and the aqueous layer was extracted with diethyl 
ether (3×20 mL). The combined organic layers were washed with saturated aqueous sodium 
chloride solution (10 mL), the washed solution was dried over sodium sulfate and the dried solution 
was filtered. The filtrate was concentrated and the crude product was used purified by flash column 
chromatography on silica gel (25% ethyl acetate in hexanes) to afford 180 (15.1 mg, 59%) as a 
slightly yellow oil. 
 
TLC (20% ethyl acetate in hexanes): Rf = 0.45 (UV, CAM). 
 
1H NMR (599 MHz, CDCl3) δ 7.85–7.81 (m, 2H), 7.69–7.64 (m, 1H), 7.59–7.53 (m, 2H), 7.26–
7.21 (m, 2H), 6.93–6.88 (m, 2H), 6.67 (d, J = 1.1 Hz, 1H), 5.59 (t, J = 6.3 Hz, 1H), 5.06–5.02 (m, 
2H), 4.96–4.93 (m, 1H), 4.70 (d, J = 11.4 Hz, 1H), 4.52 (d, J = 11.4 Hz, 1H), 4.02 (dd, J = 14.6, 
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10.5 Hz, 1H), 3.97 (s, 2H), 3.83 (s, 3H), 3.40–3.38 (m, 1H), 3.24 (dd, J = 14.6, 1.9 Hz, 1H), 2.93 
(d, J = 10.5 Hz, 1H), 2.30–2.06 (m, 4H), 1.77 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 159.7, 145.2, 
139.0, 137.5, 134.1, 133.3, 132.9, 130.4, 129.6, 128.6, 128.0, 118.4 (q, J = 320.9 Hz), 114.1, 112.7, 
97.6, 70.4, 55.5, 54.7, 44.1, 41.7, 35.1, 33.3, 26.7, 14.9. 19F NMR (377 MHz, CDCl3) δ −73.29. 
 
HR-MS (ESI): calcd for (C35H51O6NF3SSi)+ (M+NH4)+: 698.3158, found: 698.3154. 
 
IR (Diamond-ATR, neat) ṽmax: 2935, 1613, 1515, 1422, 1306, 1248, 1213, 1175, 1140, 1110, 1071, 
1034 cm-1. 
 
[𝜶]589
20  = +63.0 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
Iodide 182. Iodine (21 mg, 83 µmol, 1.5 equiv) was added to a solution of imidazole (11 mg, 
0.17 mmol, 3.0 equiv) and triphenylphosphine (21.7 mg, 82.9 µmol, 1.50 equiv) in tetrahydrofuran 
(0.55 mL) at 0 °C. After 10 min, a solution of alcohol 171 (27 mg, 55 µmol, 1 equiv) in 
tetrahydrofuran (0.3 mL) was added dropwise. After 2 h, aqueous sodium thiosulfate solution 
(0.1 M, 10 mL) was added, followed by ethyl acetate (10 mL) and the biphasic mixture was allowed 
to warm to 25 °C. The layers were separated and the aqueous layer was extracted with ethyl acetate 
(3×20 mL). The combined organic layers were washed with saturated aqueous sodium chloride 
solution (10 mL), the washed solution was dried over sodium sulfate and the dried solution was 
filtered. The filtrate was concentrated and the crude product was purified by flash column 
chromatography on silica gel (10% ethyl acetate in hexanes) to afford 182 (25 mg, 76%) as 
colorless oil. 
 
TLC (25% ethyl acetate in hexanes): Rf = 0.60 (UV, CAM). 
 
1H NMR (400 MHz, C6D6) δ 7.18 (m, 2H), 6.76 (d, J = 8.4 Hz, 2H), 6.27 (dd, J = 6.2, 1.9 Hz, 1H), 
5.52–5.43 (m, 1H), 4.90 (s, 1H), 4.85 (s, 1H), 4.80 (d, J = 6.1 Hz, 1H), 4.75 (d, J = 11.6 Hz, 1H), 
4.59 (dd, J = 6.3, 3.0 Hz, 1H), 4.40 (d, J = 11.6 Hz, 1H), 4.00 (s, 2H), 3.28 (s, 3H), 3.21 (dd, J = 
9.5, 5.7 Hz, 1H), 2.90 (dd, J = 9.5, 6.1 Hz, 1H), 2.55 (t, J = 6.6 Hz, 1H), 2.27–2.16 (m, 2H), 2.15– 
2.03 (m, 3H), 1.61 (s, 3H), 1.01 (s, 9H), 0.09 (s, 6H). 13C NMR (101 MHz, C6D6) δ 159.8, 147.7, 
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141.7, 135.2, 129.9, 129.7, 124.3, 114.1, 111.4, 104.6, 99.9, 70.2, 68.9, 54.7, 48.7, 37.9, 36.1, 26.2, 
26.1, 18.6, 13.7, −5.0. 
 
HR-MS (ESI): calcd for (C28H47IO4NSi)+ (M+NH4)+: 616.2319, found: 616.2309. 
 
IR (Diamond-ATR, neat) ṽmax: 2927, 2855, 1652, 1614, 1515, 1464, 1395, 1250, 1180, 1108, 1038 
cm-1. 
 
[𝜶]589
20  = +11.8 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
Sulfone 183. Sodium benzenesulfinate (38 mg, 0.23 mmol, 1.5 equiv) and sodium bicarbonate 
(14.1 mg, 0.17 mmol, 1.10 equiv) were added to a solution of iodide 182 (91.6 mg, 0.15 mmol, 
1 equiv) in dimethylformamide (1.5 mL), the flask was covered with aluminum foil and the solution 
was heated to 50 °C. After 16 h, heating was ceased and the solution was diluted with water (10 mL) 
and ethyl acetate (10 mL). The layers were separated and the aqueous layer was extracted with 
ethyl acetate (3×10 mL). The combined organic layers were washed with saturated aqueous sodium 
chloride solution (10 mL), the washed solution was dried over sodium sulfate and the dried solution 
was filtered. The filtrate was concentrated and the crude product was purified by flash column 
chromatography on silica gel (15% ethyl acetate in hexanes) to afford 183 (46.7 mg, 50%) as a 
colorless oil. 
 
TLC (20% ethyl acetate in hexanes): Rf = 0.32 (UV, CAM). 
 
1H NMR (599 MHz, CDCl3) δ 7.81–7.74 (m, 2H), 7.16–7.13 (m, 2H), 6.97–6.93 (m, 1H), 6.90 (dd, 
J = 8.3, 6.7 Hz, 2H), 6.78–6.73 (m, 2H), 6.21 (dd, J = 6.3, 1.8 Hz, 1H), 5.46–5.39 (m, 1H), 5.14 
(dd, J = 6.3, 3.1 Hz, 1H), 4.84 (s, 1H), 4.81–4.75 (m, 2H), 4.71 (d, J = 11.5 Hz, 1H), 4.36 (d, J = 
11.4 Hz, 1H), 4.00 (s, 2H), 3.40 (dd, J = 13.6, 3.9 Hz, 1H), 3.29 (s, 3H), 2.87 (d, J = 8.8 Hz, 1H), 
2.82 (dd, J = 13.7, 8.6 Hz, 1H), 2.52 (t, J = 6.3 Hz, 1H), 2.18–2.07 (m, 2H), 2.05–1.92 (m, J = 6.9 
Hz, 2H), 1.59 (d, J = 1.3 Hz, 3H), 1.01 (d, J = 0.6 Hz, 9H), 0.12–0.07 (m, 6H). 13C NMR (151 
MHz, CDCl3) δ 159.9, 147.0, 141.1, 140.9, 135.3, 133.1, 129.8, 129.7, 129.1, 128.4, 124.3, 114.1, 
112.1, 103.2, 99.7, 70.2, 68.9, 59.3, 54.8, 47.9, 35.6, 30.7, 26.2, 26.0, 18.6, 13.7, -5.0. 
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HR-MS (ESI): calcd for (C34H52O6NSSi)+ (M+NH4)+: 630.3285, found: 630.3270. 
 
IR (Diamond-ATR, neat) ṽmax: 2928, 2856, 1651, 1614, 1514, 1463, 1447, 1305, 1250, 1149, 1106, 
1036 cm-1. 
 
[𝜶]589
20  = +16.3 (c = 0.8 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
Chloride 184. Triethylamine trihydrofluoride (50 µL, 0.31 mmol, 7.0 equiv) was added to a 
solution of sulfone 183 (27 mg, 44 µmol, 1 equiv) in tetrahydrofuran (0.45 mL) at 25 °C. After 
16 h, the solution was carefully diluted with saturated aqueous sodium bicarbonate solution 
(10 mL) and ethyl acetate (10 mL). The layers were separated and the aqueous layer was extracted 
with ethyl acetate (3×10 mL). The combined organic layers were washed with saturated aqueous 
sodium chloride solution (10 mL) and the washed solution was dried over sodium sulfate. The dried 
solution was filtered and the filtrate was concentrated. The crude product S5 was used without 
further purification for the next step. 
 Triethylamine (20 µL, 0.14 mmol, 3.2 equiv) was added to a solution of the crude allylic 
alcohol S5 (assumed: 22 mg, 44 µmol, 1 equiv) in dichloromethane (0.3 mL) and the solution was 
cooled to ‒40 °C. Methanesulfonyl chloride (8.9 µL, 0.11 µmol, 2.6 equiv) was added dropwise. 
After 1 h 45 min, the solution was transferred to a flask containing anhydrous lithium chloride 
(11 mg, 0.26 mmol, 6.00 equiv) in tetrahydrofuran (0.3 mL) at 23 °C. Tetrahydrofuran (2×0.2 mL) 
was used to assure complete transfer.  After 1 h 30 min, aqueous pH 7 buffer solution (10 mL) and 
diethyl ether (10 mL) were added. The layers were separated and the aqueous layer was extracted 
with diethyl ether (3×20 mL). The combined organic layers were washed with saturated aqueous 
sodium chloride solution (10 mL), the washed solution was dried over sodium sulfate and the dried 
solution was filtered. The filtrate was concentrated and the crude product was used purified by flash 
column chromatography on silica gel (20% ethyl acetate in hexanes) to afford 184 (15.8 mg, 69%) 
as a slightly yellow oil. 
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1H NMR (599 MHz, C6D6) δ 7.78–7.74 (m, 2H), 7.14 (d, J = 8.5 Hz, 3H), 6.97–6.91 (m, 1H), 6.88 
(ddd, J = 8.2, 6.6, 1.2 Hz, 2H), 6.77–6.73 (m, 2H), 6.21 (dt, J = 6.3, 1.5 Hz, 1H), 5.21–5.15 (m, 
1H), 5.11 (ddd, J = 6.3, 3.2, 1.1 Hz, 1H), 4.79–4.75 (m, 3H), 4.71 (d, J = 11.5 Hz, 1H), 4.36 (d, J 
= 11.5 Hz, 1H), 3.69 (s, 2H), 3.37 (ddd, J = 13.9, 4.4, 0.9 Hz, 1H), 3.28 (s, 2H), 2.92–2.85 (m, 1H), 
2.78 (ddd, J = 13.9, 8.4, 0.9 Hz, 1H), 2.51 (t, J = 6.4 Hz, 1H), 1.98–1.92 (m, 2H), 1.89–1.78 (m, 
2H), 1.55–1.52 (m, 3H). 13C NMR (151 MHz, C6D6) δ 159.9, 146.6, 141.1, 141.0, 133.1, 132.3, 
130.1, 129.8, 129.2, 128.0, 114.1, 112.3, 103.1, 99.4, 70.2, 59.3, 54.8, 52.2, 47.9, 34.7, 30.5, 26.2, 
14.2.  
 
HR-MS (ESI): calcd for (C28H37ClO5NS)+ (M+NH4)+: 534.2081, found: 534.2072. 
 
IR (Diamond-ATR, neat) ṽmax: 2921, 1650, 1613, 1514, 1447, 1304, 1249, 1149, 1034 cm-1. 
 
[𝜶]589
20  = +19.6 (c = 0.8 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
Bromide 134. Triethylamine trihydrofluoride (50 µL, 0.31 mmol, 7.0 equiv) was added to a 
solution of sulfone 183 (26.7 mg, 43.6 µmol, 1 equiv) in tetrahydrofuran (0.45 mL) at 25 °C. After 
16 h, the solution was carefully diluted with saturated aqueous sodium bicarbonate solution 
(10 mL) and ethyl acetate (10 mL). The layers were separated and the aqueous layer was extracted 
with ethyl acetate (3×10 mL). The combined organic layers were washed with saturated aqueous 
sodium chloride solution (10 mL) and the washed solution was dried over sodium sulfate. The dried 
solution was filtered and the filtrate was concentrated. The crude product S5 was used without 
further purification for the next step. 
 Triethylamine (18 µL, 0.13 mmol, 3.0 equiv) was added to a solution of the crude allylic 
alcohol S5 (assumed: 21.7 mg, 43.6 µmol, 1 equiv) in dichloromethane (0.3 mL) and the solution 
was cooled to ‒40 °C. Methanesulfonyl chloride (6.8 µL, 87 µmol, 2.0 equiv) was added dropwise. 
After 1 h 45 min, the solution was transferred to a flask containing anhydrous lithium bromide 
(38 mg, 0.44 mmol, 10 equiv) in tetrahydrofuran (0.3 mL) at 23 °C. Tetrahydrofuran (2×0.2 mL) 
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was used to assure complete transfer. After 45 min, aqueous pH 7 buffer solution (10 mL) and 
diethyl ether (10 mL) were added. The layers were separated and the aqueous layer was extracted 
with diethyl ether (3×20 mL). The combined organic layers were washed with saturated aqueous 
sodium chloride solution (10 mL), the washed solution was dried over sodium sulfate and the dried 
solution was filtered. The filtrate was concentrated and the crude product was used purified by flash 
column chromatography on silica gel (25% ethyl acetate in hexanes) to afford 134 (18.5 mg, 76%) 
as a slightly yellow oil. 
 
TLC (25% ethyl acetate in hexanes): Rf = 0.29 (UV, CAM). 
 
1H NMR (599 MHz, CDCl3) δ 7.88–7.83 (m, 2H), 7.67–7.63 (m, 1H), 7.58–7.52 (m, 2H), 7.20 (d, 
J = 8.5 Hz, 2H), 6.88–6.83 (m, 2H), 6.28 (dd, J = 6.3, 1.9 Hz, 1H), 5.45 (t, J = 7.0 Hz, 1H), 4.97 
(dd, J = 6.3, 3.3 Hz, 1H), 4.85 (s, 1H), 4.82–4.79 (m, 2H), 4.74 (d, J = 11.6 Hz, 1H), 4.48 (d, J = 
11.6 Hz, 1H), 3.93 (s, 2H), 3.81 (s, 3H), 3.41 (dd, J = 14.2, 4.3 Hz, 1H), 3.03 (dd, J = 14.1, 8.6 Hz, 
1H), 2.73–2.67 (m, 1H), 2.39 (t, J = 6.1 Hz, 1H), 2.16–2.04 (m, 2H), 1.93–1.88 (m, 2H), 1.73–1.71 
(m, 3H). 13C NMR (151 MHz, CDCl3) δ 159.5, 146.0, 141.0, 139.7, 133.8, 132.6, 130.6, 129.7, 
129.4, 129.3, 128.1, 113.9, 112.5, 102.6, 98.8, 70.0, 59.4, 55.4, 47.8, 41.6, 34.3, 30.1, 26.3, 14.9. 
 
HR-MS (ESI): calcd for (C28H37O5NBrS)+ (M+NH4)+: 578.1576, found: 578.1569. 
 
IR (Diamond-ATR, neat) ṽmax: 3066, 2921, 1650, 1613, 1586, 1514, 1447, 1304, 1248, 1149, 1136, 
1033 cm-1. 
 
[𝜶]589
20  = +16.6 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
Bicycle 185. A solution of bromide 134 (28 mg, 50 μmol, 1 equiv) in tetrahydrofuran (1 mL) was 
added dropwise via syringe pump (addition rate: 1.1 mL/h) to a solution of sodium 
bis(trimethylsilylamide) (1.0 M in tetrahydrofuran, 0.2 mL, 0.2 mmol, 4 equiv) in tetrahydrofuran 
(4 mL) at 0 °C. Upon completion of the addition, stirring at 0 °C was continued for 15 min. 
Saturated aqueous sodium bicarbonate solution (10 mL) and ethyl acetate (10 mL) were added. The 
layers were separated and the aqueous layer was extracted with ethyl acetate (3×10 mL). The 
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combined organic layers were washed with saturated aqueous sodium chloride solution (10 mL), 
the washed solution was dried over sodium sulfate and the dried solution was filtered. The filtrate 
was concentrated. The crude product was purified by flash column chromatography on silica gel 
(20% ethyl acetate in hexanes) to afford 185 (16 mg, 67%) as a colorless oil. 
 
TLC (25% ethyl acetate in hexanes): Rf = 0.29 (UV, CAM). 
 
1H NMR (400 MHz, CDCl3) δ 7.72 (d, 3J = 7.6 Hz, 2H, Ph), 7.53 (t, 3J = 7.3 Hz, 1H, Ph), 7.34 (t, 
3J = 7.7 Hz, 2H, Ph), 7.27 (d, 3J = 9.0 Hz, 2H, PMB), 6.93 (d, 3J = 8.5 Hz, 2H, PMB), 6.01 (dd, 
3J1/2 = 6.7 Hz,  4J1/3 = 2.2 Hz, 1H, H-1), 5.54 (t, 3J8/9 = 7.7 Hz, 1H, H-8), 5.23 (t, 3J2/1 = 5.7 Hz, 1H, 
H-2), 4.97 (s, 1H, H-12a), 4.88 (s, 1H, H-12b), 4.68 (s, 1H, H-14), 4.46 (d, 2JHa/Hb = 11.8 Hz, 1H, 
PMB), 4.24 (d, 2JHb/Ha = 11.8 Hz, 1H, PMB), 3.84 (s, 3H, PMB), 3.81–3.73 (m, 1H, H-4), 2.62–
2.38 (m, 4H, H-5, H-3, H-9a), 2.30–2.21 (m, 1H, H-10a), 2.20–2.09 (m, 2H, H-9b, H-10b), 1.90 (s, 
1H, H-13), 1.68 (s, 3H, H-7). 13C NMR (101 MHz, CDCl3) δ 159.3 (PMB), 149.7 (C-11), 141.1 
(Ph), 139.0 (C-1), 133.0 (Ph), 131.5 (C-6), 130.0 (PMB), 129.0 (PMB), 128.7 (Ph), 128.4 (C-8), 
128.0 (Ph), 113.9 (C-12, PMB), 113.9 (C-12, PMB), 103.0 (C-2), 96.1 (C-14), 68.7 (PMB), 63.3 
(C-4), 55.5 (PMB), 48.3 (C-13), 39.8 (C-5), 36.8 (C-3), 35.7 (C-10), 25.5 (C-9), 17.6 (C-7). 
 
HR-MS (ESI): calcd for (C28H36O5NS)+ (M+NH4)+: 498.2314, found: 498.2309. 
 
IR (Diamond-ATR, neat) ṽmax: 3070, 2932, 2863, 2360, 1661, 1613, 1514, 1445, 1302, 1244, 1143, 
1104, 1057, 1034 cm-1. 
 
[𝜶]589
20  = +67.6 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
Sulfide 205. Potassium carbonate (10.4 mg, 75.3 µmol, 1.25 equiv) was added to a solution of 
2-mercapto pyrimidine (7.6 mg, 66 µmol, 1.1 equiv) in dimethylformamide (0.3 mL) at 25 °C. 
After 15 min, a solution of iodide 178 (45 mg, 60 µmol, 1 equiv) in dimethylformamide (0.4 mL) 
was added dropwise. After 18 h, water (10 mL) and ethyl acetate (10 mL) were added. The layers 
were separated and the aqueous layer was extracted with ethyl acetate (3×10 mL). The combined 
organic layers were washed with saturated aqueous sodium chloride solution (10 mL), the washed 
Experimental Section for Part I 
212 
 
solution was dried over sodium sulfate and the dried solution was filtered. The filtrate was 
concentrated. The crude product was purified by flash column chromatography on silica gel (10% 
ethyl acetate in hexanes) to afford 205 (34 mg, 77%) as a colorless oil. 
 
TLC (10% ethyl acetate in hexane): Rf = 0.42 (UV, CAM). 
 
1H NMR (400 MHz, CDCl3) δ 8.51 (d, J = 4.8 Hz, 2H), 7.26–7.20 (m, 2H), 6.96 (t, J = 4.8 Hz, 
1H), 6.92–6.86 (m, 2H), 6.72 (d, J = 1.2 Hz, 1H), 5.24 (tq, J = 7.0, 1.4 Hz, 1H), 5.03 (d, J = 1.7 
Hz, 1H), 4.98 (s, 1H), 4.88 (s, 1H), 4.74 (d, J = 11.6 Hz, 1H), 4.51 (d, J = 11.6 Hz, 1H), 3.94 (s, 
2H), 3.86–3.78 (m, 4H), 3.34 (dd, J = 13.9, 9.9 Hz, 1H), 3.02–2.93 (m, 2H), 2.15–2.06 (m, 2H), 
2.01–1.91 (m, 2H), 1.51 (s, 3H), 0.89 (s, 9H), 0.03 (s, 6H). 13C NMR (101 MHz, CDCl3) δ 171.6, 
159.5, 157.5, 146.3, 137.1, 136.4, 135.1, 129.5, 129.0, 123.6, 116.9, 114.1, 112.0, 98.4, 70.3, 68.7, 
55.4, 44.7, 38.0, 35.7, 31.9, 26.1, 25.8, 18.6, 13.6, −5.1; (signals for CF3 group not visible). 19F 
NMR (377 MHz, CDCl3) δ −73.36. 
 
HR-MS (ESI): calcd for (C33H46O7N2F3S2Si)+ (M+H)+: 731.2468, found: 731.2451. 
 
IR (Diamond-ATR, neat) ṽmax: 2930, 2856, 1614, 1565, 1549, 1515, 1421, 1382, 1248, 1208, 1174, 
1141, 1111, 1066, 1037 cm-1. 
 
[𝜶]589
20  = +103.0 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
 
 
Sulfone 206. Hydrogen peroxide (30 wt% in water, 16 µL, 0.15 mmol, 8.00 equiv) was added 
dropwise to a solution of sulfide 206 (14 mg, 19 µmol, 1 equiv) and ammonium molybdate 
tetrahydrate (3.6 mg, 2.9 µmol, 0.15 equiv) in ethanol (0.7 mL) at 0 °C. Upon completion of the 
addition, the solution was allowed to warm to 25 °C. After 4 days, the solution was diluted with 
saturated aqueous sodium bicarbonate solution (10 mL) and ethyl acetate (10 mL). The layers were 
separated and the aqueous layer was extracted with ethyl acetate (3×10 mL). The combined organic 
layers were washed with brine (10 mL) and aqueous sodium thiosulfate solution (0.1 M, 10 mL). 
The washed solution was dried over sodium sulfate and the dried solution was filtered. The filtrate 
was concentrated and crude 206 (13.8 mg, 94%) was used as received. 
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TLC (30% ethyl acetate in hexanes): Rf = 0.44 (UV, CAM). 
 
1H NMR (599 MHz, CDCl3) δ 8.94 (d, J = 4.9 Hz, 2H), 7.55 (t, J = 4.9 Hz, 1H), 7.26–7.23 (m, 
2H), 6.92–6.87 (m, 2H), 6.70 (d, J = 1.1 Hz, 1H), 5.33–5.29 (m, 1H), 5.05 (d, J = 1.3 Hz, 1H), 5.02 
(s, 1H), 4.90 (s, 1H), 4.71 (d, J = 11.6 Hz, 1H), 4.53 (d, J = 11.6 Hz, 1H), 4.23–4.10 (m, 2H), 3.96 
(s, 2H), 3.82 (s, 3H), 3.40 (s, 1H), 3.18 (d, J = 9.6 Hz, 1H), 2.20–2.00 (m, 4H), 1.55 (s, 3H), 0.89 
(s, 9H), 0.04 (s, 6H). 13C NMR (151 MHz, CDCl3) δ 165.69, 159.66, 158.98, 145.77, 137.45, 
137.44, 135.04, 134.13, 129.68, 128.52, 124.01, 123.74, 118.6 (q, J = 321.5 Hz), 114.16, 112.20, 
97.59, 70.30, 68.72, 55.43, 50.06, 44.65, 35.60, 33.83, 26.11, 26.09, 25.83, 18.57, 13.60, −5.12. 19F 
NMR (377 MHz, CDCl3) δ −72.86. 
 
HR-MS (ESI): calcd for (C33H49O9N3F3S2Si)+ (M+NH4)+: 780.2632, found: 780.2627. 
 
IR (Diamond-ATR, neat) ṽmax: 2954, 2930, 2857, 1566, 1515, 1421, 1387, 1330, 1248, 1212, 1174, 
1140, 1128, 1068 cm-1. 
 
[𝜶]589
20  = +61.4 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
 
Model substrate synthesis for the introduction of the side chain: 
 
 
 
Triflate 207. Sodium bicarbonate (897 mg, 10.7 mmol, 5.00 equiv) and palladium on activated 
charcoal (10 wt%, 227 mg, 0.210 mmol, 0.100 equiv) were added to a solution of enone rac-20 
(500 mg, 2.13 mmol, 1 equiv) in tetrahydrofuran (21 mL) at 25 °C. The suspension was purged 
with hydrogen gas (1 atm) through a stainless steel needle for 1 min. Stirring of the suspension was 
then continued under a hydrogen atmosphere (1 atm, balloon) at 25 °C. After 1.5 h, hydrogen gas 
was released from the flask, the suspension was purged with argon and the mixture was filtered 
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through a short pad of celite. The filter cake was rinsed with diethyl ether (100 mL). The filtrate 
was concentrated to afford a yellow oil, which was used without further purification for the next 
step. 
 A solution of lithium bis(trimethylsilyl)amide (1 M in tetrahydrofuran, 3.25 mL, 
3.25 mmol, 1.20 equiv) was added dropwise to a solution of the crude ketone (640 mg, 2.71 mmol, 
1 equiv) in tetrahydrofuran (27 mL) at –78 °C. After 45 min, a solution of 
N-phenylbis(trifluoromethansulfonimide) (1.36 g, 3.79 mmol, 1.40 equiv) in tetrahydrofuran 
(5 mL) was added dropwise. The solution was then allowed to warm to 25 °C over 1.5 h. After 
30 min at 25 °C, saturated aqueous sodium bicarbonate solution (10 mL) was added, followed by 
ethyl acetate (10 mL). The layers were separated and the aqueous layer was extracted with ethyl 
acetate (3×25 mL). The combined organic layers were washed with saturated aqueous sodium 
chloride (10 mL), the washed solution was dried over sodium sulfate and the dried solution was 
filtered. The filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (5% to 10% ethyl acetate in hexanes) to afford vinyl triflate 207 
(601 mg, 60%) as a colorless oil. 
 
Alkene 208. Formic acid (0.31 mL, 8.2 mmol, 5.0 equiv) was added dropwise to a solution of 
triflate 207 (601 mg, 1.63 mmol, 1 equiv), triethylamine (1.70 mL, 12.2 mmol, 7.50 equiv) and 
bis(triphenylphosphine)palladium(II) chloride (115 mg, 0.160 mmol, 0.100 equiv) in 
dimethylformamide (16 mL) at 0 °C. After 5 min, the solution was heated to 70 °C. When the 
solution turned dark brown (approximately after 15 min), heating was ceased and the solution was 
cooled to 25 °C. The solution was diluted with water (25 mL) and ethyl acetate (25 mL). The layers 
were separated and the aqueous layer was extracted with ethyl acetate (3×25 mL). The combined 
organic layers were washed with saturated aqueous sodium chloride solution (30 mL), the washed 
solution was dried over sodium sulfate and the dried solution was filtered. The filtrate was 
concentrated. The crude product was purified by flash column chromatography on silica gel (20% 
ethyl acetate in hexanes) to afford 208 (254 mg, 71%) as a yellow oil. 
 
1H NMR (599 MHz, CDCl3) δ 7.31–7.28 (m, 2H), 6.91–6.86 (m, 2H), 5.76–5.69 (m, 2H), 4.91 (t, 
J = 3.8 Hz, 1H), 4.77 (d, J = 12.0 Hz, 1H), 4.53 (d, J = 11.7 Hz, 1H), 4.33–4.25 (m, 1H), 4.16–4.09 
(m, 1H), 3.80 (s, 3H), 2.41–2.33 (m, 1H), 2.18–2.11 (m, 1H). 13C NMR (151 MHz, CDCl3) δ 159.4, 
130.1, 129.8, 125.4, 121.8, 114.0, 95.4, 69.0, 61.0, 55.4, 30.4. 
 
HR-MS (EI): calcd for (C13H16O3)+: 220.1099, found: 220.1093. 
 
IR (Diamond-ATR, neat) ṽmax: 3040, 2935, 2839, 1613, 1514, 1431, 1380, 1247, 1209, 1181, 1144, 
1110, 1029 cm-1. 
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Enol ether 209. To a solution of alkene 208 (250 mg, 1.13 mmol, 1 equiv) in ethanol (14 mL) were 
added tris(triphenylphosphine)rhodium(I) chloride (52.5 mg, 56.7 µmol, 0.050 equiv) and 
1,8-diazabicyclo[5.4.0]-7-undecene (0.51 mL, 3.40 mmol, 3.00 equiv). The solution was heated to 
80 °C. After 20 h, heating was ceased and the solution was concentrated. The crude product was 
purified by flash column chromatography (20% ethyl acetate in hexanes) to afford 209 (166 mg, 
66%) as a colorless oil. 
 
1H NMR (599 MHz, CDCl3) δ 7.31–7.27 (m, 2H), 6.92–6.85 (m, 2H), 6.29–6.25 (m, 1H), 5.07–
5.03 (m, 1H), 4.81–4.76 (m, 2H), 4.55 (d, J = 11.7 Hz, 1H), 3.81 (s, 3H), 2.23–2.13 (m, 1H), 1.97–
1.79 (m, 3H). 13C NMR (151 MHz, CDCl3) δ 159.3, 140.6, 130.1, 129.6, 113.9, 101.9, 95.7, 69.2, 
55.4, 26.8, 16.3. 
 
HR-MS (EI): calcd for (C13H16O3)+: 220.1099, found: 220.1097. 
 
 
 
Aldehyde 219. Lithium chloride (5.6 mg, 0.13 mmol, 2.0 equiv) was placed in a Schlenk flask and 
the flask was heated with a heat gun while being evacuated. The flask was then allowed to cool to 
25 °C and was purged with argon. This procedure was repeated two times. 
Tetrakis(triphenylphosphine)palladium (7.6 mg, 6.7 µmol, 0.1 equiv) was added, followed by a 
solution of triflate 169 (50 mg, 67 µmol, 1 equiv) in 1,4-dioxane (0.6 mL). 
Tributylstannylmethanol (64 mg, 0.20 mmol, 3.0 equiv) was then added and the mixture was 
heated to 62 °C. After 2 h, heating was ceased and the solution was cooled to 25 °C. The mixture 
was concentrated. The crude product was purified by flash column chromatography on silica gel 
(5% to 10% to 20% ethyl acetate in hexanes) to afford allylic alcohol 218 (19.2 mg, 47%) as a 
colorless oil, which contained minor tin impurities. 
 4-Methylmorpholine (3.9 mg, 33 µmol, 1.1 equiv) was added to a Schlenk flask containing 
activated molecular sieves (4 Å, 30 mg) and dichloromethane (0.5 mL) was added. After 10 min, 
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tetrapropylammonium perruthenate (2.1 mg, 6.1 µmol, 0.20 equiv) was added, followed by a 
solution of allylic alcohol 218 (19.2 mg, 30.3 µmol, 1 equiv) in dichloromethane (0.3 mL). After 
2 h, tetrapropylammonium perruthenate (2.1 mg, 6.1 µmol, 0.20 equiv) was added. After a total of 
3 h, the black suspension was filtered through a short plug of celite, covered with silica gel. The 
filter cake was rinsed with dichloromethane (10 mL). The filtrate was concentrated. The crude 
product was purified by flash column chromatography on silica gel (10% ethylacetate in hexanes) 
to afford 219 (10.3 mg, 54%) as a colorless oil. 
 
TLC (10% ethyl acetate in hexanes): Rf = 0.36 (UV, CAM). 
 
1H NMR (400 MHz, CD2Cl2) δ 9.26 (s, 1H), 7.27–7.21 (m, 3H), 6.90–6.83 (m, 2H), 5.36–5.33 (m, 
1H), 5.20 (dd, J = 2.7, 1.0 Hz, 1H), 4.85–4.83 (m, 1H), 4.81–4.75 (m, 2H), 4.54 (d, J = 11.3 Hz, 
1H), 3.97 (d, J = 1.3 Hz, 2H), 3.83–3.76 (m, 4H), 3.70 (dd, J = 9.1, 4.2 Hz, 1H), 2.99 (t, J = 2.8 
Hz, 1H), 2.67–2.58 (m, 1H), 2.23–2.00 (m, 4H), 1.57 (s, 3H), 0.93–0.87 (m, 18H), 0.53 (q, J = 7.8 
Hz, 6H), 0.04 (s, 6H). 13C NMR (101 MHz, CD2Cl2) δ 190.9, 162.9, 160.0, 148.4, 135.5, 130.1, 
129.6, 124.1, 119.7, 114.2, 111.0, 102.0, 71.1, 68.9, 61.6, 55.7, 40.2, 36.3, 36.1, 26.3, 26.2, 18.8, 
13.8, 7.1, 4.9, −5.1. 
 
HR-MS (ESI): calcd for (C35H59O6Si2)+ (M+H)+: 631.3850, found: 631.3842. 
 
IR (Diamond-ATR, neat) ṽmax: 2954, 2933, 2878, 2857, 1677, 1636, 1515, 1463, 1251, 1176, 
1091 cm-1. 
 
[𝜶]589
20  = +121.4 (c = 1.0 ∙ 10 g ∙  𝑚𝐿-1, CH2Cl2). 
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9.3 1H and 13C NMR Spectra 
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9.4 Single Crystal X-ray Analysis 
The data collections were performed either on an Oxford Diffraction Xcalibur diffractometer, on a 
Bruker D8Quest diffractometer or on a Bruker D8Venture at 100 K or at 173 K using MoKα‐
radiation (λ = 0.71073 Å, graphite monochromator). The CrysAlisPro software (version 
1.171.33.41) was applied for the integration, scaling and multi‐scan absorption correction of the 
data. The structures were solved by direct methods with SIR97163 and refined by least‐squares 
methods against F2 with SHELXL‐97.164 All non‐hydrogen atoms were refined anisotropically. 
The hydrogen atoms were placed in ideal geometry riding on their parent atoms. Further details are 
summarized in the tables at the different sections. 
Lactol 76. 
Table 22. Crystallographic data for lactol 76. 
net formula C22H40O5Si2 
Mr/g mol−1 440.72 
crystal size/mm 0.100 × 0.080 × 0.070 
T/K 100(2) 
radiation MoKα 
diffractometer 'Bruker D8Venture' 
crystal system triclinic 
space group 'P -1' 
a/Å 7.1851(4) 
b/Å 13.9847(7) 
c/Å 25.4831(14) 
α/° 92.4216(16) 
β/° 89.9812(18) 
γ/° 105.0653(17) 
V/Å3 2470.2(2) 
Z 4 
calc. density/g cm−3 1.185 
μ/mm−1 0.172 
absorption correction multi-scan 
transmission factor range 0.8209–0.9582 
refls. measured 25444 
Rint 0.0444 
mean σ(I)/I 0.0539 
θ range 2.400–25.41 
observed refls. 7262 
x, y (weighting scheme) 0.0632, 1.2490 
hydrogen refinement mixed 
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refls in refinement 9097 
parameters 542 
restraints 1 
R(Fobs) 0.0482 
Rw(F2) 0.1275 
S 1.029 
shift/errormax 0.001 
max electron density/e Å−3 0.564 
min electron density/e Å−3 −0.377 
 
 
Figure 12. Molecular structure of lactol 76. Ellipsoids are drawn at 50% probability level. 
 
Aldehyde 111. 
Table 23. Crystallographic data for aldehyde 111. 
net formula C32H50O8Si 
Mr/g mol−1 590.81 
crystal size/mm 0.100 × 0.080 × 0.040 
T/K 100.(2) 
radiation MoKα 
diffractometer 'Bruker D8 Venture TXS' 
crystal system triclinic 
space group 'P -1' 
a/Å 8.2999(2) 
Experimental Section for Part I 
320 
 
b/Å 9.1317(2) 
c/Å 21.9845(5) 
α/° 79.5184(7) 
β/° 86.2304(7) 
γ/° 77.7532(7) 
V/Å3 1600.52(6) 
Z 2 
calc. density/g cm−3 1.226 
μ/mm−1 0.121 
absorption correction Multi-Scan 
transmission factor range 0.9066–0.9420 
refls. measured 41425 
Rint 0.0259 
mean σ(I)/I 0.0235 
θ range 3.184–30.508 
observed refls. 8581 
x, y (weighting scheme) 0.0443, 0.6035 
hydrogen refinement constr 
refls in refinement 9740 
parameters 379 
restraints 1 
R(Fobs) 0.0344 
Rw(F2) 0.0959 
S 1.040 
shift/errormax 0.001 
max electron density/e Å−3 0.445 
min electron density/e Å−3 −0.266 
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Figure 13. Molecular structure of aldehyde 111. Ellipsoids are drawn at 50% probability level. 
 
Enone 112. 
Table 24. Crystallographic data for enone 112. 
net formula C32H48O7Si 
Mr/g mol−1 572.79 
crystal size/mm 0.080 × 0.050 × 0.030 
T/K 100.(2) 
radiation MoKα 
diffractometer 'Bruker D8 Venture TXS' 
crystal system triclinic 
space group 'P -1' 
a/Å 8.4856(6) 
b/Å 13.1092(10) 
c/Å 27.727(2) 
α/° 90.520(3) 
β/° 90.331(3) 
γ/° 91.105(3) 
V/Å3 3083.6(4) 
Z 4 
calc. density/g cm−3 1.234 
μ/mm−1 0.121 
absorption correction Multi-Scan 
transmission factor range 0.8637–0.9705 
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refls. measured 42452 
Rint 0.0555 
mean σ(I)/I 0.0704 
θ range 3.188–28.282 
observed refls. 12184 
x, y (weighting scheme) 0.0506, 10.3791 
hydrogen refinement constr 
refls in refinement 15254 
parameters 740 
restraints 0 
R(Fobs) 0.0806 
Rw(F2) 0.2024 
S 1.079 
shift/errormax 0.001 
max electron density/e Å−3 1.114 
min electron density/e Å−3 −0.636 
 
 
Figure 14. Molecular structure of enone 112. Ellipsoids are drawn at 50% probability level. 
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Tetracycle 116. 
Table 25. Crystallographic data for tetracycle 116. 
net formula C22H26O6 
Mr/g mol−1 386.43 
crystal size/mm 0.090 × 0.070 × 0.060 
T/K 100.(2) 
radiation MoKα 
diffractometer 'Bruker D8 Venture TXS' 
crystal system monoclinic 
space group 'P 1 21/c 1' 
a/Å 17.8424(7) 
b/Å 12.7737(5) 
c/Å 8.4584(3) 
α/° 90 
β/° 100.3920(10) 
γ/° 90 
V/Å3 1896.16(12) 
Z 4 
calc. density/g cm−3 1.354 
μ/mm−1 0.098 
absorption correction Multi-Scan 
transmission factor range 0.9080–0.9705 
refls. measured 24636 
Rint 0.0360 
mean σ(I)/I 0.0231 
θ range 3.190–26.372 
observed refls. 3354 
x, y (weighting scheme) 0.0321, 1.4007 
hydrogen refinement constr 
refls in refinement 3868 
parameters 255 
restraints 0 
R(Fobs) 0.0377 
Rw(F2) 0.0945 
S 1.055 
shift/errormax 0.001 
max electron density/e Å−3 0.286 
min electron density/e Å−3 −0.253 
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Figure 15. Molecular structure of tetracycle 116. Ellipsoids are drawn at 50% probability level. 
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I. X-Ray Crystallographic Data 
 
CCDC 1547827 contains the supplementary crystallographic data for tetrahydrocarbazolone 33. 
These data can be obtained free of charge from The Cambridge Crystallographic Data Centre 
(CCDC) via www.ccdc.cam.ac.uk/data_request/cif. 
 
Table S1. Crystallographic data for tetrahydrocarbazolone 33. 
net formula C29H29NO5 
Mr/g mol−1 471.53 
crystal size/mm 0.100×0.050×0.030 
T/K 100(2) 
radiation Mo Kα 
diffractometer 'Bruker D8 Venture TXS' 
crystal system monoclinic 
space group 'P 1 21/c 1' 
a/Å 10.5106(2) 
b/Å 4.96800(10) 
c/Å 44.4015(9) 
α/° 90 
β/° 91.3250(10) 
γ/° 90 
V/Å3 2317.88(8) 
Z 4 
calc. density/g cm−3 1.351 
μ/mm−1 0.092 
absorption correction Multi-Scan 
transmission factor range 0.9211–0.9705 
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refls. measured 22871 
Rint 0.0297 
mean σ(I)/I 0.0256 
θ range 3.331–26.372 
observed refls. 4074 
x, y (weighting scheme) 0.0343, 1.5990 
hydrogen refinement constr 
refls in refinement 4723 
parameters 319 
restraints 0 
R(Fobs) 0.0395 
Rw(F2) 0.0946 
S 1.038 
shift/errormax 0.001 
max electron density/e Å−3 0.263 
min electron density/e Å−3 −0.209 
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Figure S1. Molecular structure of tetrahydrocarbazolone 33. Displacement ellipsoids are drawn at the 50% 
probability level. 
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II. Experimental Procedures 
 
 
Scheme S1. Synthesis of N-benzyltetrahydrocarbazolone S1. 
 
N-Benzyltetrahydrocarbazolone S1. To a solution of tetrahydrocarbazolone rac-13 (90 mg, 
0.25 mmol, 1 equiv) in N,N-dimethylformamide (1.2 mL) was added sodium hydride (15 mg, 
0.37 mmol, 1.5 equiv, 60% dispersion in mineral oil) at 0 °C. After 30 min, benzyl bromide (51 mg, 
0.30 mmol, 1.5 equiv) was added and the solution was allowed to warm to 23 °C. After 2 h, the 
solution was diluted with saturated aqueous ammonium chloride solution (10 mL) and ethyl acetate 
(10 mL). The layers were separated and the aqueous layer was extracted with ethyl acetate 
(3×10 mL). The combined organic layers were washed with saturated aqueous sodium chloride 
solution (10 mL) and the washed solution was dried over sodium sulfate. The dried solution was 
filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (50% ethyl acetate in hexanes) to afford S1 as a white foam (100 mg, 
89%). TLC (50% ethyl acetate in hexanes): Rf = 0.22 (UV, KMnO4). 1H NMR (400 MHz, CD2Cl2) δ 
7.70 (s, 1H), 7.36–7.20 (m, 8H), 7.02–6.93 (m, 2H), 6.65 (s, 1H), 5.49 (d, J = 17.0 Hz, 1H), 5.29 (d, 
J = 17.1 Hz, 1H), 4.48–4.38 (m, 2H), 3.89 (s, 3H), 3.73 (s, 4H), 3.72–3.68 (m, 1H), 3.61 (dd, J = 
9.3, 6.4 Hz, 1H), 3.41–3.30 (m, 1H), 2.66 (ddd, J = 18.3, 13.6, 5.4 Hz, 1H), 2.45–2.20 (m, 3H). 13C 
NMR (100 MHz, CD2Cl2) δ 193.9, 150.8, 148.1, 147.7, 138.6, 137.2, 131.9, 129.4, 128.9, 128.2, 
128.1, 126.5, 118.2, 113.2, 103.7, 94.7, 73.7, 71.5, 56.7, 56.6, 47.9, 34.5, 33.5, 27.0. IR (Diamond-
ATR, neat) ṽmax: 2935, 1728, 1640, 1584, 1526, 1494, 1481, 1450, 1359, 1333, 1308, 1269, 1207, 
1194, 1157, 1104, 1071 cm−1. HR-MS (ESI): calcd for (C29H30O4N)+ (M+H)+: 456.2175, found: 
456.2164. 
 
 
Scheme S2. Synthesis of elimination product S2. 
 
Elimination Product S2. To a solution N-benzyltetrahydrocarbazolone S1 (17.5 mg, 38.4 µmol, 
1 equiv) in tetrahydrofuran (0.3 mL) and tert-butanol (30 µL) was added potassium tert-butoxide 
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(15.1 mg, 0.134 mmol, 3.50 equiv) at 0 °C and the solution was allowed to warm to 23 °C. After 1 
h, the solution was diluted with saturated aqueous ammonium chloride solution (5 mL) and ethyl 
acetate (5 mL). The layers were separated and the aqueous layer was extracted with ethyl acetate 
(3×5 mL). The combined organic layers were washed with saturated aqueous sodium chloride 
solution (10 mL) and the washed solution was dried over sodium sulfate. The dried solution was 
filtered and the filtrate was concentrated. The crude product was purified by flash column 
chromatography on silica gel (50% ethyl acetate in hexanes) to afford S2 as a brown solid (8.5 mg, 
64%). 1H NMR (400 MHz, CDCl3) δ 7.84 (s, 1H), 7.39–7.29 (m, 3H), 7.13–7.07 (m, 2H), 6.64 (s, 
1H), 5.51 (s, 2H), 5.34 (s, 1H), 5.13 (s, 1H), 4.00 (s, 3H), 3.82 (s, 3H), 2.86 (t, J = 6.4 Hz, 2H), 2.73 
(t, J = 6.5 Hz, 2H).13C NMR (100 MHz, CDCl3) δ 194.5, 148.8, 147.6, 145.1, 136.5, 135.1, 133.6, 
129.3, 127.9, 125.8, 117.5, 114.3, 113.1, 103.4, 93.3, 56.5, 56.3, 48.7, 39.4, 35.5. IR (Diamond-
ATR, neat) ṽmax: 2945, 1646, 1559, 1497, 1480, 1448, 1360, 1270, 1194, 1141, 1095, 1027 cm−1. 
HR-MS (ESI): calcd for (C22H22O3N)+: 348.1600, found: 348.1591. 
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III. 1H NMR and 13C NMR spectra 
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Figure S2. Key 1H-1H COSY and HMBC correlations of 46. 
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